<result><Target><Item><Target_ID> 1</Target_ID>
<Target_Name>Anti-Ogawa O-antigen monoclonal antibody S-20-4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:9954938, GI:9954939</Target_Sequence>
<Synonyms>Mab S-20-4</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1F4W, 1F4X, 1F4Y</Target_Structure>
<Comments>S-20-4 mAb is an IgG1 specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1. Among solved structures, 1F4W contains the unliganded Fab fragment; 1F4X is the Fab fragment complexed with MGS; 1F4Y is the Fab fragment complexed with MGU.</Comments>
</Item><Item><Target_ID> 2</Target_ID>
<Target_Name>Anti-IA-2 monoclonal antibody 96/3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>H Chain : QVQLQESGPGLVKPSETLSLRCNVSGVSISGFYWGWIRQPPGKGLEWIGHIFSSGSTDYSPSLKSRVDVSMDTSKNHFSLKLSSVTAADTAVYYCARVLKGVATASFDFWGRGTLVTVSS
L Chain: SYVLTQPPSVSVAPGKTATITCGADNIGTKSVHWYQQRPGQAPMLVIYYNKNRPSGIPERFSGSNSGHTATLTISRVEAGDEAAYYCQVWDTRSDLVVFGGGTKLTVLG</Target_Sequence>
<Synonyms>Mab 96/3</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>B lymphocytes from 11 insulin-dependant diabetes mellitus (IDDM) patients exhibiting high anti-IA-2 Ab levels in their sera were subjected to EBV immortalization. Cell line 96/3 from patient 9 (2 years duration of IDDM) is the only cell line showed long term stability for 12 month and could be used as constant source of anti-IA-2 Ab with a production rate of 5-8 mg/million cells in 24 h. Anti-IA-2 monoclonal antibody 96/3 belongs to IgG1 subclass and λ type. And it also revealed high affinity to recombinant IA-2ic (KD=0.13 nM) by the BIAcore method. The nucleotide sequences of hAb96/3 were determined by cloning of the VL and VH DNA fragments as scFv Abs. The  amino acid sequences were then derived. However, the sequences were not included in the GenBank.</Comments>
</Item><Item><Target_ID> 3</Target_ID>
<Target_Name>Anti-AMA1 monoclonal antibody 4G2dc1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 4G2dc1</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rat monoclonal antibody 4G2dc1 recognizes correctly folded AMA1 and blocks merozoite invasion of erythrocytes.</Comments>
</Item><Item><Target_ID> 4</Target_ID>
<Target_Name>C-C chemokine receptor type 5, CCR5</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P51681</Target_Sequence>
<Synonyms>CCR-5, CC-CKR-5, C-C CKR-5
HIV-1 fusion coreceptor
CHEMR13
CD_antigen=CD195</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2L87, 2RLL, 2RRS, 4MBS</Target_Structure>
<Comments>CCR5 is a member of the beta chemokine receptors family of integral membrane proteins. In Humans, the CCR5 gene location is on the short (p) arm at position 21 on chromosome 3. Certain populations have inherited the Delta 32 mutation resulting in the genetic deletion of a portion of the CCR5 gene. Homozygous carriers of this mutation are resistant to M-tropic strains of HIV-1 infection. There are several theoretical structure models of CCR5 in the PDB database, i.e. 1ND8, 1NE0, 1OPN, 1OPT and 1OPW.</Comments>
</Item><Item><Target_ID> 5</Target_ID>
<Target_Name>Interleukin-6 receptor subunit alpha</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P08887</Target_Sequence>
<Synonyms>IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA
IL-6R 1
Membrane glycoprotein 80, gp80
CD_antigen=CD126</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1N26, 1P9M, 2ARW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 6</Target_ID>
<Target_Name>EWS-Fli1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q16198</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 7</Target_ID>
<Target_Name>Anti-CD20 monoclonal antibody rituximab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:146387640, GI:146387641</Target_Sequence>
<Synonyms>IDEC-C2B8
Rituxan
MabThera</Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>2OSL</Target_Structure>
<Comments>Rituximab is a chimeric IgG1κ antibody against CD20. It was initially developed by IDEC Pharmaceuticals under the name IDEC-C2B8. It was approved by the U.S. Food and Drug Administration in 1997 to treat B-cell non-Hodgkin lymphomas resistant to other chemotherapy regimens. Now it is used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders.</Comments>
</Item><Item><Target_ID> 8</Target_ID>
<Target_Name>Anti-CD25 monoclonal antibody basiliximab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:284793973, GI:284793974, GI:284793975, GI:284793976, GI:284793977, GI:284793978</Target_Sequence>
<Synonyms>Simulect</Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>3IU3</Target_Structure>
<Comments>Basiliximab (trade name Simulect) is a chimeric (murine/human) monoclonal antibody (IgG1κ) against CD25. It was approved by the Food and Drug Administration in 1998 and used to prevent rejection in organ transplantation, especially in kidney transplants.</Comments>
</Item><Item><Target_ID> 9</Target_ID>
<Target_Name>Baculoviral IAP repeat-containing protein 4</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P98170</Target_Sequence>
<Synonyms>E3 ubiquitin-protein ligase XIAP
Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3
X-linked inhibitor of apoptosis protein, X-linked IAP
IAP-like protein, ILP, hILP
EC=6.3.2.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1C9Q, 1F9X, 1G3F, 1G73, 1I3O, 1I4O, 1I51, 1KMC, 1NW9, 1TFQ, 1TFT, 2ECG, 2JK7, 2KNA, 2OPY, 2OPZ, 2POI, 2POP, 2QRA, 2VSL, 3CLX, 3CM2, 3CM7, 3EYL, 3G76, 3HL5</Target_Structure>
<Comments>XIAP functions as a caspase inhibitor and is a member of the inhibitors of apoptosis (IAP) family of proteins.</Comments>
</Item><Item><Target_ID> 10</Target_ID>
<Target_Name>Anti-glycoprotein E2 monoclonal antibody AP33</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:406855809, GI:4068558010, GI:4068558011, GI:4068558012, GI:4068558013, GI:4068558014</Target_Sequence>
<Synonyms>Mab AP33</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>4G6A</Target_Structure>
<Comments>Monoclonal antibody AP33 (MAb AP33) was generated by the following procedure. BALB/c mice were immunized subcutaneously with 20 μg of a recombinant form of mammalian cell-expressed HCV strain Gla E1E2 emulsified in Freund\'s complete adjuvant. After 4 weeks, the animals were boosted with E1E2 emulsified in Freund\'s incomplete adjuvant. Mice were further boosted twice at 2-week intervals. Eight days following the last injection, the sera from tail bleeds were tested for E1E2-specific antibodies. Three weeks following the last boost, the animals were given a final intraperitoneal injection of 100 μg of purified recombinant E1E2. Spleen cells from immunized animals were removed 5 days postinjection and fused with Sp2/0-Ag 14 myeloma cells (ratio, 10:1) by using 50% polyethylene glycol 1500 in DMEM. Cells were then resuspended in HAT medium (EFC10 supplemented with histone acetyltransferase) and 20% conditioned medium (i.e., clarified EFC10 that had previously been used to grow Sp2/0 cells), plated out into 96-well microtiter plates, placed in a CO2 humidified incubator at 37°C, and left for 12 to 14 days. Medium from wells containing colonies was removed and screened by ELISA for E1E2-specific MAbs. Cells from positive wells were removed and propagated. The epitopes recognized by MAb AP33 epitope was mapped to LINTNGSWHIN (412-423) using overlapping peptides. This epitope is highly conserved across all the major genotypes and that MAb AP33 is capable of broad neutralization was demostrated with the retroviral pseudoparticles (HCVpp) assay.</Comments>
</Item><Item><Target_ID> 11</Target_ID>
<Target_Name>Anti-glycoprotein E2 monoclonal antibody 3/11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 3/11</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 3/11 was generated from rats after immunization with either baculovirus-expressed E1-E2 complexes or mammalian (human embryonal kidney) cell-expressed E2661 glycoprotein. MAb 3/11 and MAb AP33 recognize distinct yet overlapping epitopes. MAb 3/11 is capable of neutralizing HCVpp carrying strain H77 E1E2.</Comments>
</Item><Item><Target_ID> 12</Target_ID>
<Target_Name>Protein-glutamine gamma-glutamyltransferase 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P21980</Target_Sequence>
<Synonyms>Tissue transglutaminase
Transglutaminase C, TGase C, TG(C), TGC
Transglutaminase-2, TGase-2
Transglutaminase H, TGase H
EC=2.3.2.13
</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KV3, 2Q3Z, 3LY6, 3S3J, 3S3P, 3S3S</Target_Structure>
<Comments>Protein-glutamine gamma-glutamyl transferase 2 catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Reduced TGM2 activity might contribute to disorders of glucose metabolism such as diabetes.</Comments>
</Item><Item><Target_ID> 13</Target_ID>
<Target_Name>Coagulation factor XIII A chain</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00488</Target_Sequence>
<Synonyms>Coagulation factor XIIIa
Protein-glutamine gamma-glutamyltransferase A chain
Transglutaminase A chain
EC=2.3.2.13</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1EVU, 1EX0, 1F13, 1FIE, 1GGT, 1GGU, 1GGY, 1QRK</Target_Structure>
<Comments>Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.</Comments>
</Item><Item><Target_ID> 14</Target_ID>
<Target_Name>Anti-AMA1 monoclonal antibody 45B1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 45B1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal antibody 45B1 was produced from mice immunized with the purified P. yoelii yoelii AMA-1 (PyAMA-1). It belongs to the subclass IgG2a. The results of a passive immunization experiment showed that 45B1 protected mice from challenge infection of P. yoelii yoelii YM, with low parasitemias and 100% survival.</Comments>
</Item><Item><Target_ID> 15</Target_ID>
<Target_Name>Anti-P235 rhoptry protein monoclonal antibody 25.77</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 25.77</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Spleen cells from two P. yoelii-immune BALB/c mice were fused with P3-NS1/1-Ag4-1 myeloma cells in the presence of polyethylene glycol. The cells were dispensed into 144 tissue culture wells in 2-ml volumes of hypoxanthine-aminopterine-thymidine-selective  mediums,  using  RPMI-1640  medium supplemented with 10% fetal calf serum as a base. After 10 days, the culture supernatants were tested for P. yoelii-specific antibody by indirect immunofluorescence (IIF). Of 143 cultures tested, 38 were positive, 20 producing antibody apparently directed against the infected erythrocyte membrane and 18 producing antibody against the parasite itself. From the initial screening, five distinct IIF specificities were detected. Cultures representative of each of the IIF specificities were expanded in selective medium without aminopterine, and hybridoma lines were subsequently cloned in semi-solid agar overlayed with medium. Hybridoma 25.77 was one of them. Monoclonal antibody 25.77 belongs to the subclass IgG2a. It was found that 25.77 bound to antigens only present in merozoites, free and within mature schizonts. Later, it was known that this antibody was specific for the P. yoelii yoelii 235-kDa rhoptry protein family. Passive immunization with MAb 25.77 suppressed blood-stage parasitemia and restricted the parasites to reticulocytes.</Comments>
</Item><Item><Target_ID> 16</Target_ID>
<Target_Name>Anti-ochratoxin A monoclonal antibody 10G7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 10G7</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-ochratoxin A monoclonal antibody 10G7 is an IgG2a, produced from hybridoma based on BALB/c mice immunized with ochratoxin A-KLH conjugates.</Comments>
</Item><Item><Target_ID> 17</Target_ID>
<Target_Name>Vibrio cholerae El Tor Typing Phage VP1</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Vibrio phage VP1</Synonyms>
<Target_Source>Unclassified phages&gt;Vibrio phage VP1:12333</Target_Source>
<Target_Structure></Target_Structure>
<Comments>VP1 phage was used as one of the typing phages in a phage-biotyping scheme that has been used for nearly 40 years in China for the typing of O1 El Tor strains. Based on the lytic patterns of the five typing phages, El Tor strains can be clustered into 32 phage types.</Comments>
</Item><Item><Target_ID> 18</Target_ID>
<Target_Name>Tumor necrosis factor ligand superfamily member 13B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9Y275</Target_Sequence>
<Synonyms>TNF- and APOL-related leukocyte expressed ligand 1, TALL-1
B lymphocyte stimulator, BLyS
B-cell-activating factor
BAFF
Dendritic cell-derived TNF-like molecule
CD_antigen=CD257</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KXG, 1JH5, 1KD7, 1OQD, 1OQE, 1OSG, 1OTZ, 3V56</Target_Structure>
<Comments>Tumor necrosis factor ligand superfamily member 13B has two isoforms, i.e. membrane form and soluble form. It abundantly expressed in B cell lineage cells, peripheral blood leukocytes, monocytes and macrophages. This cytokine binds to TNFRSF13B/TACI, TNFRSF17/BCMA and TNFRSF13C/BAFFR, involving in the stimulation of B- and T-cell function and the regulation of humoral immunity.</Comments>
</Item><Item><Target_ID> 19</Target_ID>
<Target_Name>Acetylcholinesterase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P22303</Target_Sequence>
<Synonyms>AChE
EC=3.1.1.7</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1B41, 1F8U, 1VZJ, 2X8B, 3LII, 4EY4, 4EY5, 4EY6, 4EY7, 4EY8</Target_Structure>
<Comments>Acetylcholinesterase, is an enzyme that degrades the neurotransmitter acetylcholine, producing choline and an acetate group. It is mainly found at neuromuscular junctions and cholinergic nervous system, where its activity serves to terminate synaptic transmission. AChE has a very high catalytic activity - each molecule of AChE degrades about 25000 molecules of acetylcholine per second. Acetylcholinesterase is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen.</Comments>
</Item><Item><Target_ID> 20</Target_ID>
<Target_Name>Anti-aflatoxin B1 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The isotype of this monoclonal antibody is IgG.</Comments>
</Item><Item><Target_ID> 21</Target_ID>
<Target_Name>Avian infectious bronchitis virus (strain M41)</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence>GI: 112949615</Target_Sequence>
<Synonyms>IBV</Synonyms>
<Target_Source>Avian infectious bronchitis virus (IBV):11120</Target_Source>
<Target_Structure>3LD1</Target_Structure>
<Comments>Avian infectious bronchitis virus is a coronavirus with a non-segmented, positive-sense single-stranded RNA genome. It infects the respiratory tract, gut, kidney and reproductive systems of chickens.</Comments>
</Item><Item><Target_ID> 22</Target_ID>
<Target_Name>Anti-arginine kinase monoclonal antibody 38G6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>MAb 38G6</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma 38G6 was established through a fusion of immune splenocytes of a BALB/c mouse immunized with crude cockroach (CR) extract and mouse myeloma cells. It secreted IgG1 monoclonal immunoglobulins. The monoclonal antibody was used in a capture ELISA to detect specific IgE in serum samples of allergic Thai patients. It was found that 72% of the patients had IgE antibodies to the epitope of MAb 38G6 indicating that it was against major CR allergens among the CR allergic Thai patients.</Comments>
</Item><Item><Target_ID> 23</Target_ID>
<Target_Name>Anti-cholera toxin peptide 3 (CTP3) monoclonal antibody TE33</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:494639, GI:494640</Target_Sequence>
<Synonyms>Mab TE33</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1TET, 1ZEA</Target_Structure>
<Comments>Mab TE33 is an affinity matured murine IgG1 monoclonal antibody raised against cholera toxin peptide 3.</Comments>
</Item><Item><Target_ID> 24</Target_ID>
<Target_Name>Shrimp white spot syndrome virus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence>GI:17158105</Target_Sequence>
<Synonyms>Prawn white spot bacilliform virus
White spot syndrome virus of shrimp
White Spot Bacilliform Virus
white spot syndrome virus
white spot syndrome virus of penaeid shrimp
white spot syndrome baculovirus
WSSV</Synonyms>
<Target_Source>White spot syndrome virus (WSSV) (White spot bacilliform virus):92652</Target_Source>
<Target_Structure>2ZUG, 2ED6, 2EDM, 2GJ2, 2GJI</Target_Structure>
<Comments>WSSV is a rod-shaped double-stranded DNA virus, and the size of the enveloped viral particles have been reported to be 240-380 nm long and 70-159 nm dia and nucleocapsid core is 120-205 nm long and 95-165 nm dia. The virus has an outer lipid bilayer membrane envelope, sometimes with a tail like appendage at one end of the virion. Transmission of the virus is mainly through oral ingestion and water borne routes in farms (horizontal transmission) and vertical transmission (from infected mother prawns) in case of shrimp hatcheries. The virus is present in the wild stocks of shrimp, especially in the coastal waters adjacent to shrimp farming regions in Asian countries, but mass mortalities of wild shrimps are yet to be observed.</Comments>
</Item><Item><Target_ID> 25</Target_ID>
<Target_Name>Osteosarcoma cell line OS-732</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The OS-732 tumor cell line was derived from a biopsy obtained before x-ray or Chemotherapy from an osteosarcorna of the distal right femur of a 13-year-old Caucasian girl (M.T.). Despite amputation and treatment with radiation therapy and chemotherapy, she died approximately 3 months later with extensive pulmonary metastases. Autopsy was not performed. OS-732 cells grew to high population density in liquid medium and formed colonies in agar medium. The cell line consisted of polygonal or fusiform cells resembling the cells of the original tumor. No collagen fibers or calcium apatite microcrystals could be demonstrated in the cultured cells by electron microscopy nor were virus particles detected. Isoenzyme studies of the cell line revealed the “B” band of glucose-6-phosphate dehydrogenase. Chromosome studies of the cell line revealed a range of stem line number from 58 to 65; chromosome counts ranged from 47 to 183. Some cells had marker chromosome of varied morphology and some had minute chromosomes. Chromosome breaks were found in 30.5% of the cells (PMID: 5100401).</Comments>
</Item><Item><Target_ID> 26</Target_ID>
<Target_Name>Virion infectivity factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P12504</Target_Sequence>
<Synonyms>Vif
SOR protein</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 (isolate NY5 group M subtype B) (HIV-1):11698</Target_Source>
<Target_Structure>3DCG</Target_Structure>
<Comments>Vif forms a complex with host APOBEC3F and APOBEC3G and directs them for proteasomal degradation. APOBEC3F and APOBEC3G are cytidine deaminases that can disrupts viral nucleic acids. Thus, Vif is very important for viral replication.</Comments>
</Item><Item><Target_ID> 27</Target_ID>
<Target_Name>Anti-ViCPS monoclonal antibody ATVi</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab ATVi</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The MAb ATVi was produced against Vi polysaccharide antigen of Salmonella typhi. It was found to be highly specific to Vi possessing bacteria (PMID: 8216560).</Comments>
</Item><Item><Target_ID> 28</Target_ID>
<Target_Name>Polyclonal antibody PTS</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Polyclonal antibody PTS were from pooled sera of 10 typhoid patients. These patients was confirmed typhoid fever by high antibody titers (&gt;1:640) for one or both O and H antigens, as determined by Widal test.</Comments>
</Item><Item><Target_ID> 29</Target_ID>
<Target_Name>Anti-IL-4 monoclonal antibody 11B.11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:50812705, GI:50812707</Target_Sequence>
<Synonyms>Mab 11B.11
Mab 11B11</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mab 11B11 is a rat anti-mouse interleukin-4 monoclonal antibody of IgG1 isotype. The immunogen used to generate the 11B11 hybridoma was partially purified mouse IL-4 from PMA-stimulated EL-4 supernatant. Mab 11B11 binds with high affinity to and neutralizes both natural and recombinant mouse IL-4. It was found that administration of 11B11, like soluble IL-4R, similarly inhibited IgE production in response to anti-IgD.</Comments>
</Item><Item><Target_ID> 30</Target_ID>
<Target_Name>Plasminogen activator inhibitor 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05121</Target_Sequence>
<Synonyms>PAI, PAI-1
Endothelial plasminogen activator inhibitor
Serpin E1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A7C, 1B3K, 1C5G, 1DB2, 1DVM, 1DVN, 1LJ5, 1OC0, 3CVM, 3EOX, 3PB1, 3Q02, 3Q03, 3R4L, 3UT3, 4AQH, 9PAI</Target_Structure>
<Comments>Plasminogen activator inhibitor 1 acts as trap for tissue plasminogen activator (TPA), urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.</Comments>
</Item><Item><Target_ID> 31</Target_ID>
<Target_Name>Kallikrein-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P20151</Target_Sequence>
<Synonyms>Tissue kallikrein-2
Glandular kallikrein-1, hGK-1
EC=3.4.21.35</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Kallikrein-2 cleaves Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. It has 3 isoforms produced by alternative splicing.</Comments>
</Item><Item><Target_ID> 32</Target_ID>
<Target_Name>Listeria monocytogenes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence>GI:47097775 (serotype 1/2a str. F6854)
GI:47094674 (serotype 4b str. H7858)
GI:83316099 (serotype 4b str. F2365)
GI:16802048 (EGD-e)</Target_Sequence>
<Synonyms>L. monocytogenes</Synonyms>
<Target_Source>Listeria monocytogenes:1639</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Listeria monocytogenes is a facultative anaerobe, which lives in the cell. It is one of the most virulent foodborne pathogens, causing listeriosis.</Comments>
</Item><Item><Target_ID> 33</Target_ID>
<Target_Name>Prostate-specific antigen</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P07288</Target_Sequence>
<Synonyms>PSA
Gamma-seminoprotein
Seminin
Kallikrein-3
P-30 antigen
Semenogelase
EC=3.4.21.77</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2ZCH, 2ZCK, 2ZCL, 3QUM</Target_Structure>
<Comments>PSA is a serine protease (-Tyr-|-Xaa-) produced almost exclusively by the prostate gland. It hydrolyze semenogelin-1, leading to the liquefaction of the seminal coagulum, which allows sperm to swim freely. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer and in other prostate disorders.</Comments>
</Item><Item><Target_ID> 34</Target_ID>
<Target_Name>Macrophage receptor MARCO</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q60754</Target_Sequence>
<Synonyms>Macrophage receptor with collagenous structure</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>2OY3, 2OYA</Target_Structure>
<Comments>MARCO is a pattern recognition receptor containing a collagen-like domain and a scavenger receptor cysteine-rich (SRCR) domain. As a member of the class A scavenger receptor family, MARCO may bind both Gram-negative and Gram-positive bacteria via its intracellular, C-terminal SRCR domain.</Comments>
</Item><Item><Target_ID> 35</Target_ID>
<Target_Name>Heat shock cognate 71 kDa protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P19120</Target_Sequence>
<Synonyms>Heat shock 70 kDa protein 8
HSPA8, HSC70, HSP73
</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1ATR, 1ATS, 1BA0, 1BA1, 1BUP, 1HPM, 1HX1, 1KAX, 1KAY, 1KAZ, 1NGA, 1NGB, 1NGC, 1NGD, 1NGE, 1NGF, 1NGG, 1NGH, 1NGI, 1NGJ, 1Q2G, 1QQM, 1QQN, 1QQO, 1YUW, 2BUP, 2QW9, 2QWL, 2QWM, 2QWN, 2QWO, 2QWP, 2QWQ, 2QWR, 3C7N, 3HSC</Target_Structure>
<Comments>Heat shock cognate 71 kDa protein is constitutively expressed. It binds to nascent polypeptides to facilitate correct protein folding. It also functions as an ATPase in the disassembly of clathrin-coated vesicles during transport of membrane components through the cell.</Comments>
</Item><Item><Target_ID> 36</Target_ID>
<Target_Name>Cetuximab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:66361252, GI:66361253</Target_Sequence>
<Synonyms>IMC-C225
Erbitux</Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1YY8, 1YY9</Target_Structure>
<Comments>Cetuximab is a chimeric (mouse/human) IgG1κ antibody against epidermal growth factor receptor (EGFR). As an EGFR inhibitor, it was given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer.</Comments>
</Item><Item><Target_ID> 37</Target_ID>
<Target_Name>Trastuzumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:28948772 , GI:28948773</Target_Sequence>
<Synonyms>Herceptin, rhuMab4D5</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1N8Z, 3D6G</Target_Structure>
<Comments>Trastuzumab is a humanized IgG1κ antibody from its original version mumAb4D5, a mouse monoclonal antibody. The mumAb4D5 was generated against a HER2 over-expressing NIH 3T3 cell line. The recombinant humanized version of mumAb4D5 is also known as rhuMab4D5 and Herceptin (trade name).</Comments>
</Item><Item><Target_ID> 38</Target_ID>
<Target_Name>Anti-omp40 monoclonal antibody Pg-ompA1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 39</Target_ID>
<Target_Name>Anti-vWF monoclonal antibody 82D6A3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:83753978, GI:83753979</Target_Sequence>
<Synonyms>Mab 82D6A3</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>2ADF</Target_Structure>
<Comments>The mouse monoclonal antibody 82D6A3 is an IgG2aκ raised against human von Willebrand factor (vWF). It binds with high affinity to the VWF A3-domain and inhibits VWF binding to collagen types I, III and IV, but has no effect on vWF binding to collagen VI. Interestingly, its antithrombotic effect is not associated with significantly increased bleeding times, even at high doses.</Comments>
</Item><Item><Target_ID> 40</Target_ID>
<Target_Name>Anti-coagulation factor VIII monoclonal antibody BO2C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:15825659 , GI:15825660</Target_Sequence>
<Synonyms>Mab BO2C11,  MoAb BO2C11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1IQD</Target_Structure>
<Comments>The anti-coagulation factor VIII monoclonal antibody BO2C11 is a human IgG4k antibody produced by a cell line derived from the memory B-cell repertoire of a hemophilia A patient with inhibitor. BO2C11 recognizes the C2 domain of factor VIII and inhibits its binding to both von Willebrand factor (vWF) and phospholipids. It completely inhibits the procoagulant activity of native and activated factor VIII.</Comments>
</Item><Item><Target_ID> 41</Target_ID>
<Target_Name>Anti-spike glycoprotein monoclonal antibody 80R</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:116667257, GI:116667259</Target_Sequence>
<Synonyms>Mab 80R</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2GHW</Target_Structure>
<Comments>The monoclonal antibody 80R is a human IgG1κ selected from an nonimmune phage antibody library with recombinant S1 domain of spike protein of the SARS-CoV as antigen. It efficiently neutralizs SARS-CoV and inhibited syncytia formation between cells expressing the S protein and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2).</Comments>
</Item><Item><Target_ID> 42</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody b12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:126031291, GI:126031292 </Target_Sequence>
<Synonyms>Mab b12</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HZH, 2NY7</Target_Structure>
<Comments>The b12 was a human monoclonal IgG1 selected with recombinant gp120 from a phage Fab library that was constructed using bone marrow cDNA of an HIV-1-infected individual. The ability of b12 to neutralize laboratory-adapted HIV-1, primary HIV-1 isolates, and interfere both with the binding of gpl20 to CD4 and the interaction of gpl20 to CCR5 has been reported.</Comments>
</Item><Item><Target_ID> 43</Target_ID>
<Target_Name>Cytochrome b-245</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Cytochrome b-245 light chain: P13498, Cytochrome b-245 heavy chain: P04839</Target_Sequence>
<Synonyms>Cytochrome b-245 light chain alternative name(s):
p22 phagocyte B-cytochrome
Neutrophil cytochrome b 22 kDa polypeptide
p22-phox, p22phox
Cytochrome b(558) alpha chain
Cytochrome b558 subunit alpha
Superoxide-generating NADPH oxidase light chain subunit

Cytochrome b-245 heavy chain alternative name(s):
p22 phagocyte B-cytochrome
Neutrophil cytochrome b 91 kDa polypeptide
Heme-binding membrane glycoprotein gp91phox
CGD91-phox
gp91-phox
gp91-1
Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta
Superoxide-generating NADPH oxidase heavy chain subunit
NADPH oxidase 2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Cytochrome b-245 light chain: 1WLP
Cytochrome b-245 heavy chain: 3A1F</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 44</Target_ID>
<Target_Name>Neutrophil cytosol factor 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P14598</Target_Sequence>
<Synonyms>NCF-1
Neutrophil NADPH oxidase factor 1
47 kDa neutrophil oxidase factor
p47-phox
NCF-47K
47 kDa autosomal chronic granulomatous disease protein
Nox-organizing protein 2
Nox organizer 2
SH3 and PX domain-containing protein 1A</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GD5, 1K4U, 1KQ6, 1NG2, 1O7K, 1OV3, 1UEC, 1W70, 1WLP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 45</Target_ID>
<Target_Name>Bacillus subtilis spores</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bacillus subtilis:1423</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 46</Target_ID>
<Target_Name>Tryptase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q02844</Target_Sequence>
<Synonyms>Mast cell protease 7, mMCP-7
Tryptase alpha/beta-1
EC=3.4.21.59</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 47</Target_ID>
<Target_Name>Cryptococcus neoformans melanin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Cryptococcus neoformans (Filobasidiella neoformans):5207</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 48</Target_ID>
<Target_Name>Growth factor receptor-bound protein 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P62993</Target_Sequence>
<Synonyms>Adapter protein GRB2
SH2/SH3 adapter GRB2
Protein Ash</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AZE, 1BM2, 1BMB, 1CJ1, 1FHS, 1FYR, 1GCQ, 1GFC, 1GFD, 1GHU, 1GRI, 1IO6, 1JYQ, 1JYR, 1JYU, 1QG1, 1TZE, 1X0N, 1ZFP, 2AOA, 2AOB, 2H46, 2H5K, 2HUW, 2VVK, 2VWF, 2W0Z, 3C7I, 3IMD, 3IMJ, 3IN7, 3IN8, 3KFJ, 3MXC, 3MXY, 3N7Y, 3N84, 3N8M, 3OV1, 3OVE, 3S8L, 3S8N, 3S8O</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 49</Target_ID>
<Target_Name>Urokinase-type plasminogen activator</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00749</Target_Sequence>
<Synonyms>U-plasminogen activator, uPA</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1C5W, 1C5X, 1C5Y, 1C5Z, 1EJN, 1F5K, 1F5L, 1F92, 1FV9, 1GI7, 1GI8, 1GI9, 1GJ7, 1GJ8, 1GJ9, 1GJA, 1GJB, 1GJC, 1GJD, 1KDU, 1LMW, 1O3P, 1O5A, 1O5B, 1O5C, 1OWD, 1OWE, 1OWH, 1OWI, 1OWJ, 1OWK, 1SC8, 1SQA, 1SQO, 1SQT, 1U6Q, 1URK, 1VJ9, 1VJA, 1W0Z, 1W10, 1W11, 1W12, 1W13, 1W14, 2FD6, 2I9A, 2I9B, 2NWN, 2O8T, 2O8U, 2O8W, 2R2W, 2VIN, 2VIO, 2VIP, 2VIQ, 2VIV, 2VIW, 2VNT, 3BT1, 3BT2, 3IG6, 3KGP, 3KHV, 3KID, 3M61, 3MHW, 3MWI, 3OX7, 3OY5, 3OY6, 3PB1, 3QN7, 3U73, 4DVA, 4DW2, 4FU7, 4FU8, 4FU9, 4FUB, 4FUC, 4FUD, 4FUE, 4FUF, 4FUG, 4FUH, 4FUI, 4FUJ, 4GLY</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 50</Target_ID>
<Target_Name>Melanocyte-stimulating hormone receptor, MSH-R</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q01726</Target_Sequence>
<Synonyms>Melanocortin receptor 1, MC1-R</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 51</Target_ID>
<Target_Name>Polymeric immunoglobulin receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P01833</Target_Sequence>
<Synonyms>Poly-Ig receptor, PIgR
Hepatocellular carcinoma-associated protein TB6</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1XED, 2OCW, 3CHN, 3CM9</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 52</Target_ID>
<Target_Name>Protein tonB</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02929</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1IHR, 1QXX, 1U07, 1XX3, 2GRX, 2GSK</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 53</Target_ID>
<Target_Name>Iron(3+)-hydroxamate-binding protein fhuD</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07822</Target_Sequence>
<Synonyms>Iron(III)-hydroxamate-binding protein fhuD
Ferrichrome-binding periplasmic protein
Ferric hydroxamate uptake protein D</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1EFD, 1ESZ, 1K2V, 1K7S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 54</Target_ID>
<Target_Name>Galectin-3, Gal-3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P17931</Target_Sequence>
<Synonyms>Galactose-specific lectin 3
Mac-2 antigen
IgE-binding protein
35 kDa lectin
Carbohydrate-binding protein 35, CBP 35
Laminin-binding protein
Lectin L-29
L-31
Galactoside-binding protein, GALBP</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A3K, 1KJL, 1KJR, 2NMN, 2NMO, 2NN8, 2XG3, 3AYA, 3AYC, 3AYD, 3AYE, 3T1L, 3T1M, 3ZSJ, 3ZSK, 3ZSL, 3ZSM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 55</Target_ID>
<Target_Name>Anti-CSFV monoclonal antibody 1B5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 56</Target_ID>
<Target_Name>Anti-CSFV monoclonal antibody b4-22</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 57</Target_ID>
<Target_Name>Anti-CSFV monoclonal antibody 24/16</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 58</Target_ID>
<Target_Name>Anti-HMW-MAA monoclonal antibody 225.28S</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 59</Target_ID>
<Target_Name>Anti-TRAP monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 60</Target_ID>
<Target_Name>Metallo-beta-lactamase L1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P52700</Target_Sequence>
<Synonyms>Beta-lactamase type II
Penicillinase
EC=3.5.2.6</Synonyms>
<Target_Source>Stenotrophomonas maltophilia (Pseudomonas maltophilia) (Xanthomonas maltophilia):40324</Target_Source>
<Target_Structure>1SML, 2AIO, 2FM6, 2FU6, 2FU7, 2FU8, 2FU9, 2GFJ, 2GFK, 2H6A, 2HB9, 2QDT, 2QIN, 2QJS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 61</Target_ID>
<Target_Name>SiHa cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The SiHa cell lines are derived from a HPV16 integrated human cervical carcinoma.</Comments>
</Item><Item><Target_ID> 62</Target_ID>
<Target_Name>Peptidyl-prolyl cis-trans isomerase A, PPIase A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P62937</Target_Sequence>
<Synonyms>Rotamase A
Cyclophilin A
Cyclosporin A-binding protein
EC=5.2.1.8</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AK4, 1AWQ, 1AWR, 1AWS, 1AWT, 1AWU, 1AWV, 1BCK, 1CWA, 1CWB, 1CWC, 1CWF, 1CWH, 1CWI, 1CWJ, 1CWK, 1CWL, 1CWM, 1CWO, 1FGL, 1M63, 1M9C, 1M9D, 1M9E, 1M9F, 1M9X, 1M9Y, 1MF8, 1MIK, 1NMK, 1OCA, 1RMH, 1VBS, 1VBT, 1W8L, 1W8M, 1W8V, 1YND, 1ZKF, 2ALF, 2CPL, 2CYH, 2RMA, 2RMB, 2X25, 2X2A, 2X2C, 2X2D, 2XGY, 3CYH, 3CYS, 3K0M, 3K0N, 3K0O, 3K0P, 3K0Q, 3K0R, 3ODI, 3ODL, 3RDD, 4CYH, 5CYH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 63</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody PSA-C1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PSA-C1 mab is obtained by immunization of mice with PSA-α2M complexes.</Comments>
</Item><Item><Target_ID> 64</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody PSA-C2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PSA-C2 mab is obtained by immunization of mice with PSA-α2M complexes.</Comments>
</Item><Item><Target_ID> 65</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody PSA-C4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PSA-C4 mab is obtained by immunization of mice with PSA-α2M complexes.</Comments>
</Item><Item><Target_ID> 66</Target_ID>
<Target_Name>DNA repair protein XRCC3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O43542</Target_Sequence>
<Synonyms>X-ray repair cross-complementing protein 3</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 67</Target_ID>
<Target_Name>Anti-gastric cancer monoclonal antibody MG7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 68</Target_ID>
<Target_Name>Epidermal growth factor receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P00533</Target_Sequence>
<Synonyms>Receptor tyrosine-protein kinase ErbB-1
Proto-oncogene c-ErbB-1
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1IVO, 1M14, 1M17, 1MOX, 1NQL, 1XKK, 1YY9, 1Z9I, 2EB2, 2EB3, 2GS2, 2GS6, 2GS7, 2ITN, 2ITO, 2ITP, 2ITQ, 2ITT, 2ITU, 2ITV, 2ITW, 2ITX, 2ITY, 2ITZ, 2J5E, 2J5F, 2J6M, 2JIT, 2JIU, 2JIV, 2KS1, 2M20, 2RF9, 2RFD, 2RFE, 2RGP, 3B2U, 3B2V, 3BEL, 3BUO, 3C09, 3G5V, 3G5Y, 3GOP, 3GT8, 3IKA, 3LZB, 3NJP, 3OB2, 3OP0, 3P0Y, 3PFV, 3POZ, 3QWQ, 3UG1, 3UG2, 3VJN, 3VJO, 3VRP, 3VRR, 3W2O, 3W2P, 3W2Q, 3W2R, 3W2S, 3W32, 3W33, 4G5J, 4G5P, 4HJO, 4I1Z, 4I20, 4I21, 4I22, 4I23, 4I24</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 69</Target_ID>
<Target_Name>Anti-HMW-MAA monoclonal antibody 763.74</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 70</Target_ID>
<Target_Name>Anti-HMW-MAA monoclonal antibody GH786</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 71</Target_ID>
<Target_Name>Protein P</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P17192</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Duck hepatitis B virus (isolate brown Shanghai duck S5) (DHBV):10439</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 72</Target_ID>
<Target_Name>Anti-type 8 PS monoclonal antibody NAD</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 73</Target_ID>
<Target_Name>Anti-NE2 monclonal antibody 8C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 74</Target_ID>
<Target_Name>Anti-NE2 monclonal antibody 8H3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 75</Target_ID>
<Target_Name>Anti-hantaan virus monoclonal antibody F3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 76</Target_ID>
<Target_Name>Anti-hantaan virus monoclonal antibody B11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 77</Target_ID>
<Target_Name>Anti-gibberellin monoclonal antibody 8E9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 78</Target_ID>
<Target_Name>Anti-SARS-CoV spike glycoprotein monoclonal antibody 2C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 79</Target_ID>
<Target_Name>Anti-IFN-alpha-2b polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 80</Target_ID>
<Target_Name>Glucokinase regulatory protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q07071</Target_Sequence>
<Synonyms>Glucokinase regulator</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 81</Target_ID>
<Target_Name>Human airway epithelial cell 1HAEo-cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 82</Target_ID>
<Target_Name>Anti-hTERT polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 83</Target_ID>
<Target_Name>Anti-CD47 monoclonal antibody C5D5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 84</Target_ID>
<Target_Name>CD8+ T cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A CD8+ T cell line was generated from immunomagnetic bead-purified CD8+ peripheral blood lymphocytes of a normal subject, by repeated stimulation with interleukin (IL)-2 and PHA in the presence of autologous, irradiated peripheral blood mononuclear cells (PBMC).</Comments>
</Item><Item><Target_ID> 85</Target_ID>
<Target_Name>Src SH3 domain of Proto-oncogene tyrosine-protein kinase Src</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P12931 [84-145]</Target_Sequence>
<Synonyms>Proto-oncogene tyrosine-protein kinase Src alternative name(s):
Proto-oncogene c-Src
pp60c-src, p60-Src
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A07, 1A08, 1A09, 1A1A, 1A1B, 1A1C, 1A1E, 1FMK, 1HCS, 1HCT, 1KSW, 1O41, 1O42, 1O43, 1O44, 1O45, 1O46, 1O47, 1O48, 1O49, 1O4A, 1O4B, 1O4C, 1O4D, 1O4E, 1O4F, 1O4G, 1O4H, 1O4I, 1O4J, 1O4K, 1O4L, 1O4M, 1O4N, 1O4O, 1O4P, 1O4Q, 1O4R, 1SHD, 1Y57, 1YI6, 1YOJ, 1YOL, 1YOM, 2BDF, 2BDJ, 2H8H, 2SRC, 3VRO, 4F59, 4F5A, 4F5B, 4HXJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 86</Target_ID>
<Target_Name>Fyn SH3 domain of tyrosine-protein kinase Fyn</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P06241 [82-143]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase Fyn alternative name(s):
Proto-oncogene c-Fyn
p59-Fyn
Proto-oncogene Syn
SLK
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A0N, 1AOT, 1AOU, 1AVZ, 1AZG, 1EFN, 1FYN, 1G83, 1M27, 1NYF, 1NYG, 1SHF, 1ZBJ, 2DQ7, 3H0F, 3H0H, 3H0I, 3UA6, 3UA7, 4D8D, 4EIK</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 87</Target_ID>
<Target_Name>Lyn SH3 domain of tyrosine-protein kinase Lyn</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P07948 [62-128]</Target_Sequence>
<Synonyms>EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1W1F, 1WA7, 3A4O</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 88</Target_ID>
<Target_Name>PI3K SH3 domain of PI3-kinase subunit p85-alpha</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P27986 [3-79]</Target_Sequence>
<Synonyms>PI3-kinase subunit p85-alpha alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit alpha
PtdIns-3-kinase regulatory subunit alpha
PI3-kinase regulatory subunit alpha
PI3K regulatory subunit alpha
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha
PtdIns-3-kinase regulatory subunit p85-alpha</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A0N, 1AZG, 1H9O, 1PBW, 1PHT, 1PIC, 1PKS, 1PKT, 2IUG, 2IUH, 2IUI, 2RD0, 2V1Y, 3HHM, 3HIZ, 3I5R, 3I5S, 4A55</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 89</Target_ID>
<Target_Name>Abl SH3 domain of tyrosine-protein kinase ABL1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00520 [61-121]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase ABL1 alternative name(s):
Abelson murine leukemia viral oncogene homolog 1
Proto-oncogene c-Abl
p150
EC=2.7.10.2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1ABO, 1ABQ, 1FPU, 1IEP, 1M52, 1OPJ, 1OPK, 2HZN, 2QOH, 2Z60, 3DK3, 3DK6, 3DK7, 3IK3, 3K5V, 3KF4, 3KFA, 3MS9, 3MSS, 3OXZ, 3OY3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 90</Target_ID>
<Target_Name>GYF domain of protein CD2BP2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O95400 [280-338]</Target_Sequence>
<Synonyms>Protein CD2BP2 alternative name(s):
CD2 antigen cytoplasmic tail-binding protein 2
CD2 cytoplasmic domain-binding protein 2
CD2 tail-binding protein 2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GYF, 1L2Z, 1SYX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 91</Target_ID>
<Target_Name>GYF domain of protein PERQ2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q6Y7W6 [533-581]</Target_Sequence>
<Synonyms>Protein PERQ2 alternative name(s):
PERQ amino acid-rich with GYF domain-containing protein 2
GRB10-interacting GYF protein 2
Trinucleotide repeat-containing gene 15 protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 92</Target_ID>
<Target_Name>GYF domain of protein SMY2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P32909 [205-261]</Target_Sequence>
<Synonyms>Protein SMY2 alternative name(s):
Suppressor of MYO2-66 protein</Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure>3FMA, 3K3V</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 93</Target_ID>
<Target_Name>GYF domain of protein SYH1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q02875 [149-205]</Target_Sequence>
<Synonyms>Protein SYH1 alternative name(s):
Uncharacterized protein YPL105C</Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 94</Target_ID>
<Target_Name>GYF domain of protein PR-SYH1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q02875 [140-205]</Target_Sequence>
<Synonyms>Protein SYH1 alternative name(s):
Uncharacterized protein YPL105C</Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 95</Target_ID>
<Target_Name>GYF domain of protein GYN4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9FMM3</Target_Sequence>
<Synonyms>Protein GYN4 alternative name(s):
Gb|AAC80623.1</Synonyms>
<Target_Source>Arabidopsis thaliana (Mouse-ear cress):3702</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 96</Target_ID>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Integrin alpha-5: P08648, Integrin beta-1: P05556</Target_Sequence>
<Synonyms>Integrin alpha-5 alternative name(s):
Fibronectin receptor subunit alpha
Integrin alpha-F
VLA-5
CD49 antigen-like family member E
CD_antigen=CD49e

Integrin beta-1 alternative name(s):
Fibronectin receptor subunit beta
VLA-4 subunit beta
CD_antigen=CD29</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-5: 3VI3, 3VI4                
Integrin beta-1: 3G9W, 3T9K, 3VI3, 3VI4, 4DX9
</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 97</Target_ID>
<Target_Name>Neutrophil cytosol factor 2, NCF-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P19878</Target_Sequence>
<Synonyms>Neutrophil NADPH oxidase factor 2
NADPH oxidase activator 2
67 kDa neutrophil oxidase factor
p67-phox</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E96, 1HH8, 1K4U, 1OEY, 1WM5, 2DMO</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 98</Target_ID>
<Target_Name>Anti-lactotransferrin monoclonal antibody mAbRWL1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monoclonal IgM antibody mAbRWL1 was produced from a cord blood B cell hybridoma and originally characterized as binding to a fraction of human lactoferrin. This mAb recognize a conformational epitope present in a CNBr digestion fraction of lactoferrin.</Comments>
</Item><Item><Target_ID> 99</Target_ID>
<Target_Name>Anti-lactotransferrin monoclonal antibody mAbRWL2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monoclonal IgM antibody mAbRWL2 was produced from a cord blood B cell hybridoma and originally characterized as binding to a fraction of human lactoferrin. This mAb recognize a conformational epitope present in a CNBr digestion fraction of lactoferrin.</Comments>
</Item><Item><Target_ID> 100</Target_ID>
<Target_Name>Human gastric cancer cells GC9811-P</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 101</Target_ID>
<Target_Name>Anti-parvalbumin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Parvalbumin-specific antibodies IgE were purified from serum samples of 16 fish-allergic patients.</Comments>
</Item><Item><Target_ID> 102</Target_ID>
<Target_Name>Anti-Nipah virus polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 103</Target_ID>
<Target_Name>Pancreatic triacylglycerol lipase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00591</Target_Sequence>
<Synonyms>Pancreatic lipase, PL
EC=3.1.1.21
EC=3.1.1.3</Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure>1ETH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 104</Target_ID>
<Target_Name>Anti-EcA polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 105</Target_ID>
<Target_Name>Anti-NPS polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>New Zealand rabbits were immunized with an NPS fraction of M. tuberculosis. After three immunizations, the hyperimmune antiserum mainly includes the antibodies reacting against non-protein components from the NPS fraction of M. tuberculosis.</Comments>
</Item><Item><Target_ID> 106</Target_ID>
<Target_Name>Langerhans cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 107</Target_ID>
<Target_Name>Anti-lycoprotein G monoclonal antibody MnAb1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 108</Target_ID>
<Target_Name>Anti-lycoprotein G monoclonal antibody MnAb2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 109</Target_ID>
<Target_Name>Anti-ACTH monoclonal antibody A2H8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 110</Target_ID>
<Target_Name>Anti-ACTH monoclonal antibody 57</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 111</Target_ID>
<Target_Name>Anti-ACTH monoclonal antibody FZ10-A32</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 112</Target_ID>
<Target_Name>Geminin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O75496</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1T6F, 1UII, 2LP0, 2WVR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 113</Target_ID>
<Target_Name>Anti-GPIIIa49-66 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 114</Target_ID>
<Target_Name>Vascular endothelial growth factor receptor 1, VEGFR-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P17948</Target_Sequence>
<Synonyms>Vascular permeability factor receptor
Tyrosine-protein kinase receptor FLT
Tyrosine-protein kinase FRT
Fms-like tyrosine kinase 1, FLT-1
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FLT, 1QSV, 1QSZ, 1QTY, 1RV6, 2XAC, 3HNG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 115</Target_ID>
<Target_Name>Bacillus anthracis Spore</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bacillus anthracis:1392</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 116</Target_ID>
<Target_Name>Lipopolysaccharide, LPS</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli:562</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 117</Target_ID>
<Target_Name>Cardiac glycoside digoxin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Cardiac glycoside digoxin is a kind of large rigid hydrophobic hapten without charged groups.</Comments>
</Item><Item><Target_ID> 118</Target_ID>
<Target_Name>16-acetylgitoxin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>16-acetylgitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</Comments>
</Item><Item><Target_ID> 119</Target_ID>
<Target_Name>Gitoxin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Gitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</Comments>
</Item><Item><Target_ID> 120</Target_ID>
<Target_Name>16-formylgitoxin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>16-formylgitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</Comments>
</Item><Item><Target_ID> 121</Target_ID>
<Target_Name>Furin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P23188</Target_Sequence>
<Synonyms>Paired basic amino acid residue-cleaving enzyme, PACE
Dibasic-processing enzyme
Prohormone convertase 3
EC=3.4.21.75</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1P8J</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 122</Target_ID>
<Target_Name>Fibronectin type-II 1 domain of MMP-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08253 [228-276]</Target_Sequence>
<Synonyms>MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 123</Target_ID>
<Target_Name>Fibronectin type-II 2 domain of MMP-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08253 [286-334]</Target_Sequence>
<Synonyms>MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 124</Target_ID>
<Target_Name>Fibronectin type-II 3 domain of MMP-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08253 [344-392]</Target_Sequence>
<Synonyms>MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 125</Target_ID>
<Target_Name>Fibronectin type-II 1-3 domain of MMP-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08253 [228-392]</Target_Sequence>
<Synonyms>MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 126</Target_ID>
<Target_Name>Anti-colicin-A monoalonal antibody 1C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 127</Target_ID>
<Target_Name>Integrin alpha-M, integrin </Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P11215</Target_Sequence>
<Synonyms>Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 128</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody 17b</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:12084266, GI:12084267</Target_Sequence>
<Synonyms>Mab 17b (1.7b, sCD4-17b, 1.7B)</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1G9M, 1G9N, 1GC1, 1RZ8, 1RZJ, 1RZK, 1YYL, 1YYM, 2I5Y, 2I60, 2NXY, 2NXZ, 2NY0, 2NY1, 2NY2, 2NY3, 2NY4, 2NY5, 2NY6</Target_Structure>
<Comments>The monoclonal antibody 17b is a human IgG1κ generated with an Epstein-Barr virus immortalized B-cell clone isolated from an HIV-1-infected individual by the laboratory of James Robinson (Tulaine University).</Comments>
</Item><Item><Target_ID> 129</Target_ID>
<Target_Name>Anti-P24 monoclonal antibody 13b5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:12084541 , GI:12084542 </Target_Sequence>
<Synonyms>Mab 13b5</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1E6J, 1E6O</Target_Structure>
<Comments>The monoclonal antibody 13B5 is derived from immunization of mice with a 243-residue recombinant P24 protein of HIV-1 strain HXB2 (which is designated RH24 ). Mab 13b5 is a mouse monoclonal IgG1κ antibody, which is available from bioMérieux.</Comments>
</Item><Item><Target_ID> 130</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody CG10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 131</Target_ID>
<Target_Name>T-cell surface glycoprotein YE1/48</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20937</Target_Sequence>
<Synonyms>T lymphocyte antigen A1
Lymphocyte antigen 49a, Ly-49a</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1QO3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 132</Target_ID>
<Target_Name>Anti-LPS monoclonal monoclonal MoAb 9-2-L3,7,9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MoAb 9-2-L3,7,9 is mouse immunoglobulin
(Ig)G2A and reactive against Neisseria meningococcal LPS immunotype L3,7,9.</Comments>
</Item><Item><Target_ID> 133</Target_ID>
<Target_Name>Anti-LPS monoclonal monoclonal MoAb 1-6-C</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MoAb 1-6-C is mouse immunoglobulin
IgG1 and reactive against Neisseria meningococci group-C PS.</Comments>
</Item><Item><Target_ID> 134</Target_ID>
<Target_Name>Anti-LPS monoclonal monoclonal MoAb 4-2-C</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MoAb 1-6-C is mouse immunoglobulin
IgG3 and reactive against Neisseria meningococci group-C PS.</Comments>
</Item><Item><Target_ID> 135</Target_ID>
<Target_Name>Anti-LPS monoclonal monoclonal MoAbR3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MoAb 1-6-C is mouse immunoglobulin
IgM and reactive against C1qR(P).</Comments>
</Item><Item><Target_ID> 136</Target_ID>
<Target_Name>Matrix metalloproteinase-9, MMP-9</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P14780</Target_Sequence>
<Synonyms>92 kDa type IV collagenase
92 kDa gelatinase
Gelatinase B, GELB
EC=3.4.24.35</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GKC, 1GKD, 1ITV, 1L6J, 2OVX, 2OVZ, 2OW0, 2OW1, 2OW2, 4H1Q, 4H2E, 4H3X, 4H82, 4HMA</Target_Structure>
<Comments>Matrix metalloproteinases (MMPs) play critical roles in a multiple number of autoimmunity diseases progression and metastasis of solid tumor. Gelatinases including MMP‐2 and MMP‐9 are extremely overexpressed in multiple pathological processes. MMP‐9 and MMP‐2 breakdown the extracellular matrix component gelatin very efficaciously.</Comments>
</Item><Item><Target_ID> 137</Target_ID>
<Target_Name>Anti-ferritin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Polyclonal mouse antisera against recombinant SjFer were collected after the third immunization. Specific IgG was purified by saturated ammonium sulphate precipitation.</Comments>
</Item><Item><Target_ID> 138</Target_ID>
<Target_Name>Anti-FASLG receptor monoclonal antibody SA-7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 139</Target_ID>
<Target_Name>Anti-FASLG receptor monoclonal antibody SA-8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 140</Target_ID>
<Target_Name>Synapsin-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P17599</Target_Sequence>
<Synonyms>Synapsin I</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1AUV, 1AUX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 141</Target_ID>
<Target_Name>Anti-GD2 monoclonal antibody 14G2a</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 142</Target_ID>
<Target_Name>96-well immunoassay plate (polystyrene, PS)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 143</Target_ID>
<Target_Name>Anti-M. hyopneumoniae polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgG was purified from antiserum by a modified protein-A method.</Comments>
</Item><Item><Target_ID> 144</Target_ID>
<Target_Name>Galectin-1, Gal-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P09382</Target_Sequence>
<Synonyms>Lectin galactoside-binding soluble 1
Beta-galactoside-binding lectin L-14-I
Lactose-binding lectin 1
S-Lac lectin 1
Galaptin
14 kDa lectin
HPL
HBL
Putative MAPK-activating protein PM12
14 kDa laminin-binding protein, HLBP14</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GZW, 1W6M, 1W6N, 1W6O, 1W6P, 1W6Q, 2KM2, 2ZKN, 3OY8, 3OYW, 3T2T</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 145</Target_ID>
<Target_Name>16 kDa beta-galactoside-binding lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P23668</Target_Sequence>
<Synonyms>C-16
Galectin CG-16</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure>1QMJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 146</Target_ID>
<Target_Name>Calpain-1 catalytic subunit</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07384</Target_Sequence>
<Synonyms>Calpain-1 large subunit
Calcium-activated neutral proteinase 1, CANP 1
Calpain mu-type
Micromolar-calpain, muCANP
Cell proliferation-inducing gene 30 protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ZCM, 2ARY</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 147</Target_ID>
<Target_Name>Anti-P25-LHRH polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P25 (KLIPNASLIENCTKAEL) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</Comments>
</Item><Item><Target_ID> 148</Target_ID>
<Target_Name>Anti-P27-LHRH polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P27 (AELGEYEKLLNSVLEPI) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</Comments>
</Item><Item><Target_ID> 149</Target_ID>
<Target_Name>Anti-P35-LHRH polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P35 (TAAQITAGIALHQSNLN) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</Comments>
</Item><Item><Target_ID> 150</Target_ID>
<Target_Name>NeutrAvidin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 151</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P1 (2C3D4)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 152</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P2 (8C6C4A12)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 153</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P4 (2D2A12G3)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 154</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P5 (15BC2G1)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 155</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P6 (1B4D3F10)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 156</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P7 (16B1C9H7)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 157</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P9 (4A2D5D6)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 158</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P10 (1A4B10E1)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 159</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P17 (8C1E11)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 160</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody F11 (9B4C1D8)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 161</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody F20 (9A4G1A8)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 162</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody F21 (9A5A11A11)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 163</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody P20 (7A5F12)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 164</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody LD5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 165</Target_ID>
<Target_Name>Anti-leptospira monoclonal antibody LF9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 166</Target_ID>
<Target_Name>Anti-leptospira polyclonal antibody 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 167</Target_ID>
<Target_Name>Anti-leptospira polyclonal antibody 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 168</Target_ID>
<Target_Name>Anti-leptospira polyclonal antibody 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 169</Target_ID>
<Target_Name>Anti-leptospira polyclonal antibody 4</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 170</Target_ID>
<Target_Name>Anti-ManLAM monoclonal antibody CS40</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 171</Target_ID>
<Target_Name>Anti-RAPs polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-RAPs antibodies were purified by applying the sera to an affinity column (rProteinA FF resin, Amersham Pharmacia) according to the manufacturers instructions. Antibodies were eluted with 0.2M Gly-HCl (pH 3.0).</Comments>
</Item><Item><Target_ID> 172</Target_ID>
<Target_Name>Anti-PDC-E2 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sera used were from individuals with typical PBC. IgG was prepared from the sera by affinity purification on protein A Sepharose (Pharmacia, Uppsala, Sweden).</Comments>
</Item><Item><Target_ID> 173</Target_ID>
<Target_Name>Anti-Gb3 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 174</Target_ID>
<Target_Name>Recombinant protein N36(L8)C34</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus 1:11676</Target_Source>
<Target_Structure></Target_Structure>
<Comments>N36(L8)C34 is a model of the  HIV-1gp41 core, , a six-helix bundle formed between the N- and C-terminal heptad repeats. For expression of N36(L8)C34, the gene fragments coding for N36 (spanning residues 546-581 in gp41) and C34 (spanning 628-661 in gp41) were PCR-amplified, respectively, from the corresponding plasmid coding gp160 with the primers.</Comments>
</Item><Item><Target_ID> 175</Target_ID>
<Target_Name>Polyglutamine containing 62 consecutive glutamines</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 176</Target_ID>
<Target_Name>UDP-N-acetylmuramoylalanine--D-glutamate ligase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q9HVZ9</Target_Sequence>
<Synonyms>UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase
D-glutamic acid-adding enzyme
EC=6.3.2.9</Synonyms>
<Target_Source>Pseudomonas aeruginosa:287</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 177</Target_ID>
<Target_Name>Trisialogangliosides (GT1b), NGF-differentiated PC12 cells</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 178</Target_ID>
<Target_Name>XGC9811-L cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human gastric carcinoma cell line XGC9811 was inoculated into nude mice by tail vein injection. After 3-4 weeks, the mice were killed and a few liver-metastatic nodules were harvested aseptically. Single cell suspensions were made by mincing and trypsinization and were cultured in vitro. The cells in this culture were designated as XGC9811-L1. The same procedure was repeated using XGC9811-L1 cells and the XGC9811-L cell line was established upon the fourth cycle of stepwise selection.</Comments>
</Item><Item><Target_ID> 179</Target_ID>
<Target_Name>Integrin alpha-X-beta-2, integrin αxβ2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-X: P20702, Integrin beta-2: P05107</Target_Sequence>
<Synonyms>Integrin alpha-X alternative name(s):
Leukocyte adhesion glycoprotein p150,95 alpha chain
Leukocyte adhesion receptor p150,95
Leu M5
CD11 antigen-like family member C
CD_antigen=CD11c

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-X: 1N3Y, 2LUV, 3K6S, 3K71, 3K72
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 180</Target_ID>
<Target_Name>Integrin alpha-M-beta-2, integrin αmβ2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-M: P11215, Integrin beta-2: P05107</Target_Sequence>
<Synonyms>Integrin alpha-M alternative name(s):
Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 181</Target_ID>
<Target_Name>DNA topoisomerase 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P11387</Target_Sequence>
<Synonyms>DNA topoisomerase I
EC=5.99.1.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A31, 1A35, 1A36, 1EJ9, 1K4S, 1K4T, 1LPQ, 1NH3, 1R49, 1RR8, 1RRJ, 1SC7, 1SEU, 1T8I, 1TL8</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 182</Target_ID>
<Target_Name>Anthrax toxin receptor 1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q9H6X2</Target_Sequence>
<Synonyms>Tumor endothelial marker 8</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3N2N,6ADL,6ADM,6ADR,6CX1</Target_Structure>
<Comments>cDNA encoding the human ATR/TEM8 VWA domain was purchased from ATCC.</Comments>
</Item><Item><Target_ID> 183</Target_ID>
<Target_Name>Anthrax toxin receptor 2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P58335</Target_Sequence>
<Synonyms>Capillary morphogenesis gene 2 protein, CMG-2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1SHT, 1SHU, 1T6B, 1TZN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 184</Target_ID>
<Target_Name>Hepatoma cell line SMMC-7721</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 185</Target_ID>
<Target_Name>RNA-directed RNA polymerase NS5B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis C virus:11103</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 186</Target_ID>
<Target_Name>Plasmodium falciparum-infected red blood cells (iRBCs)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 187</Target_ID>
<Target_Name>Nontypeable Haemophilus influenzae, strain R2866</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Haemophilus influenzae (strain R2866):262728</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Nontypeable Haemophilus influenzae (NTHi) is an obligate parasite of the oropharynx of humans, in whom it commonly causes mucosal infections such as otitis media, sinusitis, and bronchitis.</Comments>
</Item><Item><Target_ID> 188</Target_ID>
<Target_Name>Anti-sperm polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 189</Target_ID>
<Target_Name>Newcastle disease virus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Newcastle disease virus:11176</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 190</Target_ID>
<Target_Name>Anti-NS4A monoclonal antibody 2E3C2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 191</Target_ID>
<Target_Name>Hepatocellular carcinoma cell lines BEL-7402</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 192</Target_ID>
<Target_Name>Monoclonal antibody CM22 IgM</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 193</Target_ID>
<Target_Name>Silver nanowires</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 194</Target_ID>
<Target_Name>Anti-tenascin-C monoclonal antibody ST2146</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Production of ST2146 was carried out through cultivation of cST2146 hybridoma cells in protein-free medium, in a 2 L perfusion MD2 bioreactor.</Comments>
</Item><Item><Target_ID> 195</Target_ID>
<Target_Name>Anti-MC-LR monoclonal antibody MC10E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 196</Target_ID>
<Target_Name>Anti-dsDNA polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 197</Target_ID>
<Target_Name>Endothelial protein C receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q9UNN8</Target_Sequence>
<Synonyms>Endothelial cell protein C receptor
Activated protein C receptor, APC receptor
CD_antigen=CD201</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1L8J, 1LQV, 3JTC</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 198</Target_ID>
<Target_Name>Anti-CCR5 monoclonal antibody 3A9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 199</Target_ID>
<Target_Name>PreS domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis B virus (HBV):10407</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 200</Target_ID>
<Target_Name>Pesticidal crystal protein cry11Aa</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21256</Target_Sequence>
<Synonyms>Insecticidal delta-endotoxin CryXIA(a)
Crystaline entomocidal protoxin
72 kDa crystal protein</Synonyms>
<Target_Source>Bacillus thuringiensis subsp. israelensis:1430</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 201</Target_ID>
<Target_Name>Anti-GD2 monoclonal antibody ch14.18</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mouse-human chimeric antibody ch14.18, a chimeric IgG antibody, directed against the disialoganglioside GD2, was constructed by joining the cDNA for the variable region of the murine monoclonal antibody 14.18 with human gamma 1 constant region.</Comments>
</Item><Item><Target_ID> 202</Target_ID>
<Target_Name>Anti-tumor monoclonal antibody BAT</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 203</Target_ID>
<Target_Name>Human pancreatic adenocarcinoma cell line Capan-2</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 204</Target_ID>
<Target_Name>C-C motif chemokine 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P13500</Target_Sequence>
<Synonyms>Small-inducible cytokine A2
Monocyte chemoattractant protein 1
Monocyte chemotactic protein 1, MCP-1
Monocyte chemotactic and activating factor, MCAF
Monocyte secretory protein JE
HC11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1DOK, 1DOL, 1DOM, 1DON, 1ML0, 2BDN, 2NZ1, 3IFD, 4DN4</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 205</Target_ID>
<Target_Name>Trisialogangliosides (GT1b)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 206</Target_ID>
<Target_Name>Anti-EGF monoclonal antibody EGF-10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 207</Target_ID>
<Target_Name>Src SH2-GST fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 208</Target_ID>
<Target_Name>PTP-alpha-GST fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 209</Target_ID>
<Target_Name>PTP1B-GST fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 210</Target_ID>
<Target_Name>Anti-gE monoclonal antibody 14B11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 211</Target_ID>
<Target_Name>Anti-gE monoclonal antibody 13E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 212</Target_ID>
<Target_Name>Anti-gE monoclonal antibody 17C9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 213</Target_ID>
<Target_Name>Anti-gE monoclonal antibody 8G11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 214</Target_ID>
<Target_Name>Amino acid 27-135 of SLAM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q13291</Target_Sequence>
<Synonyms>Signaling lymphocytic activation molecule
IPO-3
CDw150
CD_antigen=CD150</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1D4T, 1D4W, 1KA6, 1KA7, 1M27</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 215</Target_ID>
<Target_Name>Anti-phl p 5a monoclonal antibody IgE</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phl p 5a-specific IgE was purified from patient sera by means of affinity chromatography.</Comments>
</Item><Item><Target_ID> 216</Target_ID>
<Target_Name>Long neurotoxin 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01391</Target_Sequence>
<Synonyms>Neurotoxin 3
Alpha-cobratoxin, Alpha-CbT, Cbtx</Synonyms>
<Target_Source>Naja kaouthia (Monocled cobra) (Naja siamensis):8649</Target_Source>
<Target_Structure>1CTX, 1LXG, 1LXH, 1YI5, 4AEA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 217</Target_ID>
<Target_Name>Anti-MBP monoclonal antibody MK16 Fab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MK16 is a murine antibody directed against the multiple sclerosis associated human MHC class II molecule HLA-DR2b (DR2b) in complex with a myelin basic protein (MBP)-derived peptide corresponding to residues 85-99 (MBP 85-99).</Comments>
</Item><Item><Target_ID> 218</Target_ID>
<Target_Name>Cerebellar granule neurons</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 219</Target_ID>
<Target_Name>Self-assembled monolayer (SAM) of a Gb3 mimic</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 220</Target_ID>
<Target_Name>Anti-collagen alpha-1(II) chain monoclonal antibody CB268</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 221</Target_ID>
<Target_Name>Anti-collagen alpha-1(II) chain monoclonal antibody CII-C1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:170292415; GI:170292416</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CII-C1 was derived from a mouse of the DBA/1 strain, susceptible to collagen-induced arthritis, after immunization with native chicken type II collagen; it reacts with native helical type II collagen but not with the isolated chains of denatured collagen. Isotype: IgG2a, kappa.</Comments>
</Item><Item><Target_ID> 222</Target_ID>
<Target_Name>Anti-nucleosome monoclonal antibody #32</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 223</Target_ID>
<Target_Name>GST A1-1 fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 224</Target_ID>
<Target_Name>GST P1-1 fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 225</Target_ID>
<Target_Name>GST M2-2 fused protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 226</Target_ID>
<Target_Name>Anti-MCPS monoclonal antibody 1E4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 227</Target_ID>
<Target_Name>psi RNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus 1:11676</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 228</Target_ID>
<Target_Name>Silicon dioxide, SiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 229</Target_ID>
<Target_Name>Laminin-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 230</Target_ID>
<Target_Name>Heat shock protein HSP 90-beta, HSP 90</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08238</Target_Sequence>
<Synonyms>Heat shock 84 kDa, HSP 84, HSP84</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1QZ2, 1UYM, 3NMQ, 3PRY</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 231</Target_ID>
<Target_Name>E3 ubiquitin-protein ligase NEDD4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P46934</Target_Sequence>
<Synonyms>Neural precursor cell expressed developmentally down-regulated protein 4, NEDD-4
Cell proliferation-inducing gene 53 protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2KPZ, 2KQ0, 2XBB, 2XBF, 3B7Y, 4BBN, 4BE8</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 232</Target_ID>
<Target_Name>Death-associated protein kinase 3</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>O43293</Target_Sequence>
<Synonyms>DAP kinase 3
DAP-like kinase, Dlk
ZIP-kinase
EC=2.7.11.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1YRP, 2J90, 3BHY, 3BQR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 233</Target_ID>
<Target_Name>E3 ubiquitin-protein ligase Mdm2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q00987</Target_Sequence>
<Synonyms>p53-binding protein Mdm2
Oncoprotein Mdm2
Double minute 2 protein, Hdm2
EC=6.3.2.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1RV1, 1T4E, 1T4F, 1YCR, 1Z1M, 2AXI, 2C6A, 2C6B, 2F1Y, 2FOP, 2GV2, 2HDP, 2LZG, 2M86, 2RUH, 2VJE, 2VJF, 3EQS, 3G03, 3IUX, 3IWY, 3JZK, 3JZR, 3JZS, 3LBK, 3LBL, 3LNJ, 3LNZ, 3MQS, 3TJ2, 3TPX, 3TU1, 3V3B, 3VBG, 3VZV, 3W69, 4DIJ, 4ERE, 4ERF, 4HBM, 4HFZ, 4HG7, 4JV7, 4JV9, 4JVE, 4JVR, 4JWR, 4MDN, 4MDQ, 4OAS, 4OBA, 4OCC, 4ODE, 4ODF, 4OGN, 4OGT, 4OGV, 4OQ3, 4QO4, 4QOC, 4UMN, 4WT2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 234</Target_ID>
<Target_Name>Anti-LAM monoclonal antibody CS-35</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>An immunoglobulin G3 (IgG3) anti-LAM mouse MAb, MAb CS-35, was acquired as a tissue culture supernatant in RPMI medium containing 10% fetal calf serum.</Comments>
</Item><Item><Target_ID> 235</Target_ID>
<Target_Name>Anti-BCG polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbits were similarly immunized with heat-killed whole M. bovis BCG cells, and a panel of sera which should contain polyclonal antibodies that mainly recognize surface-exposed mycobacterial antigens was thus raised.</Comments>
</Item><Item><Target_ID> 236</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody NS1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 237</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody NS2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 238</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody NS5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 239</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody CS6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 240</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody CS8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 241</Target_ID>
<Target_Name>Anti-p22 monoclonal antibody CS9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 242</Target_ID>
<Target_Name>Mouse pancreas</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 243</Target_ID>
<Target_Name>Human gastric cancer cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 244</Target_ID>
<Target_Name>C57Bl/6 female mice muscle</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 245</Target_ID>
<Target_Name>C57Bl/6 female mice pancreas</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 246</Target_ID>
<Target_Name>C57Bl/6 female mice brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 247</Target_ID>
<Target_Name>C57Bl/6 female mice kidney</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 248</Target_ID>
<Target_Name>C57Bl/6 female mice uterus</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 249</Target_ID>
<Target_Name>C57Bl/6 female mice bowel</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 250</Target_ID>
<Target_Name>Vascular cell adhesion protein 1, V-CAM 1, VCAM-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P29533</Target_Sequence>
<Synonyms>CD_antigen=CD106</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 251</Target_ID>
<Target_Name>Mouse abdominal skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 252</Target_ID>
<Target_Name>V-type proton ATPase 116 kDa subunit a isoform 4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9HBG4</Target_Sequence>
<Synonyms>V-ATPase 116 kDa isoform a4
Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4
Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 253</Target_ID>
<Target_Name>Vascular endothelial growth factor A, VEGF-A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P15692</Target_Sequence>
<Synonyms>Vascular permeability factor, VPF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BJ1, 1CZ8, 1FLT, 1KAT, 1KMX, 1MJV, 1MKG, 1MKK, 1QTY, 1TZH, 1TZI, 1VGH, 1VPF, 1VPP, 2FJG, 2FJH, 2QR0, 2VGH, 2VPF, 3BDY, 3P9W, 3QTK, 3S1B, 3S1K, 3V2A, 4DEQ, 4GLN, 4GLS, 4KZN, 4QAF, 4WPB</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 254</Target_ID>
<Target_Name>Mouse brain microvasculature</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 255</Target_ID>
<Target_Name>Phenoxibenzoic acid-polyclonal antibody complex</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 256</Target_ID>
<Target_Name>Umbilical endothelial cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 257</Target_ID>
<Target_Name>Proteinase K</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P06873</Target_Sequence>
<Synonyms>Tritirachium alkaline proteinase
Endopeptidase K
EC=3.4.21.64</Synonyms>
<Target_Source>Tritirachium album (Engyodontium album):37998</Target_Source>
<Target_Structure>1BJR, 1CNM, 1EGQ, 1HT3, 1IC6, 1OYO, 1P7V, 1P7W, 1PEK, 1PFG, 1PJ8, 1PTK, 2DP4, 2DQK, 2DUJ, 2G4V, 2HD4, 2HPZ, 2ID8, 2PKC, 2PQ2, 2PRK, 2PWA, 2PWB, 2PYZ, 2V8B, 3AJ8, 3AJ9, 3D9Q, 3DDZ, 3DE0, 3DE1, 3DE2, 3DE3, 3DE4, 3DE5, 3DE6, 3DE7, 3DVQ, 3DVR, 3DVS, 3DW1, 3DW3, 3DWE, 3DYB, 3GT3, 3GT4, 3I2Y, 3I30, 3I34, 3I37, 3L1K, 3OSZ, 3PRK, 3PTL, 3Q40, 3Q5G, 3QMP, 4B5L, 4DJ5, 4FON</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 258</Target_ID>
<Target_Name>Cathepsin S</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P25326</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 259</Target_ID>
<Target_Name>Hronchial epithelial cells (16HBE14o-)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 260</Target_ID>
<Target_Name>EGTA-treated 16HBE14o- cell monolayers</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 261</Target_ID>
<Target_Name>A disintegrin and metalloproteinase with thrombospondin motifs 4</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>O75173</Target_Sequence>
<Synonyms>ADAMTS-4, ADAM-TS 4, ADAM-TS4
Aggrecanase-1
ADMP-1
EC=3.4.24.82</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2RJP, 3B2Z</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 262</Target_ID>
<Target_Name>Human primary atherosclerotic tissues</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 263</Target_ID>
<Target_Name>Melanin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 264</Target_ID>
<Target_Name>HBJ127</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 265</Target_ID>
<Target_Name>Kasumi-1 acute myeloid leukemia cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 266</Target_ID>
<Target_Name>Hepatocellular carcinoma cell line HCCLM3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 267</Target_ID>
<Target_Name>Human epidermoid carcinoma A431 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 268</Target_ID>
<Target_Name>Genhance 680, GH680</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 269</Target_ID>
<Target_Name>HT-1376 human bladder tumor cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 270</Target_ID>
<Target_Name>Anti-HAV polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 271</Target_ID>
<Target_Name>Non-small cell lung cancer (CL1-5)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 272</Target_ID>
<Target_Name>Seam 3 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Seam-3 is a protective monoclonal antibody agaimst Neisseria meningitidis serogroup B capsular polysaccharide.</Comments>
</Item><Item><Target_ID> 273</Target_ID>
<Target_Name>Peroxisome proliferator-activated receptor gamma, PPAR-gamma</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P37231</Target_Sequence>
<Synonyms>Nuclear receptor subfamily 1 group C member 3</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FM6, 1FM9, 1I7I, 1K74, 1KNU, 1NYX, 1PRG, 1RDT, 1WM0, 1ZEO, 1ZGY, 2ATH, 2F4B, 2FVJ, 2G0G, 2G0H, 2GTK, 2HFP, 2HWQ, 2HWR, 2I4J, 2I4P, 2I4Z, 2OM9, 2P4Y, 2POB, 2PRG, 2Q59, 2Q5P, 2Q5S, 2Q61, 2Q6R, 2Q6S, 2Q8S, 2QMV, 2VSR, 2VST, 2VV0, 2VV1, 2VV2, 2VV3, 2VV4, 2XKW, 2YFE, 2ZK0, 2ZK1, 2ZK2, 2ZK3, 2ZK4, 2ZK5, 2ZK6, 2ZNO, 2ZVT, 3ADS, 3ADT, 3ADU, 3ADV, 3ADW, 3ADX, 3AN3, 3AN4, 3B0Q, 3B0R, 3B1M, 3B3K, 3BC5, 3CDP, 3CDS, 3CS8, 3CWD, 3D6D, 3DZU, 3DZY, 3E00, 3ET0, 3ET3, 3FEJ, 3FUR, 3G9E, 3GBK, 3H0A, 3HO0, 3HOD, 3IA6, 3K8S, 3KMG, 3LMP, 3NOA, 3OSI, 3OSW, 3PBA, 3PO9, 3PRG, 3QT0, 3R5N, 3R8A, 3R8I, 3S9S, 3SZ1, 3T03, 3TY0, 3U9Q, 3V9T, 3V9V, 3V9Y, 3VJH, 3VJI, 3VN2, 3VSO, 3VSP, 4A4V, 4A4W, 4E4K, 4E4Q, 4EM9, 4EMA, 4F9M, 4FGY, 4PRG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 274</Target_ID>
<Target_Name>Anti-MUC1 monoclonal antibody PR81</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PR81 MAb is a murine IgG1 kappa light chain monoclonal antibody raised against human MUC1.</Comments>
</Item><Item><Target_ID> 275</Target_ID>
<Target_Name>Gamma-aminobutyric acid receptor-associated protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O95166</Target_Sequence>
<Synonyms>GABA(A) receptor-associated protein
MM46</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GNU, 1KLV, 1KM7, 1KOT, 3D32, 3DOW, 3WIM, 4XC2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 276</Target_ID>
<Target_Name>Anti-HGF-cMET monoclonal antibody SFN68</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986, Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>SFN68 is derived from a rabbit/human chimeric Fab library constructed using phage display after immunization with HGF-cMet complex. Its isotype is IgG1. SFN68 Fab was immobilized to the microtiter plates via mouse anti-HA antibody and then used for panning.</Comments>
</Item><Item><Target_ID> 277</Target_ID>
<Target_Name>Anti-GMDP monoclonal antibody E6/1.2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 278</Target_ID>
<Target_Name>Beta amyloid peptide (12-28)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05067 [12-28]</Target_Sequence>
<Synonyms>Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 279</Target_ID>
<Target_Name>Beta amyloid peptide (25-35)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05067 [25-35]</Target_Sequence>
<Synonyms>Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 280</Target_ID>
<Target_Name>Beta-amyloid protein 42</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05067 [672-713]</Target_Sequence>
<Synonyms>Beta-APP42</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 281</Target_ID>
<Target_Name>Beta amyloid peptide (1-20)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05067 [1-20]</Target_Sequence>
<Synonyms>Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 282</Target_ID>
<Target_Name>Anti-PYANPSL polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-PYANPSL IgG was purified from serum of mice immunized with KLH-PYANPSL conjugate. Anti-KLH mouse IgG were used in panning to remove either anti-peptide IgG allotype/isotype-matched IgG or anti-KLH Ig-specific phage particles.</Comments>
</Item><Item><Target_ID> 283</Target_ID>
<Target_Name>Anti-WAANPSM polyclonal antibody  IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-WAANPSM IgG was purified from serum of mice immunized with KLH-WAANPSM conjugate. Anti-KLH mouse IgG were used in panning to remove either anti-peptide IgG allotype/isotype-matched IgG or anti-KLH Ig-specific phage particles.</Comments>
</Item><Item><Target_ID> 284</Target_ID>
<Target_Name>Tumor-associated glycoprotein (TAG-72)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human tumor-associated glycoprotein (TAG-72) is a mucin-like molecules that is expressed on a variety of epithelial malignancies.</Comments>
</Item><Item><Target_ID> 285</Target_ID>
<Target_Name>Nasopharyngeal carcinoma cell CEN-1</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 286</Target_ID>
<Target_Name>l,2-Dioleoyl-sn-glycero-3-phosphatidylserine</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phosphatidylserine (PS) is a well-characterized biomarker for apoptosis.</Comments>
</Item><Item><Target_ID> 287</Target_ID>
<Target_Name>Mouse inflammatory small bowel</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The bowel was removed from 8-week-old male C57BL/6Ncrj mice. The reaction mixture was first incubated with normal small bowel for 10 min at 37a</Comments>
</Item><Item><Target_ID> 288</Target_ID>
<Target_Name>Human blood outgrowth endothelial cells, HBOEC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 289</Target_ID>
<Target_Name>Beta-nerve growth factor, Beta-NGF</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01138</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1SG1, 1WWW, 2IFG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 290</Target_ID>
<Target_Name>Gonadotropin-releasing hormone promoter (GP) </Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 291</Target_ID>
<Target_Name>Human rotavirus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rotavirus:10912</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 292</Target_ID>
<Target_Name>Hepatocellular carcinoma cell line HepG2</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 293</Target_ID>
<Target_Name>Colon cancer cell line SW480</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 294</Target_ID>
<Target_Name>Hepatocyte growth factor receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P08581</Target_Sequence>
<Synonyms>HGF receptor
Scatter factor receptor, SF receptor
HGF/SF receptor
Tyrosine-protein kinase Met
Proto-oncogene c-Met
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FYR, 1R0P, 1R1W, 1SHY, 1SSL, 2G15, 2RFN, 2RFS, 2UZX, 2UZY, 2WD1, 2WGJ, 2WKM, 3A4P, 3BUX, 3C1X, 3CCN, 3CD8, 3CE3, 3CTH, 3CTJ, 3DKC, 3DKF, 3DKG, 3EFJ, 3EFK, 3F66, 3F82, 3I5N, 3L8V, 3LQ8, 3Q6U, 3Q6W, 3QTI, 3R7O, 3RHK, 3U6H, 3U6I, 3VW8, 3ZBX, 3ZC5, 3ZCL, 3ZXZ, 3ZZE, 4AOI, 4AP7, 4DEG, 4DEH, 4DEI, 4EEV, 4GG5, 4GG7, 4IWD, 4K3J, 4KNB, 4MXC, 4O3T, 4O3U, 4R1V, 4R1Y, 4XMO, 4XYF</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 295</Target_ID>
<Target_Name>Thyroid follicular carcinoma cell line FRO82-2</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 296</Target_ID>
<Target_Name>Arabidopsis Fip1 ortholog encoded by At5g58040 (AtFip1[V])</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9FGU0</Target_Sequence>
<Synonyms>Genomic DNA, chromosome 5, TAC clone:K21L19</Synonyms>
<Target_Source>Arabidopsis thaliana (Mouse-ear cress):3702</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 297</Target_ID>
<Target_Name>Glioma cell line 9L</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 298</Target_ID>
<Target_Name>Anti-ACE monoclonal antibody CG1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 299</Target_ID>
<Target_Name>Anti-B-subtype HIV-1 polyclonal antibody pre-HAART IgG from Patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 300</Target_ID>
<Target_Name>Anti-B-subtype HIV-1 polyclonal antibody  post-HAART IgG from Patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 301</Target_ID>
<Target_Name>Anti-B-subtype HIV-1 polyclonal antibody pre-HAART IgG from Patient 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 302</Target_ID>
<Target_Name>Vascular endothelial growth factor receptor 3, VEGFR-3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P35916</Target_Sequence>
<Synonyms>Tyrosine-protein kinase receptor FLT4
Fms-like tyrosine kinase 4, FLT-4
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 303</Target_ID>
<Target_Name>Anti-mycobacterial HSP60 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 304</Target_ID>
<Target_Name>Paracetamol(4-acetamidophenol, 4AAP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 305</Target_ID>
<Target_Name>Anti-CD4 monoclonal antibody 5145A</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 306</Target_ID>
<Target_Name>Anti-A. paragallinarum strain 0083 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 307</Target_ID>
<Target_Name>serine repeat antigen 5, SERA5</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmodium falciparum:5833</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 308</Target_ID>
<Target_Name>Acute myeloid leukemia cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human acute myeloid leukemia cells are freshly obtained from AML from patients.</Comments>
</Item><Item><Target_ID> 309</Target_ID>
<Target_Name>Sin Nombre virus (SNV) strain SN77734</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sin Nombre virus:37705</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 310</Target_ID>
<Target_Name>Cysteine-rich protein 1, CRP-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P50238</Target_Sequence>
<Synonyms>Cysteine-rich intestinal protein, CRIP
Cysteine-rich heart protein, CRHP, hCRHP</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 311</Target_ID>
<Target_Name>Fresh human colonic adenomas</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 312</Target_ID>
<Target_Name>Anti-ErbB2 monoclonal antibody A21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 313</Target_ID>
<Target_Name>Anti-SHIV polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Macaca mulatta (Rhesus macaque):9544</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 314</Target_ID>
<Target_Name>Colon cancer cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 315</Target_ID>
<Target_Name>Kallikrein-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P06870</Target_Sequence>
<Synonyms>Tissue kallikrein
Kidney/pancreas/salivary gland kallikrein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1SPJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 316</Target_ID>
<Target_Name>Kallikrein-6</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q92876</Target_Sequence>
<Synonyms>Protease M
Neurosin
Zyme
SP59
Serine protease 9
Serine protease 18
EC=3.4.21.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GVL, 1L2E, 1LO6, 3VFE, 4D8N</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 317</Target_ID>
<Target_Name>Large intestinal cancer cell line LoVo</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 318</Target_ID>
<Target_Name>Claudin-4</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O35054</Target_Sequence>
<Synonyms>Clostridium perfringens enterotoxin receptor, CPE-receptor, CPE-R</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 319</Target_ID>
<Target_Name>Hepatocellular carcinoma line Mahlavu</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 320</Target_ID>
<Target_Name>HEK293 cells transfected with hFcRn and hβ2m (293c11)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 321</Target_ID>
<Target_Name>Acute T-lymphoblastic leukemia Molt-4 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 322</Target_ID>
<Target_Name>Chymotrypsinogen A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00766</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1AB9, 1ACB, 1AFQ, 1CA0, 1CBW, 1CGI, 1CGJ, 1CHG, 1CHO, 1DLK, 1EX3, 1GCD, 1GCT, 1GG6, 1GGD, 1GHA, 1GHB, 1GL0, 1GL1, 1GMC, 1GMD, 1GMH, 1HJA, 1K2I, 1MTN, 1N8O, 1OXG, 1P2M, 1P2N, 1P2O, 1P2Q, 1T7C, 1T8L, 1T8M, 1T8N, 1T8O, 1VGC, 1YPH, 2CGA, 2CHA, 2GCH, 2GCT, 2GMT, 2P8O, 2VGC, 2Y6T, 3BG4, 3GCH, 3GCT, 3RU4, 3T62, 3VGC, 4CHA, 4GCH, 4VGC, 5CHA, 5GCH, 6CHA, 6GCH, 7GCH, 8GCH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 323</Target_ID>
<Target_Name>Chitinase A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07254</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Serratia marcescens:615</Target_Source>
<Target_Structure>1CTN, 1EHN, 1EIB, 1FFQ, 1FFR, 1K9T, 1NH6, 1RD6, 1X6L, 1X6N, 2WK2, 2WLZ, 2WM0</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 324</Target_ID>
<Target_Name>Chitinase B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P11797</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Serratia marcescens:615</Target_Source>
<Target_Structure>1E6N, 1GOI, 1H0G, 1H0I, 1O6I, 1OGB, 1OGG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 325</Target_ID>
<Target_Name>Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P12318</Target_Sequence>
<Synonyms>Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a
CDw32
CD_antigen=CD32</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FCG, 1H9V, 3D5O, 3RY4, 3RY5, 3RY6</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 326</Target_ID>
<Target_Name>Human B cell Burkitt lymphoma cell line Raji</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 327</Target_ID>
<Target_Name>Cadherin-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P19022</Target_Sequence>
<Synonyms>Neural cadherin, N-cadherin
CDw325
CD_antigen=CD325</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 328</Target_ID>
<Target_Name>Platelet glycoprotein Ib alpha chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07359</Target_Sequence>
<Synonyms>Glycoprotein Ibalpha, GP-Ib alpha, GPIb-alpha, GPIbA
Antigen CD42b-alpha
CD_antigen=CD42b</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GWB, 1M0Z, 1M10, 1OOK, 1P8V, 1P9A, 1QYY, 1SQ0, 1U0N, 2BP3, 3P72, 3PMH, 4C2A, 4C2B, 4CH2, 4CH8, 4MGX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 329</Target_ID>
<Target_Name>Tetragonal BaTiO3</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 330</Target_ID>
<Target_Name>Rat small intestinal mucosal tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 331</Target_ID>
<Target_Name>Secretion chaperone</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>A9CI62</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Agrobacterium tumefaciens (strain C58 / ATCC 33970):176299</Target_Source>
<Target_Structure>2Q2H, 2Q2I</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 332</Target_ID>
<Target_Name>Mouse digestive tract</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 333</Target_ID>
<Target_Name>Ischemic stroke tissue from transient middle cerebral artery occlusion model</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 334</Target_ID>
<Target_Name>FVIII inhibitor positive plasma samples before rituximab treatment</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 335</Target_ID>
<Target_Name>FVIII inhibitor positive plasma samples after rituximab treatment</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 336</Target_ID>
<Target_Name>Carbon Black FW-18</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 337</Target_ID>
<Target_Name>Long fibrous cellulose</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 338</Target_ID>
<Target_Name>Denuded cartilage grafts</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 339</Target_ID>
<Target_Name>Magnetic particles (BacMPs)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Magnetospirillum magneticum:84159</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 340</Target_ID>
<Target_Name>Anti-H5N1 virus monoclonal antibody 8H5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal antibody 8H5 (IgG2a) was generated by successively immunizing Balb/c mice with five strains of H5N1 avian influenza virus representing different major genetic subgroups of the virus prevalent since 2002 and found to have caused human infection. The antibody has been shown to be reactive against all of the major genetic groups of H5N1 viruses prevalent since 1997, and it was found to neutralize different H5N1 virus exhibiting broad but distinct H5 specificity.</Comments>
</Item><Item><Target_ID> 341</Target_ID>
<Target_Name>Implantation serine proteinase complex (Serine protease 28, 29)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Serine protease 28: Q924N9, Serine protease 29: Q99MS4</Target_Sequence>
<Synonyms>Serine protease 28 alternative name(s):
Implantation serine proteinase 1, ISP-1
Strypsin
Tryptase-like proteinase
EC=3.4.21.-

Serine protease 29 alternative name(s):
Implantation serine proteinase 2, ISP-2
Strypsin-2
Strypsin-related protein
Tryptase-like proteinase
EC=3.4.21.-</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 342</Target_ID>
<Target_Name>Monoclonal antibody ME361</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>ME361 is a mouse IgG2a monoclonal antibody against GD2 ganglioside. The 15mer phage library was reacted with biotinylated mAb ME361 immobilized on streptavidin-coated polystyrene f100 mm Petri dishes.</Comments>
</Item><Item><Target_ID> 343</Target_ID>
<Target_Name>Highly metastatic prostate carcinoma cell line PC-3M-1E8</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 344</Target_ID>
<Target_Name>Mouse thymus vasculature</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Female BALB/c mice ages 6 to 8 weeks were used.</Comments>
</Item><Item><Target_ID> 345</Target_ID>
<Target_Name>Mouse kidney</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Female BALB/c mice ages 6 to 8 weeks were used.</Comments>
</Item><Item><Target_ID> 346</Target_ID>
<Target_Name>Angiopoietin-1 receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q02763</Target_Sequence>
<Synonyms>Tyrosine-protein kinase receptor TIE-2, hTIE2
Tyrosine-protein kinase receptor TEK
Tunica interna endothelial cell kinase
p140 TEK
CD_antigen=CD202b
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FVR, 2GY5, 2GY7, 2OO8, 2OSC, 2P4I, 2WQB, 3BEA, 3L8P, 4K0V</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 347</Target_ID>
<Target_Name>Hematite particles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 348</Target_ID>
<Target_Name>Anti-LPS monoclonal antibody 9D5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>9D5 is an IgG3 monoclonal antiobody specific to lipopolysaccharide (LPS) of pathogenic Burkholderia pseudomallei strains. It showed partial protection against melioidosis in BALB/c mice.</Comments>
</Item><Item><Target_ID> 349</Target_ID>
<Target_Name>Anti-EPS monoclonal antibody 4B11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>4B11 is an IgG2 monoclonal antiobody specific to exopolysaccharide (EPS) of pathogenic Burkholderia pseudomallei strains. It showed partial protection against melioidosis in BALB/c mice.</Comments>
</Item><Item><Target_ID> 350</Target_ID>
<Target_Name>Monoclonal antibody BPA</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BPA is an IgA monoclonal antiobody against proteins of pathogenic Burkholderia pseudomallei strains.</Comments>
</Item><Item><Target_ID> 351</Target_ID>
<Target_Name>Monoclonal antibody BPM</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BPM is an IgM monoclonal antiobody against proteins of pathogenic Burkholderia pseudomallei strains.</Comments>
</Item><Item><Target_ID> 352</Target_ID>
<Target_Name>Anti-Pru p 3 polyclonal antibody IgE (from OSA-pool)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 353</Target_ID>
<Target_Name>Anti-Pru p 3 polyclonal antibody IgE (from SYS-pool)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 354</Target_ID>
<Target_Name>Anti-catalase monoclonal antibody C001</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C001 was an IgG1(κ) monoclonal antibody produced by the hybridoma technique using recombinant Catalase-GST as the immunogen.</Comments>
</Item><Item><Target_ID> 355</Target_ID>
<Target_Name>Anti-nucleoprotein monoclonal antibody N1H5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>N1H5 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Nipah virus (NiV) expressed in E. coli.</Comments>
</Item><Item><Target_ID> 356</Target_ID>
<Target_Name>Anti-nucleoprotein monoclonal antibody N4E2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>N4E2 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Nipah virus (NiV) expressed in E. coli.</Comments>
</Item><Item><Target_ID> 357</Target_ID>
<Target_Name>Anti-nucleoprotein monoclonal antibody H2F5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>H2F5 (IgM) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Hendra virus (HeV) expressed in E. coli.</Comments>
</Item><Item><Target_ID> 358</Target_ID>
<Target_Name>Anti-nucleoprotein monoclonal antibody H3G5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>H3G5 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Hendra virus (HeV) expressed in E. coli.</Comments>
</Item><Item><Target_ID> 359</Target_ID>
<Target_Name>Enterotoxin type B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01552</Target_Sequence>
<Synonyms>SEB</Synonyms>
<Target_Source>Staphylococcus aureus:1280</Target_Source>
<Target_Structure>1D5M, 1D5X, 1D5Z, 1D6E, 1GOZ, 1SBB, 1SE3, 1SE4, 1SEB, 2SEB, 3GP7, 3R8B, 3SEB</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 360</Target_ID>
<Target_Name>L-alpha-phosphatidylserine</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 361</Target_ID>
<Target_Name>Anti-blood group A antigen monclonal antibody NaM87-1F6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NaM87-1F6 was bought from BD Biosciences. It is an monoclonal antibody of isotype (IgG3, κ) against blood group A antigen.</Comments>
</Item><Item><Target_ID> 362</Target_ID>
<Target_Name>Anti-HSP90 monoclonal antibody AC88</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>AC88 is an IgG1 monoclonal antibody, generated by immunizing mice with HSP90 of Achlya ambisexualis.</Comments>
</Item><Item><Target_ID> 363</Target_ID>
<Target_Name>Anti-DnaK monoclonal antibody 8E2/2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>8E2/2 is an IgG1 monoclonal antibody, generated by immunizing mice with DnaK of E. coli.</Comments>
</Item><Item><Target_ID> 364</Target_ID>
<Target_Name>Pooled typhoid patients' sera (TPS)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Ten TPS were pooled together.</Comments>
</Item><Item><Target_ID> 365</Target_ID>
<Target_Name>U87MG glioblastoma cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 366</Target_ID>
<Target_Name>Thioredoxin-1, Trx-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0AA25</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1F6M, 1KEB, 1M7T, 1OAZ, 1SKR, 1SKS, 1SKW, 1SL0, 1SL1, 1SL2, 1SRX, 1T7P, 1T8E, 1THO, 1TK0, 1TK5, 1TK8, 1TKD, 1TXX, 1X9M, 1X9S, 1X9W, 1XOA, 1XOB, 1ZCP, 1ZYQ, 1ZZY, 2AJQ, 2BTO, 2EIO, 2EIQ, 2EIR, 2FCH, 2FD3, 2H6X, 2H6Y, 2H6Z, 2H70, 2H71, 2H72, 2H73, 2H74, 2H75, 2H76, 2O8V, 2TIR, 2TRX, 3DYR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 367</Target_ID>
<Target_Name>Anti-cathepsin L1/L2 IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 368</Target_ID>
<Target_Name>Omalizumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Omalizumab (Xolair) is a humanized IgG1κ monoclonal antibody against IgE approved for treatment of moderate to severe asthma. Omalizumab tightly binds to free circulating IgE molecules and prevents binding of these molecules to FcεRI on mast cells and basophils and FcεRII on various cell types.</Comments>
</Item><Item><Target_ID> 369</Target_ID>
<Target_Name>Heparin-binding growth factor 2, HBGF-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P09038</Target_Sequence>
<Synonyms>Basic fibroblast growth factor, BFGF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BAS, 1BFB, 1BFC, 1BFF, 1BFG, 1BLA, 1BLD, 1CVS, 1EV2, 1FGA, 1FQ9, 1II4, 1IIL, 2BFH, 2FGF, 4FGF</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 370</Target_ID>
<Target_Name>High affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P12314</Target_Sequence>
<Synonyms>Fc-gamma RIA, FcgammaRIa
Fc-gamma RI, FcRI
CD_antigen=CD64</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3RJD</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 371</Target_ID>
<Target_Name>Serum of a pars planitis patient</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The pars planitis patient is on an active phase of the disease. Patients with PP were considered to be in the active phase of the disease if they had moderate or severe vitritis (with pars plana snowbanks).</Comments>
</Item><Item><Target_ID> 372</Target_ID>
<Target_Name>Anti-hstone H1 monoclonal antibody 16G9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target 16G9 is an IgM monoclonal antibody against histone H1 with MLR-inhibitory activity.</Comments>
</Item><Item><Target_ID> 373</Target_ID>
<Target_Name>CD40 ligand, CD40-L</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P29965</Target_Sequence>
<Synonyms>Tumor necrosis factor ligand superfamily member 5
TNF-related activation protein, AP
T-cell antigen Gp39
CD_antigen=CD154</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ALY, 1I9R, 3LKJ, 3QD6</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 374</Target_ID>
<Target_Name>Agglutinin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q2F1K8</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Helix pomatia (Roman snail) (Edible snail):6536</Target_Source>
<Target_Structure>2CCV, 2CE6, 2CGY, 2CGZ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 375</Target_ID>
<Target_Name>Semiconductor crystalline surface GaAs(100)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 376</Target_ID>
<Target_Name>Semiconductor crystalline surface InAs(100)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 377</Target_ID>
<Target_Name>Semiconductor crystalline surface GaN(0001)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 378</Target_ID>
<Target_Name>Semiconductor crystalline surface ZnSe(100)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 379</Target_ID>
<Target_Name>Semiconductor crystalline surface ZnTe(100)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 380</Target_ID>
<Target_Name>Semiconductor crystalline surface GaAs(111)A
</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 381</Target_ID>
<Target_Name>Semiconductor crystalline surface GaSb(100)
</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 382</Target_ID>
<Target_Name>Semiconductor crystalline surface CdSe(100)
</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 383</Target_ID>
<Target_Name>Glycoprotein Gn, glycoprotein G1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>GI:30313865</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Andes virus:46607</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 384</Target_ID>
<Target_Name>Glycoprotein Gc, glycoprotein G2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>GI:30313865</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Andes virus:46607</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 385</Target_ID>
<Target_Name>S-ribosylhomocysteine lyase</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>B2CMA5</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Streptococcus suis:1307</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 386</Target_ID>
<Target_Name>Anti-hCXCR1 monoclonal antibody 5A12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This mouse monoclonal antibody (clone 5A12; isotype: IgG2b, kappa) is against human CXCR1.</Comments>
</Item><Item><Target_ID> 387</Target_ID>
<Target_Name>Anti-hCXCR2 monoclonal antibody 6C6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This mouse monoclonal antibody (clone 6C6; isotype: IgG1, lamda) is against human CXCR2.</Comments>
</Item><Item><Target_ID> 388</Target_ID>
<Target_Name>Platelet glycoprotein VI, GPVI</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9HCN6</Target_Sequence>
<Synonyms>Glycoprotein 6</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2GI7</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 389</Target_ID>
<Target_Name>Commercially pure titanium, cp-Ti</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 390</Target_ID>
<Target_Name>Avian influenza virus (H9N2) particles</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Avian influenza virus strain A/Chicken/Iran/16/2000(H9N2):566362</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 391</Target_ID>
<Target_Name>Streptavidin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P22629</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Streptomyces avidinii:1895</Target_Source>
<Target_Structure>1DF8, 1HQQ, 1HXL, 1HXZ, 1HY2, 1I9H, 1KFF, 1KL3, 1KL4, 1KL5, 1LCV, 1LCW, 1LCZ, 1LUQ, 1MEP, 1MK5, 1MM9, 1MOY, 1N43, 1N4J, 1N7Y, 1N9M, 1N9Y, 1NBX, 1NC9, 1NDJ, 1NQM, 1PTS, 1RST, 1RSU, 1RXH, 1RXJ, 1RXK, 1SLD, 1SLE, 1SLF, 1SLG, 1SRE, 1SRF, 1SRG, 1SRH, 1SRI, 1SRJ, 1STP, 1STR, 1STS, 1SWA, 1SWB, 1SWC, 1SWD, 1SWE, 1SWF, 1SWG, 1SWH, 1SWJ, 1SWK, 1SWL, 1SWN, 1SWO, 1SWP, 1SWQ, 1SWR, 1SWS, 1SWT, 1SWU, 1VWA, 1VWB, 1VWC, 1VWD, 1VWE, 1VWF, 1VWG, 1VWH, 1VWI, 1VWJ, 1VWK, 1VWL, 1VWM, 1VWN, 1VWO, 1VWP, 1VWQ, 1VWR, 2BC3, 2F01, 2G5L, 2GH7, 2IZA, 2IZB, 2IZC, 2IZD, 2IZE, 2IZF, 2IZG, 2IZH, 2IZI, 2IZJ, 2IZK, 2IZL, 2QCB, 2RTA, 2RTB, 2RTC, 2RTD, 2RTE, 2RTF, 2RTG, 2RTH, 2RTI, 2RTJ, 2RTK, 2RTL, 2RTM, 2RTN, 2RTO, 2RTP, 2RTQ, 2RTR, 2WPU, 2Y3E, 2Y3F, 3MG5, 3PK2, 3RDM, 3RDO, 3RDQ, 3RDS, 3RDU, 3RDX, 3RE5, 3RE6, 3RY1, 3RY2, 3T6F, 3T6L, 4DNE, 4EKV, 4GJS, 4GJV, 4JO6</Target_Structure>
<Comments>Streptavidin is a tetrameric protein purified from the bacterium Streptomyces avidinii. It has an extraordinarily high affinity for biotin; the dissociation constant of the biotin-streptavidin complex is about 10(-14) M, making it one of the strongest non-covalent interactions known in nature.</Comments>
</Item><Item><Target_ID> 392</Target_ID>
<Target_Name>Anti-cEG95 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-cEG95 are purified polyclonal antibodies against conformational epitopes on EG95.</Comments>
</Item><Item><Target_ID> 393</Target_ID>
<Target_Name>Protein SMG7</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q92540</Target_Sequence>
<Synonyms>SMG-7 homolog, hSMG-7
EST1-like protein C</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1YA0</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 394</Target_ID>
<Target_Name>Polystyrene/polyurethane magnetic beads</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The beads are made of polystyrene coated with a surface layer of polyurethane.</Comments>
</Item><Item><Target_ID> 395</Target_ID>
<Target_Name>Anti-neuwiedase polyclonal antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>These polyclonal antibodies are protective against NEU activity.</Comments>
</Item><Item><Target_ID> 396</Target_ID>
<Target_Name>Anti-SPACc polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 397</Target_ID>
<Target_Name>Cadherin-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P12830</Target_Sequence>
<Synonyms>Epithelial cadherin, E-cadherin
Uvomorulin
CAM 120/80
CD_antigen=CD324</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1O6S, 2O72, 2OMT, 2OMU, 2OMV, 2OMX, 2OMY, 2OMZ, 3FF7, 3FF8, 3L6X, 3L6Y</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 398</Target_ID>
<Target_Name>Anti-rabies virus polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibodies were purified from a healthymale volunteer immunized with Rabipur®.</Comments>
</Item><Item><Target_ID> 399</Target_ID>
<Target_Name>Anti-MrkD monoclonal antibody E01</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 400</Target_ID>
<Target_Name>Anti-CTGF monoclonal antibody 7G2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 401</Target_ID>
<Target_Name>Phytophthora capsici extract</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Phytophthora capsici:4784</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 402</Target_ID>
<Target_Name>UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q59650</Target_Sequence>
<Synonyms>UDP-MurNAc-L-Ala-D-Glu:meso-diaminopimelate ligase
Meso-diaminopimelate-adding enzyme
Meso-A2pm-adding enzyme
UDP-N-acetylmuramyl-tripeptide synthetase
UDP-MurNAc-tripeptide synthetase
EC=6.3.2.13</Synonyms>
<Target_Source>Pseudomonas aeruginosa:287</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 403</Target_ID>
<Target_Name>Anti-GA4 monoclonal antibody 8/E9-Gibberellin A4 complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>GI:24158782, GI:24158783</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 404</Target_ID>
<Target_Name>The idiosyncratic pseudoknot structure (h18) formed by the segment 500–545 of 16S rRNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bacillus anthracis:1392</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A synthetic 59-nt RNA/DNA hybrid was composed of a 49-nt RNA segment representing h18 of Bacillus anthracis 16S rRNA followed by a 10-nt poly-dA tail with biotin attached at the 3' end.</Comments>
</Item><Item><Target_ID> 405</Target_ID>
<Target_Name>MMP-2-processed pepsin-extracted collagen IV from human placenta</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 406</Target_ID>
<Target_Name>Hp-AS-pwk RNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli:562</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hp-AS-pwk RNA was taken as a bacterial (Escherichia coli) A-site rRNA model.</Comments>
</Item><Item><Target_ID> 407</Target_ID>
<Target_Name>Human breast cancer cell line MDA-MB-231</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 408</Target_ID>
<Target_Name>Human breast cancer cell line MCF-7</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 409</Target_ID>
<Target_Name>Human IgG-Fc acid conformer</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In therapeutic antibody preparation, acidic pH conditions are generally used for elution from Protein A affinity column of IgG or for its viral inactivation. Exposing IgG to low pH conditions induces conformational changes, leading to the non-native conformer (acid conformer) of human IgG. The acid conformer was easily generated at acidic pH (&lt;pH 3.0) and at moderate temperatures (20-40 °C). The conformer was present in a monomeric form functionally maintaining antigen or Fc receptor binding, but showed a tendency to aggregate with a long incubation time at neutral pH (&gt;25 °C).</Comments>
</Item><Item><Target_ID> 410</Target_ID>
<Target_Name>Anti-BoNT monoclonal antibody F1-40</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:193783174; GI:257348218</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>F1-40 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the light chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection.</Comments>
</Item><Item><Target_ID> 411</Target_ID>
<Target_Name>PDZ10 domain of Multiple PDZ domain protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O75970 [1629-1712]</Target_Sequence>
<Synonyms>Multiple PDZ domain protein alternative name(s):
Multi-PDZ domain protein 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2FCF, 2FNE, 2IWN, 2IWO, 2IWP, 2IWQ, 2O2T, 2OPG, 2QG1</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 412</Target_ID>
<Target_Name>PDZ3 domain of Postsynaptic density protein 95 (PSD-95)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P78352 [313-393]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KEF, 3I4W, 3K82, 3ZRT</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 413</Target_ID>
<Target_Name>Embryonal Rhabdomyosarcoma cell line RD</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 414</Target_ID>
<Target_Name>Ouabain</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 415</Target_ID>
<Target_Name>Disintegrin domain of ADAM 15</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q13444 [421-508]</Target_Sequence>
<Synonyms>ADAM 15 alternative name(s):
Disintegrin and metalloproteinase domain-containing protein 15
Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15, MDC-15
Metalloprotease RGD disintegrin protein
Metargidin
EC=3.4.24.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 416</Target_ID>
<Target_Name>Natriuretic peptides B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16860</Target_Sequence>
<Synonyms>Gamma-brain natriuretic peptide</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1YK1, 3N56</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 417</Target_ID>
<Target_Name>Anti-Human KGF monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 418</Target_ID>
<Target_Name>Anti-BoNT monoclonal antibody F1-2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:224830459</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>F1-2 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the heavy chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. The sequence of the kappa light chain used by F1-2 remain undetermined.</Comments>
</Item><Item><Target_ID> 419</Target_ID>
<Target_Name>Anti-BoNT monoclonal antibody F1-5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:224830461</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>F1-5 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the heavy chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. The sequence of the kappa light chain used by F1-5 remain undetermined.</Comments>
</Item><Item><Target_ID> 420</Target_ID>
<Target_Name>Anti-RBD of SARS-CoV spike protein monoclonal antibody S1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</Comments>
</Item><Item><Target_ID> 421</Target_ID>
<Target_Name>Anti-RBD of SARS-CoV spike protein monoclonal antibody S2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</Comments>
</Item><Item><Target_ID> 422</Target_ID>
<Target_Name>Anti-RBD of SARS-CoV spike protein monoclonal antibody S3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</Comments>
</Item><Item><Target_ID> 423</Target_ID>
<Target_Name>Bone-like mineral (BLM) films; Hydroxyapatite (HA) disks</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 424</Target_ID>
<Target_Name>Rat nose-to-brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 425</Target_ID>
<Target_Name>Monocyte differentiation antigen CD14</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08571</Target_Sequence>
<Synonyms>Myeloid cell-specific leucine-rich glycoprotein
CD_antigen=CD14</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4GLP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 426</Target_ID>
<Target_Name>Zinc oxide, ZnO</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 427</Target_ID>
<Target_Name>NCI-H1299 non-small cell lung cancer cell line </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 428</Target_ID>
<Target_Name>Concanavalin-A, Con A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02866</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canavalia ensiformis (Jack bean) (Horse bean):3823</Target_Source>
<Target_Structure>1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 429</Target_ID>
<Target_Name>ConA and Lentil lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02866; P02870</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canavalia ensiformis (Jack bean) (Horse bean):3823, Lens culinaris (Lentil, Cicer lens):3864</Target_Source>
<Target_Structure>ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin: 1LEM, 1LEN, 1LES, 2LAL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 430</Target_ID>
<Target_Name>ConA, LCA and Pea lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02866, P02870, P02867</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canavalia ensiformis (Jack bean) (Horse bean):3823, Pisum sativum (Garden pea):3888</Target_Source>
<Target_Structure>ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin: 1LEM, 1LEN, 1LES, 2LAL
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 431</Target_ID>
<Target_Name>LCA and Pea lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02870; P02867</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Lens culinaris (Lentil, Cicer lens):3864, Pisum sativum (Garden pea):3888</Target_Source>
<Target_Structure>Lectin: 1LEM, 1LEN, 1LES, 2LAL
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 432</Target_ID>
<Target_Name>ConA and Pea lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02866, P02867</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canavalia ensiformis (Jack bean) (Horse bean):3823, Lens culinaris (Lentil, Cicer lens):3864, Pisum sativum (Garden pea):3888</Target_Source>
<Target_Structure>ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 433</Target_ID>
<Target_Name>Pea lectin and Lentil lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02867, P02870</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Pisum sativum (Garden pea):3888, Lens culinaris (Lentil, Cicer lens):3864</Target_Source>
<Target_Structure>Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN
Lectin: 1LEM, 1LEN, 1LES, 2LAL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 434</Target_ID>
<Target_Name>Anti-NAV polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Equus caballus (Horse)9796</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 435</Target_ID>
<Target_Name>Anti-enteroaggregative Escherichia coli (EAEC) polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 436</Target_ID>
<Target_Name>Anti-serine protease pet autotransporter polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 437</Target_ID>
<Target_Name>Anti-serine protease pic autotransporter polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 438</Target_ID>
<Target_Name>Anti-PfMIF monoclonal antibody B9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 439</Target_ID>
<Target_Name>Anti-lipid-transfer protein polyclonal antibody IgE</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 440</Target_ID>
<Target_Name>Serine-aspartate repeat-containing protein G</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9KI13</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus epidermidis:1282</Target_Source>
<Target_Structure>1R17, 1R19, 2RAL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 441</Target_ID>
<Target_Name>Serine-aspartate repeat-containing protein C</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O86487</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus aureus (strain Newman):426430</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 442</Target_ID>
<Target_Name>GTPase HRas</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01112</Target_Sequence>
<Synonyms>Transforming protein p21
p21ras
H-Ras-1
c-H-ras
Ha-Ras</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>121P, 1AA9, 1AGP, 1BKD, 1CLU, 1CRP, 1CRQ, 1CRR, 1CTQ, 1GNP, 1GNQ, 1GNR, 1HE8, 1IAQ, 1IOZ, 1JAH, 1JAI, 1K8R, 1LF0, 1LF5, 1LFD, 1NVU, 1NVV, 1NVW, 1NVX, 1P2S, 1P2T, 1P2U, 1P2V, 1PLJ, 1PLK, 1PLL, 1Q21, 1QRA, 1RVD, 1WQ1, 1XCM, 1XD2, 1XJ0, 1ZVQ, 1ZW6, 221P, 2C5L, 2CE2, 2CL0, 2CL6, 2CL7, 2CLC, 2CLD, 2EVW, 2LCF, 2Q21, 2QUZ, 2RGA, 2RGB, 2RGC, 2RGD, 2RGE, 2RGG, 2UZI, 2VH5, 2X1V, 3DDC, 3I3S, 3K8Y, 3K9L, 3K9N, 3KKM, 3KKN, 3KUD, 3L8Y, 3L8Z, 3LBH, 3LBI, 3LBN, 3LO5, 3OIU, 3OIV, 3OIW, 3RRY, 3RRZ, 3RS0, 3RS2, 3RS3, 3RS4, 3RS5, 3RS7, 3RSL, 3RSO, 3TGP, 421P, 4DLR, 4DLS, 4DLT, 4DLU, 4DLV, 4DLW, 4DLX, 4DLY, 4DLZ, 4DST, 4DSU, 4EFL, 4EFM, 4EFN, 4Q21, 521P, 5P21, 621P, 6Q21, 721P, 821P</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 443</Target_ID>
<Target_Name>Tyrosine-protein kinase Lck</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P06239</Target_Sequence>
<Synonyms>Proto-oncogene Lck
Lymphocyte cell-specific protein-tyrosine kinase
p56-LCK
LSK
T cell-specific protein-tyrosine kinase
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BHF, 1BHH, 1CWD, 1CWE, 1FBZ, 1H92, 1IJR, 1KIK, 1LCJ, 1LCK, 1LKK, 1LKL, 1Q68, 1Q69, 1QPC, 1QPD, 1QPE, 1QPJ, 1X27, 2IIM, 2OF2, 2OF4, 2OFU, 2OFV, 2OG8, 2PL0, 2ZM1, 2ZM4, 2ZYB, 3AC1, 3AC2, 3AC3, 3AC4, 3AC5, 3AC8, 3ACJ, 3ACK, 3AD4, 3AD5, 3AD6, 3B2W, 3BRH, 3BYM, 3BYO, 3BYS, 3BYU, 3KMM, 3KXZ, 3LCK, 3MPM, 4D8K</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 444</Target_ID>
<Target_Name>IgE of melon-allergic patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 445</Target_ID>
<Target_Name>Brain (brain endothelium)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 446</Target_ID>
<Target_Name>Anti-Toxoplasma gondii tachyzoites monoclonal antibody A4D12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The A4D12 monoclonal antibody was produce by immunized mice with toxoplasma gondii tachyzoites and it was isotyped as IgG1 isotype, kappa light chain.</Comments>
</Item><Item><Target_ID> 447</Target_ID>
<Target_Name>Anti-chCD132 monoclonal antibody C10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody C10 exhibited strong binding of chCD132 on the surface of Con A-activated splenic mononuclear cells and inhibited the lymphocyte proliferation induced by rchIL-2 in dose-dependent manner.</Comments>
</Item><Item><Target_ID> 448</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 7G5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 7G5 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 449</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 6G5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 6G5 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 450</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 2F9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 2F9 is a neutralizing monoclonal antibody of IgG2b isotype.</Comments>
</Item><Item><Target_ID> 451</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 7B7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 7B7 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 452</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 2G11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 2G11 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 453</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 3E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 3E7 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 454</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 8H8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 8H8 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 455</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 4F3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 4F3 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 456</Target_ID>
<Target_Name>Anti-chicken IL-2 monoclonal antibody 6H10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody 6H10 is a neutralizing monoclonal antibody of IgG1 isotype.</Comments>
</Item><Item><Target_ID> 457</Target_ID>
<Target_Name>Human embryonic stem cell line H9</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 458</Target_ID>
<Target_Name>Human embryo carcinoma cell line NCCIT</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 459</Target_ID>
<Target_Name>Anti-TSOL18 monoclonal antibody 17E1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal antibody 17E1 was produced using purified glycosylated TSOL18 produced in Pichia pastoris as the immunogen. It belonged to IgG2a, with kappa light chain.</Comments>
</Item><Item><Target_ID> 460</Target_ID>
<Target_Name>Prostate carcinoma cell line PC3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The PC3 (CRL-1435) cells were derived from a bone metastasis of grade IV prostatic adenocarcinoma.</Comments>
</Item><Item><Target_ID> 461</Target_ID>
<Target_Name>Heart of the normotensive Wistar Kyoto rat (WKY)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 462</Target_ID>
<Target_Name>Heart of the stroke prone spontaneously hypertensive rat (SHRSP)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 463</Target_ID>
<Target_Name>von Willebrand factor, vWF</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04275</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AO3, 1ATZ, 1AUQ, 1FE8, 1FNS, 1IJB, 1IJK, 1M10, 1OAK, 1SQ0, 1U0N, 1UEX, 2ADF, 3GXB, 3HXO, 3HXQ, 3PPV, 3PPW, 3PPX, 3PPY, 3ZQK, 4DMU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 464</Target_ID>
<Target_Name>Lipopolysaccharide (LPS)-activated alveolar macrophages (AMs)</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 465</Target_ID>
<Target_Name>Interleukin 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O42288</Target_Sequence>
<Synonyms>Interleukin-2</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 466</Target_ID>
<Target_Name>IL-2 alpha receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q90WJ4</Target_Sequence>
<Synonyms>Interleukin-2 alpha receptor</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 467</Target_ID>
<Target_Name>Bevacizumab-treated tumor vasculature in nude mice</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 468</Target_ID>
<Target_Name>Mitochondrial fission 1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9Y3D6</Target_Sequence>
<Synonyms>FIS1 homolog, hFis1
Tetratricopeptide repeat protein 11, TPR repeat protein 11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1NZN, 1PC2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 469</Target_ID>
<Target_Name>Troponin I, cardiac muscle</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P19429</Target_Sequence>
<Synonyms>Cardiac troponin I</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1J1D, 1J1E, 1LXF, 1MXL, 1OZS, 2KGB, 2KRD, 2L1R</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 470</Target_ID>
<Target_Name>Troponin I, cardiac muscle</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P23693</Target_Sequence>
<Synonyms>Cardiac troponin I</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 471</Target_ID>
<Target_Name>Tumor necrosis factor receptor superfamily member 10B</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O14763</Target_Sequence>
<Synonyms>Death receptor 5
TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
CD_antigen=CD262</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1D0G, 1D4V, 1DU3, 1ZA3, 2H9G, 4I9X</Target_Structure>
<Comments>Death receptor 5, also known as TNFRSF10B, is a receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis.</Comments>
</Item><Item><Target_ID> 472</Target_ID>
<Target_Name>Receptor tyrosine-protein kinase erbB-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P04626</Target_Sequence>
<Synonyms>p185erbB2
Proto-oncogene c-ErbB-2
Proto-oncogene Neu
Tyrosine kinase-type cell surface receptor HER2
Metastatic lymph node gene 19 protein, MLN 19
CD_antigen=CD340
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1MFG, 1MFL, 1MW4, 1N8Z, 1QR1, 1S78, 2A91, 2JWA, 2KS1, 2L4K, 2N2A, 3BE1, 3H3B, 3MZW, 3N85, 3PP0, 3RCD, 3WLW, 3WSQ, 4GFU, 4HRL, 4HRM, 4HRN, 5K33, 5KWG, 5MY6, 5O4G, 5OB4, 5TQS, 6ATT, 6BGT</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 473</Target_ID>
<Target_Name>Breast cancer cell line BT-474</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 474</Target_ID>
<Target_Name>Pea aphid guts</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Pea aphid (Acyrthosiphon pisum):7029</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 475</Target_ID>
<Target_Name>Purified serum IgG from ankylosing spondylitis patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 476</Target_ID>
<Target_Name>Gap junction alpha-1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08050</Target_Sequence>
<Synonyms>Connexin-43, Cx43
Gap junction 43 kDa heart protein</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure>1R5S, 3CYY</Target_Structure>
<Comments>In fact, the target is recombinant Cx43CT (amino acids 255 to 382 of rCx43).</Comments>
</Item><Item><Target_ID> 477</Target_ID>
<Target_Name>Capsid protein p24, CA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03366</Target_Sequence>
<Synonyms>Gag-Pol polyprotein
Pr160Gag-Pol</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</Target_Source>
<Target_Structure>1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 478</Target_ID>
<Target_Name>C-CANC</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03366</Target_Sequence>
<Synonyms>Gag-Pol polyprotein
Pr160Gag-Pol</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</Target_Source>
<Target_Structure>1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</Target_Structure>
<Comments>The protein C-CANC comprises the C-CA region, SP1 and NC.</Comments>
</Item><Item><Target_ID> 479</Target_ID>
<Target_Name>Murine bone marrow</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 480</Target_ID>
<Target_Name>Murine hematopoietic stem cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 481</Target_ID>
<Target_Name>Chlorine-doped polypyrrole, PPyCl</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 482</Target_ID>
<Target_Name>Human glioma cell lines</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 483</Target_ID>
<Target_Name>Undifferentiated P19 embryonic carcinoma stem cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 484</Target_ID>
<Target_Name>Quinoprotein glucose dehydrogenase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P15877</Target_Sequence>
<Synonyms>Glucose dehydrogenase [pyrroloquinoline-quinone]
Pyrroloquinoline quinone glucose dehydrogenase, PQQGDH, PQQ-glucose dehydrogenase
EC=1.1.5.2</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 485</Target_ID>
<Target_Name>Human saphenous vein vascular smooth muscle cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 486</Target_ID>
<Target_Name>Gastrointestinal tract tissue, GIT tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 487</Target_ID>
<Target_Name>Integrase, IN</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03366 [1160-1447]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</Target_Source>
<Target_Structure>1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 488</Target_ID>
<Target_Name>Bovine serum albumin (BSA)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02769</Target_Sequence>
<Synonyms>Allergen=Bos d 6</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>2L7U, 3V03, 4F5S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 489</Target_ID>
<Target_Name>Harpin hrpZ</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9F0B0</Target_Sequence>
<Synonyms>HrpZ-Psph protein
Harpin-Psph</Synonyms>
<Target_Source>Pseudomonas syringae pv. phaseolicola:319</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 490</Target_ID>
<Target_Name>Aluminum</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 491</Target_ID>
<Target_Name>Mild steel</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 492</Target_ID>
<Target_Name>Anti-phomopsin A monoclonal antibody C3C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 493</Target_ID>
<Target_Name>Anti-AMA-1 monoclonal antibody 5G8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 494</Target_ID>
<Target_Name>Anti-apical membrane protein 1 monoclone antibody 1F9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>monoclone antibody 1F9 against AMA-1</Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 495</Target_ID>
<Target_Name>Apical membrane antigen 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16445</Target_Sequence>
<Synonyms>Merozoite surface antigen</Synonyms>
<Target_Source>Plasmodium chabaudi:5825</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 496</Target_ID>
<Target_Name>Mitochondrial import receptor subunit TOM70</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O94826</Target_Sequence>
<Synonyms>Mitochondrial precursor proteins import receptor
Translocase of outer membrane 70 kDa subunit</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 497</Target_ID>
<Target_Name>Anti-Nef antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 498</Target_ID>
<Target_Name>Protein Nef</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03404</Target_Sequence>
<Synonyms>Negative factor, F-protein
3'ORF</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</Target_Source>
<Target_Structure>1ZEC, 3TB8</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 499</Target_ID>
<Target_Name>1,3-diketones 1-BSA and 2-BSA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02769</Target_Sequence>
<Synonyms>Bovine serum albumin</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>2L7U, 3V03, 4F5S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 500</Target_ID>
<Target_Name>Phosphatidylserine, PS</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phosphatidylserine (PS) is involved in a variety of cellular events, including blood coagulation, phagocytic elimination of aged or pathological red blood cells, intracellular membrane fusion, and activation of protein kinase C.</Comments>
</Item><Item><Target_ID> 501</Target_ID>
<Target_Name>Tom20 missing residues 2-28</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q15388</Target_Sequence>
<Synonyms>Mitochondrial import receptor subunit TOM20 homolog
Mitochondrial 20 kDa outer membrane protein
Outer mitochondrial membrane receptor Tom20</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4APO</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 502</Target_ID>
<Target_Name>[PA63]7 complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P13423</Target_Sequence>
<Synonyms>(Protective antigen)7</Synonyms>
<Target_Source>Bacillus anthracis:1392</Target_Source>
<Target_Structure>1ACC, 1T6B, 1TZN, 1TZO, 3ETB, 3INO, 3KWV, 3MHZ, 3Q8A, 3Q8B, 3Q8C, 3Q8E, 3Q8F, 3TEW, 3TEX, 3TEY, 3TEZ, 4EE2</Target_Structure>
<Comments>Bacillus anthracis secretes a three-component toxin that assembles into complexes after the individual proteins are released by the bacterium. Protective antigen (PA) is the toxin component that targets mammalian cells by binding to the cellular receptors ANTXR1 and ANTXR2. PA is processed by proteases, either in the blood or on the cell surface, into a 63 kDa fragment that can self-associate into ring-shaped heptamers, referred to as [PA63]7.</Comments>
</Item><Item><Target_ID> 503</Target_ID>
<Target_Name>Isotactic poly(methyl methacrylate), st-PMMA</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 504</Target_ID>
<Target_Name>SH3 domain of tyrosine-protein kinase Lck</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P06239 [61-121]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase Lck alternative name(s):
Proto-oncogene Lck
Lymphocyte cell-specific protein-tyrosine kinase
p56-LCK
LSK
T cell-specific protein-tyrosine kinase
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BHF, 1BHH, 1CWD, 1CWE, 1FBZ, 1H92, 1IJR, 1KIK, 1LCJ, 1LCK, 1LKK, 1LKL, 1Q68, 1Q69, 1QPC, 1QPD, 1QPE, 1QPJ, 1X27, 2IIM, 2OF2, 2OF4, 2OFU, 2OFV, 2OG8, 2PL0, 2ZM1, 2ZM4, 2ZYB, 3AC1, 3AC2, 3AC3, 3AC4, 3AC5, 3AC8, 3ACJ, 3ACK, 3AD4, 3AD5, 3AD6, 3B2W, 3BRH, 3BYM, 3BYO, 3BYS, 3BYU, 3KMM, 3KXZ, 3LCK, 3MPM, 4D8K</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 505</Target_ID>
<Target_Name>HUVECs co-cultured with gastric cancer cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Human umbilical vein endothelial cells co-cultured with gastric cancer cells
Co-HUVECs</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 506</Target_ID>
<Target_Name>Paclitaxel (Taxol)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Paclitaxel (Taxol), an effective anticancer agent, is known to bind to tubulin and induce tubulin polymerization.</Comments>
</Item><Item><Target_ID> 507</Target_ID>
<Target_Name>Anti-N domain of human ACE monoclonal antibody 5F1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 508</Target_ID>
<Target_Name>Wistar Kyoto (WKY) rats' kidney</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 509</Target_ID>
<Target_Name>Tumor endothelial cells, TEC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 510</Target_ID>
<Target_Name>Human melanoma cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 511</Target_ID>
<Target_Name>Titanium dioxide, TiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 512</Target_ID>
<Target_Name>Complement receptor type 2, Cr2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P20023</Target_Sequence>
<Synonyms>Complement C3d receptor
Epstein-Barr virus receptor, EBV receptor
CD_antigen=CD21</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GHQ, 1LY2, 1W2R, 1W2S, 2GSX, 3OED</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 513</Target_ID>
<Target_Name>Glutathione S-transferase Mu 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P28161</Target_Sequence>
<Synonyms>GSTM2-2
GST class-mu 2
EC=2.5.1.18</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HNA, 1HNB, 1HNC, 1XW5, 1YKC, 2AB6, 2C4J, 2GTU, 3GTU, 3GUR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 514</Target_ID>
<Target_Name>Anti-gp91-phox Monoclonal antibody CL5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 515</Target_ID>
<Target_Name>HPV-16 E7 oncoprotein (28-LNDSSEEEDEI-38)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03129 [28-38]</Target_Sequence>
<Synonyms>Protein E7</Synonyms>
<Target_Source>Human papillomavirus type 16:333760</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 516</Target_ID>
<Target_Name>PreS region of the large surface antigen (LHB)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03138 [2-63]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979) (HBV-D):490133</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 517</Target_ID>
<Target_Name>TG1 Escherichia coli cells, E.coli</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli:562</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 518</Target_ID>
<Target_Name>Integrin alpha-IIb-beta-3, integrin αIIbβ3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Integrin alpha-IIb: P08514, Integrin beta-3: P05106</Target_Sequence>
<Synonyms>Integrin alpha-IIb alternative name(s):
Platelet membrane glycoprotein IIb
GPalpha IIb, GPIIb
CD_antigen=CD41

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa, GPIIIa
CD_antigen=CD61</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-IIb: 1DPK, 1DPQ, 1KUP, 1KUZ, 1M8O, 1S4W, 1TYE, 2K1A, 2K9J, 2KNC, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3NID, 3NIF, 3NIG, 3T3M, 3T3P
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2L91, 2LJD, 2LJE, 2LJF, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG, 3T3M, 3T3P, 4G1E, 4G1M</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 519</Target_ID>
<Target_Name>Kallikrein-14, hK14</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9P0G3</Target_Sequence>
<Synonyms>Kallikrein-like protein 6, KLK-L6</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 520</Target_ID>
<Target_Name>Ligand-binding domain of androgen receptor(AR)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P10275 [690-919]</Target_Sequence>
<Synonyms>Dihydrotestosterone receptor
Nuclear receptor subfamily 3 group C member 4</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E3G, 1GS4, 1T5Z, 1T63, 1T65, 1XJ7, 1XOW, 1XQ3, 1Z95, 2AM9, 2AMA, 2AMB, 2AO6, 2AX6, 2AX7, 2AX8, 2AX9, 2AXA, 2HVC, 2OZ7, 2PIO, 2PIP, 2PIQ, 2PIR, 2PIT, 2PIU, 2PIV, 2PIW, 2PIX, 2PKL, 2PNU, 2Q7I, 2Q7J, 2Q7K, 2Q7L, 2YHD, 2YLO, 2YLP, 2YLQ, 2Z4J, 3B5R, 3B65, 3B66, 3B67, 3B68, 3BTR, 3L3X, 3L3Z, 3RLJ, 3RLL, 3V49, 3V4A, 3ZQT, 4HLW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 521</Target_ID>
<Target_Name>Interferon-binding domain of human p300</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>IBD of p300</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 522</Target_ID>
<Target_Name>Anti-VP2 monoclonal antibody 2F2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 523</Target_ID>
<Target_Name>Kinase domain of VEGFR2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P35968 [834-1162]</Target_Sequence>
<Synonyms>VEGFR2 alternative name(s):
Vascular endothelial growth factor receptor 2
Kinase insert domain receptor
Protein-tyrosine kinase receptor flk-1
Fetal liver kinase 1, FLK-1
CD_antigen=CD309
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1VR2, 1Y6A, 1Y6B, 1YWN, 2OH4, 2P2H, 2P2I, 2QU5, 2QU6, 2RL5, 2X1W, 2X1X, 2XIR, 3B8Q, 3B8R, 3BE2, 3C7Q, 3CJF, 3CJG, 3CP9, 3CPB, 3CPC, 3DTW, 3EFL, 3EWH, 3KVQ, 3S35, 3S36, 3S37, 3U6J, 3VHE, 3VHK, 3VID, 3VNT, 3VO3, 4AG8, 4AGC, 4AGD, 4ASD, 4ASE</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 524</Target_ID>
<Target_Name>Anti-human VEGF monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 525</Target_ID>
<Target_Name>Estrogen receptor, ER</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P03372</Target_Sequence>
<Synonyms>Estradiol receptor
ER-alpha
Nuclear receptor subfamily 3 group A member 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A52, 1ERE, 1ERR, 1G50, 1GWQ, 1GWR, 1HCP, 1HCQ, 1L2I, 1PCG, 1QKT, 1QKU, 1R5K, 1SJ0, 1UOM, 1X7E, 1X7R, 1XP1, 1XP6, 1XP9, 1XPC, 1XQC, 1YIM, 1YIN, 1ZKY, 2AYR, 2B1V, 2B1Z, 2B23, 2BJ4, 2FAI, 2G44, 2G5O, 2I0J, 2IOG, 2IOK, 2JF9, 2JFA, 2LLO, 2LLQ, 2OCF, 2OUZ, 2P15, 2POG, 2Q6J, 2Q70, 2QA6, 2QA8, 2QAB, 2QE4, 2QGT, 2QGW, 2QH6, 2QR9, 2QSE, 2QXM, 2QXS, 2QZO, 2R6W, 2R6Y, 2YAT, 2YJA, 3CBM, 3CBO, 3CBP, 3DT3, 3ERD, 3ERT, 3HLV, 3HM1, 3L03, 3OS8, 3OS9, 3OSA, 3Q95, 3Q97, 3UU7, 3UUA, 3UUC, 3UUD, 4AA6, 4DMA, 4IU7, 4IUI, 4IV2, 4IV4, 4IVW, 4IVY, 4IW6, 4IW8, 4IWC, 4IWF, 4JC3, 4JDD</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 526</Target_ID>
<Target_Name>60 kDa chaperonin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0A6F5</Target_Sequence>
<Synonyms>Protein Cpn60
GroEL protein</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1AON, 1DK7, 1DKD, 1FY9, 1FYA, 1GR5, 1GRL, 1GRU, 1J4Z, 1JON, 1KID, 1KP8, 1KPO, 1LA1, 1MNF, 1OEL, 1PCQ, 1PF9, 1SS8, 1SVT, 1SX3, 1SX4, 1XCK, 2C7C, 2C7D, 2C7E, 2CGT, 2EU1, 2NWC, 2YEY, 3C9V, 3CAU, 4AAQ, 4AAR, 4AAS, 4AAU, 4AB2, 4AB3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 527</Target_ID>
<Target_Name>Anti-Cyt b monoclonal antibodies 7D5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 528</Target_ID>
<Target_Name>Collagenase 3</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P45452</Target_Sequence>
<Synonyms>Matrix metalloproteinase-13, MMP-13
EC=3.4.24.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1EUB, 1FLS, 1FM1, 1PEX, 1XUC, 1XUD, 1XUR, 1YOU, 1ZTQ, 2D1N, 2E2D, 2OW9, 2OZR, 2PJT, 2YIG, 3ELM, 3I7G, 3I7I, 3KEC, 3KEJ, 3KEK, 3KRY, 3LJZ, 3O2X, 3TVC, 3ZXH, 456C, 4A7B, 830C</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 529</Target_ID>
<Target_Name>Human spermatozoa</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 530</Target_ID>
<Target_Name>Envelope glycoprotein gp120 (SU)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04578 [33-511]</Target_Sequence>
<Synonyms>Glycoprotein 120, gp120</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 (isolate HXB2 group M subtype B) (HIV-1):11706</Target_Source>
<Target_Structure>1AIK, 1DF4, 1DF5, 1DLB, 1G9M, 1GC1, 1GZL, 1K33, 1K34, 1RZJ, 2CMR, 2NY7, 2PV6, 2XRA, 3DNL, 3DNN, 3DNO, 3IDX, 3IDY, 3TYG, 3VIE, 4JPJ, 4JPK</Target_Structure>
<Comments>The surface protein gp120 (SU) attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. This peculiar 2 stage receptor-interaction strategy allows gp120 to maintain the highly conserved coreceptor-binding site in a cryptic conformation, protected from neutralizing antibodies. Surface protein gp120 (SU) may target the virus to gut-associated lymphoid tissue (GALT) by binding host ITGA4/ITGB7 (alpha-4/beta-7 integrins), a complex that mediates T-cell migration to the GALT. The surface protein gp120 is also a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells.</Comments>
</Item><Item><Target_ID> 531</Target_ID>
<Target_Name>Mosquito salivary gland</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Anopheles gambiae (African malaria mosquito):7165</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 532</Target_ID>
<Target_Name>Mosquito midgut lumen</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Anopheles gambiae (African malaria mosquito):7165</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 533</Target_ID>
<Target_Name>TrpE protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00895</Target_Sequence>
<Synonyms>Anthranilate synthase component 1
Anthranilate synthase component I</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 534</Target_ID>
<Target_Name>p85-N-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O00459 [330-425]</Target_Sequence>
<Synonyms>p85 alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit beta
PtdIns-3-kinase regulatory subunit beta
PI3-kinase regulatory subunit beta
PI3K regulatory subunit beta
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta
PtdIns-3-kinase regulatory subunit p85-beta
PI3-kinase subunit p85-beta</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2KT1, 2XS6, 3MTT, 3O5Z</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 535</Target_ID>
<Target_Name>p85-C-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>O00459 [622-716]</Target_Sequence>
<Synonyms>p85 alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit beta
PtdIns-3-kinase regulatory subunit beta
PI3-kinase regulatory subunit beta
PI3K regulatory subunit beta
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta
PtdIns-3-kinase regulatory subunit p85-beta
PI3-kinase subunit p85-beta</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2KT1, 2XS6, 3MTT, 3O5Z</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 536</Target_ID>
<Target_Name>PLCγ1-N-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P19174 [550-657]</Target_Sequence>
<Synonyms>PLCγ1 alternative name(s):
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1
Phosphoinositide phospholipase C-gamma-1
Phospholipase C-gamma-1
PLC-gamma-1
Phospholipase C-II, PLC-II
PLC-148
EC=3.1.4.11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HSQ, 2HSP, 4EY0, 4FBN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 537</Target_ID>
<Target_Name>PLCγ1-C-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P19174 [668-756]</Target_Sequence>
<Synonyms>PLCγ1 alternative name(s):
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1
Phosphoinositide phospholipase C-gamma-1
Phospholipase C-gamma-1
PLC-gamma-1
Phospholipase C-II, PLC-II
PLC-148
EC=3.1.4.11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HSQ, 2HSP, 4EY0, 4FBN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 538</Target_ID>
<Target_Name>GAP-N-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20936 [181-272]</Target_Sequence>
<Synonyms>GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 539</Target_ID>
<Target_Name>GAP-C-SH2 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20936 [351-441]</Target_Sequence>
<Synonyms>GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 540</Target_ID>
<Target_Name>GAP-N+C-SH2 (includes SH3 domain)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20936 [181-441]</Target_Sequence>
<Synonyms>GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 541</Target_ID>
<Target_Name>Integrin alpha-V-beta-6, integrin αVβ6</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-V: P06756, Integrin beta-6: P18564</Target_Sequence>
<Synonyms>Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE, 4G1E, 4G1M</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 542</Target_ID>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-V: P06756, Integrin beta-3: P05106</Target_Sequence>
<Synonyms>Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa, GPIIIa
CD_antigen=CD61</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 543</Target_ID>
<Target_Name>Hyaluronan, HA</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Hyaluronan (HA), a high molecular weight glycosaminoglycan, is expressed abundantly in the extracellular matrix and on cell surfaces.</Comments>
</Item><Item><Target_ID> 544</Target_ID>
<Target_Name>Transferrin receptor protein 1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P02786</Target_Sequence>
<Synonyms>TfR1, TfR, TR, Trfr
T9
p90
CD_antigen=CD71</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CX8, 1DE4, 1SUV, 2NSU, 3KAS, 3S9L, 3S9M, 3S9N</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 545</Target_ID>
<Target_Name>M protein from patient 3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 546</Target_ID>
<Target_Name>M protein from patient 6</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 547</Target_ID>
<Target_Name>Hhydroxyethyl radical-modified bovine serum albumin, BSA-HER</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02769</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>2L7U, 3V03, 4F5S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 548</Target_ID>
<Target_Name>Acetaldehyde-modified bovine serum albumin, BSA-AcH</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02769</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>2L7U, 3V03, 4F5S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 549</Target_ID>
<Target_Name>HIV-1 protease, HIV-1 PR</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q9YQ34</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus:12721</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 550</Target_ID>
<Target_Name>Matrix metalloproteinase-14, MMP-14</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P50281</Target_Sequence>
<Synonyms>Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1
Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP
MMP-X1
EC=3.4.24.80</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BQQ, 1BUV, 3C7X, 3MA2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 551</Target_ID>
<Target_Name>Protein Rev</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P69718</Target_Sequence>
<Synonyms>Regulator of expression of viral proteins
Anti-repression transactivator
ART/TRS</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate HXB3) (HIV-1):11707</Target_Source>
<Target_Structure>3LPH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 552</Target_ID>
<Target_Name>Anti-BLG polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Two eight-week old White New Zealand rabbits were immunised by injection at multiple subcutaneous sites with beta lactoglobulin B.</Comments>
</Item><Item><Target_ID> 553</Target_ID>
<Target_Name>Protein Nef</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03406</Target_Sequence>
<Synonyms>Negative factor, F-protein
3'ORF</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</Target_Source>
<Target_Structure>1AVV, 1AVZ, 1EFN, 4D8D</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 554</Target_ID>
<Target_Name>Protein NefR90</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NefR90 a Nef variant containing an engineered F90R mutation that interferes
with docking of the native Hck RT-loop.</Comments>
</Item><Item><Target_ID> 555</Target_ID>
<Target_Name>Anti-NTX monoclonal antibody BNTX18</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 556</Target_ID>
<Target_Name>Cucumber mosaic virus, CMV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Cucumber mosaic virus (cucumber mosaic cucumovirus):12305</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 557</Target_ID>
<Target_Name>PDZ2 domain of hPTPE1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q12923 [1368-1452]</Target_Sequence>
<Synonyms>hPTPE1 Alternative name(s):
Tyrosine-protein phosphatase non-receptor type 13
Protein-tyrosine phosphatase 1E, PTP-E1
PTP-BAS
Protein-tyrosine phosphatase PTPL1
Fas-associated protein-tyrosine phosphatase 1, FAP-1
EC=3.1.3.48</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1D5G, 1Q7X, 1WCH, 3LNX, 3LNY, 3PDZ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 558</Target_ID>
<Target_Name>Anti-GAD65 monoclonal antibody MICA3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 559</Target_ID>
<Target_Name>Anti-GAD65 monoclonal antibody MICA4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 560</Target_ID>
<Target_Name>Anti-E1 protein polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 561</Target_ID>
<Target_Name>HrNMT</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>N terminal fused His6 NMT</Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 562</Target_ID>
<Target_Name>Glycylpeptide N-tetradecanoyltransferase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P14743</Target_Sequence>
<Synonyms>Peptide N-myristoyltransferase
Myristoyl-CoA:protein N-myristoyltransferase, NMT
Cell division control protein 72
EC=2.3.1.97</Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure>1IIC, 1IID, 2NMT, 2P6E, 2P6F, 2P6G</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 563</Target_ID>
<Target_Name>14-3-3 protein theta</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P27348</Target_Sequence>
<Synonyms>14-3-3 protein tau
14-3-3 protein T-cell
Protein HS1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2BTP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 564</Target_ID>
<Target_Name>Anti-human SP-A monoclonal antibody  PE10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 565</Target_ID>
<Target_Name>Anti-human SP-A monoclonal antibody PC6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 566</Target_ID>
<Target_Name>Human neutrophil cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 567</Target_ID>
<Target_Name>Anti-Bet v 1 polyclonal antibody IgE</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 568</Target_ID>
<Target_Name>Anti-gpIIIa monoclonal antibody Y2/51</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 569</Target_ID>
<Target_Name>Anti-gpIIb/IIIa monoclonal antibody 5B12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 570</Target_ID>
<Target_Name>Anti-human platelet polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 571</Target_ID>
<Target_Name>Anti-chlamydia pneumoniae monoclonal antibody RR-402</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 572</Target_ID>
<Target_Name>Polyclonal sera from patients with C. pneumoniae infection</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 573</Target_ID>
<Target_Name>Anti-SHP-1 monoclonal antibody 6D41</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 574</Target_ID>
<Target_Name>Anti-SHP-1 monoclonal antibody 3E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 575</Target_ID>
<Target_Name>Anti-SHP-1 monoclonal antibody 4E6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 576</Target_ID>
<Target_Name>Texas red fluorophore dye</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 577</Target_ID>
<Target_Name>Rhodamine red fluorophore dye</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 578</Target_ID>
<Target_Name>Oregon green 514 fluorophore dye</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 579</Target_ID>
<Target_Name>Fluorescein fluorophore dye</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 580</Target_ID>
<Target_Name>U1 small nuclear RNA, U1 snRNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 581</Target_ID>
<Target_Name>Anticodon stem and loop of yeast tRNA(Phe) (tRNA(ACPhe))</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Saccharomyces cerevisiae (Baker's yeast):4932</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 582</Target_ID>
<Target_Name>Anti-gG2 monoclonal antibody H5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 583</Target_ID>
<Target_Name>Anti-gG2 monoclonal antibody H7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 584</Target_ID>
<Target_Name>Anti-gG2 monoclonal antibody F11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 585</Target_ID>
<Target_Name>Anti-gG2 monoclonal antibody E5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 586</Target_ID>
<Target_Name>Anti-MAPS monoclonal antibody 9C10 </Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 587</Target_ID>
<Target_Name>Pancreatic alpha-amylase, PA</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00690</Target_Sequence>
<Synonyms>1,4-alpha-D-glucan glucanohydrolase
EC=3.2.1.1</Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure>1BVN, 1DHK, 1HX0, 1JFH, 1KXQ, 1KXT, 1KXV, 1OSE, 1PIF, 1PIG, 1PPI, 1UA3, 1VAH, 1WO2, 3L2L, 3L2M</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 588</Target_ID>
<Target_Name>Anti-c-myc protein monoclonal antibody 9E10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 589</Target_ID>
<Target_Name>pFc' fragments of HAT</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 590</Target_ID>
<Target_Name>Anti-GPIb monoclonal antibody 6B4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 591</Target_ID>
<Target_Name>Anti-GPIb monoclonal antibody 12G1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 592</Target_ID>
<Target_Name>Anti-GPIb monoclonal antibody 12E4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 593</Target_ID>
<Target_Name>Anti-GPIb monoclonal antibody 27A10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 594</Target_ID>
<Target_Name>HLA class II histocompatibility antigen, DRB1-1 beta chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04229</Target_Sequence>
<Synonyms>MHC class II antigen DRB1*1, DR-1, DR1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AQD, 1DLH, 1FYT, 1HXY, 1JWM, 1JWS, 1JWU, 1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1R5I, 1SEB, 1SJE, 1SJH, 1T5W, 1T5X, 2FSE, 2G9H, 2IAM, 2IAN, 2ICW, 2IPK, 2OJE, 2XN9, 3L6F, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 3S4S, 3S5L, 4AEN, 4AH2, 4E41, 4FQX, 4GBX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 595</Target_ID>
<Target_Name>High molecular mass serum fraction</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 596</Target_ID>
<Target_Name>Madin-Darby canine kidney cells strain II, MDCKII</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 597</Target_ID>
<Target_Name>Tobacco plasmodesmal-enriched cell wall fraction, W2 cell fraction</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Nicotiana tabacum (Common tobacco):4097</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 598</Target_ID>
<Target_Name>Human foetal tracheal epithelial cell line CFT-2</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 599</Target_ID>
<Target_Name>Rabbit hyperimmune serum against peptide (MSESHVKISRTIIRGTSPST)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 600</Target_ID>
<Target_Name>Anti-peptide (MSESHVKISRTIIRGTSPST) polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 601</Target_ID>
<Target_Name>Anti-CA monoclonal antibody A-56.36</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 602</Target_ID>
<Target_Name>Anti-Myohemerythrin monoclonal antibody A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was generated against the MHr peptide fragment EVVPHKKMHKDFLEKIGGL(69-87), binding to myohemerythrin strongly with a dissociation constants of 50nM.</Comments>
</Item><Item><Target_ID> 603</Target_ID>
<Target_Name>Anti-Myohemerythrin monoclonal antibody M33</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was generated against the myohemerythrin (MHr) pprotein, binding to MHr with a dissociation constants of 640nM.</Comments>
</Item><Item><Target_ID> 604</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab001</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 605</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab003</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 606</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab004</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 607</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab005</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 608</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab006</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 609</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab007</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 610</Target_ID>
<Target_Name>Tyrosine-protein kinase Yes</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09324</Target_Sequence>
<Synonyms>p61-Yes
EC=2.7.10.2</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 611</Target_ID>
<Target_Name>Anti-HIV-l isotype MN gp120 monoclonal antibody 58.2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:4558278, GI:4558277</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 612</Target_ID>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:693814, GI:693815</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>OV-TL3, raised after immunization with an extract of an endometrioid cancer biopsy, has a reactivity pattern highly restricted to ovarian carcinomas and was shown to react with a surface glycoprotein by molecular cloning of the antigen. Isotype: IgG1, kappa.</Comments>
</Item><Item><Target_ID> 613</Target_ID>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL16</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:693816, GI:693817</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>OV-TL16 was raised after immunization with cyst fluid obtained from a poorly differentiated ovarian carcinoma. Isotype: IgG1, kappa.</Comments>
</Item><Item><Target_ID> 614</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363160</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 615</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363159</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 616</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE13</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363153</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 617</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE14</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:854291</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 618</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE15</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363160</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 619</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE19</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363164</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 620</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE20</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363166</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 621</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363167</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 622</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE22</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363168</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 623</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE23</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363169</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 624</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE24</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363170</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 625</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE25</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363171</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 626</Target_ID>
<Target_Name>Anti-beta-endorphin monoclonal antibody 3-E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This antibody was first described by Gramsch C. et al. on J Neurochem (PMID: 6187900). Its immunogen was a fragment of synthetic human beta-endorphin (YGGF) coupled with polylysine or thyroglobulin. Its isotype: IgG2a.</Comments>
</Item><Item><Target_ID> 627</Target_ID>
<Target_Name>Interleukin-1 receptor type 1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P14778</Target_Sequence>
<Synonyms>IL-1RT-1, IL-1RT1, IL-1R-1
Interleukin-1 receptor type I
Interleukin-1 receptor alpha, IL-1R-alpha
p80
CD121 antigen-like family member A
CD_antigen=CD121a</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1G0Y, 1IRA, 1ITB, 4DEP, 4GAF</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 628</Target_ID>
<Target_Name>E-selectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16581</Target_Sequence>
<Synonyms>Endothelial leukocyte adhesion molecule 1, ELAM-1
Leukocyte-endothelial cell adhesion molecule 2, LECAM2
CD62 antigen-like family member E
CD_antigen=CD62E</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ESL, 1G1T</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 629</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody PAb240</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PAb240 is a mouse monoclonal IgG1 derived by fusion of Sp2 myeloma cells with spleen cells from a mouse immunized with a beta-galactosidase fusion protein containing a p53 domain corresponding to amino acids 156-214 of mammalian origin.</Comments>
</Item><Item><Target_ID> 630</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody DO-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DO-1 is a mouse monoclonal IgG2a derived by fusion of X63Ag 8.653 mouse myeloma cells with spleen cells from a BALB/C mouse immunized with recombinant wild type p53 protein. The epitope maps to amino acids 11-25 of wt and mutant p53 of human origin.</Comments>
</Item><Item><Target_ID> 631</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody DO-7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DO-7 is a mouse monoclonal IgG2b derived from mouse immunized with recombinant wild type p53 protein. The epitope maps to amino acids 20-25 of p53 of human origin.</Comments>
</Item><Item><Target_ID> 632</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody Bp53-11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Bp53-11 is a mouse monoclonal IgG2a derived from mouse immunized with recombinant human p53 protein.</Comments>
</Item><Item><Target_ID> 633</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody Bp53-12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Bp53-12 is a mouse monoclonal IgG2a derived from mouse immunized with recombinant human p53 protein.</Comments>
</Item><Item><Target_ID> 634</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody Bp53-19</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Bp53-19 is a mouse monoclonal IgG derived from mouse immunized with recombinant human p53 protein.</Comments>
</Item><Item><Target_ID> 635</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody PAb421</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PAb421 is a mouse monoclonal IgG2a derived from mouse immunized with synthetic peptide corresponding to aa 371-380 of human p53.</Comments>
</Item><Item><Target_ID> 636</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody PAb122</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PAb122 is a mouse monoclonal IgG2b, kappa.</Comments>
</Item><Item><Target_ID> 637</Target_ID>
<Target_Name>Protein S100-B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02638</Target_Sequence>
<Synonyms>S100 calcium-binding protein B
S-100 protein subunit beta
S-100 protein beta chain</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1CFP, 1MHO, 1PSB, 3CR2, 3CR4, 3CR5, 3GK1, 3GK2, 3GK4, 3IQO, 3IQQ, 3LK0, 3LK1, 3LLE, 3RLZ, 3RM1, 4FQO</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 638</Target_ID>
<Target_Name>Antigen-presenting glycoprotein CD1d1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P11609</Target_Sequence>
<Synonyms>CD_antigen=CD1d.1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1CD1, 1Z5L, 1ZHN, 2AKR, 2FIK, 2GAZ, 2Q7Y, 3ARB, 3ARD, 3ARE, 3ARF, 3ARG, 3AU1, 3G08, 3GML, 3GMM, 3GMN, 3GMO, 3GMP, 3GMQ, 3GMR, 3HE6, 3HE7, 3ILP, 3ILQ, 3MA7, 3O8X, 3O9W, 3QI9, 3QUX, 3QUY, 3QUZ, 3RUG, 3RZC, 3SCM, 3SDA, 3SDC, 3SDD, 3T1F, 3TA3, 3TN0, 3TO4, 3TVM, 3UBX, 4APQ, 4EI5, 4ELM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 639</Target_ID>
<Target_Name>Anti-keratin 19 monoclonal antibody BM19.21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BM19.21 is a subclone of Ks19.2 (Achtstatter, 1988), also monospecific for keratin 19.</Comments>
</Item><Item><Target_ID> 640</Target_ID>
<Target_Name>Anti-keratin 19 monoclonal antibody LE64</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>LE64 is a mouse monoclonal IgG2a, generated against detergent insoluble cytoskeleton extracts from a cultured simple epithelium derived cell line, PtK, cells.</Comments>
</Item><Item><Target_ID> 641</Target_ID>
<Target_Name>Anti-keratin 19 monoclonal antibody KM4.62</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>KM4.62 was reported to be monospecific for keratin 19.</Comments>
</Item><Item><Target_ID> 642</Target_ID>
<Target_Name>Anti-keratin 19 monoclonal antibody LP2K</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>LP2K was reported to be monospecific for keratin 19.</Comments>
</Item><Item><Target_ID> 643</Target_ID>
<Target_Name>Anti-keratin 19 monoclonal antibody BA16</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BA16 is a mouse monoclonal IgG1 derived by fusion of X63Ag 8.653 mouse myeloma cells with spleen cells from a BALB/C mouse immunized with detergent-insoluble extract of human mammary epithelial organoids. BA16 was reported to be monospecific for keratin 19.</Comments>
</Item><Item><Target_ID> 644</Target_ID>
<Target_Name>MAR DNA Affinity Column</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Multimeric wild-type MAR DNA (25)5 (top strand of the monomer sequence: 59-TCTTTAATTTCTAATATATTTAGAAttc-39) was used in the experiment.</Comments>
</Item><Item><Target_ID> 645</Target_ID>
<Target_Name>Purified IgM lamda receptor of the human Burkitt lymphoma cell line SUP-B8</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 646</Target_ID>
<Target_Name>Anti-p22phox monoclonal antibody 44.1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was produced against the Triton X-100-solubilized wheat germ agglutinin and heparin-Ultrogel-purified cytochrome b protein.</Comments>
</Item><Item><Target_ID> 647</Target_ID>
<Target_Name>Anti-gp91phox monoclonal antibody 54.1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was produced against the Triton X-100-solubilized wheat germ agglutinin and heparin-Ultrogel-purified cytochrome b protein.</Comments>
</Item><Item><Target_ID> 648</Target_ID>
<Target_Name>Stromelysin-1, SL-1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08254</Target_Sequence>
<Synonyms>Matrix metalloproteinase-3, MMP-3
Transin-1
EC=3.4.24.17</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1B3D, 1B8Y, 1BIW, 1BM6, 1BQO, 1C3I, 1C8T, 1CAQ, 1CIZ, 1CQR, 1D5J, 1D7X, 1D8F, 1D8M, 1G05, 1G49, 1G4K, 1HFS, 1HY7, 1OO9, 1QIA, 1QIC, 1SLM, 1SLN, 1UEA, 1UMS, 1UMT, 1USN, 2D1O, 2JNP, 2JT5, 2JT6, 2SRT, 2USN, 3OHL, 3OHO, 3USN, 4DPE, 4JA1</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 649</Target_ID>
<Target_Name>Matrilysin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09237</Target_Sequence>
<Synonyms>Pump-1 protease
Uterine metalloproteinase
Matrix metalloproteinase-7, MMP-7
Matrin
EC=3.4.24.23</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1MMP, 1MMQ, 1MMR, 2DDY, 2Y6C, 2Y6DY</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 650</Target_ID>
<Target_Name>Urokinase plasminogen activator surface receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q03405</Target_Sequence>
<Synonyms>U-PAR, uPAR
Monocyte activation antigen Mo3
CD_antigen=CD87</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1YWH, 2FD6, 2I9B, 3BT1, 3BT2, 3U73, 3U74, 4K24, 4QTI</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 651</Target_ID>
<Target_Name>Biotin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence>CID: 171548
SMILES: O=C1N[C@@H]2[C@@H](SC[C@@H]2N1)CCCCC(=O)O</Target_Sequence>
<Synonyms>Vitamin B7, Vitamin H
Coenzyme R, Biopeiderm
PDB component identifier: BTN</Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure>1AVD,1BDO,1BIB,1DF8,1F27,1HXD,1KQS,1LUQ,1MEP,1MK5,1N43,1N9M,1NDJ,1NQM,1STP,1SWD,1SWE,1SWG,1SWK,1SWN,1SWP,1SWR,1SWT,1WBI,1WPY,1XNY,1Y52,1Y55,2AVI,2B8G,2BDO,2C1Q,2C4I,2DTH,2DTO,2DXT,2EJ9,2EJF,2EJG,2F01,2FYK,2GH7,2IZF,2IZG,2IZH,2IZI,2IZJ,2JGS,2RTD,2RTE,2RTF,2RTG,2UYW,2UZ2,2Y3F,2ZGW,2ZSC,3EFR,3EFS,3EW2,3G8C,3IB9,3MG5,3O34,3RDM,3RDO</Target_Structure>
<Comments>Biotin is a water-soluble B-complex vitamin discovered by Bateman in 1916. The Empirical formula of Biotin is C10H16O3N2S, with an unusual structure composed of a ureido (tetrahydroimidizalone) ring fused with a tetrahydrothiophene ring. Biotin is necessary for cell growth, the production of fatty acids, and the metabolism of fats and amino acids. It plays a role in the citric acid cycle, which is the process by which biochemical energy is generated during aerobic respiration. Biotin not only assists in various metabolic reactions but also helps to transfer carbon dioxide. Biotin may also be helpful in maintaining a steady blood sugar level. </Comments>
</Item><Item><Target_ID> 652</Target_ID>
<Target_Name>Proto-oncogene tyrosine-protein kinase Src</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00523</Target_Sequence>
<Synonyms>Proto-oncogene c-Src
pp60c-src, p60-Src</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure>1F1W, 1F2F, 1NLO, 1NLP, 1P13, 1PRL, 1PRM, 1RLP, 1RLQ, 1SRL, 1SRM, 2HWO, 2HWP, 2OIQ, 2PTK, 2QI8, 2QLQ, 2QQ7, 3D7T, 3D7U, 3DQW, 3DQX, 3EL7, 3EL8, 3EN4, 3EN5, 3EN6, 3EN7, 3F3T, 3F3U, 3F3V, 3F3W, 3F6X, 3FJ5, 3G5D, 3G6G, 3G6H, 3GEQ, 3LOK, 3OEZ, 3OF0, 3QLF, 3QLG, 3SVV, 3TZ7, 3TZ8, 3TZ9, 3U4W, 3U51, 3UQF, 3UQG, 4AGW, 4DGG, 4FIC, 4HVU, 4HVV, 4HVW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 653</Target_ID>
<Target_Name>Brain blood vessels</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 654</Target_ID>
<Target_Name>Kidney blood vessels</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 655</Target_ID>
<Target_Name>Anti-G(o) monoclonal antibody 3E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>3E7 is a mouse monoclonal IgG1 derived by fusion of Sp2 myeloma cells with spleen cells from a mouse immunized with purified brain G-proteins from either human or bovine.</Comments>
</Item><Item><Target_ID> 656</Target_ID>
<Target_Name>Erythropoietin receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P19235</Target_Sequence>
<Synonyms>EPO-R</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CN4, 1EBA, 1EBP, 1EER, 1ERN, 2JIX, 2MV6, 4Y5V, 4Y5X, 4Y5Y</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 657</Target_ID>
<Target_Name>Tyrosine-protein kinase Blk</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P51451</Target_Sequence>
<Synonyms>B lymphocyte kinase
p55-Blk
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 658</Target_ID>
<Target_Name>Tyrosine-protein kinase SYK</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P43405</Target_Sequence>
<Synonyms>Spleen tyrosine kinase
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A81, 1CSY, 1CSZ, 1XBA, 1XBB, 1XBC, 3BUW, 3EMG, 3FQE, 3FQH, 3FQS, 3SRV, 3TUB, 3TUC, 3TUD, 3VF8, 3VF9, 4DFL, 4DFN, 4F4P, 4FL1, 4FL2, 4FL3, 4FYN, 4FYO, 4FZ6</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 659</Target_ID>
<Target_Name>Toxic shock syndrome toxin-1, TSST-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P06886</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus aureus:1280</Target_Source>
<Target_Structure>1AW7, 1QIL, 1TS2, 1TS3, 1TS4, 1TS5, 2QIL, 2TSS, 3TSS, 4TSS, 5TSS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 660</Target_ID>
<Target_Name>Anti-HBsAg polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Chimpanzee:9598</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 661</Target_ID>
<Target_Name>Tyrosine-protein kinase ITK/TSK</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q03526</Target_Sequence>
<Synonyms>T-cell-specific kinase
IL-2-inducible T-cell kinase
Kinase EMT
Kinase TLK
EC=2.7.10.2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1AWJ, 1LUI, 1LUK, 1LUM, 1LUN, 2ETZ, 2EU0, 2K79, 2K7A, 2RN8, 2RNA, 3S9K</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 662</Target_ID>
<Target_Name>HLA class II histocompatibility antigen DR13</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01903, Q5Y7A7</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>MHC class II antigen DRA: 1A6A, 1AQD, 1BX2, 1D5M, 1D5X, 1D5Z, 1D6E, 1DLH, 1FV1, 1FYT, 1H15, 1HQR, 1HXY, 1J8H, 1JWM, 1JWS, 1JWU, 1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1R5I, 1SEB, 1SJE, 1SJH, 1T5W, 1T5X, 1YMM, 1ZGL, 2FSE, 2G9H, 2IAM, 2IAN, 2ICW, 2IPK, 2OJE, 2Q6W, 2SEB, 2WBJ, 2XN9, 3C5J, 3L6F, 3O6F, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 3S4S, 3S5L, 3T0E, 4AEN, 4AH2, 4E41, 4FQX, 4GBX, 4H1L</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 663</Target_ID>
<Target_Name>Integrin alpha-6-beta-1, integrin α6β1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-6: P23229, Integrin beta-1: P05556</Target_Sequence>
<Synonyms>Integrin alpha-6 alternative name(s):
VLA-6
CD49 antigen-like family member F
CD_antigen=CD49f

Integrin beta-1 alternative name(s):
Fibronectin receptor subunit beta
VLA-4 subunit beta
CD_antigen=CD29</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin beta-1: 3G9W, 3T9K, 3VI3, 3VI4, 4DX9</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 664</Target_ID>
<Target_Name>Intercellular adhesion molecule 1, ICAM-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P05362</Target_Sequence>
<Synonyms>Major group rhinovirus receptor
CD_antigen=CD54</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1D3E, 1D3I, 1D3L, 1IAM, 1IC1, 1MQ8, 1P53, 1Z7Z, 2OZ4, 3TCX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 665</Target_ID>
<Target_Name>Anti-CD80 monoclonal antibody L307.4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgG1, kappa</Comments>
</Item><Item><Target_ID> 666</Target_ID>
<Target_Name>Alpha-bungarotoxin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P60615, P60616</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bungarus multicinctus (Many-banded krait):8616</Target_Source>
<Target_Structure>Alpha-BTX A31: 1ABT, 1BXP, 1HAA, 1HAJ, 1HC9, 1HOY, 1IDG, 1IDH, 1IDI, 1IDL, 1IK8, 1IKC, 1JBD, 1KC4, 1KFH, 1KL8, 1L4W, 1LJZ, 1RGJ, 2ABX, 2BTX
Alpha-BTX V31:1HC9, 2QC1</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 667</Target_ID>
<Target_Name>Anti-MSP1 monoclonal antibody D14-3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>D14-3 is a monoclonal antibody raised against the the Mr 42000 C-terminal fragment (Pv42) of Plasmodium vivax merozoite surface protein 1 (PvMSPl).</Comments>
</Item><Item><Target_ID> 668</Target_ID>
<Target_Name>Calmodulin, CaM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04353</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Spinacia oleracea (Spinach):3562</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 669</Target_ID>
<Target_Name>Aequorin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07164, P02592</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Aequorea victoria (Jellyfish):6100</Target_Source>
<Target_Structure>1SL8, 1EJ3, 1UHH, 1UHI, 1UHJ, 1UHK
 </Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 670</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody GV1A8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GV1A8 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gp120/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</Comments>
</Item><Item><Target_ID> 671</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody GV4D3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GV4D3 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gp120/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</Comments>
</Item><Item><Target_ID> 672</Target_ID>
<Target_Name>Anti-GXM monoclonal antibody 2E9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>2E9 is a human monoclonal antibody (IgM, lamda) elicited by the investigational cryptococcal capsular polysaccharide vaccine glucuronoxylomannan-tetanus toxoid (GXM-TT).</Comments>
</Item><Item><Target_ID> 673</Target_ID>
<Target_Name>Anti-dystrophin monoclonal antibody MANDYS142</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MANDYS142 was raised against the central rod region of dystrophin.</Comments>
</Item><Item><Target_ID> 674</Target_ID>
<Target_Name>Anti-DNA monoclonal antibody F14.6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>F14.6 is a monoclonal IgG2a polyreactive antibody obtained from the splenocytes of an 8-month-old (NZB x NZW)Fl mouse that spontaneously developed a lupus-like syndrome, after fusion with X63 myeloma cells.</Comments>
</Item><Item><Target_ID> 675</Target_ID>
<Target_Name>Anti-DNA monoclonal antibody J20.8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>J20.8 is a monoclonal IgG2a polyreactive antibody obtained from the splenocytes of an 8-month-old (NZB x NZW)Fl mouse that spontaneously developed a lupus-like syndrome, after fusion with X63 myeloma cells.</Comments>
</Item><Item><Target_ID> 676</Target_ID>
<Target_Name>Tissue-type plasminogen activator</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00750</Target_Sequence>
<Synonyms>t-plasminogen activator, t-PA, tPA
INN=Alteplase
INN=Reteplase</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A5H, 1BDA, 1PK2, 1PML, 1RTF, 1TPG, 1TPK, 1TPM, 1TPN</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 677</Target_ID>
<Target_Name>Anti-PSM monoclonal antibody 7E11-C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>7E11-C5 is a monoclonal antibody (IgG2a, kappa) against prostate-specific membrane antigen (PSMA).</Comments>
</Item><Item><Target_ID> 678</Target_ID>
<Target_Name>Calmodulin, CaM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P62157</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1A29, 1AK8, 1CDM, 1CM1, 1CM4, 1CMF, 1CMG, 1DEG, 1FW4, 1LIN, 1PRW, 1QIV, 1QIW, 1XA5, 2F2O, 2F2P, 2FOT, 3IF7</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 679</Target_ID>
<Target_Name>Thomsen-Friedenreich antigen (T antigen, TF antigen)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Thomsen-Friedenreich (TF) antigen is a precursor structure of MN blood group antigens and is also expressed by about 90% of human carcinomas. The immunodominant group of TF antigen is β-galactosyl(1-3)-α-N-acetylglactosamine.</Comments>
</Item><Item><Target_ID> 680</Target_ID>
<Target_Name>Protease precursor, pPR</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10210</Target_Sequence>
<Synonyms>Capsid protein P40
Virion structural protein UL26</Synonyms>
<Target_Source>Human herpesvirus 1 (strain 17) (HHV-1) (Human herpes simplex virus 1):10299</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 681</Target_ID>
<Target_Name>Anti-Hantaan virus glycoprotein G2 monoclonal antibody mAbGDO5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 682</Target_ID>
<Target_Name>Anti-P53 monoclonal antibody mAbBp53-11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 683</Target_ID>
<Target_Name>Phosphoenolpyruvate-protein phosphotransferase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08839</Target_Sequence>
<Synonyms>Phosphotransferase system, enzyme I
EC=2.7.3.9</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1EZA, 1EZB, 1EZC, 1EZD, 1ZYM, 2EZA, 2EZB, 2EZC, 2HWG, 2KX9, 2L5H, 2MP0, 2XDF, 3EZA, 3EZB, 3EZE</Target_Structure>
<Comments>General (non sugar-specific) component of the phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS). This major carbohydrate active-transport system catalyzes the phosphorylation of incoming sugar substrates concomitantly with their translocation across the cell membrane. Enzyme I transfers the phosphoryl group from phosphoenolpyruvate (PEP) to the phosphoryl carrier protein (HPr).</Comments>
</Item><Item><Target_ID> 684</Target_ID>
<Target_Name>Anti-preS1 monoclonal antibody MA18/7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MA18/7 is a monoclonal mouse IgG1 produced after immunization of mice with HBV virions of the ay subtype.</Comments>
</Item><Item><Target_ID> 685</Target_ID>
<Target_Name>Anti-C5a monoclonal antibody 2925</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 2925 was raised against the nonapeptide ISHKDMQLG of C5a(65-73).</Comments>
</Item><Item><Target_ID> 686</Target_ID>
<Target_Name>Anti-c-myc monoclonal antibody MYC-X-5/1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MYC-X-5/1 is a monoclonal antibody (IgG2a, kappa) derived by fusion of SP2/0 mouse myeloma cells with spleen cells from a Balb/c mouse immunized with recombinant human c-myc protein.</Comments>
</Item><Item><Target_ID> 687</Target_ID>
<Target_Name>Caveolin-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P33724</Target_Sequence>
<Synonyms>Vesicular integral-membrane protein VIP21</Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 688</Target_ID>
<Target_Name>Anti-FIV monoclonal antibody 3e3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The 3e3 monoclonal antibody was derived by fusion of mouse myeloma cells with spleen cells from a Balb/c mouse immunized with a synthetic peptide from the surface glycoprotein (396-415) of the feline immunodeficiency virus coupled to BSA.</Comments>
</Item><Item><Target_ID> 689</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody A32</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb A32 is a monoclonal human IgG1 obtained from immortalized antibody-producing peripheral cell clones from individuals infected with HIV-1. Human MAb A32 was shown to recognize gpl20 derived from most (&gt;93%) HIV-1 clade B isolates.</Comments>
</Item><Item><Target_ID> 690</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody 19b</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 19b is a monoclonal human IgG1 obtained from immortalized antibody-producing peripheral cell clones from individuals infected with HIV-1. The ability of MAb 19b to neutralize laboratory-adapted strains of HIV-1, neutralize primary isolates of HIV-1, bind display phage with sequences mimicking the noncontiguous determinant in gpl20 V3 region, and to interfere in the interaction of gpl20 and CCR5 in infectivity of CD4+ cells has been reported.</Comments>
</Item><Item><Target_ID> 691</Target_ID>
<Target_Name>HMG box 1 domain of high mobility group protein B1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P09429[9-79]</Target_Sequence>
<Synonyms>High mobility group protein B1 alternative name(s):
High mobility group protein 1, HMG-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2LY4, 2YRQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 692</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody 447-52D</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 447-52D (IgG3, lamda) recognizes the most prevalent clade B V3 region apex sequence, GPXR.</Comments>
</Item><Item><Target_ID> 693</Target_ID>
<Target_Name>Anti-gp41 monoclonal antibody 50-69</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgG2 kappa</Comments>
</Item><Item><Target_ID> 694</Target_ID>
<Target_Name>Mice carrying human MDA-MB-435 breast carcinoma xenografts</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 695</Target_ID>
<Target_Name>Protein Vpr</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05928</Target_Sequence>
<Synonyms>Viral protein R
R ORF protein</Synonyms>
<Target_Source>Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 696</Target_ID>
<Target_Name>CD81 antigen</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P60033</Target_Sequence>
<Synonyms>26 kDa cell surface protein TAPA-1
Target of the antiproliferative antibody 1
Tetraspanin-28, Tspan-28
CD_antigen: CD81</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1G8Q, 1IV5</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 697</Target_ID>
<Target_Name>Chaperone surA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0ABZ6</Target_Sequence>
<Synonyms>Peptidyl-prolyl cis-trans isomerase surA, PPIase surA
Rotamase surA
Survival protein A</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1M5Y, 2PV1, 2PV2, 2PV3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 698</Target_ID>
<Target_Name>SurA (delta-P2)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0ABZ6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1M5Y, 2PV1, 2PV2, 2PV3</Target_Structure>
<Comments>An expression vector for a SurA deletion lacking the second P2 parvulin-like domain (SurA(delta P2), residues 21-281 and 390-428) was created using the overlap-extension methodology.</Comments>
</Item><Item><Target_ID> 699</Target_ID>
<Target_Name>Anti-b558 monoclonal antibody NL7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 700</Target_ID>
<Target_Name>Monoclonal antibody 5E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MoAb 5E8 (IgG1 subclass) is against an antigen presenton the bile canalicular membrane of rat hepatocytes.</Comments>
</Item><Item><Target_ID> 701</Target_ID>
<Target_Name>Anti-GXM monoclonal antibody 2H1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:2914305; GI:2914304</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>2H1P</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 702</Target_ID>
<Target_Name>Proximal convoluted tubules, PCT</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 703</Target_ID>
<Target_Name>Atherosclerotic lesion surfaces</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 704</Target_ID>
<Target_Name>Anti-estradiol monoclonal antibody E2-15</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 705</Target_ID>
<Target_Name>Anti-BTx-A monoclonal antibody BT57-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 706</Target_ID>
<Target_Name>Anti-BTx-A monoclonal antibody BT150-3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 707</Target_ID>
<Target_Name>Anti-glutamic acid decarboxylase monoclonal antibody GAD-6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GAD-6, a murine IgG2a monoclonal antibody (mAb) specific for the 65 kDa isoform of glutamic acid decarboxylase (GAD65) (Chang and Gottlieb, 1988)</Comments>
</Item><Item><Target_ID> 708</Target_ID>
<Target_Name>Anti-glutamic acid decarboxylase monoclonal antibody N-mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>N-mAb (GC3208, clone 11) is a murine IgG1 mAb that specifically recognises resi-dues 4-17 of GAD65 (Ziegler et al., 1994).</Comments>
</Item><Item><Target_ID> 709</Target_ID>
<Target_Name>Anti-glutamic acid decarboxylase monoclonal antibody C-mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C-mAb (GC3108, clone 111) is a murine IgG1 mAb that recognises the C-terminus of GAD65 and GAD67 (residues 572-585 of GAD65) (Ziegler et al., 1996).</Comments>
</Item><Item><Target_ID> 710</Target_ID>
<Target_Name>Vascular smooth muscle cells, VSMC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 711</Target_ID>
<Target_Name>Murine microglial cell line EOC 20</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 712</Target_ID>
<Target_Name>LNCaP prostate carcinoma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 713</Target_ID>
<Target_Name>Fibroblast growth factor receptor 1, FGFR-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P11362</Target_Sequence>
<Synonyms>Basic fibroblast growth factor receptor 1 (BFGFR or bFGF-R-1)
Fms-like tyrosine kinase 2 (FLT-2)
N-sam
Proto-oncogene c-Fgr
CD_antigen: CD331</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AGW, 1CVS, 1EVT, 1FGI, 1FGK, 1FQ9, 1XR0, 2CR3, 2FGI, 3C4F, 3DPK, 3GQI, 3GQL, 3JS2, 3KRJ, 3KRL, 3KXX, 3KY2, 3OJV, 3RHX, 3TT0, 4F63, 4F64, 4F65, 4NK9, 4NKA, 4NKS, 4RWI, 4RWJ, 4RWK, 4RWL, 4UWB, 4UWC, 4UWY, 4V01, 4V04, 4V05, 4WUN, 4ZSA, 5A46, 5A4C, 5AM6, 5AM7, 5B7V, 5EW8, 5FLF, 5O49, 5O4A, 5UQ0, 5UR1, 5VND, 5W21, 5W59, 5ZV2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 714</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody 5E4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 715</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody 5E4 and H117</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 716</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody H117</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 717</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody 5A10 and 4G10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 718</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody 4G10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 719</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody H50</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 720</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody H50 and 9C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 721</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody 9C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 722</Target_ID>
<Target_Name>Capsid protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03148</Target_Sequence>
<Synonyms>Core protein
Core antigen
HBcAg
p21.5</Synonyms>
<Target_Source>Hepatitis B virus genotype A2 subtype adw2 (strain Rutter 1979) (HBV-A):480116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 723</Target_ID>
<Target_Name>Fibroblast growth factor receptor 2, FGFR-2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P21802</Target_Sequence>
<Synonyms>Keratinocyte growth factor receptor
K-sam
CD_antigen=CD332</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1DJS, 1E0O, 1EV2, 1GJO, 1II4, 1IIL, 1NUN, 1OEC, 1WVZ, 2FDB, 2PSQ, 2PVF, 2PVY, 2PWL, 2PY3, 2PZ5, 2PZP, 2PZR, 2Q0B, 3B2T, 3CAF, 3CLY, 3CU1, 3DAR, 3EUU, 3OJ2, 3OJM, 3RI1, 4J23, 4J95, 4J96, 4J97, 4J98, 4J99</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 724</Target_ID>
<Target_Name>Alzheimer's disease specific monoclonal antibody MN423</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 725</Target_ID>
<Target_Name>Anti-LOS polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 726</Target_ID>
<Target_Name>Monoclonal antibody HC-10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb HC-10 (IgG2a) which recognizes a determinant preferentially expressed on all β2m-free HLA-B and -C HC and on β2m-free HLA-A3, A10, A28, A29, A30, A31, A32, and A33 HC.</Comments>
</Item><Item><Target_ID> 727</Target_ID>
<Target_Name>Zinc ion, Zn(2+)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 728</Target_ID>
<Target_Name>Integrin alpha-M-beta-2, integrin αMβ2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-M: P11215, Integrin beta-2: P05107</Target_Sequence>
<Synonyms>Integrin alpha-M alternative name(s):
Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 729</Target_ID>
<Target_Name>Cortical collecting duct, CCD</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 730</Target_ID>
<Target_Name>Mouse skeletal muscles</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 731</Target_ID>
<Target_Name>Anti-C.pneumoniae monoclonal antibody 8A6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 732</Target_ID>
<Target_Name>Human submucosal-gland carcinoma, Calu-3 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 733</Target_ID>
<Target_Name>Cell division protein ftsA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0ABH0</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 734</Target_ID>
<Target_Name>Human urothelial cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 735</Target_ID>
<Target_Name>Allergen-specific IgE-mimicking monoclonal antibody 2A1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Six-week-old BALB/c mice were each injected intraperitoneally with 50 μg of an equal mixture of total proteins from rye, Bermuda and timothy grass pollens in Hunter\'s Titermax adjuvant (CytRx, Athens, GA, USA). Then mAb 2A1 was puri¢ed by protein G chromatography.</Comments>
</Item><Item><Target_ID> 736</Target_ID>
<Target_Name>RG2 rat glioma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 737</Target_ID>
<Target_Name>Integrin alpha-V-beta-5, integrin αvβ5</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-V: P06756, Integrin beta-5: P18084</Target_Sequence>
<Synonyms>Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE, 4G1E, 4G1M
</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 738</Target_ID>
<Target_Name>Peripheral-type benzodiazepine receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q541E3</Target_Sequence>
<Synonyms>Putative uncharacterized protein
Translocator protein</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 739</Target_ID>
<Target_Name>Chaperone protein hscA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0A6Z1</Target_Sequence>
<Synonyms>Hsc66</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1U00</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 740</Target_ID>
<Target_Name>Serum antibodies with Lyme disease</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 741</Target_ID>
<Target_Name>Beta-lactamase TEM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P62593</Target_Sequence>
<Synonyms>TEM-1
TEM-2
TEM-3
TEM-4
TEM-5
TEM-6
TEM-8/CAZ-2
TEM-16/CAZ-7
TEM-24/CAZ-6
IRT-4
Penicillinase</Synonyms>
<Target_Source>Escherichia coli:562</Target_Source>
<Target_Structure>1AXB, 1BT5, 1BTL, 1CK3, 1ERM, 1ERO, 1ERQ, 1ESU, 1FQG, 1JTD, 1JTG, 1JVJ, 1JWP, 1JWV, 1JWZ, 1LHY, 1LI0, 1LI9, 1M40, 1NXY, 1NY0, 1NYM, 1NYY, 1PZO, 1PZP, 1S0W, 1TEM, 1XPB, 1XXM, 1YT4, 1ZG4, 1ZG6, 2B5R, 2V1Z, 2V20, 3C7U, 3C7V, 3CMZ, 3DTM, 3JYI, 3TOI, 4DXB, 4DXC, 4GKU, 4IBR, 4IBX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 742</Target_ID>
<Target_Name>BAG family molecular chaperone regulator 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99933</Target_Sequence>
<Synonyms>BAG-1
Bcl-2-associated athanogene 1
HAP46
</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HX1, 1WXV, 3FZF, 3FZH, 3FZK, 3FZL, 3FZM, 3LDQ, 3M3Z</Target_Structure>
<Comments>BAG family molecular chaperone regulator 1 is a protein that inhibits the chaperone activity of HSP70/HSC70 by promoting substrate release. It has anti-apoptotic activity through inhibiting the pro-apoptotic function of PPP1R15A.</Comments>
</Item><Item><Target_ID> 743</Target_ID>
<Target_Name>Polarized human umbilical vein endothelial (HUVE) cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 744</Target_ID>
<Target_Name>C-C chemokine receptor type 3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P51677</Target_Sequence>
<Synonyms>C-C CKR-3, CC-CKR-3, CCR-3, CCR3, CKR3Eosinophil eotaxin receptor
CD_antigen=CD193</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 745</Target_ID>
<Target_Name>Eotaxin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P51671</Target_Sequence>
<Synonyms>C-C motif chemokine 11
Small-inducible cytokine A11
Eosinophil chemotactic protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1EOT, 2EOT</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 746</Target_ID>
<Target_Name>Botulinum neurotoxin A light chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P18645 [2-448]</Target_Sequence>
<Synonyms>Botulinum neurotoxin A alternative name(s):
Botulinum neurotoxin type A, BoNT/A
Bontoxilysin-A, BOTOX</Synonyms>
<Target_Source>Clostridium botulinum:1491</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 747</Target_ID>
<Target_Name>Botulinum neurotoxin B light chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10844 [2-441]</Target_Sequence>
<Synonyms>Botulinum neurotoxin B alternative name(s):
Botulinum neurotoxin type B, BoNT/B
Bontoxilysin-B
</Synonyms>
<Target_Source>Clostridium botulinum:1491</Target_Source>
<Target_Structure>1EPW, 1F31, 1F82, 1G9A, 1G9B, 1G9C, 1G9D, 1I1E, 1S0B, 1S0C, 1S0D, 1S0E, 1S0F, 1S0G, 1Z0H, 2ETF, 2NM1, 2NP0, 2XHL, 3ZUQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 748</Target_ID>
<Target_Name>Botulinum neurotoxin C1 light chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P18640 [2-449]</Target_Sequence>
<Synonyms>Botulinum neurotoxin C1 alternative name(s):
Botulinum neurotoxin type C1, BoNT/C1
Bontoxilysin-C1
</Synonyms>
<Target_Source>Clostridium botulinum:1491</Target_Source>
<Target_Structure>2QN0, 3DEB, 3N7K, 3R4S, 3R4U</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 749</Target_ID>
<Target_Name>Cellulose-binding domain (CBD)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 750</Target_ID>
<Target_Name>DNA topoisomerase 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P11387</Target_Sequence>
<Synonyms>DNA topoisomerase I
EC=5.99.1.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A31, 1A35, 1A36, 1EJ9, 1K4S, 1K4T, 1LPQ, 1NH3, 1R49, 1RR8, 1RRJ, 1SC7, 1SEU, 1T8I, 1TL8</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 751</Target_ID>
<Target_Name>Anti-JL1 leukemia-specific monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 752</Target_ID>
<Target_Name>Purified IgGs from serum of prostate cancer patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 753</Target_ID>
<Target_Name>Purified IgGs from serum of prostate cancer patient 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 754</Target_ID>
<Target_Name>Purified IgGs from serum of prostate cancer patient 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 755</Target_ID>
<Target_Name>Mycobacterium paratuberculosis</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mycobacterium paratuberculosis:1770</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 756</Target_ID>
<Target_Name>Deoxyribonuclease-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>O00115, Q8WZ79</Target_Sequence>
<Synonyms>Deoxyribonuclease-2-alpha alternative name(s):
Deoxyribonuclease II alpha, DNase II alpha
Acid DNase
Lysosomal DNase II
R31240_2
EC=3.1.22.1

Deoxyribonuclease-2-beta alternative name(s):
Deoxyribonuclease II beta, DNase II beta
DNase2-like acid DNase
DNase II-like acid DNase
Endonuclease DLAD
EC=3.1.22.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 757</Target_ID>
<Target_Name>Anti-human IFN-b monoclonal antibody YSB-2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 758</Target_ID>
<Target_Name>P-selectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16109</Target_Sequence>
<Synonyms>Granule membrane protein 140, GMP-140
Platelet activation dependent granule-external membrane protein, PADGEM
Leukocyte-endothelial cell adhesion molecule 3, LECAM3
CD62 antigen-like family member P
CD_antigen=CD62P</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FSB, 1G1Q, 1G1R, 1G1S, 1HES</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 759</Target_ID>
<Target_Name>Anti-L2/HNK-1 monoclonal antibody L2-412</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 760</Target_ID>
<Target_Name>Cholesteryl ester transfer protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P47896</Target_Sequence>
<Synonyms>Lipid transfer protein I</Synonyms>
<Target_Source>Macaca fascicularis (Crab eating macaque) (Cynomolgus monkey):9541</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 761</Target_ID>
<Target_Name>IgG from the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 762</Target_ID>
<Target_Name>Anti-syndecan-1 monoclonal antibody B-B2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The isotype of B-B2 is IgG2b.</Comments>
</Item><Item><Target_ID> 763</Target_ID>
<Target_Name>Anti-syndecan-1 monoclonal antibody B-B4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The isotype of B-B2 is IgG1.</Comments>
</Item><Item><Target_ID> 764</Target_ID>
<Target_Name>MDDQRDLISNNEQLK peptide</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04233 [17-30]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A6A, 1ICF, 1IIE, 1L3H, 1MUJ, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 4AEN, 4AH2</Target_Structure>
<Comments>MDDQRDLISNNEQLK is a synthetic peptide derived from the cytosolic tail of MHC class II associated invariant chain (Ii, HLA class II histocompatibility antigen gamma chain, CD74). This peptide contained a leucine class endosomal sorting signal (LI), known to be recognised as an autonomous functional unit during targeting of class II complexes to antigen processing compartments. The C-terminal lysine was included to allow biotinylation at both ends, as biotin is attached to free amino groups.</Comments>
</Item><Item><Target_ID> 765</Target_ID>
<Target_Name>HMG box 2 domain of high mobility group protein B1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P09429 [95-163]</Target_Sequence>
<Synonyms>High mobility group protein B1 alternative name(s):
High mobility group protein 1, HMG-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2LY4, 2YRQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 766</Target_ID>
<Target_Name>Anti-chicken GAD monoclonal antibody GAD1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GAD1 was derived from a mouse immunized with glutamate decarboxylase (GAD) from chicken brain. It reacts with a conformational epitope of GAD, and does not react by Western blotting.</Comments>
</Item><Item><Target_ID> 767</Target_ID>
<Target_Name>Constant region of humanized anti-Tac monoclonal antibody (HAT)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 768</Target_ID>
<Target_Name>Anti-mucin monoclonal antibody C595</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C595 is a murine IgG3 subclass monoclonal antibody which was raised by immunisation of BALB/c mice with human urinary mucin obtained by affinity purification.</Comments>
</Item><Item><Target_ID> 769</Target_ID>
<Target_Name>IgG fraction of anti-EHV-1 serum</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Equus caballus (Horse)9796</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Selecting equine antiserum (F19) was from a gnotobiotic foal infected with EHV-1 strain RAC-H.</Comments>
</Item><Item><Target_ID> 770</Target_ID>
<Target_Name>WW-EF-ZZ fusion protein from utrophin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P46939</Target_Sequence>
<Synonyms>Utrophin alternative name(s):
Dystrophin-related protein 1, DRP-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BHD, 1QAG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 771</Target_ID>
<Target_Name>Human dendritic cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 772</Target_ID>
<Target_Name>Carbon nanotubes</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 773</Target_ID>
<Target_Name>SEM-5 SH3 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P29355 [154-213]</Target_Sequence>
<Synonyms>SEM-5 alternative name(s):
Sex muscle abnormal protein 5</Synonyms>
<Target_Source>Caenorhabditis elegans:6239</Target_Source>
<Target_Structure>1K76, 1KFZ, 1SEM, 2SEM, 3SEM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 774</Target_ID>
<Target_Name>Anti-mouse CD45 monoclonal antibody IBL-8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 775</Target_ID>
<Target_Name>Immunoglobulin fractions obtained from vitiligo patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 776</Target_ID>
<Target_Name>Anti-WNV E protein monoclonal antibody E16</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:78101113, GI:78101114</Target_Sequence>
<Synonyms>Mab E16</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1ZTX</Target_Structure>
<Comments>The monoclonal antibody E16 is an mouse IgG2bκ that can neutralize 10 different strains in vitro and have shown therapeutic efficacy in mice even when administered as a single dose 5 days after West Nile virus (WNV) infection. The construction of the hybridoma producing E16 monocloanl antibody is described briefly in the following sentences. BALB/c mice were primed and boosted at 3-week intervals with insect cell-generated, purified, recombinant WNV E protein (25 μg) that was complexed with adjuvant. Approximately 1 month after the last boost, serum was harvested and tested for immunoreactivity against solid-phase purified E protein. Mice with high titers (&gt;1/10,000) were boosted intravenously with purified E protein (5 μg) in PBS. Three days later, splenocytes were harvested and fused to P3X63Ag8.653 myeloma cells to generate hybridomas.</Comments>
</Item><Item><Target_ID> 777</Target_ID>
<Target_Name>Anti-H Fer monoclonal antibody H107</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 778</Target_ID>
<Target_Name>Anti-PTX S1 monoclonal antibody 1B7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 779</Target_ID>
<Target_Name>Anti-capsid protein 1 monoclonal antibody C4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb C4 belongs to the IgG1 subclass and has κ type light chains.</Comments>
</Item><Item><Target_ID> 780</Target_ID>
<Target_Name>Mouse cardiac tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 781</Target_ID>
<Target_Name>Nucleocapsid protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>B5A495</Target_Sequence>
<Synonyms>Nucleocapsid protein N</Synonyms>
<Target_Source>Porcine reproductive and respiratory syndrome virus (PRRSV):28344</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 782</Target_ID>
<Target_Name>Mouse embryonic stem cell line M9</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 783</Target_ID>
<Target_Name>Anti-ARD1A polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-ARD1A polyclonal antibody purified from colon cancer patient serum belongs to the IgG class.</Comments>
</Item><Item><Target_ID> 784</Target_ID>
<Target_Name>Primary cardiac myocytes (PCM)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 785</Target_ID>
<Target_Name>Campylobacter jejuni </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Campylobacter jejuni:197</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 786</Target_ID>
<Target_Name>Toxin A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16154</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Clostridium difficile:1496</Target_Source>
<Target_Structure>2F6E, 2G7C, 2QJ6, 3HO6, 4DMV, 4DMW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 787</Target_ID>
<Target_Name>Phakopsora pachyrhizi urediniospores</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Phakopsora pachyrhizi:170000</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 788</Target_ID>
<Target_Name>MLV/HIV 89.6 pseudovirions</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human immunodeficiency virus 1:11676</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CD4-activated retroviral particles carrying Env from the R5X4 HIV-1 89.6 strain, MLV Gag Pol particles pseudotyped with HIV-1 R5X4 89.6 Env in the presence of sCD4.</Comments>
</Item><Item><Target_ID> 789</Target_ID>
<Target_Name>B16F10-Nex2 melanoma cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 790</Target_ID>
<Target_Name>Extracellular domain of TβR1 (TβR1-ED) </Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P36897 [25-125]</Target_Sequence>
<Synonyms>TβR1 alternative name(s):
TGF-beta receptor type-1, TGFR-1
Activin receptor-like kinase 5, ALK-5
Serine/threonine-protein kinase receptor R4, SKR4
TGF-beta type I receptor
Transforming growth factor-beta receptor type I, TGF-beta receptor type I, TbetaR-I</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1B6C, 1IAS, 1PY5, 1RW8, 1VJY, 2L5S, 2PJY, 2WOT, 2WOU, 2X7O, 3FAA, 3GXL, 3HMM, 3KCF, 3KFD, 3TZM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 791</Target_ID>
<Target_Name>Anti-E(rns) glycoprotein monoclonal antibody M2172</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb M2172 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 792</Target_ID>
<Target_Name>Anti-E(rns) glycoprotein monoclonal antibody M2171</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb M2171 belongs to the IgG2b subclass.</Comments>
</Item><Item><Target_ID> 793</Target_ID>
<Target_Name>Anti-E(rns) glycoprotein monoclonal antibody M2165</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb M2165 belongs to the IgG2b subclass.</Comments>
</Item><Item><Target_ID> 794</Target_ID>
<Target_Name>Anti-E(rns) glycoprotein monoclonal antibody M2180</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb M2180 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 795</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 1H4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 796</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 2B3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 797</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 5F6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 798</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 4G12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 799</Target_ID>
<Target_Name>Anti-HIV1 plasma IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 800</Target_ID>
<Target_Name>Adherent primary cardiac myocytes, APCM</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>APCM cells are freshly isolated by the same procedure as the non-adherent PCM but are then allowed to adhere to tissue culture wells coated with laminin.</Comments>
</Item><Item><Target_ID> 801</Target_ID>
<Target_Name>Mouse embryonic stem (ES) cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 802</Target_ID>
<Target_Name>Anti-LBP monoclonal antibody M392-2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 803</Target_ID>
<Target_Name>Rat lactating mammary gland</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 804</Target_ID>
<Target_Name>Rhipicephalus microplus eggs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Boophilus microplus (Cattle tick):6941</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 805</Target_ID>
<Target_Name>Intact oocytes surrounded by ZP proteins</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 806</Target_ID>
<Target_Name>Anti-larval proteins of R. microplus polyclonal antibodies IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 807</Target_ID>
<Target_Name>Anti-tick subolesin polyclonal antibody (S2)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sheep IgG were obtained from sheep immunized and protected against tick infestations.</Comments>
</Item><Item><Target_ID> 808</Target_ID>
<Target_Name>Anti-tick subolesin polyclonal antibody (S9)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sheep IgG were obtained from sheep immunized and protected against tick infestations.</Comments>
</Item><Item><Target_ID> 809</Target_ID>
<Target_Name>Anti-mosquito subolesin polyclonal antibody (S4)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sheep IgG were obtained from sheep immunized and protected against tick infestations.</Comments>
</Item><Item><Target_ID> 810</Target_ID>
<Target_Name>Anti-mosquito subolesin polyclonal antibody (S5)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sheep IgG were obtained from sheep immunized and protected against tick infestations.</Comments>
</Item><Item><Target_ID> 811</Target_ID>
<Target_Name>Anti-Ap[17-30] polyconal antibody from patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 812</Target_ID>
<Target_Name>Anti-Ap[17-30] polyconal antibody from patient 8</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 813</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 2E6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 814</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 3A1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 815</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 3B3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 816</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 5A9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 817</Target_ID>
<Target_Name>Anti-IL-2 monoclonal antibody 5C3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 818</Target_ID>
<Target_Name>Beta-amyloid protein 42 (Beta-APP42)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P12023 [672-713]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>2ROZ, 2YSZ, 2YT0, 2YT1</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 819</Target_ID>
<Target_Name>Glycine receptor subunit alpha-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P07727</Target_Sequence>
<Synonyms>Glycine receptor 48 kDa subunit
Glycine receptor strychnine-binding subunit</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 820</Target_ID>
<Target_Name>Anti-EGFR monoclonal antibody 12H23</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>12H23 is a murine monoclonal antibody that can recognize the CC16 epitope.</Comments>
</Item><Item><Target_ID> 821</Target_ID>
<Target_Name>Human 143B osteosarcoma cell lines</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 822</Target_ID>
<Target_Name>GaAs semi-insulating substrate</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 823</Target_ID>
<Target_Name>Anti-SEB monoclonal antibody ab53981</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 824</Target_ID>
<Target_Name>Anti-S100A4 monoclonal antibody 22.3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 22.3 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 825</Target_ID>
<Target_Name>Anti-S100A4 monoclonal antibody 22.1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 22.1 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 826</Target_ID>
<Target_Name>Na+ Montmorillonite (MMT)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 827</Target_ID>
<Target_Name>Primary Ammonium C18 Modified Montmorillonite (MMT)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 828</Target_ID>
<Target_Name>Quaternary Ammonium C18 Modified Montmorillonite (MMT)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 829</Target_ID>
<Target_Name>Chymase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P21842</Target_Sequence>
<Synonyms>Alpha-chymase
Mast cell protease I
EC=3.4.21.39</Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 830</Target_ID>
<Target_Name>Breast cancer tumors</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 831</Target_ID>
<Target_Name>Mixed liver/kidney tissue extracts</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 832</Target_ID>
<Target_Name>Pd wire</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 833</Target_ID>
<Target_Name>TIMREX SLP30 Primary Synthetic Potato graphite</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 834</Target_ID>
<Target_Name>AFM standard highly ordered pyrolytic graphite (HOPG)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 835</Target_ID>
<Target_Name>N006 nano graphene platelets</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 836</Target_ID>
<Target_Name>Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q3UHN9</Target_Sequence>
<Synonyms>Glucosaminyl N-deacetylase/N-sulfotransferase 1, NDST-1
N-heparan sulfate sulfotransferase 1, N-HSST 1
[Heparan sulfate]-glucosamine N-sulfotransferase 1, HSNST 1
EC=2.8.2.8</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 837</Target_ID>
<Target_Name>Human OE33 (esophageal adenocarcinoma) cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 838</Target_ID>
<Target_Name>Lupus-derived monoclonal antibody BT164</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BT164 is a lupus-derived monoclonal antibody that was recently established by selection on apoptotic chromatin (van Bavel et al, unpublished data).</Comments>
</Item><Item><Target_ID> 839</Target_ID>
<Target_Name>Hyperbranched poly(phenylene vinylene) (hypPPV)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 840</Target_ID>
<Target_Name>Linear poly(phenylene vinylene) (linPPV)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 841</Target_ID>
<Target_Name>Apoptosis regulator Bcl-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10415</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1G5M, 1GJH, 1YSW, 2O21, 2O22, 2O2F, 2W3L, 2XA0, 4AQ3</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 842</Target_ID>
<Target_Name>Anti-urease B monoclonal antibody U001</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 843</Target_ID>
<Target_Name>Indium nitride (InN) semiconductor (SC) material</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 844</Target_ID>
<Target_Name>Fibrosarcoma cell line NG4TL4-tk</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 845</Target_ID>
<Target_Name>Human leukemia cells MOLT-4</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 846</Target_ID>
<Target_Name>Macrophages isolated from primary human lung squamous carcinoma</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 847</Target_ID>
<Target_Name>Peptide SLGLSFYQPPEGDNALC</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target is a peptide corresponding to the N-terminal half of the human PMCA1 exdom 1 (exdom 1X) consisting of residues 121-137 (SLGLSFYQPPEGDNALC, Protein bank P20020). The PMCA1 sequence is identical in rabbit, man, rat, mouse, pig and cow.</Comments>
</Item><Item><Target_ID> 848</Target_ID>
<Target_Name>In vitro M cell coculture system</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A human colon carcinoma cell line, Caco-2, and a human Burkitt's lymphoma cell line, Raji, were purchased from the American Type Culture Collection (Manassas, VA). The in vitro M cell coculture model was assembled as described by Kerne′is et al. and modified by Gullberg et al. Briefiy, 0.1 and 1.5 ml DMEM supplemented with 10% FBS were added to the apical and basolateral sides of the transwell, respectively, and the transwells then were preincubated for 30 min in a CO2 incubator. The Caco-2 cells then were spread to the apical side of the transwell. After incubation for 3 h, the medium at the apical side was changed, and the upper medium was changed every other day for the next 14 d of culture. Raji cells suspended in RPMI 1640/DMEM (1:2) mixture then were added to the basolateral chamber of the transwell, and the coculture was maintained for 2 d. Caco-2 cells cultured alone by this procedure, without the Raji cells, served as a control.</Comments>
</Item><Item><Target_ID> 849</Target_ID>
<Target_Name>PC-3 human prostate carcinoma cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 850</Target_ID>
<Target_Name>Soluble 37/48kDa oligomer formation of Aβ(1-42)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 851</Target_ID>
<Target_Name>Virulent isolate of Paracoccidioides brasiliensis (Pb18)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Paracoccidioides brasiliensis:121759</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 852</Target_ID>
<Target_Name>Primary rat lung alveolar epithelial primary cell cultures</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 853</Target_ID>
<Target_Name>Ganglioside GM3</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 854</Target_ID>
<Target_Name>Germania</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 855</Target_ID>
<Target_Name>Extracellular domain of Tie2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q02763 [23-745]</Target_Sequence>
<Synonyms>Tie2 alternative name(s):
Angiopoietin-1 receptor
Tyrosine-protein kinase receptor TIE-2, hTIE2
Tyrosine-protein kinase receptor TEK
Tunica interna endothelial cell kinase
p140 TEK
CD_antigen=CD202b</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FVR, 2GY5, 2GY7, 2OO8, 2OSC, 2P4I, 2WQB, 3BEA, 3L8P, 4K0V</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 856</Target_ID>
<Target_Name>Anti-M2e monoclonal antibody 8C6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 857</Target_ID>
<Target_Name>Doxorubicin</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Doxorubicin is a kind of multidrug-resistance (MDR) drugs.</Comments>
</Item><Item><Target_ID> 858</Target_ID>
<Target_Name>Anti-FMDV Asia1 antigen monoclonal antibody 3E11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 3E11 belongs to the IgG1 subclass and has κ type light chains.</Comments>
</Item><Item><Target_ID> 859</Target_ID>
<Target_Name>Methylmalonic aciduria and homocystinuria type C protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9Y4U1</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3SBY, 3SBZ, 3SC0, 3SOM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 860</Target_ID>
<Target_Name>Glutathione S-transferase, GST</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 861</Target_ID>
<Target_Name>Cytoplasmic domain of CORYNE</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q9LYU7 [84-401]</Target_Sequence>
<Synonyms>CORYNE alternative name(s):
Inactive leucine-rich repeat receptor-like protein kinase CORYNE
Protein SUPPRESSOR OF OVEREXPRESSION OF LLP1 2</Synonyms>
<Target_Source>Arabidopsis thaliana (Mouse-ear cress):3702</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 862</Target_ID>
<Target_Name>Dry degummed silk fibroin fibers</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bombyx mori (Silk moth):7091</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 863</Target_ID>
<Target_Name>Anti-HIV-1 gp41 MPER monoclonal antibody 2F5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 864</Target_ID>
<Target_Name>Anti-DENV2 monoclonal antibody 2A10G6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 2A10G6 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 865</Target_ID>
<Target_Name>Unmodified helix 31 of bacterial 16S ribosomal RNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sequence of unmodified helix 31 is 5'-GUUCGAUGCAACGCGAAC-3'.</Comments>
</Item><Item><Target_ID> 866</Target_ID>
<Target_Name>Modified helix 31 of bacterial 16S ribosomal RNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sequence of modified helix 31 is 5'-GUUCGAU-m(2)G-m(5)C-AACGCGAAC-3'.</Comments>
</Item><Item><Target_ID> 867</Target_ID>
<Target_Name>Anti-WNV C protein monoclonal antibody 6D3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 868</Target_ID>
<Target_Name>Gliadin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Triticum aestivum (Wheat):4565</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 869</Target_ID>
<Target_Name>Single-crystal hydroxyapatite (HAP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 870</Target_ID>
<Target_Name>Polycrystalline hydroxyapatite (HAP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 871</Target_ID>
<Target_Name>Amino acid (160)REVPYAYIREGHEKQ(174) of MMP-14</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P50281 [160-174]</Target_Sequence>
<Synonyms>MMP-14 alternative name(s):
Matrix metalloproteinase-14
Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1
Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP
MMP-X1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BQQ, 1BUV, 3C7X, 3MA2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 872</Target_ID>
<Target_Name>Myelin basic protein, MBP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02686</Target_Sequence>
<Synonyms>Myelin A1 protein
Myelin membrane encephalitogenic protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BX2, 1FV1, 1HQR, 1YMM, 1ZGL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 873</Target_ID>
<Target_Name>Excised murine peripheral nerves</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 874</Target_ID>
<Target_Name>Nerve tissue (sciatic, brachial plexus, cranial nerves)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 875</Target_ID>
<Target_Name>Ischemic region of left ventricular (LV) </Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 876</Target_ID>
<Target_Name>Non-ischemic region of left ventricular (LV) </Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 877</Target_ID>
<Target_Name>Right ventricular (RV) </Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 878</Target_ID>
<Target_Name>Intact matrices (Integra ®)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 879</Target_ID>
<Target_Name>Solubilized matrices (Integra ®)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 880</Target_ID>
<Target_Name>Cryostat-sectioned matrices (Integra ®)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 881</Target_ID>
<Target_Name>Anti-human TGF-β1 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 882</Target_ID>
<Target_Name>Candida albicans, C. albicans</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Candida albicans (Yeast):5476</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 883</Target_ID>
<Target_Name>Patient CA502 ascitic IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 884</Target_ID>
<Target_Name>Mouse colonic dysplasia</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 885</Target_ID>
<Target_Name>Purified lgG of tuberculosis serum</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 886</Target_ID>
<Target_Name>Protein E7</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03129</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human papillomavirus type 16:333760</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 887</Target_ID>
<Target_Name>Anti-gastric cancer antigen monoclonal antibody MGb1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 888</Target_ID>
<Target_Name>Anti-CCR5 monoclonal antibody 5C7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 889</Target_ID>
<Target_Name>Concanavalin-A, Con A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02866</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canavalia ensiformis (Jack bean) (Horse bean):3823</Target_Source>
<Target_Structure>1APN, 1BXH, 1C57, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 1XQN, 2CNA, 2CTV, 2ENR, 2UU8, 2YZ4, 3CNA, 3D4K, 3ENR, 5CNA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 890</Target_ID>
<Target_Name>Anti-fiber tail monoclonal antibody 4D2.5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 891</Target_ID>
<Target_Name>Anti-penton base monoclonal antibody 20G1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 892</Target_ID>
<Target_Name>Penton capsomer</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03275, P03276</Target_Sequence>
<Synonyms>Penton base-fiber complex</Synonyms>
<Target_Source>Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</Target_Source>
<Target_Structure>2C9F</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 893</Target_ID>
<Target_Name>Penton protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03276</Target_Sequence>
<Synonyms>Penton base protein
Virion component III
pIII</Synonyms>
<Target_Source>Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</Target_Source>
<Target_Structure>1X9P, 1X9T, 2C6S, 2C9F, 2C9G, 4V4U</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 894</Target_ID>
<Target_Name>Fiber protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03275</Target_Sequence>
<Synonyms>pIV</Synonyms>
<Target_Source>Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</Target_Source>
<Target_Structure>1QHV, 1QIU, 1V1H, 1V1I, 2BLD, 2C9F, 4AR2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 895</Target_ID>
<Target_Name>Head domain of fiber protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03275 [399-582]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</Target_Source>
<Target_Structure>1QHV, 1QIU, 1V1H, 1V1I, 1X9T, 2C9F, 4AR2, 4V4U</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 896</Target_ID>
<Target_Name>Shaft domain of fiber protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03275 [45-392]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</Target_Source>
<Target_Structure>1QHV, 1QIU, 1V1H, 1V1I, 2BLD, 2C9F, 4AR2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 897</Target_ID>
<Target_Name>PEA10 mouse fibroblast cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 898</Target_ID>
<Target_Name>Anti-DENV1 envelope protein monoclonal antibody 4E11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 899</Target_ID>
<Target_Name>Anti-WNV E protein monoclonal antibody E24</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 900</Target_ID>
<Target_Name>Anti-WNV E protein monoclonal antibody E60</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 901</Target_ID>
<Target_Name>Anti-WNV E protein monoclonal antibody E113</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 902</Target_ID>
<Target_Name>Anti-WNV E protein monoclonal antibody E121</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 903</Target_ID>
<Target_Name>Anti-WNV polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 904</Target_ID>
<Target_Name>Anti-HBsAg polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 905</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody GV4H3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GV4H3 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gpl2O/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</Comments>
</Item><Item><Target_ID> 906</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody GV1G2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GV1G2 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gpl2O/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</Comments>
</Item><Item><Target_ID> 907</Target_ID>
<Target_Name>Anti-HIV-1 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 908</Target_ID>
<Target_Name>Anti-HER-2 extracellular domain polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 909</Target_ID>
<Target_Name>Anti-HER-2 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mice were immunized with plasmids expressing either the full length protein (HER-2).</Comments>
</Item><Item><Target_ID> 910</Target_ID>
<Target_Name>Anti-HER-2 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mice were inoculated with TUBO tumors, which express rat HER-2.</Comments>
</Item><Item><Target_ID> 911</Target_ID>
<Target_Name>α, β-tubulins from bovine brain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 912</Target_ID>
<Target_Name>Anti-CD6 monoclonal antibody ior t1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-human CD6 MAb ior t1 (IgG2a, κ) was obtained after immunization of BALB/c mice with peripheral blood mononuclear cells (PBMC) from a Sezary\'s syndrome patient.</Comments>
</Item><Item><Target_ID> 913</Target_ID>
<Target_Name>Anti-Der p 1 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 914</Target_ID>
<Target_Name>Anti-Der p 2 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 915</Target_ID>
<Target_Name>Synthetic ligand for FK506-binding protein, SLF</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 916</Target_ID>
<Target_Name>Irinotecan, Iri</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>CPT-11</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 917</Target_ID>
<Target_Name>Anti-transferrin monoclonal antibody hTf345</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 918</Target_ID>
<Target_Name>Anti-b558 monoclonal antibody 7A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 919</Target_ID>
<Target_Name>Anti-b558 monoclonal antibody 8G11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 920</Target_ID>
<Target_Name>Anti-E. coli K1 monoclonal antibody HmenB1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</Comments>
</Item><Item><Target_ID> 921</Target_ID>
<Target_Name>Anti-E. coli K1 monoclonal antibody HmenB3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</Comments>
</Item><Item><Target_ID> 922</Target_ID>
<Target_Name>Anti-E. coli K1 monoclonal antibody HmenB13</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</Comments>
</Item><Item><Target_ID> 923</Target_ID>
<Target_Name>Anti-E. coli K1 monoclonal antibody HmenB14</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</Comments>
</Item><Item><Target_ID> 924</Target_ID>
<Target_Name>Polyclonal antibody IgE from birch pollen-allergic patient #1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 925</Target_ID>
<Target_Name>Polyclonal antibody IgE from birch pollen-allergic patient #2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 926</Target_ID>
<Target_Name>Polyclonal antibody IgE from birch pollen-allergic patient #3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 927</Target_ID>
<Target_Name>Polyclonal antibody IgE from birch pollen-allergic patient #4</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 928</Target_ID>
<Target_Name>Polyclonal antibody IgE from birch pollen-allergic patient #5</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 929</Target_ID>
<Target_Name>Estrogen receptor beta, ER-beta</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q92731</Target_Sequence>
<Synonyms>ESR2
ESTRB
NR3A2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1L2J, 1NDE, 1QKM, 1U3Q, 1U3R, 1U3S, 1U9E, 1X76, 1X78, 1X7B, 1X7J, 1YY4, 1YYE, 1ZAF, 2FSZ, 2GIU, 2I0G, 2JJ3, 2NV7, 2QTU, 2YJD, 2YLY, 2Z4B, 3OLL, 3OLS, 3OMO, 3OMP, 3OMQ, 4J24, 4J26</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 930</Target_ID>
<Target_Name>Anti-FPR monoclonal antibody NFPR1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 931</Target_ID>
<Target_Name>Anti-FPR monoclonal antibody NFPR2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 932</Target_ID>
<Target_Name>Silver nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 933</Target_ID>
<Target_Name>Cobalt nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 934</Target_ID>
<Target_Name>Interleukin-6, IL-6</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05231</Target_Sequence>
<Synonyms>B-cell stimulatory factor 2, BSF-2
CTL differentiation factor, CDF
Hybridoma growth factor
Interferon beta-2, IFN-beta-2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ALU, 1IL6, 1P9M, 2IL6</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 935</Target_ID>
<Target_Name>Banana streak virus, BSV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Banana streak virus:69577</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 936</Target_ID>
<Target_Name>Anti-gp120 monoclonal antibody F105</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>F105 is a human IgG1 MAb directed against the envelope glycoprotein gp120.</Comments>
</Item><Item><Target_ID> 937</Target_ID>
<Target_Name>Anti-rhodopsin monoclonal antibody 4B4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 938</Target_ID>
<Target_Name>Anti-cytochrome b-245 monoclonal antibody 449</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 449 is a mouse IgG1 against human neutrophil flavocytochrome b.</Comments>
</Item><Item><Target_ID> 939</Target_ID>
<Target_Name>Anti-MOMP monoclonal antibody GZD1E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GZD1E8 is a major outer membrane protein of C. pneumoniae.</Comments>
</Item><Item><Target_ID> 940</Target_ID>
<Target_Name>Anti-PSA monoclpnal antibody 30H12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monoclonal anti-PSA Ab of the IgG2a isotype was directed to Neisseria meningitidis B capsular polysaccharide.</Comments>
</Item><Item><Target_ID> 941</Target_ID>
<Target_Name>Octyltrimethoxysilane</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>C8 ink</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 942</Target_ID>
<Target_Name>Anti-TNF-α polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 943</Target_ID>
<Target_Name>Serum 14018 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 944</Target_ID>
<Target_Name>Anti-HBsAg monoclonal antibody H166</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 945</Target_ID>
<Target_Name>Anti-HBsAg monoclonal antibody H5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 946</Target_ID>
<Target_Name>Anti-HBsAg monoclonal antibody H35</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 947</Target_ID>
<Target_Name>Anti-HBsAg monoclonal antibody H53</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 948</Target_ID>
<Target_Name>Anti-HCV core protein monoclonal antibody 14-153-462</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 949</Target_ID>
<Target_Name>Anti-V3 loop of HIV gp120 monoclonal antibody 1001</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 950</Target_ID>
<Target_Name>Anti-CMV CP polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 951</Target_ID>
<Target_Name>Anti-PSV-J polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 952</Target_ID>
<Target_Name>Anti-TAV-V polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 953</Target_ID>
<Target_Name>Anti-TAV-C polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 954</Target_ID>
<Target_Name>Anti-F-actin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 955</Target_ID>
<Target_Name>Ig gamma-1 chain C region</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>P01857</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AJ7, 1AQK, 1BEY, 1D5B, 1D5I, 1D6V, 1DFB, 1DN2, 1E4K, 1FC1, 1FC2, 1FCC, 1GAF, 1H3T, 1H3U, 1H3V, 1H3W, 1H3Y, 1HKL, 1HZH, 1I7Z, 1L6X, 1OP3, 1OQO, 1OQX, 1T83, 1T89, 1VGE, 2DTS, 2GJ7, 2I5Y, 2IWG, 2J6E, 2JB5, 2JB6, 2O5X, 2O5Y, 2O5Z, 2OSL, 2QAD, 2QL1, 2QQK, 2QQL, 2QQN, 2QR0, 2R56, 2RCS, 2VXQ, 3AGV, 3AVE, 3AY4, 3B2U, 3B2V, 3BDY, 3BE1, 3BKY, 3BN9, 3BQU, 3C08, 3C09, 3C2S, 3CFJ, 3CFK, 3CSY, 3D0L, 3D0V, 3D6G, 3D85, 3DJ9, 3DNK, 3DO3, 3DRO, 3DRQ, 3DVG, 3DVN, 3EYF, 3EYO, 3EYQ, 3RY6, 3S7G, 3SGJ, 3SGK, 3TV3, 3TWC, 3TYG, 3U0W, 3U7W, 3U7Y, 3V7M, 3V8C, 3V95, 4ACP, 4B7I, 4DZ8, 4EOW, 4J12</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 956</Target_ID>
<Target_Name>Anti-lymphotoxin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 957</Target_ID>
<Target_Name>ICR male mice brain parenchyma</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 958</Target_ID>
<Target_Name>Anti-β-1,2-linked mannoside monoclonal antibody DJ2.8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 959</Target_ID>
<Target_Name>Insulin-like growth factor-binding protein 1, IGFBP-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08833</Target_Sequence>
<Synonyms>IBP-1, IGF-binding protein 1
Placental protein 12, PP12</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ZT3, 1ZT5, 2DSQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 960</Target_ID>
<Target_Name>Human serum albumin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02768</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AO6, 1BJ5, 1BKE, 1BM0, 1E78, 1E7A, 1E7B, 1E7C, 1E7E, 1E7F, 1E7G, 1E7H, 1E7I, 1GNI, 1GNJ, 1H9Z, 1HA2, 1HK1, 1HK2, 1HK3, 1HK4, 1HK5, 1N5U, 1O9X, 1TF0, 1UOR, 1YSX, 2BX8, 2BXA, 2BXB, 2BXC, 2BXD, 2BXE, 2BXF, 2BXG, 2BXH, 2BXI, 2BXK, 2BXL, 2BXM, 2BXN, 2BXO, 2BXP, 2BXQ, 2ESG, 2I2Z, 2I30, 2VDB, 2VUE, 2VUF, 2XSI, 2XVQ, 2XVU, 2XVV, 2XVW, 2XW0, 2XW1, 2YDF, 3A73, 3B9L, 3B9M, 3CX9, 3JQZ, 3JRY, 3LU6, 3LU7, 3LU8, 3SQJ, 3TDL, 3UIV, 4E99, 4EMX, 4HGK, 4HGM, 4IW1, 4IW2, 4K2C</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 961</Target_ID>
<Target_Name>Rabbit serum albumin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P49065</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure>3V09</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 962</Target_ID>
<Target_Name>Rat serum albumin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02770</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 963</Target_ID>
<Target_Name>Anti-ATPase alpha-1 subunit monoclonal antibody M8-P1-A3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 964</Target_ID>
<Target_Name>Anti-sperm whale myoglobin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 965</Target_ID>
<Target_Name>Anti-TPO monoclomal antibody T13</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 966</Target_ID>
<Target_Name>A549 bronchial epithelial cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 967</Target_ID>
<Target_Name>Anti-p34 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A subgenomic fragment-encoding amino-acid 167-298 (p34-cx) was expressed in E. coli as described in Materials and methods. The recombinant p-34cx fragment was used to immunize calves.</Comments>
</Item><Item><Target_ID> 968</Target_ID>
<Target_Name>Anti-PRRSV neutralizing monoclonal antibody ISU25-C1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>ISU25-C1 is an IgG1(λ) anti-PRRSV KY-35 isolate MAb directed against a sequential epitope on GP5, as demonstrated by the recognition of the protein electrophoresed under denaturing conditions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difiuoride membrane. It has neutralization activity against several PRRSV isolates.</Comments>
</Item><Item><Target_ID> 969</Target_ID>
<Target_Name>Anti-PRRSV polycolonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 970</Target_ID>
<Target_Name>Anti-peptide SGSGANNSSSSHFQSIYNC polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-peptide SGSGANNSSSSHFQSIYNC antibodies were affinity purified from anti-PRRSV pooled precipitated antibodies.</Comments>
</Item><Item><Target_ID> 971</Target_ID>
<Target_Name>Rhesus monkey neural stem cells (R-NS cells)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Macaca mulatta (Rhesus macaque):9544</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Neural stem (NS) cells are derived from embryonic stem (ES) cells.</Comments>
</Item><Item><Target_ID> 972</Target_ID>
<Target_Name>Bacillus cereus ATCC 4342</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bacillus cereus ATCC 4342:526977</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 973</Target_ID>
<Target_Name>β-galactosidase</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 974</Target_ID>
<Target_Name>Bovine fibrinogen</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 975</Target_ID>
<Target_Name>Single-walled carbon nanotubes, SWNTs</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 976</Target_ID>
<Target_Name>Hydroxyapatite, HA</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 977</Target_ID>
<Target_Name>ICR male mice brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 978</Target_ID>
<Target_Name>AC3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>B5B3X0</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Tomato leaf curl Kerala virus:551531</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 979</Target_ID>
<Target_Name>The first and second extracellular loops of CCR5</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The amino acid sequences of the first and second extracellular loops of CCR5 (YAANEWVFGNI, RSQKEGFHYTCSPHFPHTQYHFWKSFQTLK) were synthesized by GLS Company (Shanghai, China).</Comments>
</Item><Item><Target_ID> 980</Target_ID>
<Target_Name>Anti-PSA monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 981</Target_ID>
<Target_Name>Human ovarian tumor cell line SK-OV-3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 982</Target_ID>
<Target_Name>Lead Ion, Pb(2+)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 983</Target_ID>
<Target_Name>Anti-HMW-MAA monoclonal antibody VT80.12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 984</Target_ID>
<Target_Name>Anti-HMW-MAA monoclonal antibody VF1-TP43</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 985</Target_ID>
<Target_Name>Major outer membrane protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q6J0N9</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Leptospira noguchii serovar Pomona:280502</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 986</Target_ID>
<Target_Name>Anti-VSG LiTat 1.5 monoclonal antibody H12H3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb H12H3 belongs to the IgG3 subclass.</Comments>
</Item><Item><Target_ID> 987</Target_ID>
<Target_Name>Anti-VSG LiTat 1.3 monoclonal antibody H13F7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb H13F7 belongs to the IgG3 subclass.</Comments>
</Item><Item><Target_ID> 988</Target_ID>
<Target_Name>Anti-VSG LiTat 1.3 monoclonal antibody H18C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb H18C11 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 989</Target_ID>
<Target_Name>Human antimicrobial peptide LL-37</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>LL-37 is the only member of the human cathelicidin antimicrobial peptide family and is commonly expressed in various tissues, including epithelium. The sequence of LL-37 is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES.</Comments>
</Item><Item><Target_ID> 990</Target_ID>
<Target_Name>Rabbit chondrocyte</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 991</Target_ID>
<Target_Name>Heparan sulfate, HS</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 992</Target_ID>
<Target_Name>3-O-sulfated heparan sulfate, 3-OS HS</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 993</Target_ID>
<Target_Name>Mouse adipose stromal cells, ASCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 994</Target_ID>
<Target_Name>Mouse lung stromal cells, LSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 995</Target_ID>
<Target_Name>Etoposide, VP-16</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Etoposide (VP-16) is a semi-synthetic derivative of podophyllotoxin that was originally isolated from the herbaceous perennial plant Podophyllum peltatum. This compound stabilizes DNA-topoisomerase II (top II) cleavage complexes and arrests cell cycle in S or G2/M phase, which results in apoptotic cell death.</Comments>
</Item><Item><Target_ID> 996</Target_ID>
<Target_Name>Lipoate-protein ligase A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P32099</Target_Sequence>
<Synonyms>Lipoate--protein ligase
EC=2.7.7.63</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1X2G, 1X2H, 3A7A, 3A7R</Target_Structure>
<Comments>E. coli lipoic acid ligase (LplA) catalyzes ATP-dependent covalent ligation of lipoic acid onto specific lysine sidechains of three acceptor proteins involved in oxidative metabolism.</Comments>
</Item><Item><Target_ID> 997</Target_ID>
<Target_Name>CSF samples from neurocysticercosis patient #1</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 998</Target_ID>
<Target_Name>CSF samples from neurocysticercosis patient #2</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 999</Target_ID>
<Target_Name>Melanoma-derived growth regulatory protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q16674</Target_Sequence>
<Synonyms>Melanoma inhibitory activity protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HJD, 1I1J, 1K0X</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1000</Target_ID>
<Target_Name>Anti-JEV E protein monoclonal antibody E3.3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1001</Target_ID>
<Target_Name>Deoxyribonucleotides, DNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Double-stranded oligodeoxyribonucleotides (duplex ODNs) is composed of 36 base pairs and contains the 5'-TCGA-3' recognition sequence.</Comments>
</Item><Item><Target_ID> 1002</Target_ID>
<Target_Name>Single stranded oligonucleotides consisting of cytosine</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1003</Target_ID>
<Target_Name>Anti-LOS monoclonal antibody 9-2-L379</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 9-2-L379 belongs to the IgG2a subclass</Comments>
</Item><Item><Target_ID> 1004</Target_ID>
<Target_Name>Anti-HIV-1 monoclonal antibdoy 2G12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1005</Target_ID>
<Target_Name>Hsp70-peptide complexes, Hsp70-PCs</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1006</Target_ID>
<Target_Name>Peptide NNYDDISLRARP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1007</Target_ID>
<Target_Name>Peptide TMGFTAPREPHY</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1008</Target_ID>
<Target_Name>Peptide IERPLHESVLAT</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1009</Target_ID>
<Target_Name>Human adipose stem cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1010</Target_ID>
<Target_Name>Mouse 3T3-L1 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>3T3-L1 is a cell line derived from 3T3 cells that is used in biological research on adipose tissue. Differentiation of 3T3-L1 postconfluent preadipocytes was induced by treatment with insulin, dexamethasone, and isobutylmethylxanthine in DMEM/FCS.</Comments>
</Item><Item><Target_ID> 1011</Target_ID>
<Target_Name>Quartz</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1012</Target_ID>
<Target_Name>SiO2 wafer</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1013</Target_ID>
<Target_Name>L1(0) phase of FePt, L1(0) FePt</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1014</Target_ID>
<Target_Name>Anti-beta-endorphin monoclonal antibody 3-E7 Fab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This antibody was first described by Gramsch C. et al. on J Neurochem (PMID: 6187900). Its immunogen was a fragment of synthetic human beta-endorphin (YGGF) coupled with polylysine or thyroglobulin. Its isotype: IgG2a.</Comments>
</Item><Item><Target_ID> 1015</Target_ID>
<Target_Name>Anti-HCV polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1016</Target_ID>
<Target_Name>Human neuroblastoma cell line WAC 2</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>WAC 2 cell line is a derivative of neuroblastoma cell line SH-EP and expresses high levels of the MYCN gene.</Comments>
</Item><Item><Target_ID> 1017</Target_ID>
<Target_Name>CD19+ cells from patient #16</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1018</Target_ID>
<Target_Name>CD19+ cells from patient #25</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1019</Target_ID>
<Target_Name>CD19+ cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1020</Target_ID>
<Target_Name>Anti-CPS monoclonal antibody 13D9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 13D9 belongs to the IgG2a subclass.</Comments>
</Item><Item><Target_ID> 1021</Target_ID>
<Target_Name>Neuropilin-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O14786</Target_Sequence>
<Synonyms>Vascular endothelial cell growth factor 165 receptor
CD_antigen=CD304</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KEX, 2QQI, 2QQM, 2QQN, 3I97, 4DEQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1022</Target_ID>
<Target_Name>Anti-NSP2 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1023</Target_ID>
<Target_Name>Semiconductor InP(001) surface</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1024</Target_ID>
<Target_Name>Semiconductor InP(111) surface</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1025</Target_ID>
<Target_Name>Anti-EG95 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1026</Target_ID>
<Target_Name>H1299 cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1027</Target_ID>
<Target_Name>Anti-DENV2 monoclonal antibody Ab4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb Ab4 belongs to the IgG1 subclass.</Comments>
</Item><Item><Target_ID> 1028</Target_ID>
<Target_Name>Mouse prostate</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1029</Target_ID>
<Target_Name>Anti-phosphotyrosine monoclonal antibody PY20</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1030</Target_ID>
<Target_Name>Peptide  IDQYRMQRDKEFRLKQ</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q96LB4 [44-59]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1031</Target_ID>
<Target_Name>Trinitrotoluene, TNT</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1032</Target_ID>
<Target_Name>2,4-dinitrotoluene, DNT</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1033</Target_ID>
<Target_Name>Human lewis lung carcinoma, LLC</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1034</Target_ID>
<Target_Name>Mouse GL261 glioblastoma</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1035</Target_ID>
<Target_Name>Semiconductor GaN(0001) surface</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1036</Target_ID>
<Target_Name>Anti-DON monoclonal antibody 6F5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1037</Target_ID>
<Target_Name>B-cell lymphoma/leukemia 10</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O95999</Target_Sequence>
<Synonyms>B-cell CLL/lymphoma 10, Bcl-10
CARD-containing molecule enhancing NF-kappa-B
CARD-like apoptotic protein, hCLAP
CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER
Cellular homolog of vCARMEN, cCARMEN
Cellular-E10, c-E10
Mammalian CARD-containing adapter molecule E10, mE10</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Bcl-X(L), an antiapoptotic member of the Bcl-2 family, is a mitochondrial protein that inhibits activation of Bax and Bak, which commit the cell to apoptosis, and it therefore represents a potential target for drug discovery.</Comments>
</Item><Item><Target_ID> 1038</Target_ID>
<Target_Name>Anti-p53 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1039</Target_ID>
<Target_Name>Internal ribosomal entry site, IRES</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis C virus:11103</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hepatitis C virus (HCV) is a positive strand RNA flavivirus that is a major causative agent of serious liver disease, making new treatment modalities an urgent priority. Because HCV translation initiation occurs by a mechanism that is fundamentally distinct from that of host mRNAs, it is an attractive target for drug discovery. The translation of HCV mRNA is initiated from an internal ribosomal entry site (IRES), independent of cap and poly(A) recognition and bypassing eIF4F complex formation.</Comments>
</Item><Item><Target_ID> 1040</Target_ID>
<Target_Name>Thymidylate synthase mRNA, TS </Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence>GI:186972144</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Thymidylate synthase (TS), an essential enzyme for catalyzing the biosynthesis of thymidylate, is a critical therapeutic target in cancer therapy.</Comments>
</Item><Item><Target_ID> 1041</Target_ID>
<Target_Name>Calmodulin, CaM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P62158</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CDL, 1CLL, 1CTR, 1IWQ, 1J7O, 1J7P, 1K90, 1K93, 1L7Z, 1LVC, 1NKF, 1PK0, 1S26, 1SK6, 1SW8, 1WRZ, 1XFU, 1XFV, 1XFW, 1XFX, 1XFY, 1XFZ, 1Y6W, 1YR5, 1YRT, 1YRU, 1ZOT, 1ZUZ, 2BE6, 2F3Y, 2F3Z, 2HF5, 2I08, 2JZI, 2K0E, 2K0F, 2K0J, 2K61, 2KNE, 2KUG, 2KUH, 2L53, 2L7L, 2LGF, 2LL6, 2LL7, 2LQC, 2LQP, 2LV6, 2M55, 2R28, 2V01, 2V02, 2VAY, 2W73, 2WEL, 2X0G, 2Y4V, 3BYA, 3DVE, 3DVJ, 3DVK, 3DVM, 3EWT, 3EWV, 3G43, 3HR4, 3O77, 3O78, 3OXQ, 3SUI, 3UCT, 3UCW, 3UCY, 4DCK, 4DJC, 4GOW</Target_Structure>
<Comments>Calmodulin mediates the control of a large number of enzymes and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CEP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.</Comments>
</Item><Item><Target_ID> 1042</Target_ID>
<Target_Name>Botulinum neurotoxin A light chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q45894 [2-448]</Target_Sequence>
<Synonyms>Botulinum neurotoxin A alternative name(s):
Botulinum neurotoxin type A, BoNT/A
Bontoxilysin-A, BOTOX</Synonyms>
<Target_Source>Clostridium botulinum:1491</Target_Source>
<Target_Structure>1E1H, 2G7K, 2G7N, 2G7P, 2G7Q</Target_Structure>
<Comments>Botulinum neurotoxins (BoNTs) are extremely toxic.</Comments>
</Item><Item><Target_ID> 1043</Target_ID>
<Target_Name>Anti-polyhistidine monoclonal antibody HIS-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody recognizes synthetic polyHistidine, as well as native or denatured, reduced forms of proteins tagged with 6X histidines, expressed in selected vectors.</Comments>
</Item><Item><Target_ID> 1044</Target_ID>
<Target_Name>Guanine nucleotide-binding protein G(i) subunit alpha-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10824</Target_Sequence>
<Synonyms>Adenylate cyclase-inhibiting G alpha protein</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure>1AGR, 1AS0, 1AS2, 1AS3, 1BH2, 1BOF, 1CIP, 1GDD, 1GFI, 1GG2, 1GIA, 1GIL, 1GIT, 1GP2, 1SHZ, 1SVK, 1SVS, 2BCJ, 2ZJY, 2ZJZ, 3AH8, 3D7M, 3FFA, 3FFB, 3V00</Target_Structure>
<Comments>Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane.</Comments>
</Item><Item><Target_ID> 1045</Target_ID>
<Target_Name>Penicillin binding protein 2a, PBP2a</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q7DHH4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus aureus:1280</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1046</Target_ID>
<Target_Name>Prothrombin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00734 [328-622]</Target_Sequence>
<Synonyms>EC=3.4.21.5</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A2C, 1A3B, 1A3E, 1A46, 1A4W, 1A5G, 1A61, 1ABI, 1ABJ, 1AD8, 1AE8, 1AFE, 1AHT, 1AI8, 1AIX, 1AWF, 1AWH, 1AY6, 1B5G, 1B7X, 1BA8, 1BB0, 1BCU, 1BHX, 1BMM, 1BMN, 1BTH, 1C1U, 1C1V, 1C1W, 1C4U, 1C4V, 1C4Y, 1C5L, 1C5N, 1C5O, 1CA8, 1D3D, 1D3P, 1D3Q, 1D3T, 1D4P, 1D6W, 1D9I, 1DE7, 1DIT, 1DM4, 1DOJ, 1DWB, 1DWC, 1DWD, 1DWE, 1DX5, 1E0F, 1EB1, 1EOJ, 1EOL, 1FPC, 1FPH, 1G30, 1G32, 1G37, 1GHV, 1GHW, 1GHX, 1GHY, 1GJ4, 1GJ5, 1H8D, 1H8I, 1HAG, 1HAH, 1HAI, 1HAO, 1HAP, 1HBT, 1HDT, 1HGT, 1HLT, 1HUT, 1HXE, 1HXF, 1IHS, 1IHT, 1JMO, 1JOU, 1JWT, 1K21, 1K22, 1KTS, 1KTT, 1LHC, 1LHD, 1LHE, 1LHF, 1LHG, 1MH0, 1MU6, 1MU8, 1MUE, 1NM6, 1NO9, 1NRN, 1NRO, 1NRP, 1NRQ, 1NRR, 1NRS, 1NT1, 1NU7, 1NU9, 1NY2, 1NZQ, 1O0D, 1O2G, 1O5G, 1OOK, 1OYT, 1P8V, 1PPB, 1QBV, 1QHR, 1QJ1, 1QJ6, 1QJ7, 1QUR, 1RD3, 1RIW, 1SB1, 1SFQ, 1SG8, 1SGI, 1SHH, 1SL3, 1SR5, 1T4U, 1T4V, 1TA2, 1TA6, 1TB6, 1TBZ, 1THP, 1THR, 1THS, 1TMB, 1TMT, 1TMU, 1TOM, 1TQ0, 1TQ7, 1TWX, 1UMA, 1UVS, 1VR1, 1VZQ, 1W7G, 1WAY, 1WBG, 1XM1, 1XMN, 1YPE, 1YPG, 1YPJ, 1YPK, 1YPL, 1YPM, 1Z71, 1Z8I, 1Z8J, 1ZGI, 1ZGV, 1ZRB, 2A0Q, 2A2X, 2A45, 2AFQ, 2ANK, 2ANM, 2B5T, 2BDY, 2BVR, 2BVS, 2BVX, 2BXT, 2BXU, 2C8W, 2C8X, 2C8Y, 2C8Z, 2C90, 2C93, 2CF8, 2CF9, 2CN0, 2FEQ, 2FES, 2GDE, 2GP9, 2H9T, 2HGT, 2HNT, 2HPP, 2HPQ, 2HWL, 2JH0, 2JH5, 2JH6, 2OD3, 2PGB, 2PGQ, 2PKS, 2PW8, 2R2M, 2THF, 2UUF, 2UUJ, 2UUK, 2V3H, 2V3O, 2ZC9, 2ZDA, 2ZDV, 2ZF0, 2ZFF, 2ZFP, 2ZFQ, 2ZFR, 2ZG0, 2ZGB, 2ZGX, 2ZHE, 2ZHF, 2ZHQ, 2ZHW, 2ZI2, 2ZIQ, 2ZNK, 2ZO3, 3B23, 3B9F, 3BEF, 3BEI, 3BF6, 3BIU, 3BIV, 3BV9, 3C1K, 3C27, 3D49, 3DA9, 3DD2, 3DHK, 3DT0, 3DUX, 3E6P, 3EE0, 3EGK, 3EQ0, 3F68, 3GIC, 3GIS, 3HAT, 3HKJ, 3HTC, 3JZ1, 3JZ2, 3K65, 3LDX, 3LU9, 3NXP, 3P17, 3P6Z, 3P70, 3PMH, 3PO1, 3QDZ, 3QGN, 3QLP, 3QTO, 3QTV, 3QWC, 3QX5, 3R3G, 3RLW, 3RLY, 3RM0, 3RM2, 3RML, 3RMM, 3RMN, 3RMO, 3S7H, 3S7K, 3SHA, 3SHC, 3SI3, 3SI4, 3SQE, 3SQH, 3SV2, 3T5F, 3TU7, 3U69, 3U8O, 3U8R, 3U8T, 3U98, 3U9A, 3UTU, 3UWJ, 4AX9, 4AYV, 4AYY, 4AZ2, 4BAH, 4BAK, 4BAM, 4BAN, 4BAO, 4BAQ, 4DIH, 4DII, 4DT7, 4DY7, 4E05, 4E06, 4E7R, 4H6S, 4H6T, 4HFP, 4HFY, 4HTC, 4THN, 5GDS, 7KME, 8KME</Target_Structure>
<Comments>Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.</Comments>
</Item><Item><Target_ID> 1047</Target_ID>
<Target_Name>Three RNA targets (λ-boxBR, GNRA tetraloop, and P22 boxBL)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Three different RNA targets differs only in their loop structures.</Comments>
</Item><Item><Target_ID> 1048</Target_ID>
<Target_Name>Cationic trypsin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00760</Target_Sequence>
<Synonyms>Beta-trypsin</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure>1AQ7, 1AUJ, 1AZ8, 1BJU, 1BJV, 1BTP, 1BTW, 1BTX, 1BTY, 1BTZ, 1C1N, 1C1O, 1C1P, 1C1Q, 1C1R, 1C1S, 1C1T, 1C2D, 1C2E, 1C2F, 1C2G, 1C2H, 1C2I, 1C2J, 1C2K, 1C2L, 1C2M, 1C5P, 1C5Q, 1C5R, 1C5S, 1C5T, 1C5U, 1C5V, 1C9T, 1CE5, 1D6R, 1EB2, 1EJM, 1EZX, 1F0T, 1F0U, 1F2S, 1G36, 1G3B, 1G3C, 1G3D, 1G3E, 1G9I, 1GBT, 1GHZ, 1GI0, 1GI1, 1GI2, 1GI3, 1GI4, 1GI5, 1GI6, 1GJ6, 1HJ9, 1J8A, 1JIR, 1JRS, 1JRT, 1K1I, 1K1J, 1K1L, 1K1M, 1K1N, 1K1O, 1K1P, 1LQE, 1MAX, 1MAY, 1MTS, 1MTU, 1MTV, 1MTW, 1N6X, 1N6Y, 1NC6, 1NTP, 1O2H, 1O2I, 1O2J, 1O2K, 1O2L, 1O2M, 1O2N, 1O2O, 1O2P, 1O2Q, 1O2R, 1O2S, 1O2T, 1O2U, 1O2V, 1O2W, 1O2X, 1O2Y, 1O2Z, 1O30, 1O31, 1O32, 1O33, 1O34, 1O35, 1O36, 1O37, 1O38, 1O39, 1O3A, 1O3B, 1O3C, 1O3D, 1O3E, 1O3F, 1O3G, 1O3H, 1O3I, 1O3J, 1O3K, 1O3L, 1O3M, 1O3N, 1O3O, 1OPH, 1OX1, 1OYQ, 1P2I, 1P2J, 1P2K, 1PPC, 1PPE, 1PPH, 1QA0, 1QB1, 1QB6, 1QB9, 1QBN, 1QBO, 1QCP, 1QL7, 1QL8, 1RXP, 1S0Q, 1S0R, 1SBW, 1SFI, 1SMF, 1TAB, 1TAW, 1TGB, 1TGC, 1TGN, 1TGS, 1TGT, 1TIO, 1TLD, 1TNG, 1TNH, 1TNI, 1TNJ, 1TNK, 1TNL, 1TPA, 1TPO, 1TPP, 1TPS, 1TX7, 1TX8, 1TYN, 1UTN, 1UTO, 1UTP, 1UTQ, 1V2J, 1V2K, 1V2L, 1V2M, 1V2N, 1V2O, 1V2P, 1V2Q, 1V2R, 1V2S, 1V2T, 1V2U, 1V2V, 1V2W, 1XUF, 1XUG, 1XUH, 1XUI, 1XUJ, 1XUK, 1Y3U, 1Y3V, 1Y3W, 1Y3X, 1Y3Y, 1Y59, 1Y5A, 1Y5B, 1Y5U, 1YP9, 1YYY, 1ZR0, 1ZZZ, 2A7H, 2AGE, 2AGG, 2AGI, 2AH4, 2AYW, 2BLV, 2BLW, 2BTC, 2BY5, 2BY6, 2BY7, 2BY8, 2BY9, 2BYA, 2BZA, 2CMY, 2D8W, 2F3C, 2FI3, 2FI4, 2FI5, 2FTL, 2FTM, 2FX4, 2FX6, 2G55, 2G5N, 2G5V, 2G81, 2G8T, 2ILN, 2J9N, 2O9Q, 2OTV, 2OXS, 2PLX, 2PTC, 2PTN, 2QN5, 2QYI, 2TGA, 2TGD, 2TGP, 2TGT, 2TIO, 2TLD, 2TPI, 2UUY, 2XTT, 2ZDK, 2ZDL, 2ZDM, 2ZDN, 2ZFS, 2ZFT, 2ZHD, 2ZQ1, 2ZQ2, 3A7T, 3A7V, 3A7W, 3A7X, 3A7Y, 3A7Z, 3A80, 3A81, 3A82, 3A83, 3A84, 3A85, 3A86, 3A87, 3A88, 3A89, 3A8A, 3A8B, 3A8C, 3A8D, 3AAS, 3AAU, 3AAV, 3ATI, 3ATK, 3ATL, 3ATM, 3BTD, 3BTE, 3BTF, 3BTG, 3BTH, 3BTK, 3BTM, 3BTQ, 3BTT, 3BTW, 3D65, 3E8L, 3GY2, 3GY3, 3GY4, 3GY5, 3GY6, 3GY7, 3GY8, 3I29, 3ITI, 3LJJ, 3LJO, 3M35, 3M7Q, 3MFJ, 3MI4, 3NK8, 3NKK, 3OTJ, 3PLB, 3PLK, 3PLP, 3PM3, 3PMJ, 3PTB, 3PTN, 3PWB, 3PWC, 3PYH, 3Q00, 3QK1, 3RDZ, 3RU4, 3RXA, 3RXB, 3RXC, 3RXD, 3RXE, 3RXF, 3RXG, 3RXH, 3RXI, 3RXJ, 3RXK, 3RXL, 3RXM, 3RXO, 3RXP, 3RXQ, 3RXR, 3RXS, 3RXT, 3RXU, 3RXV, 3T25, 3T26, 3T27, 3T28, 3T29, 3TPI, 3UNQ, 3UNR, 3UNS, 3UOP, 3UPE, 3UQO, 3UQV, 3UUZ, 3UWI, 3UY9, 3V0X, 3V12, 3V13, 3VEQ, 3VPK, 4AB8, 4AB9, 4ABA, 4ABB, 4ABD, 4ABE, 4ABF, 4ABG, 4ABH, 4ABI, 4ABJ, 4AOQ, 4AOR, 4B1T, 4B2A, 4B2B, 4B2C, 4I8G, 4I8H, 4I8J, 4I8K, 4I8L, 4J2Y, 4TPI, 5PTP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1049</Target_ID>
<Target_Name>Anti-c-myc monoclonal antibody 9E10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The 9E10 monoclonal antibody recognizes the amino acid sequence EQKLISEEDL, which is a specific portion of the human c-myc gene product. This antibody is highly specific and is unlikely to alter the activity of the cloned sequence.</Comments>
</Item><Item><Target_ID> 1050</Target_ID>
<Target_Name>Prepilin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8Z1L1</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Salmonella typhi:90370</Target_Source>
<Target_Structure>3FHU, 3FHV</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1051</Target_ID>
<Target_Name>Model membranes</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1052</Target_ID>
<Target_Name>Cobalt(II) complex, Co(II)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1053</Target_ID>
<Target_Name>Anti-FLAG M2 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-FLAG M2 monoclonal antibody is a purified IgG1 monoclonal antibody isolated from a murine cell culture that binds to FLAG fusion proteins. Unlike anti-FLAG M1 antibody, the M2 antibody will recognize the FLAG sequence at the N-terminus, Met-N-terminus or C-terminus of FLAG fusion proteins. Anti-FLAG M2 monoclonal antibody is useful for identification of FLAG fusion proteins by common immunological procedures. It is also useful for affinity purification of FLAG fusion proteins when bound to a solid support.</Comments>
</Item><Item><Target_ID> 1054</Target_ID>
<Target_Name>Anti-β-cat monoclonal antibody 36a</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1055</Target_ID>
<Target_Name>Anti-β-cat monoclonal antibody 48a</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1056</Target_ID>
<Target_Name>Envelope glycoprotein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P27958 [384-746]</Target_Sequence>
<Synonyms>NS1
gp68
gp70</Synonyms>
<Target_Source>Hepatitis C virus genotype 1a (isolate H) (HCV):11108</Target_Source>
<Target_Structure>1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2XI2, 2XI3</Target_Structure>
<Comments>Envelope glycoprotein E2 is a chain of genome polyprotein.</Comments>
</Item><Item><Target_ID> 1057</Target_ID>
<Target_Name>C-reactive protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02741</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1B09, 1GNH, 1LJ7, 3L2Y, 3PVN, 3PVO</Target_Structure>
<Comments>Displays several functions associated with host defense: it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells.</Comments>
</Item><Item><Target_ID> 1058</Target_ID>
<Target_Name>Surface protein gp120, SU</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Glycoprotein 120, gp120</Synonyms>
<Target_Source>Human immunodeficiency virus 1:11676</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1059</Target_ID>
<Target_Name>Anti-T7·Tag monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The T7·Tag® Antibody is a mouse monoclonal antibody (IgG2b) directed against the 11 amino acid gene 10 leader peptide expressed by many of the pET translation vectors as well as pSCREEN and pRSET vectors. Because the peptide is the natural amino terminal end of the T7 major capsid protein, the antibody also recognizes T7 bacteriophage.</Comments>
</Item><Item><Target_ID> 1060</Target_ID>
<Target_Name>Human breast ductal carcinoma cell line, ZR-75-1</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1061</Target_ID>
<Target_Name>Cuprous oxide, Cu(2)O</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1062</Target_ID>
<Target_Name>Human red blood cells, RBCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1063</Target_ID>
<Target_Name>Heparin</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1064</Target_ID>
<Target_Name>IgG from human, mouse, rat, rabbit and goat</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606, Mus musculus (Mouse):10090, Rattus norvegicus (Rat):10116, Oryctolagus cuniculus (Rabbit):9986, Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1065</Target_ID>
<Target_Name>C crystalline face of synthetic sapphire, α-Al(2)O(3)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1066</Target_ID>
<Target_Name>A crystalline face of synthetic sapphire, α-Al(2)O(3)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1067</Target_ID>
<Target_Name>R crystalline face of synthetic sapphire, α-Al(2)O(3)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1068</Target_ID>
<Target_Name>Zinc sufide, ZnS</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1069</Target_ID>
<Target_Name>Lead sulphide, PbS</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1070</Target_ID>
<Target_Name>Cadmium sulfide, CdS</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1071</Target_ID>
<Target_Name>6Al-4V Ti</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1072</Target_ID>
<Target_Name>(001)-oriented TiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1073</Target_ID>
<Target_Name>(100)-oriented TiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1074</Target_ID>
<Target_Name>(110)-oriented TiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1075</Target_ID>
<Target_Name>Silica, Si</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1076</Target_ID>
<Target_Name>Gold</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1077</Target_ID>
<Target_Name>Titanium, Ti</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1078</Target_ID>
<Target_Name>Stainless steel</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1079</Target_ID>
<Target_Name>Bulk steel (edges)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1080</Target_ID>
<Target_Name>Iridium oxide, IrO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1081</Target_ID>
<Target_Name>Anti-RESA monoclonal antibody MAb 18/2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1082</Target_ID>
<Target_Name>Grass carp hemorrhage virus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Grass carp hemorrhagic virus:128986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Grass carp hemorrhage virus (GCHV), a member of Reoviridae, causes severe hemorrhagic disease of grass carp (Ctenopharyngodon idellus) in China</Comments>
</Item><Item><Target_ID> 1083</Target_ID>
<Target_Name>Newcastle disease virus, NDV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Newcastle disease virus (isolate AF2240) (NDV):351071</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Newcastle disease virus (NDV) which causes a major disease in poultry, is grouped under the family of Paramyxoviridae.</Comments>
</Item><Item><Target_ID> 1084</Target_ID>
<Target_Name>Apical membrane antigen 1, AMA1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q7KQK5</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmodium falciparum (isolate 3D7):36329</Target_Source>
<Target_Structure>1Z40, 2Q8A, 2Q8B, 2Z8V, 2Z8W, 3SRJ, 3ZWZ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1085</Target_ID>
<Target_Name>Regulatory protein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03120</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Human papillomavirus type 16:333760</Target_Source>
<Target_Structure>1BY9, 1DTO, 1R8P, 1ZZF, 2NNU, 2Q79, 3MI7</Target_Structure>
<Comments>Plays an accessory role in initiation of DNA replication. A dimer of E2 interacts with a dimer of E1 in order to improve specificity of E1 DNA binding activity. Once the complex recognizes and binds DNA at specific sites, the E2 dimer is removed from DNA. E2 also regulates viral transcription through binding to the E2RE response element (5'-ACCNNNNNNGGT-3') present in multiple copies in the regulatory regions of the viral genome. Activates or represses transcription depending on E2RE's position with regards to proximal promoter elements including the TATA-box. Repression occurs by sterically hindering the assembly of the transcription initiation complex.</Comments>
</Item><Item><Target_ID> 1086</Target_ID>
<Target_Name>Human antibodies eluted from the surface of infected red blood cell (iRBC)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1087</Target_ID>
<Target_Name>Large envelope protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03139</Target_Sequence>
<Synonyms>L glycoprotein
L-HBsAg, LHB
Large S protein
Large surface protein
Major surface antigen</Synonyms>
<Target_Source>Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979) (HBV-D):10419</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell receptors and thereby initiating infection. This interaction determines the species specificity and liver tropism. This attachment induces virion internalization predominantly through caveolin-mediated endocytosis. The large envelope protein also assumes fusion between virion membrane and endosomal membrane.</Comments>
</Item><Item><Target_ID> 1088</Target_ID>
<Target_Name>Interferon alpha/beta receptor 2, IFN-R-2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P48551</Target_Sequence>
<Synonyms>IFN-alpha binding protein, IFN-alpha/beta receptor 2
Interferon alpha binding protein
Type I interferon receptor 2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1N6U, 1N6V, 2HYM, 2KZ1, 2LAG, 3S8W, 3S9D, 3SE3, 3SE4</Target_Structure>
<Comments>Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation.</Comments>
</Item><Item><Target_ID> 1089</Target_ID>
<Target_Name>Envelope glycoprotein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99IB8 [384-750]</Target_Sequence>
<Synonyms>NS1
gp68
gp70</Synonyms>
<Target_Source>Hepatitis C virus genotype 2a (isolate JFH-1) (HCV):356411</Target_Source>
<Target_Structure>2KZQ, 2LIF, 2XXD, 2XYM, 3I5K, 4AEP, 4AEX, 4E76, 4E78, 4E7A</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1090</Target_ID>
<Target_Name>Interleukin-10, IL-10</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P22301</Target_Sequence>
<Synonyms>Cytokine synthesis inhibitory factor, CSIF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ILK, 1INR, 1J7V, 1LK3, 1Y6K, 2H24, 2ILK</Target_Structure>
<Comments>Inhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells.</Comments>
</Item><Item><Target_ID> 1091</Target_ID>
<Target_Name>Ganglioside GM1</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GM1 (monosialotetrahexosylganglioside) the &quot;prototype&quot; ganglioside, is a member of the ganglio series of gangliosides which contain one sialic acid residue. GM1 has important physiological properties and impacts neuronal plasticity and repair mechanisms, and the release of neurotrophins in the brain. Besides its function in the physiology of the brain, GM1 acts as the site of binding for both Cholera toxin and E. coli heat-labile enterotoxin.</Comments>
</Item><Item><Target_ID> 1092</Target_ID>
<Target_Name>Hemagglutinin, HA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Influenza A virus (strain A/Puerto Rico/8/1934 H1N1):211044</Target_Source>
<Target_Structure>1RU7, 1RVX, 1RVZ</Target_Structure>
<Comments>Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglycoconjugate receptors on the host cell surface at an initial step in the infection process; consequently, HA inhibitors are considered potential candidates for antiviral drugs.</Comments>
</Item><Item><Target_ID> 1093</Target_ID>
<Target_Name>Hemagglutinin, HA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O40714</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Influenza A virus (A/Wuhan/359/1995(H3N2)):63106</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglycoconjugate receptors on the host cell surface at an initial step in the infection process; consequently, HA inhibitors are considered potential candidates for antiviral drugs.</Comments>
</Item><Item><Target_ID> 1094</Target_ID>
<Target_Name>α form of poly(L-lactide) crystalline films</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>???</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PLLA is one of the most commonly used synthetic polymers in the biomedical field because of its many excellent physical properties such as thermal stability, mechanical properties, biocompatibility, and biodegradability to nontoxic products.</Comments>
</Item><Item><Target_ID> 1095</Target_ID>
<Target_Name>Anti-biotin polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-biotin antibody was obtained from Sigma(B3640), which was produced in goat with Biotin-KLH conjugate as immunogen.</Comments>
</Item><Item><Target_ID> 1096</Target_ID>
<Target_Name>GSI-B4 isolectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8W1R6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Griffonia simplicifolia:3850</Target_Source>
<Target_Structure>1GNZ, 1HQL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1097</Target_ID>
<Target_Name>Anti-pig Xenoreactive Natural Antibodies, XNAs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human anti-pig XNAs, primarily of IgM isotype, were eluted from porcine aortic endothelial cell. They were captured to be the target of biopanning by biotinylated mouse anti-human IgM, which was imobilized by streptavidin coated on the surface of the culture plates.</Comments>
</Item><Item><Target_ID> 1098</Target_ID>
<Target_Name>Fc domain of IgG (IGHG1,IGHG2,IGHG3,IGHG4)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01857, P01859, P01860, P01861</Target_Sequence>
<Synonyms>Ig gamma chain C region, Human IgG Fc fragment</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>IGHG1: 1AJ7, 1AQK, 1BEY, 1D5B, 1D5I, 1D6V, 1DFB, 1DN2, 1E4K, 1FC1, 1FC2, 1FCC, 1GAF, 1H3T, 1H3U, 1H3V, 1H3W, 1H3X, 1H3Y, 1HKL, 1HZH, 1I7Z, 1L6X, 1N7M, 1OP3, 1OQO, 1OQX, 1T83, 1T89, 1VGE, 2DTS, 2GJ7, 2I5Y, 2IWG, 2J6E, 2JB5, 2JB6, 2O5X, 2O5Y, 2O5Z, 2OSL, 2QAD, 2QL1, 2QQK, 2QQL, 2QQN, 2QR0, 2R56, 2RCJ, 2RCS, 2VXQ, 2WAH, 3AGV, 3AVE, 3AY4, 3B2U, 3B2V, 3BDY, 3BE1, 3BKY, 3BN9, 3BQU, 3C08, 3C09, 3C2S, 3CFJ, 3CFK, 3CSY, 3D0L, 3D0V, 3D6G, 3D85, 3DJ9, 3DNK, 3DO3, 3DRO, 3DRQ, 3DVG, 3DVN, 3EYF, 3EYO, 3EYQ, 3FJT, 3O11, 3RY6, 3S7G, 3SGJ, 3SGK, 3TV3, 3TWC, 3TYG, 3U0W, 3U7W, 3U7Y, 3V7M, 3V8C, 3V95, 3WJJ, 3WJL, 3WKN, 3WN5, 4ACP, 4B7I, 4BM7, 4BSV, 4BSW, 4BYH, 4CDH, 4D9Q, 4D9R, 4DAG, 4DZ8, 4EOW, 4J12, 4KU1, 4LLD, 4LLM, 4LLQ, 4N0U, 4NQS, 4NQT, 4NQU, 4NWT, 4NWU, 4O4Y, 4O51, 4Q6Y, 4Q74, 4Q7D, 4W4N, 4W4O, 4X4M
IGHG2: 2QSC, 4HAF, 4HAG, 4L4J
IGHG4: 1ADQ, 1BBJ, 2FL5, 4B53, 4C54, 4C55, 4D2N</Target_Structure>
<Comments>Defects in IGHG1 are a cause of multiple myeloma, which is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection.</Comments>
</Item><Item><Target_ID> 1099</Target_ID>
<Target_Name>Anti-IgE polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The polyclonal antibody was isolated from the serum of an asthma patient with high titre of IgG1 anti-IgE.</Comments>
</Item><Item><Target_ID> 1100</Target_ID>
<Target_Name>SB-365579</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>SB-365579 is a biotinylated derivative of SB-236057 (biotin conjugated to the spiropiperidine moiety). The compound SB-236057 is a serotonin receptor 1B (5-HT1B) inverse agonist that has been identified to be teratogenic in rats, rabbits and mice.</Comments>
</Item><Item><Target_ID> 1101</Target_ID>
<Target_Name>SB-365580</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>SB-365580 is a biotinylated derivative of SB-236057 (biotin conjugate in lieu of the oxadiazole ring). The compound SB-236057 is a serotonin receptor 1B (5-HT1B) inverse agonist that has been identified to be teratogenic in rats, rabbits and mice.</Comments>
</Item><Item><Target_ID> 1102</Target_ID>
<Target_Name>70 kDa heat shock cognate protein 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q5QHT4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Vigna radiata (Mung bean):157791</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1103</Target_ID>
<Target_Name>Cobalt ion, Co(2+)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1104</Target_ID>
<Target_Name>Microcystin-LR, MC-LR</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Cyanobacteria:1117</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Microcystins are a group of stable cyclic heptapeptide toxins produced by cyanobacterial blooms, which cause environmental contamination.</Comments>
</Item><Item><Target_ID> 1105</Target_ID>
<Target_Name>Anti-E2 protein monoclonal antibody HQ06</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>mAb HQ06</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb HQ06 directed against the E2 protein of Classical swine fever virus (CSFV) was generated by immunization of BALB/c mice with the recombinant truncated E2 protein (aa 754-881) of CSFV Shimen/HVRI strain (GenBank accession no. AY775178) expressed in Escherichia coli. The mAb showed reactivity and neutralizing activity with Shimen/HVRI strain in infected PK15 cells in virus neutralization test.</Comments>
</Item><Item><Target_ID> 1106</Target_ID>
<Target_Name>Sulfated Lewis X</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>HSO3-LeX, HSO3LeX</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sulfated Lewis X is widely distributed in tumor mucin.</Comments>
</Item><Item><Target_ID> 1107</Target_ID>
<Target_Name>Sulfated Lewis A</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>HSO3-LeA, HSO3LeA</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sulfated Lewis A is widely distributed in tumor mucin.</Comments>
</Item><Item><Target_ID> 1108</Target_ID>
<Target_Name>Anti-human DAF monoclonal antibody DG3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab DG3</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The IgG1 mAbs DG3 are specific to the human DAF.</Comments>
</Item><Item><Target_ID> 1109</Target_ID>
<Target_Name>p53-binding domains of MDM2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q00987 [25-109]</Target_Sequence>
<Synonyms>MDM2 alternative name(s):
E3 ubiquitin-protein ligase Mdm2
Double minute 2 protein
Oncoprotein Mdm2
p53-binding protein Mdm2
EC=6.3.2.-</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1RV1, 1T4E, 1T4F, 1YCR, 1Z1M, 2AXI, 2C6A, 2C6B, 2F1Y, 2FOP, 2GV2, 2HDP, 2LZG, 2M86, 2RUH, 2VJE, 2VJF, 3EQS, 3G03, 3IUX, 3IWY, 3JZK, 3JZR, 3JZS, 3LBK, 3LBL, 3LNJ, 3LNZ, 3MQS, 3TJ2, 3TPX, 3TU1, 3V3B, 3VBG, 3VZV, 3W69, 4DIJ, 4ERE, 4ERF, 4HBM, 4HFZ, 4HG7, 4JV7, 4JV9, 4JVE, 4JVR, 4JWR, 4MDN, 4MDQ, 4OAS, 4OBA, 4OCC, 4ODE, 4ODF, 4OGN, 4OGT, 4OGV, 4OQ3, 4QO4, 4QOC, 4UMN, 4WT2</Target_Structure>
<Comments>E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as an ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways.</Comments>
</Item><Item><Target_ID> 1110</Target_ID>
<Target_Name>p53-binding domains of MDMX</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O15151 [24-108]</Target_Sequence>
<Synonyms>MDMX alternative name(s):
Protein Mdm4
Double minute 4 protein
Mdm2-like p53-binding protein
Protein Mdmx
p53-binding protein Mdm4</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2CR8, 2VJE, 2VJF, 2VYR, 3DAB, 3EQY, 3FDO, 3FE7, 3FEA, 3JZO, 3JZP, 3JZQ, 3LBJ, 3MQR, 3U15</Target_Structure>
<Comments>Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions.</Comments>
</Item><Item><Target_ID> 1111</Target_ID>
<Target_Name>Monoclonal antibody 3-4B</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>MAb 3-4B</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb 3-4B is a mouse monoclonal IgM that reacts with the large subunit of Caenorhabditis elegans RNA polymerase II and with a fusion protein containing 148 residues of that polypeptide.</Comments>
</Item><Item><Target_ID> 1112</Target_ID>
<Target_Name>Insulin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Insulin normally binds a cell surface receptor, although it has also been shown to bind a hexapeptide.</Comments>
</Item><Item><Target_ID> 1113</Target_ID>
<Target_Name>Interleukin-2 receptor subunit alpha</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P01589</Target_Sequence>
<Synonyms>IL-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, IL2-RA
TAC antigen
p55
CD_antigen=CD25</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1Z92, 2B5I, 2ERJ, 3IU3, 3NFP</Target_Structure>
<Comments>IL-2Rα is the extracellular binding domain of the small (α) subunit of the IL-2 receptor; it binds the polypeptide hormone IL-2 without the large subunit.</Comments>
</Item><Item><Target_ID> 1114</Target_ID>
<Target_Name>Syndiotactic polystyrene film</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>sPS film</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>sPS adopts TTGG helical conformations (T and G indicate trans and gauche conformations, respectively) when films are appropriately prepared with suitable solvents such as xylene and toluene.</Comments>
</Item><Item><Target_ID> 1115</Target_ID>
<Target_Name>Petri dish (polystyrene, PS)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Petri plate
Cell culture dish</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A Petri dish (or Petri plate or cell culture dish) is a shallow glass or plastic cylindrical lidded dish that biologists use to culture cells or small moss plants.</Comments>
</Item><Item><Target_ID> 1116</Target_ID>
<Target_Name>Mouse pooled sera immunized with VHBL plasmid DNA</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1117</Target_ID>
<Target_Name>Anti-mut-II monoclonal antibody LmmAbB2D4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab LmmAbB2D4</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1118</Target_ID>
<Target_Name>Rat synovial tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1119</Target_ID>
<Target_Name>Anti-CAEV polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgG fraction was purified from serum at 12-week post-infection (pi).</Comments>
</Item><Item><Target_ID> 1120</Target_ID>
<Target_Name>Recombinant 4e5 domain of human stabilin-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8WWQ8</Target_Sequence>
<Synonyms>Stabilin-2 alternative name(s):
FAS1 EGF-like and X-link domain-containing adhesion molecule 2
Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2, FEEL-2
Hyaluronan receptor for endocytosis</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Recombinant 4e5 domain of human stabilin-2 was constructed with the fourth FAS domain, the third EGF repeat domain, and the fifth FAS domain.</Comments>
</Item><Item><Target_ID> 1121</Target_ID>
<Target_Name>Plasmodium berghei ookinetes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmodium berghei (strain Anka):5823</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The ookinete is a motile stage of malaria parasites that forms in the midgut lumen of the mosquito vector within the infective bloodmeal bolus.</Comments>
</Item><Item><Target_ID> 1122</Target_ID>
<Target_Name>Membrane primary amine oxidase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q16853</Target_Sequence>
<Synonyms>EC=1.4.3.21
Copper amine oxidase
HPAO
Semicarbazide-sensitive amine oxidase, SSAO
Vascular adhesion protein 1, VAP-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1PU4, 1US1, 2C10, 2C11, 2Y73, 2Y74, 3ALA</Target_Structure>
<Comments>Vascular adhesion protein-1 (VAP-1/AOC3) is an endothelial cell molecule that is rapidly translocated from the intracellular storage granules to the endothelial cell surface on inflammation. It contributes to several steps in the extravasation cascade and controls trafficking of lymphocytes, granulocytes, and monocytes to sites of inflammation.</Comments>
</Item><Item><Target_ID> 1123</Target_ID>
<Target_Name>Soluble ectodomain of APP isoform sAPPα695</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05067</Target_Sequence>
<Synonyms>APP alternative name(s):
ABPP
APPI
Alzheimer disease amyloid protein
Cerebral vascular amyloid peptide, CVAP
PreA4
Protease nexin-II, PN-II</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments>The amyloid precursor protein (APP) is well known for giving rise to the amyloid-β peptide and for its role in Alzheimer's disease. Much less is known, however, on the physiological roles of APP in the development and plasticity of the central nervous system.</Comments>
</Item><Item><Target_ID> 1124</Target_ID>
<Target_Name>Human thymic CD4+CD25+ T cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Thymic CD4+CD25+ cells play an important role in immune regulation and are continuously developed in the thymus as an independent lineage.</Comments>
</Item><Item><Target_ID> 1125</Target_ID>
<Target_Name>PreS1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis B virus (HBV):10407</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1126</Target_ID>
<Target_Name>Anti-Li venom monoclonal antibody LimAb7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab LimAb7</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal antibody LimAb7 can neutralize the dermonecrotic activity of crude Li venom.</Comments>
</Item><Item><Target_ID> 1127</Target_ID>
<Target_Name>Influenza A virus (A/goose/Jilin/hb/2003(H5N1))</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Influenza A virus (A/goose/Jilin/hb/2003(H5N1)):404186</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Influenza A virus causes influenza in birds and some mammals and is the only species of influenzavirus A. Influenzavirus A is a genus of the Orthomyxoviridae family of viruses.</Comments>
</Item><Item><Target_ID> 1128</Target_ID>
<Target_Name>Porcine skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1129</Target_ID>
<Target_Name>Porcine dermis</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1130</Target_ID>
<Target_Name>Ig-like C2-type 1-3 domain of c-kit</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P10721 [27-308]</Target_Sequence>
<Synonyms>c-kit alternative name(s):
Mast/stem cell growth factor receptor Kit, SCFR
Piebald trait protein, PBT
Proto-oncogene c-Kit
Tyrosine-protein kinase Kit
p145 c-kit
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
CD_antigen=CD117
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1PKG, 1T45, 1T46, 2E9W, 2EC8, 2VIF, 3G0E, 3G0F, 4HVS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1131</Target_ID>
<Target_Name>The tegument of schistosoma japonicum schistosomula</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Schistosoma japonicum (Blood fluke):6182</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1132</Target_ID>
<Target_Name>BH3 motif of Mcl-1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P97287</Target_Sequence>
<Synonyms>Mcl-1 protein alternative name(s):
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog
Bcl-2-related protein EAT/mcl1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1WSX, 2JM6, 2NL9, 2NLA, 2ROC, 2ROD, 3IO9, 4G35</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1133</Target_ID>
<Target_Name>Goat anti-mouse IgG (Fc) polycloanl antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1134</Target_ID>
<Target_Name>Anti-CEA monoclonal antibody Col-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab Col-1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monoclonal anti-CEA anitbody Col-1 monoclonalis is an IgG2a made from BALB/C mice immunized with extract of colon carcinoma cells.</Comments>
</Item><Item><Target_ID> 1135</Target_ID>
<Target_Name>Human DA-MB-435eb.1 tumor xenografts</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1136</Target_ID>
<Target_Name>Pancreatic phospholipase A2 </Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Vipera ammodytes ammodytes (Western sand viper):8705</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Pancreatic phospholipase (neurotoxin found in the venom glands of long-nosed viper, Vipera ammodytes ammodytes) belongs to a group of secretory phospholipases A2 (EC 3.1.1.4) that catalyze the hydrolysis of the sn-2 ester bond of phospholipids.</Comments>
</Item><Item><Target_ID> 1137</Target_ID>
<Target_Name>Phospholipase A2, ammodytoxin C</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P11407</Target_Sequence>
<Synonyms>Phosphatidylcholine 2-acylhydrolase
EC=3.1.1.4</Synonyms>
<Target_Source>Vipera ammodytes ammodytes (Western sand viper):8705</Target_Source>
<Target_Structure>3G8H</Target_Structure>
<Comments>Ammodytoxin C (neurotoxin found in the venom glands of long-nosed viper, Vipera ammodytes ammodytes) belongs to a group of secretory phospholipases A2 (EC 3.1.1.4) that catalyze the hydrolysis of the sn-2 ester bond of phospholipids.</Comments>
</Item><Item><Target_ID> 1138</Target_ID>
<Target_Name>Rabbit anti-PrV polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1139</Target_ID>
<Target_Name>Rabbit anti-PRRSV polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1140</Target_ID>
<Target_Name>CD44 antigen protein</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P16070</Target_Sequence>
<Synonyms>CDw44
Epican
Extracellular matrix receptor III, ECMR-III
GP90 lymphocyte homing/adhesion receptor
HUTCH-I
Heparan sulfate proteoglycan
Hermes antigen
Hyaluronate receptor
Phagocytic glycoprotein 1, PGP-1
CD_antigen=CD44</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1POZ, 1UUH, 2I83</Target_Structure>
<Comments>CD44, a cancer-associated membrane glycoprotein involved in cell adhesion and tumor progression, has been implicated as a cancer stem cell antigen in several cancers including breast cancer.</Comments>
</Item><Item><Target_ID> 1141</Target_ID>
<Target_Name>Rat visceral adipose tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1142</Target_ID>
<Target_Name>Alanine aminotransferase 1, ALT1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P24298</Target_Sequence>
<Synonyms>Glutamate pyruvate transaminase 1, GPT 1
Glutamic--alanine transaminase 1
Glutamic--pyruvic transaminase 1
EC=2.6.1.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>ALT catalyzes the reversible transamination of L-alanine and a-ketoglutarate to pyruvate and L-glutamate with pyridoxal 59-phosphate as a coenzyme. ALT is found mainly in the liver, but is also found in red blood cells, heart cells, muscle tissue and other organs, such as the pancreas and kidneys.</Comments>
</Item><Item><Target_ID> 1143</Target_ID>
<Target_Name>Anti-SP1 polyclonal antibody IgGs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1144</Target_ID>
<Target_Name>Anti-SP2 polyclonal antibody IgGs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1145</Target_ID>
<Target_Name>Mouse cardiomyocyte</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Cardiomyocytes derived from pluripotent stem cells (PSCs) offer a large source of cardiomyocytes.</Comments>
</Item><Item><Target_ID> 1146</Target_ID>
<Target_Name>Mouse mesenchymal stem cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1147</Target_ID>
<Target_Name>Anti-CYR61 monoclonal antibody 093G9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1148</Target_ID>
<Target_Name>Anti-CYR61 monoclonal antibody 096B7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1149</Target_ID>
<Target_Name>Caspase recruitment domain (CARD) of APAF-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O14727 [1-90]</Target_Sequence>
<Synonyms>APAF-1 alternative name(s):
Apoptotic protease-activating factor 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1C15, 1CWW, 1CY5, 1Z6T, 2P1H, 2YGS, 3IZA, 3YGS</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1150</Target_ID>
<Target_Name>Human renal carcinoma cell line A498</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1151</Target_ID>
<Target_Name>Sera from early-stage primary HCC patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1152</Target_ID>
<Target_Name>Human chronic myeloid leukemia (CML) cell lines KT-1/A3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1153</Target_ID>
<Target_Name>Urease</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Helicobacter pylori (Campylobacter pylori):210</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1154</Target_ID>
<Target_Name>Anti-CD11b monoclonal antibody 44a</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1155</Target_ID>
<Target_Name>MBP mouse Kelch protein (MBP-Kelch)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9Z2X8 [308-624]</Target_Sequence>
<Synonyms>Kelch-like ECH-associated protein 1
Cytosolic inhibitor of Nrf2, INrf2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1X2J, 1X2R, 2DYH, 2Z32, 3ADE</Target_Structure>
<Comments>MBP-Kelch is a fusion protein of the Kelch-repeat domain of mouse Keap1 (residues 308-624) and maltose-binding protein (MBP).</Comments>
</Item><Item><Target_ID> 1156</Target_ID>
<Target_Name>Anti-Bla g 2 monoclonal antibody 7C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 7C11</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1157</Target_ID>
<Target_Name>Clusterin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10909</Target_Sequence>
<Synonyms>Aging-associated gene 4 protein
Apolipoprotein J, Apo-J
Complement cytolysis inhibitor, CLI
Complement-associated protein SP-40,40
Ku70-binding protein 1
NA1/NA2
Testosterone-repressed prostate message 2, TRPM-2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Clusterin (CLU) is a well-conserved glycoprotein, which is also known as dimeric acidic glycoprotein, testosterone repressed prostate message-2, sulfated glycoprotein-2 and complement lysis inhibitor.</Comments>
</Item><Item><Target_ID> 1158</Target_ID>
<Target_Name>Serine protease 28</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q924N9</Target_Sequence>
<Synonyms>Implantation serine proteinase 1, ISP-1
Strypsin
Tryptase-like proteinase
EC=3.4.21.-</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1159</Target_ID>
<Target_Name>Tenascin, TN</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q80YX1</Target_Sequence>
<Synonyms>Hexabrachion
Tenascin-C, TN-C</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1160</Target_ID>
<Target_Name>Bovine rotavirus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bovine rotavirus:10927</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1161</Target_ID>
<Target_Name>Anti-influenza A H2N2 monoclonal antibody C179</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1162</Target_ID>
<Target_Name>Anti-influenza A H1N1 monoclonal antibody IV.C102</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1163</Target_ID>
<Target_Name>Anti-influenza A H3N2 polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1164</Target_ID>
<Target_Name>SIV sera from patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1165</Target_ID>
<Target_Name>C-X-C chemokine receptor type 1, CXCR-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P25024</Target_Sequence>
<Synonyms>CXC-R1
CDw128a
High affinity interleukin-8 receptor A, IL-8R A
IL-8 receptor type 1
CD_antigen=CD181</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ILP, 1ILQ, 2LNL</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1166</Target_ID>
<Target_Name>C-X-C chemokine receptor type 2, CXCR-2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P25025</Target_Sequence>
<Synonyms>CXC-R2
CDw128b
GRO/MGSA receptor
High affinity interleukin-8 receptor B, IL-8R B
IL-8 receptor type 2
CD_antigen=CD182</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1167</Target_ID>
<Target_Name>Interleukin-8, IL-8</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P10145</Target_Sequence>
<Synonyms>C-X-C motif chemokine 8
Emoctakin
Granulocyte chemotactic protein 1, GCP-1
Monocyte-derived neutrophil chemotactic factor, MDNCF
Monocyte-derived neutrophil-activating peptide, MONAP
Neutrophil-activating protein 1, NAP-1
Protein 3-10C
T-cell chemotactic factor</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1ICW, 1IKL, 1IKM, 1IL8, 1ILP, 1ILQ, 1QE6, 1ROD, 2IL8, 3IL8</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1168</Target_ID>
<Target_Name>Prestin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99NH7</Target_Sequence>
<Synonyms>Solute carrier family 26 member 5</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Prestin is a bidirectional voltage-to-force converter, it can operate at microsecond rates. It uses cytoplasmic anions as extrinsic voltage sensors, probably chloride and bicarbonate. After binding to a site with millimolar affinity, these anions are translocated across the membrane in response to changes in the transmembrane voltage. They move towards the extracellular surface following hyperpolarization, and towards the cytoplasmic side in response to depolarization. As a consequence, this translocation triggers conformational changes in the protein that ultimately alter its surface area in the plane of the plasma membrane.</Comments>
</Item><Item><Target_ID> 1169</Target_ID>
<Target_Name>Graphite flakes</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1170</Target_ID>
<Target_Name>Purified immunoglobulin G (IgG) from sera of knee OA patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1171</Target_ID>
<Target_Name>Gadolinium  oxide  (GdO)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1172</Target_ID>
<Target_Name>Anti-gp75 monoclonal antibody 5E7C</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 5E7C</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1173</Target_ID>
<Target_Name>Low-density lipoprotein receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P01130</Target_Sequence>
<Synonyms>LDL receptor</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AJJ, 1D2J, 1F5Y, 1F8Z, 1HJ7, 1HZ8, 1I0U, 1IJQ, 1LDL, 1LDR, 1N7D, 1XFE, 2FCW, 2KRI, 2LGP, 2W2M, 2W2N, 2W2O, 2W2P, 2W2Q, 3BPS, 3GCW, 3GCX, 3M0C, 3P5B, 3P5C, 3SO6</Target_Structure>
<Comments>LDL receptor binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. In case of HIV-1 infection, functions as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells.</Comments>
</Item><Item><Target_ID> 1174</Target_ID>
<Target_Name>Fibrin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1175</Target_ID>
<Target_Name>Soluble fibrin fragment DD(E)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Prepared as previously described. 13 DD(E) used in this study contained subunits of 61 kD and 72 kD, assigned to fragments E1 and E2 and present in a roughly 1:1 ratio, and 180 kD (fragment DD).</Comments>
</Item><Item><Target_ID> 1176</Target_ID>
<Target_Name>Anti-RPV-H monoclonal antibody C1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab C1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-RPV-H C1 mAb derived from a hybridoma line was purified from cell culture supernatant using the ImmunoPure (G) IgG Purification Kit (Pierce) according to the manufacturer's instructions.</Comments>
</Item><Item><Target_ID> 1177</Target_ID>
<Target_Name>Phosphocarrier protein HPr</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P0AA04</Target_Sequence>
<Synonyms>Histidine-containing protein
EC=2.7.11.-</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1CM2, 1CM3, 1GGR, 1HDN, 1J6T, 1OPD, 1PFH, 1POH, 1VRC, 2JEL, 2LRK, 2LRL, 2XDF, 3CCD, 3EZA, 3EZB, 3EZE</Target_Structure>
<Comments>General (non sugar-specific) component of the phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS). This major carbohydrate active-transport system catalyzes the phosphorylation of incoming sugar substrates concomitantly with their translocation across the cell membrane. The phosphoryl group from phosphoenolpyruvate (PEP) is transferred to the phosphoryl carrier protein HPr by enzyme I. Phospho-HPr then transfers it to the permease (enzymes II/III).</Comments>
</Item><Item><Target_ID> 1178</Target_ID>
<Target_Name>Human bone marrow-derived mesenchymal stem cell, hBMMSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1179</Target_ID>
<Target_Name>Whole Mycobacterium bovis cells, WCA</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mycobacterium bovis:1765</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1180</Target_ID>
<Target_Name>Ethanol-extracted Mycobacterium bovis cell surface antigens, EEA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mycobacterium bovis:1765</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1181</Target_ID>
<Target_Name>Cell surface lipoprotein MPB83</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0CAX7</Target_Sequence>
<Synonyms>Lipoprotein p23</Synonyms>
<Target_Source>Mycobacterium bovis:1765</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1182</Target_ID>
<Target_Name>Anti-LPS monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The LPS antibody (Abcam, Cambridge, MA, CAT# ab35654) was a monoclonal antibody, which was produced by vaccinating mice with whole Escherichia coli O111B4J5 cells.</Comments>
</Item><Item><Target_ID> 1183</Target_ID>
<Target_Name>Transcriptional regulatory protein devR (dosR)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P95193</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mycobacterium tuberculosis:1773</Target_Source>
<Target_Structure>1ZLJ, 1ZLK, 3C3W, 3C57</Target_Structure>
<Comments>DevR is a key regulator of the dormancy response in Mycobacterium tuberculosis (M. tb).</Comments>
</Item><Item><Target_ID> 1184</Target_ID>
<Target_Name>Thiamethoxam, TMX</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Thiamethoxam (TMX) is an organic solid.</Comments>
</Item><Item><Target_ID> 1185</Target_ID>
<Target_Name>Anti-SapA monoclonal antibody A2D5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab A2D5</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1186</Target_ID>
<Target_Name>Anti-MSP1a monoclonal antibody 15D2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mab 15D2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1187</Target_ID>
<Target_Name>Human corneal epithelial cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1188</Target_ID>
<Target_Name>Thiacloprid</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Thiacloprid is an insecticide of the neonicotinoid class. Its mechanism of action involves disruption of the insect's nervous system by inhibiting nicotinic acetylcholine receptors.</Comments>
</Item><Item><Target_ID> 1189</Target_ID>
<Target_Name>Imidacloprid</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Imidacloprid is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids which act on the central nervous system of insects with much lower toxicity to mammals. The chemical works by interfering with the transmission of stimuli in the insect nervous system. Specifically, it causes a blockage in the nicotinergic neuronal pathway. This blockage leads to the accumulation of acetylcholine, an important neurotransmitter, resulting in the insect's paralysis, and eventually death. It is effective on contact and via stomach action.</Comments>
</Item><Item><Target_ID> 1190</Target_ID>
<Target_Name>Extracellular domain of human carbonic anhydrase IX</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q16790 [38-414]</Target_Sequence>
<Synonyms>Carbonic anhydrase 9 alternative name(s):
Carbonate dehydratase IX
Carbonic anhydrase IX, CA-IX, CAIX
Membrane antigen MN
P54/58N
Renal cell carcinoma-associated antigen G250, RCC-associated antigen G250
pMW1
EC=4.2.1.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2HKF, 3IAI</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1191</Target_ID>
<Target_Name>Anti-D2NS1 monoclonal antibody DB16-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1192</Target_ID>
<Target_Name>CD133 extracellular fraction</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O54990 [418-434]</Target_Sequence>
<Synonyms>CD133 alternative name(s):
Prominin-1
Antigen AC133 homolog
Prominin-like protein 1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1193</Target_ID>
<Target_Name>Porcine ear skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1194</Target_ID>
<Target_Name>Chitin</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Chitin, a poly-β-1,4-N-acetylglucosamine (GlcNAc), is one of most abundant biopolymers in nature, because it is the main component of the exoskeleton of arthropods, such as insects, arachnids and crustaceans, and is a structural polysaccharide in fungal cell walls.</Comments>
</Item><Item><Target_ID> 1195</Target_ID>
<Target_Name>Type IV secretion system protein virB8</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q7CEG3</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Brucella suis biovar 1 (strain 1330):204722</Target_Source>
<Target_Structure>2BHM, 4AKY, 4AKZ</Target_Structure>
<Comments>The virB system could be required for the establishment of the replication niche in the host.</Comments>
</Item><Item><Target_ID> 1196</Target_ID>
<Target_Name>Major prion protein, PrP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04156</Target_Sequence>
<Synonyms>ASCR
PrP27-30
PrP33-35C
CD_antigen=CD230</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E1G, 1E1J, 1E1P, 1E1S, 1E1U, 1E1W, 1FKC, 1FO7, 1H0L, 1HJM, 1HJN, 1I4M, 1OEH, 1OEI, 1QLX, 1QLZ, 1QM0, 1QM1, 1QM2, 1QM3, 2IV4, 2IV5, 2IV6, 2K1D, 2KUN, 2LBG, 2LEJ, 2LFT, 2LSB, 2LV1, 2OL9, 2W9E, 3HAF, 3HAK, 3HEQ, 3HER, 3HES, 3HJ5, 3HJX, 3MD4, 3MD5, 3NHC, 3NHD, 3NVF, 4DGI, 4E1H, 4E1I</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1197</Target_ID>
<Target_Name>Human gastric cancer specimens</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1198</Target_ID>
<Target_Name>Cardiac phospholamban, PLB</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P26678</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1PLP, 1ZLL, 2HYN</Target_Structure>
<Comments>Phospholamban has been postulated to regulate the activity of the calcium pump of cardiac sarcoplasmic reticulum.</Comments>
</Item><Item><Target_ID> 1199</Target_ID>
<Target_Name>Human osteosarcoma MG-63 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1200</Target_ID>
<Target_Name>72 kDa type IV collagenase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08253</Target_Sequence>
<Synonyms>72 kDa gelatinase
Gelatinase A
Matrix metalloproteinase-2, MMP-2
TBE-1
EC=3.4.24.24</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</Target_Structure>
<Comments>Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture.</Comments>
</Item><Item><Target_ID> 1201</Target_ID>
<Target_Name>IgGs purified from equine sera</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgGs were purified from a pool comprised of 20 sera from animals naturally infected with equine infectious anemia virus.</Comments>
</Item><Item><Target_ID> 1202</Target_ID>
<Target_Name>Caspase-6, CASP-6</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P55212</Target_Sequence>
<Synonyms>Apoptotic protease Mch-2
EC=3.4.22.59</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2WDP, 3K7E, 3NKF, 3NR2, 3OD5, 3P45, 3P4U, 3QNW, 3S70, 3S8E, 3V6L, 3V6M, 4EJF, 4FXO, 4HVA</Target_Structure>
<Comments>Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves poly(ADP-ribose) polymerase in vitro, as well as lamins. Overexpression promotes programmed cell death.</Comments>
</Item><Item><Target_ID> 1203</Target_ID>
<Target_Name>Anti-MgPa polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1204</Target_ID>
<Target_Name>Anti-VSG LiTat 1.3 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1205</Target_ID>
<Target_Name>Anti-VSG LiTat 1.5 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1206</Target_ID>
<Target_Name>Oxygen-terminated sides of single-crystalline ZnO (000-1)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1207</Target_ID>
<Target_Name>Zinc-terminated sides of single-crystalline ZnO (0001)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1208</Target_ID>
<Target_Name>Helicase, Hel</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>A0MD28 [3021-3462]</Target_Sequence>
<Synonyms>Nsp10
EC=3.6.4.12
EC=3.6.4.13</Synonyms>
<Target_Source>Porcine reproductive and respiratory syndrome virus (isolate Pig/United States/SD 01-08/2001) (PRRSV):857306</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1209</Target_ID>
<Target_Name>RNA-directed RNA polymerase, Pol, RdRp</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>A0MD28 [2335-3020]</Target_Sequence>
<Synonyms>Nsp9
EC=2.7.7.48</Synonyms>
<Target_Source>Porcine reproductive and respiratory syndrome virus (isolate Pig/United States/SD 01-08/2001) (PRRSV):857306</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1210</Target_ID>
<Target_Name>Zirconia</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1211</Target_ID>
<Target_Name>Amorphous spherical silica particles (15 nm diameter)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1212</Target_ID>
<Target_Name>Amorphous spherical silica particles (82 nm diameter)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1213</Target_ID>
<Target_Name>Amorphous spherical silica particles (450 nm diameter)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1214</Target_ID>
<Target_Name>Anti-MDA-LDL monoclonal antibody LR04</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>LRO4 is a monoclonal IgM Ab that was cloned from the spleens of cholesterol-fed Ldlr -/-mice.</Comments>
</Item><Item><Target_ID> 1215</Target_ID>
<Target_Name>Anti-VACV A33  monoclonal antidbody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb-1G10 was initially characterized as an A33-binding monoclonal antibody that could provide partial protection in vivo against an intranasal VACV-WR challenge in a mouse model, as well as block EV spread in cell culture.</Comments>
</Item><Item><Target_ID> 1216</Target_ID>
<Target_Name>Protein tyrosine phosphatases(PTPRJ-His6)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P23470</Target_Sequence>
<Synonyms>DEP-1
HPTP???</Synonyms>
<Target_Source>Homo sapiens (Human) :9606</Target_Source>
<Target_Structure>2H4V, 2HY3, 2NLK, 2PBN, 3JXH, 3QCB, 3QCC, 3QCD, 3QCE, 3QCF, 3QCG, 3QCH, 3QCI, 3QCJ, 3QCK, 3QCL, 3QCM, 3QCN </Target_Structure>
<Comments>PTPRJ (also named DEP-1, HPTPη, or CD148) is down-regulated in mammary cancer cells, and its restoration blocks their proliferation.</Comments>
</Item><Item><Target_ID> 1217</Target_ID>
<Target_Name>Tomato-stained cotton swatches</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The real target is carotenoid.</Comments>
</Item><Item><Target_ID> 1218</Target_ID>
<Target_Name>Paprika-stained cotton swatches</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The real target is carotenoid.</Comments>
</Item><Item><Target_ID> 1219</Target_ID>
<Target_Name>Lens epithelium-derived growth factor (LEDGF)/p75</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q5XXA9</Target_Sequence>
<Synonyms>LEDGF</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments>LEDGF/p75 is a chromatin-associated protein that tethers the preintegration complex to the host chromatin through its direct interaction with IN thereby supporting HIV replication.</Comments>
</Item><Item><Target_ID> 1220</Target_ID>
<Target_Name>Platelet-derived growth factor receptor β (PDGFRβ)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P09619</Target_Sequence>
<Synonyms>Beta platelet-derived growth factor receptor
Beta-type platelet-derived growth factor receptor
CD140 antigen-like family member B
Platelet-derived growth factor receptor 1
</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GQ5, 1H9O, 2L6W, 3MJG </Target_Structure>
<Comments>The platelet-derived growth factor receptor β (PDGFRβ) is a transmembrane glycoprotein that belongs to the receptor tyrosine kinase family.</Comments>
</Item><Item><Target_ID> 1221</Target_ID>
<Target_Name>Mouse gut</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1222</Target_ID>
<Target_Name>Human immunoglobulin G (hIgG)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human immunoglobulin G (hIgG),the second most abundant protein in human serum,is usually removed using Protein A or G.</Comments>
</Item><Item><Target_ID> 1223</Target_ID>
<Target_Name>CD59</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P13987</Target_Sequence>
<Synonyms>1F5 antigen
20 kDa homologous restriction factor
MAC-inhibitory protein
MEM43 antigen
Membrane attack complex inhibition factor
Membrane inhibitor of reactive lysis
Protectin
CD_antigen=CD59</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CDQ, 1CDR, 1CDS, 1ERG, 1ERH, 2J8B, 2OFS, 2UWR, 2UX2, 4BIK</Target_Structure>
<Comments>CD59 is a Mr 18-20kDa protein and anchored through glycanphosphatidylinositol to the cell membrane.The mature form of the CD59 polypeptide is consisting of 77 amino acids starting with Leu and terminating with Asn.</Comments>
</Item><Item><Target_ID> 1224</Target_ID>
<Target_Name>Ganglioside GM2</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1225</Target_ID>
<Target_Name>Ganglioside GD1a</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1226</Target_ID>
<Target_Name>Interleukin-10 receptor subunit alpha (IL-10RA)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q13651</Target_Sequence>
<Synonyms>CDw210a
Interleukin-10 receptor subunit 1
CD_antigen=CD210</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1J7V, 1LQS, 1Y6K, 1Y6M, 1Y6N </Target_Structure>
<Comments>Defects in IL10RA are the cause of inflammatory bowel disease type 28 (IBD28).</Comments>
</Item><Item><Target_ID> 1227</Target_ID>
<Target_Name>Staphylococcus aureus, S.aureus</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Staphylococcus aureus is an opportunistic pathogen causing disease in humans and animals.It has been found as part of normal flora on human skin and mucosal surfaces and account for large proportion of nosocomial infections and community-acquired infections.</Comments>
</Item><Item><Target_ID> 1228</Target_ID>
<Target_Name>cAb29</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>cAb29 is a chimeric antibody that was selected
from a large panel of PA-neutralizing monoclonal antibodies.</Comments>
</Item><Item><Target_ID> 1229</Target_ID>
<Target_Name>Boron nitride nanospheres,NNS</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BN has the advantage of a high biocompatibility, with easier cellular uptake and lower toxicity than carbon.</Comments>
</Item><Item><Target_ID> 1230</Target_ID>
<Target_Name>Mouse retina</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1231</Target_ID>
<Target_Name>Human bone</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1232</Target_ID>
<Target_Name>Human marrow</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1233</Target_ID>
<Target_Name>Human fat</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1234</Target_ID>
<Target_Name>Human skeletal muscle</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1235</Target_ID>
<Target_Name>Human prostate</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1236</Target_ID>
<Target_Name>Human skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1237</Target_ID>
<Target_Name>Human multiple organs</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1238</Target_ID>
<Target_Name>Nd2O3 nanocrystals</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1239</Target_ID>
<Target_Name>Human mammary carcinoma cell line SK-BR-3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1240</Target_ID>
<Target_Name>Human Platele</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1241</Target_ID>
<Target_Name>G protein β1γ1 subunits</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Spodoptera frugiperda (Sf):7108</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1242</Target_ID>
<Target_Name>Sera from RA patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1243</Target_ID>
<Target_Name>Anti-LeY antigen monoclonal antibody B3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1244</Target_ID>
<Target_Name>Mouse lung</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1245</Target_ID>
<Target_Name>Mouse skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1246</Target_ID>
<Target_Name>Mouse intestine</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1247</Target_ID>
<Target_Name>Mouse uterus</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1248</Target_ID>
<Target_Name>Human dermal microvascular endothelial cells, HDMECs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1249</Target_ID>
<Target_Name>Mouse adrenal gland</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1250</Target_ID>
<Target_Name>NG2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8VHY0</Target_Sequence>
<Synonyms>Chondroitin sulfate proteoglycan NG2
Proteoglycan AN2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NG2 is the rat homologue of the human melanoma proteoglycan,also known as the high molecular weight melanoma-associated antigen. </Comments>
</Item><Item><Target_ID> 1251</Target_ID>
<Target_Name>KIX domain of p300/CBP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1252</Target_ID>
<Target_Name>HNSCC cell line MDA167Tu </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1253</Target_ID>
<Target_Name>Dysplastic skin</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1254</Target_ID>
<Target_Name>The human cell lines  16HBE14o-</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1255</Target_ID>
<Target_Name>LOX-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q9EQ09</Target_Sequence>
<Synonyms>Oxidized low-density lipoprotein receptor 1
Ox-LDL receptor 1
Lectin-like oxidized LDL receptor 1
Lectin-like oxLDL receptor 1
Lectin-type oxidized LDL receptor 1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090 </Target_Source>
<Target_Structure></Target_Structure>
<Comments>LOX-1 is a receptor normally expressed at low levels exclusively on venous and arterial vascular endothelial cells but strongly upregulated in dysfunctional endothelium associated with hypertension and atherogenesis.</Comments>
</Item><Item><Target_ID> 1256</Target_ID>
<Target_Name>PMCA398 </Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PM Ca2+ pumps are encoded by four plasma membrane Ca2+-ATPase (PMCA) genes, and their transcripts can be alternatively spliced.The isoform PMCA1b is most widely expressed. The PM Ca2+ pump protein models show ten transmembrane and five extracellular domains. The second putative extracellular domain of PMCA1b in rabbit contains the residues 401-413 (KRPWLAECTPIYI. Including additional amino acids flanking this sequence, replacing serine for cysteine, and adding a cysteine at the COOH terminus, the peptide PMCA398 (WVQKRPWLAESTPIYIQYFVKC) was synthesized.</Comments>
</Item><Item><Target_ID> 1257</Target_ID>
<Target_Name>U87-MG glioma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1258</Target_ID>
<Target_Name>Human melanoma cell line MeWo</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1259</Target_ID>
<Target_Name>Bacterial cell wall precursor lipid I </Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phage display screens made use of lipid I inspired targets in both natural and enantiomeric forms.First,by doing so the amount of chemical space explored in the screen is effectively doubled.Secondly,it was considered that L-peptides selected in the screen that possess high affinity for natural lipidI/II might in fact be toxic towards the E.coli used in the amplification step of the phage display experiment ,so using enantiomeric forms  was viewed as a way of avoiding any such negative selection bias.</Comments>
</Item><Item><Target_ID> 1260</Target_ID>
<Target_Name>Anti-CK 8/18 complex monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>K94 monoclonal antibody, a tumor-associated autoantibody purified from another B-cell hybridoma clone derived from a mouse model of HCC, was analyzed and identified as an anti-cytokeratin (CK) 8/18 complex antibody. </Comments>
</Item><Item><Target_ID> 1261</Target_ID>
<Target_Name>Eukaryotic initiation factor (eIF)4E</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>eIF4E initiates cap-dependent translation by binding to the cap structure found at the 59 end of mRNA. eIF4E is part of the large  eIF4F complex which includes other proteins such as eIF4G and eIF4A. eIF4F forms a complex with the 40S ribosomal subunit and eIF3, which then shuttles along the 59-untranslated region (59-UTR) of the mRNA until it arrives at the AUG initiation codon.</Comments>
</Item><Item><Target_ID> 1262</Target_ID>
<Target_Name>Karilysin catalytic domain, Kly18</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>D0EM77</Target_Sequence>
<Synonyms>Karilysin protease</Synonyms>
<Target_Source>Bacteroides forsythus (Tannerella forsythensis):28112 </Target_Source>
<Target_Structure>2XS3, 2XS4, 4IN9</Target_Structure>
<Comments>Karilysin, a newly identified metalloprotease isolated from T. forsythia is secreted as a 472-residue protein and has the following composition; a 20-residue signal sequence, a 14-residue pro-peptide, an 18 kDa catalytic peptidase domain and a 30 kDa C-terminal domain of unknown function.</Comments>
</Item><Item><Target_ID> 1263</Target_ID>
<Target_Name>Calretinin, CR</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P22676</Target_Sequence>
<Synonyms>29 kDa calbindin</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Calretinin (CR), a Ca+2-binding protein highly expressed in subpopulations of neurons in thebrain, inhibits CDI and enhances CDF by binding directly to α12.1.</Comments>
</Item><Item><Target_ID> 1264</Target_ID>
<Target_Name>Human IgA, hIgA</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IgA is secreted in the mucus as a dimer (secretory form of IgA) connected by a joining chain via intermolecular disulfide bridges, whereas the major form of IgA in plasma is monomeric. IgA has two subclasses: IgA1 and IgA2.</Comments>
</Item><Item><Target_ID> 1265</Target_ID>
<Target_Name>Unphosphorylated ERα LBD</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).</Comments>
</Item><Item><Target_ID> 1266</Target_ID>
<Target_Name>Phosphorylated ERβ LBD, ERβ LBD-P</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).  ERβ LBD-P contained a phosphorylated Y488.</Comments>
</Item><Item><Target_ID> 1267</Target_ID>
<Target_Name>Phosphorylated ERα LBD, ERα LBD-P</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).  ERa LBD-P  contained  a phosphorylated Y537.</Comments>
</Item><Item><Target_ID> 1268</Target_ID>
<Target_Name>Unphosphorylated ERβ  LBD</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).</Comments>
</Item><Item><Target_ID> 1269</Target_ID>
<Target_Name>Anti-PI-LPS monoclonal antibody 1E4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1270</Target_ID>
<Target_Name>Bone marrow-derived dendritic cells, BMDCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1271</Target_ID>
<Target_Name>Mouse liver</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1272</Target_ID>
<Target_Name>Mouse spleen</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1273</Target_ID>
<Target_Name>Mouse visceral adipose tissues</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1274</Target_ID>
<Target_Name>DOX-SAM</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Doxorubicin, a commonly used cancer chemotherapy agent, elicits several potent biological effects, including synergistic-antitumor activity in combination with cisplatin. A derivative of doxorubicin underinvestigation is synthesized to form a self-assembled monolayer (SAM).</Comments>
</Item><Item><Target_ID> 1275</Target_ID>
<Target_Name>Monoclonal antibody 6D10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1276</Target_ID>
<Target_Name>IgG from human</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1277</Target_ID>
<Target_Name>Anti-OmpU polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1278</Target_ID>
<Target_Name>Male Sprague-Dawley (SD) mouse brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1279</Target_ID>
<Target_Name>cGP antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1280</Target_ID>
<Target_Name>Mink enteritis virus, MEV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mink enteritis virus (MEV) is the causative pathogen of mink viral gastroenteritis, an acute, violent, and highly contagious disease that causes violent diarrhea as the main clinical symptom.</Comments>
</Item><Item><Target_ID> 1281</Target_ID>
<Target_Name>Extracellular domain of human ErbB-2, ErbB-2-ECD</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The erbB-2 proto-oncogene, also known as HER-2 or neu, is frequently altered in human cancers. This gene encodes an 185 kDa protein, denoted p185, which is also referred to as ErbB-2. ErbB-2 along with three other known homologous proteins, ErbB-1 (epidermal growth factor receptor, EGFR), ErbB-3, and ErbB-4, form the ErbB family or subclass I of receptor tyrosine kinases (RTKs). ErbB-2-ECD is the recombinant extracellular domain of human ErbB-2.</Comments>
</Item><Item><Target_ID> 1282</Target_ID>
<Target_Name>B-lymphocyte WI-L2 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1283</Target_ID>
<Target_Name>The breast cancer cell line SKBR3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1284</Target_ID>
<Target_Name>Anti-MRP1 monoclonal antibody MRPr1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1285</Target_ID>
<Target_Name>Glutamate carboxypeptidase 2
EC=3.4.17.21</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q04609</Target_Sequence>
<Synonyms>Cell growth-inhibiting gene 27 protein
Folate hydrolase 1
Folylpoly-gamma-glutamate carboxypeptidase
FGCP
Glutamate carboxypeptidase II
GCPII
Membrane glutamate carboxypeptidase
mGCP
N-acetylated-alpha-linked acidic dipeptidase I
NAALADase I
Prostate-specific membrane antigen
PSM
PSMA
Pteroylpoly-gamma-glutamate carboxypeptidase</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1Z8L?</Target_Structure>
<Comments>There are high frequencies of prostate-specific membrane antigen (PSMA) overexpression in all stages and grades of PCa patients. PSMA is a 100-kDa transmembrane glycoprotein with folate hydrolase activity (hydrolysis of the terminal glutamates fromclinked polyglutamates) as well as NAALADase activity (hydrolysis of the terminal glutamate from the neuropeptide NAAG), which was found not only in normal prostate epithelium but also in the central nervous system and the proximal gastrointestinal tract.</Comments>
</Item><Item><Target_ID> 1286</Target_ID>
<Target_Name>Human adenocarcinoma lung cancer cell line A549</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1287</Target_ID>
<Target_Name>Human colon cancer cell line HT29</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1288</Target_ID>
<Target_Name>Anti-CD18 monoclonal antibody MHM23</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1289</Target_ID>
<Target_Name>The  ECs injured by ox-LDL</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1290</Target_ID>
<Target_Name>Tumor-related antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1291</Target_ID>
<Target_Name>Human MTC-derived TT cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1292</Target_ID>
<Target_Name>Human MTC xenografts</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1293</Target_ID>
<Target_Name>Nasopharyngeal carcinoma (NPC) cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1294</Target_ID>
<Target_Name>PED3 domain of PMCA1b</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit): 9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The plasma membrane Ca2+ pump (PMCA) is a Ca2+-Mg2+-ATPase that expels Ca2+ from cells to help them maintain low concentrations of cytosolic Ca2+ ([Ca2+]i). It contains five putative extracellular domains (PEDs).</Comments>
</Item><Item><Target_ID> 1295</Target_ID>
<Target_Name>Prostate Carcinoma Cell Line DU-145</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1296</Target_ID>
<Target_Name>Extracellular domain 1 of plasma membrane Ca2+-pump isoform 4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The plasma membrane Ca2+-pump is a protein with 10 transmembrane  domains, 5 putative extracellular domains and 3 major cytosolic domains.</Comments>
</Item><Item><Target_ID> 1297</Target_ID>
<Target_Name>The ECV304 cells injured by ox-LDL</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1298</Target_ID>
<Target_Name>Medullary thyroid carcinoma, MTC</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1299</Target_ID>
<Target_Name>PED1 of PMCA4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1300</Target_ID>
<Target_Name>B lymphocyte A20 cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1301</Target_ID>
<Target_Name>C8161 xenograft tumors</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1302</Target_ID>
<Target_Name>Human breast cancer tumor</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1303</Target_ID>
<Target_Name>B16-F10 tumors</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1304</Target_ID>
<Target_Name>PC-3 human prostate cancer cell xenografts</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1305</Target_ID>
<Target_Name>Mouse PDAC cells </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1306</Target_ID>
<Target_Name>Anti-protein monoclonal antibody BPM</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1307</Target_ID>
<Target_Name>Anti-protein monoclonal antibody BPA</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1308</Target_ID>
<Target_Name>Anti-uPAR monoclonal antibody IIIF10 </Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown </Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1309</Target_ID>
<Target_Name>Anti-huPENK monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1310</Target_ID>
<Target_Name>Aminopeptidase N</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P15144</Target_Sequence>
<Synonyms>Myeloid plasma membrane glycoprotein CD13
Microsomal aminopeptidase
Alanyl aminopeptidase
Aminopeptidase M
CD_antigen
gp150
AP-M
CD13</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1311</Target_ID>
<Target_Name>CNS endothelial cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1312</Target_ID>
<Target_Name>Lewis  lung  carcinoma  (LLC)  tumor cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1313</Target_ID>
<Target_Name>Human factor H</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1314</Target_ID>
<Target_Name>Human CD4+CD25+ thymic cells </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1315</Target_ID>
<Target_Name>Monoclonal antibody TP25.99</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mouse mAb TP25.99 is among the few mAb reacting with both β2m-associated and β2 m-free HLA class I heavy chains.</Comments>
</Item><Item><Target_ID> 1316</Target_ID>
<Target_Name>THP-1 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1317</Target_ID>
<Target_Name>The embryonic progenitor cell line W10</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The embryonic progenitor cell line, W10, expresses markers such as transcription factor, heart and neural crest derivatives-expressed 2 (HAND2) and distal HOX genes such as HOXA4 and HOXB7.</Comments>
</Item><Item><Target_ID> 1318</Target_ID>
<Target_Name>Primary cultured chondrocytes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Primary cultured chondrocytes secrete a large number of matrix proteins in native conformation to provide a rich array of possible targets for peptide binding.</Comments>
</Item><Item><Target_ID> 1319</Target_ID>
<Target_Name>Anti-topo-I antibodies, pt4 anti-Ap1-17 Abs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-topo-I antibodies (Abs) are associated with more diffuse cutaneous involvement, pulmonary fibrosis, renal involvement and, possibly, higher disease severity.</Comments>
</Item><Item><Target_ID> 1320</Target_ID>
<Target_Name>The cell surface of E. coli</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC):199310</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1321</Target_ID>
<Target_Name>Tumor necrosis factor alpha, TNF-α</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9UBM5</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Tumor necrosis factor alpha (TNF-α) is a proinflammatory cytokine produced in many inflammatory and autoimmune diseases. Mature TNF-α is secreted as a 157-amino acid form with a molecular weight of 17kDa. Before being released from cells, TNF-α is anchored in the plasma membrane as a 26 kDa precursor containing both hydrophobic and hydrophilic regions.</Comments>
</Item><Item><Target_ID> 1322</Target_ID>
<Target_Name>VPAC1 receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies.</Comments>
</Item><Item><Target_ID> 1323</Target_ID>
<Target_Name>Anti-CFP10-ESAT-6 (CE) pAbs </Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1324</Target_ID>
<Target_Name>U251 glioma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1325</Target_ID>
<Target_Name>Serine/threonine-protein kinase StkP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8KY50</Target_Sequence>
<Synonyms>Eukaryotic-type Ser/Thr protein kinase
ESTPK</Synonyms>
<Target_Source>Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4):170187</Target_Source>
<Target_Structure></Target_Structure>
<Comments>StkP and its orthologous Ser/Thr kinases contain an intracellular kinase domain and four environmentally responsive extracellular PASTA domains, in crystallographic studies, to bind to the ß-lactam cefuroxime. It has been shown that the extracellular PASTA-containing domain of StkP binds to both chemically synthesized fragments of cell wall peptidoglycan and to ß-lactam antibiotics that mimic the terminal portions of the peptidoglycan pentapeptide moiety.</Comments>
</Item><Item><Target_ID> 1326</Target_ID>
<Target_Name>Prostate adenocarcinoma cells, PC-3 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1327</Target_ID>
<Target_Name>Recombinant serotype D NTNHA, rNTNHA-D</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1328</Target_ID>
<Target_Name>Anti-human KGF mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1329</Target_ID>
<Target_Name>Anti-rabies virus IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1330</Target_ID>
<Target_Name>Fibroblast growth factor 8, FGF-8</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P55075</Target_Sequence>
<Synonyms>Androgen-induced growth factor
AIGF
Heparin-binding growth factor 8
HBGF-8
</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2FDB</Target_Structure>
<Comments>FGF8 belongs to the fibroblast growth factor family of at least 23 members. Alternative splicing of the human FGF8 gene allows transcription of four different isoforms designated FGF8a, FGF8b, FGF8e, and FGF8f. FGF8b is the real target. It has also been found to have a strongly angiogenic and transforming potential in comparison to FGF8a and FGF8e. FGF8b is expressed and secreted by the epithelium, and it signals directionally to mesenchyme by binding FGFR3c, FGFR4, FGFR2c, or FGFR1c. </Comments>
</Item><Item><Target_ID> 1331</Target_ID>
<Target_Name>NEP1–35</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NEP1-35 (NH2-SFRIYKGVIQAIQKSDEGHPFRAYLE-SEVAISEEL-COOH) was synthesized. It contained 1–33 residues of Nogo-66, covering two putative regions pivotal for the affinity of Nogo-66 to NgR1, residues 1–10 (RIYKGVIQAI) and 30–33 (SEEL).</Comments>
</Item><Item><Target_ID> 1332</Target_ID>
<Target_Name>The human colon carcinoma Caco-2 cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1333</Target_ID>
<Target_Name>Protein S100-B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04271</Target_Sequence>
<Synonyms>S-100 protein beta chain
S-100 protein subunit beta
S100 calcium-binding protein B</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1MQ1, 1UWO, 2H61, 2PRU, 3CZT, 3D0Y, 3D10, 3HCM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1334</Target_ID>
<Target_Name>BetaC1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>C5ICF8</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Cotton leaf curl Multan betasatellite:649192</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The βC1 protein was expressed in prokaryotic system as 6XHis-bC1 fusion protein and recombinant protein showed size- and sequence-specific DNA binding activity.</Comments>
</Item><Item><Target_ID> 1335</Target_ID>
<Target_Name>Brz2001</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Brz2001 is a specific DWARF4 inhibitor in plant hormone brassinosteroid biosynthesis. Brz2001 belongs to the triazole series of compound that
shows low solubility in solvents, as represented by antifungal agents such as fluconazole.</Comments>
</Item><Item><Target_ID> 1336</Target_ID>
<Target_Name>Epoxy</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Epoxies are advanced thermosetting polymers, which exhibit excellent electrical, mechanical, and chemical properties for awide variety of applications as adhesives, protective coatings, electrical encapsulants, pharmaceuticals, etc.</Comments>
</Item><Item><Target_ID> 1337</Target_ID>
<Target_Name>Anti-IL1β(163-171) monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mouse MAb was obtained by immunization with an oligopeptide of sequence VQGEESNDKDK.</Comments>
</Item><Item><Target_ID> 1338</Target_ID>
<Target_Name>Anti-TcTS Abs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1339</Target_ID>
<Target_Name>E. acerulina sporozoites</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1340</Target_ID>
<Target_Name>Polyclonal RRi-11 plasma</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Macaca mulatta (Rhesus macaque):9544</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1341</Target_ID>
<Target_Name>Polyclonal RTr-11 plasma</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Macaca mulatta (Rhesus macaque):9544</Target_Source>
<Target_Structure></Target_Structure>
<Comments>RTr-11 showed anamnestic cellular immune responses compatible with cryptic infection.</Comments>
</Item><Item><Target_ID> 1342</Target_ID>
<Target_Name>Glyphosate</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Glyphosate (N-(phosphonomethyl)glycine) is a herbicide that is used to kill weeds in farms, parks, and gardens. Glyphosate is toxic to plants because it can interfere with the synthesis of aromatic amino acids such as phenylalanine, tyrosine, and tryptophan by inhibiting the enzyme activity of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).</Comments>
</Item><Item><Target_ID> 1343</Target_ID>
<Target_Name>Crystalline cellulose
nanowhiskers, CNWs</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1344</Target_ID>
<Target_Name>Metuximab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Metuximab is the generic name of HAb18, a mouse monoclonal antibody of IgG1 class. The hybridoma producing HAb18 was made from mice immunized with a cell suspension of fresh human hepatocellular carcinoma tissues.</Comments>
</Item><Item><Target_ID> 1345</Target_ID>
<Target_Name>Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q9Y237</Target_Sequence>
<Synonyms>Parvulin-17
Par17</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1EQ3, 1FJD, 3UI4, 3UI5, 3UI6</Target_Structure>
<Comments>Par17 is expressed in all human tissues and cell lines examined so far and originates from alternative transcription initiation. Thus, Par17 is N-terminally extended by 25 amino acids when compared with Par14.</Comments>
</Item><Item><Target_ID> 1346</Target_ID>
<Target_Name>Par17-GST</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GST-tagged Par17 protein was expressed as follows. The Par17 nucleotide sequence was cloned in-frame into the expression vector pET41-PreSc. The construct was transformed into E. coli BL21 competent cells.</Comments>
</Item><Item><Target_ID> 1347</Target_ID>
<Target_Name>Anti-PAP sera sample 1, PAP1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1348</Target_ID>
<Target_Name>Anti-PAP sera sample 2, PAP2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1349</Target_ID>
<Target_Name>Anti-PAP sera sample 3, PAP3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1350</Target_ID>
<Target_Name>Anti-PAP sera sample 4, PAP4</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1351</Target_ID>
<Target_Name>BT483 breast cancer cells</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Breast cancer cell line BT483 was obtained from the American Type Culture Collection. BT483 cells were grown in DMEM (Invitrogen) containing 20 mM L-glutamine.</Comments>
</Item><Item><Target_ID> 1352</Target_ID>
<Target_Name>Siliceous spicules</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Suberites domuncula (Sponge):55567</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1353</Target_ID>
<Target_Name>Gamma-irradiated Salmonella spp.</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Salmonella, a genus belonging to the Enterobacteriaceae family, is comprised of two species, bongori and enterica. Salmonella enterica is further classified into six subspecies with over 2500 serovars currently known, of which 1531 are part of the subspecies enterica and are the causative agents of more than 99% of human Salmonellosis cases.</Comments>
</Item><Item><Target_ID> 1354</Target_ID>
<Target_Name>Monocyte-derived immature DCs (iDCs)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Dendritic cells (DCs) are key regulators of T- and B-cell immunity, owing to their superior ability to capture, process, and present antigens compared to other antigen-presenting cells (APCs).</Comments>
</Item><Item><Target_ID> 1355</Target_ID>
<Target_Name>Norwalk virus virus-like particles, NV VLPs</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NV VLPs were expressed and purified as reported previously. Briefly, the VP1 and VP2 capsid proteins were expressed from a baculovirus vector in Sf9 insect cells and purified using a cesium chloride gradient. Proper VLP structure was confirmed by electron microscopy.</Comments>
</Item><Item><Target_ID> 1356</Target_ID>
<Target_Name>Appetite-regulating hormone</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9UBU3</Target_Sequence>
<Synonyms>Growth hormone secretagogue
Growth hormone-releasing peptide
Motilin-related peptide
Protein M46
</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Ghrelin, an orexigenic peptide hormone, is predominantly produced in the enteroendocrine cells in the stomach and hypothalamus. Approximately 90 % of the total plasma ghrelin is in the form of pharmacologically inactive des-acyl ghrelin, while the active form, octanoyl ghrelin, comprises approximately 10 %. The active form of ghrelin is a peptide of 28 amino acids esterified at the Ser3 residue with an octanoic fatty acid. Octanoylation is catalysed by ghrelin-O-acyltransferase (GOAT).</Comments>
</Item><Item><Target_ID> 1357</Target_ID>
<Target_Name>Serum from AS patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1358</Target_ID>
<Target_Name>Granulocytic myeloid-derived suppressor cells, granulocytic MDSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Toll/interleukin-1 receptor-like protein 4
CD_antigen
CD282</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1359</Target_ID>
<Target_Name>NSCLC tumor cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1360</Target_ID>
<Target_Name>Anti-SFV FLAG mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1361</Target_ID>
<Target_Name>Anti-SFV V2 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1362</Target_ID>
<Target_Name>Anti-SFV V3 mVAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1363</Target_ID>
<Target_Name>Anti-SFV V7 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1364</Target_ID>
<Target_Name>Anti-SFV V8 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1365</Target_ID>
<Target_Name>Anti-SFV V10 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1366</Target_ID>
<Target_Name>Anti-SFV V11 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</Comments>
</Item><Item><Target_ID> 1367</Target_ID>
<Target_Name>Neural stem cells, NSC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>NSC are undifferentiated multipotent stem cells found in the subventricular and subgranular zones of the mammalian adult brain. NSC represent a good cell type for neuroregenerative purposes not only because of their ability to differentiate into neurons, astrocytes and oligodendrocytes in vitro but also because they do not show tumorigenic potentials upon transplantation in different animal models of neurodegenerative diseases. Moreover, the neural differentiation of NSC can be modulated by specific peptide sequences present in extracellular matrices, in soluble molecules and/or in membrane-bound cell molecules.</Comments>
</Item><Item><Target_ID> 1368</Target_ID>
<Target_Name>Diamond-like carbon, DLC</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Diamond like carbon (DLC) is an amorphous carbon material that is used as an extremely wear-resistant coating material. DLC coatings are chemically stable, optically transparent and have good mechanical properties due to their hardness, low friction coefficient, high wear and corrosion resistance, and smoothness.</Comments>
</Item><Item><Target_ID> 1369</Target_ID>
<Target_Name>Anti-DENV2-NS1 pAb</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1370</Target_ID>
<Target_Name>Vitamin B12-binding protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P37028</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1N2Z, 1N4A, 1N4D, 2QI9, 4DBL, 4FI3</Target_Structure>
<Comments>Periplasmic binding protein BtuF is a bilobed 28 kDa protein. Its two globular domains are connected by a single rigid R-helix, characteristic of class III periplasmic binding proteins. The N-terminal domain of BtuF extends from residues 1 to 106, and the C-terminal domain includes residues 130-244 of the mature protein. Cyanocobalamin is bound in a cleft between the globular domains making contact with residues in both domains.</Comments>
</Item><Item><Target_ID> 1371</Target_ID>
<Target_Name>Anti-FhuA Fhu4.1 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1372</Target_ID>
<Target_Name>Anti-FhuA Fhu6.4 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1373</Target_ID>
<Target_Name>Anti-FhuA Fhu6.6 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1374</Target_ID>
<Target_Name>Aminopeptidase N</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P15145</Target_Sequence>
<Synonyms>AP-N
pAPN
Alanyl aminopeptidase
Aminopeptidase M
AP-M
Microsomal aminopeptidase
gp130
CD_antigen=CD13
EC=3.4.11.2</Synonyms>
<Target_Source>Sus scrofa (Pig): 9823</Target_Source>
<Target_Structure>4F5C, 4FKE, 4FKH, 4FKK, 4H5H, 4HOL, 4HOM </Target_Structure>
<Comments>Porcine aminopeptidase N (pAPN) is a cellular receptor of transmissible gastroenteritis virus (TGEV), a porcine coronavirus. Interaction between the spike (S) protein of TGEV and pAPN initiates cell infection.</Comments>
</Item><Item><Target_ID> 1375</Target_ID>
<Target_Name>MDR GC cells SGC7901/ADR or SGC7901/VCR</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1376</Target_ID>
<Target_Name>Pancreatic metastasis</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1377</Target_ID>
<Target_Name>HTLA-230-derived primary tumor</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1378</Target_ID>
<Target_Name>GI-LI-N-derived primary tumor</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1379</Target_ID>
<Target_Name>Anti-NS2 4D4 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1380</Target_ID>
<Target_Name>Pb2+</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1381</Target_ID>
<Target_Name>Anti-blood group A  antigen monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1JV5</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1382</Target_ID>
<Target_Name>Anti-TTPI 4H11D10B11 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1383</Target_ID>
<Target_Name>Spike glycoprotein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P59594</Target_Sequence>
<Synonyms>S glycoprotein
Peplomer protein
E2</Synonyms>
<Target_Source>Human SARS coronavirus (SARS-CoV) (Severe acute respiratory syndrome coronavirus):227859</Target_Source>
<Target_Structure>1WNC, 1WYY, 1ZV7, 1ZV8, 1ZVB, 2AJF, 2BEQ, 2BEZ, 2DD8, 2FXP, 2GHV, 2GHW, 3BGF, 3D0G, 3D0H, 3D0I, 3SCI, 3SCJ, 3SCK, 3SCL</Target_Structure>
<Comments>Spike glycoprotein cleaves into two proteins: S1 and S2. Spike protein S1 attaches the virion to the cell membrane by interacting with human ACE2 and CLEC4M/DC-SIGNR, initiating the infection. And spike protein S1 is used as the target in the panning.</Comments>
</Item><Item><Target_ID> 1384</Target_ID>
<Target_Name>Anti-CsdA A3G5 mAb</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1385</Target_ID>
<Target_Name>Toll-like receptor 2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O60603</Target_Sequence>
<Synonyms>Toll/interleukin-1 receptor-like protein 4
CD_antigen=CD282</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FYW, 1FYX, 1O77, 2Z7X, 2Z80</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1386</Target_ID>
<Target_Name>MD-2 mimic peptide, NH2-FSKGKYKCV-COOH</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The sequence of MD-2 from the report of Shimazu et al (NCBI sequence, BAA78717) was used in the study. MD-2 mimic peptides were synthesized.</Comments>
</Item><Item><Target_ID> 1387</Target_ID>
<Target_Name>Listeria monocytogenes serotype 4b</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>NCTC 4885</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Listeria monocytogenes is one of six species within the Listeriagenus. It is Gram positive, facultative anaerobic, non-spore-forming, rod-shaped bacteria 0.5 µm in width and 1-1.5 µm in length.</Comments>
</Item><Item><Target_ID> 1388</Target_ID>
<Target_Name>Amyloid β peptide, Aβ40</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence>P05067</Target_Sequence>
<Synonyms>ABPP
APPI
APP
Alzheimer disease amyloid protein
Cerebral vascular amyloid peptide
CVAP
PreA4
Protease nexin-II
PN-II</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2LZ3, 2LZ4, 2M4J, 2M9R, 2M9S, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</Target_Structure>
<Comments>The primary agent of neurodegeneration is a peptide of 39–43 amino acid residues known as amyloid peptide (Aβ). The majority of secreted Aβ is 40 amino acids long (Aβ40).</Comments>
</Item><Item><Target_ID> 1389</Target_ID>
<Target_Name>Transforming growth factor beta-1, TGF-beta-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01137</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KLA, 1KLC, 1KLD, 3KFD</Target_Structure>
<Comments>Transforming growth factor beta (TGFβ) belongs to a family of regulatory cytokines. Among them, isoforms TGFβ1, TGFβ2 and TGFβ3 participate in a large number of biological processes such as cell proliferation, embryonic development, immune-modulation, angiogenesis, tumorogenesis, and balance between cell mass and extracellular matrix.</Comments>
</Item><Item><Target_ID> 1390</Target_ID>
<Target_Name>Anti- FASN monoclonal antibody K1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Splenocytes from H-ras12V transgenic mice at about 10 months old were used for the construction of B-cell hybridoma cell pool producing tumor-associated autoantibodies. Cell fusion and selection of B-cell hybridoma were performed. The reactivity of antibodies produced by these B-cell clones was determined by intracellular staining of HepG2 or Hepa-1c1c7 cells with each autoantibody, followed by flow cytometric analysis as described below. The isotypes of each autoantibody were determined using an isotyping kit (Pierce). For preparation of K1 autoantibody, ascites fluid was produced and antibody was purified using protein L-agarose (Pierce).</Comments>
</Item><Item><Target_ID> 1391</Target_ID>
<Target_Name>Anti-PCV2 Cap polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (Pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Affinity-purified Cap-specific polyclonal antibodies served as ligands in this research to increase specificity and efficiency for the selection, and were produced from blood samples collected from swine of different ages (piglets, finishing pigs and sows) and of diverse health status (with subclinical or silent infections) at a PCV2-infected pig farm in Hunan province.</Comments>
</Item><Item><Target_ID> 1392</Target_ID>
<Target_Name>Rat mesenchymal stem cells, rMSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116 </Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1393</Target_ID>
<Target_Name>M2 macrophages</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1394</Target_ID>
<Target_Name>Bacteriorhodopsin, BR</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence>P02945</Target_Sequence>
<Synonyms>Bacterioopsin
BO</Synonyms>
<Target_Source>Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) (Halobacterium halobium):64091</Target_Source>
<Target_Structure>1AP9, 1AT9, 1BCT, 1BHA, 1BHB, 1BM1, 1BRD, 1BRR, 1BRX, 1C3W, 1C8R, 1C8S, 1CWQ, 1DZE, 1E0P, 1F4Z, 1F50, 1FBB, 1FBK, 1IW6, 1IW9, 1IXF, 1JV6, 1JV7, 1KG8, 1KG9, 1KGB, 1KME, 1L0M, 1M0K, 1M0L, 1M0M, 1MGY, 1O0A, 1P8H, 1P8I, 1P8U, 1PXR, 1PXS, 1PY6, 1Q5I, 1Q5J, 1QHJ, 1QKO, 1QKP, 1QM8, 1R2N, 1R84, 1S51, 1S52, 1S53, 1S54, 1S8J, 1S8L, 1TN0, 1TN5, 1UCQ, 1VJM, 1X0I, 1X0K, 1X0S, 1XJI, 2AT9, 2BRD, 2I1X, 2I20, 2I21, 2NTU, 2NTW, 2WJK, 2WJL, 2ZFE, 2ZZL, 3COC, 3COD, 3HAN, 3HAO, 3HAP, 3HAQ, 3HAR, 3HAS, 3MBV, 3NS0, 3NSB, 3T45, 3UTV, 3UTW, 3UTX, 3UTY, 3VHZ, 3VI0, 4FPD, 4HWL, 4HYX</Target_Structure>
<Comments>Just like GPCRs, which form the largest family of drug targets, BR possesses seven transmembrane helices connected by small loops. BR is also well characterized concerning its spectroscopic and biophysical properties. In previous works by Bayburt and his coworkers it was shown that BR can be assembled into nanodiscs in monomeric and oligomeric forms.</Comments>
</Item><Item><Target_ID> 1395</Target_ID>
<Target_Name>Nanodiscs</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Nanodiscs are nanometer-sized phospholipid bilayers encircled by two copies of an amphipathicahelical protein, called membrane scaffold protein (MSP).</Comments>
</Item><Item><Target_ID> 1396</Target_ID>
<Target_Name>Membrane protein, M protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P04135</Target_Sequence>
<Synonyms>E1 glycoprotein
Matrix glycoprotein
Membrane glycoprotein</Synonyms>
<Target_Source>Porcine transmissible gastroenteritis coronavirus (strain Purdue) (TGEV):11151</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The virus responsible for TGE (TGEV) has a glycoprotein surface envelope and positive-sense RNA genome of approximately 28.5 kb. The virus consists of four structural proteins: spike (S), small membrane (sM or E), membrane (M), and nucleocapsid (N) proteins. The M protein is the most abundant component of the coronavirus particle.</Comments>
</Item><Item><Target_ID> 1397</Target_ID>
<Target_Name>Protein-glutamine gamma-glutamyltransferase Z</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q96PF1</Target_Sequence>
<Synonyms>Transglutaminase Z
TG(Z)
TGZ
TGase Z
EC=2.3.2.13
Transglutaminase-7
TGase-7</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Transglutaminases (TGs: E.C. 2.3.2.13) are an enzyme family comprising of eight members: FXIII and TG1-TG7. These enzymes catalyze cross-linking reactions via formation of an isopeptide bond between a peptide-bound glutamine and lysine residues, in a calcium-dependent manner. TGZ has been found in the skin epidermis.</Comments>
</Item><Item><Target_ID> 1398</Target_ID>
<Target_Name>Anti-SMN monoclonal antibody MANSMA1-21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monoclonal antibodies (MANSMA1-21) were produced by immunization of BALB/c mice.</Comments>
</Item><Item><Target_ID> 1399</Target_ID>
<Target_Name>Bevacizumab (Avastin)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Bevacizumab (Avastin), which is a humanized monoclonal antibody that binds VEGF, has been approved for the treatment of cancer.</Comments>
</Item><Item><Target_ID> 1400</Target_ID>
<Target_Name>U-CLL mAb068</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:45439529</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL068's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 068 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1401</Target_ID>
<Target_Name>M-CLL mAb169</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:215982737</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL169's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 169 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1402</Target_ID>
<Target_Name>M-CLL mAb183 </Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:3004685</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL183's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 183 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1403</Target_ID>
<Target_Name>M-CLL mAb255</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:215982713</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL255's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 255 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1404</Target_ID>
<Target_Name>M-CLL mAb412</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:45439545</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL412's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 412 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1405</Target_ID>
<Target_Name>U-CLL mAb014</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:3004691</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL014's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 014 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1406</Target_ID>
<Target_Name>U-CLL mAb114</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence> GI:30407981</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL114's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 114 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1407</Target_ID>
<Target_Name>U-CLL mAb270</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:19848551</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In brief, ribonucleic acid (RNA) from  patient CLL270's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 270 were expressed as human IgG1.</Comments>
</Item><Item><Target_ID> 1408</Target_ID>
<Target_Name>Atherosclerotic plaques</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Carotid plaques used for panning were classified as AHA 5B/C (plaque with calcification and low lipid levels) and 5A (plaque with fibrous cap).</Comments>
</Item><Item><Target_ID> 1409</Target_ID>
<Target_Name>Ovarian cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1410</Target_ID>
<Target_Name>Anti-Efb-C polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1411</Target_ID>
<Target_Name>Ceramic fluorapatite</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Ceramic fluorapatite (40μm particle size,600-800 Å pore size) was obtained from BioRad Laboratories (Hercules, California, USA).</Comments>
</Item><Item><Target_ID> 1412</Target_ID>
<Target_Name>Palladium powder</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1413</Target_ID>
<Target_Name>Serine protease 29</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q99MS4</Target_Sequence>
<Synonyms>Implantation serine proteinase 2
ISP-2
Strypsin-2
Strypsin-related protein
Tryptase-like proteinase</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Implantation serine proteinase 2 (ISP2), a S1 family serine proteinase, is known for its role in the critical processes of embryo hatching and implantation in the mouse uterus.</Comments>
</Item><Item><Target_ID> 1414</Target_ID>
<Target_Name>Tumor necrosis factor receptor superfamily member 5</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P25942</Target_Sequence>
<Synonyms>B-cell surface antigen CD40
Bp50
CD40L receptor
CDw40
CD40</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CZZ, 1D00, 1FLL, 1LB6, 3QD6</Target_Structure>
<Comments>The CD40/CD40L dyad is deemed to play a central role in several inflammatory processes, including atherosclerosis. As CD40 is overexpressed in atherosclerotic lesions, it constitutes a promising candidate for targeted imaging approaches.</Comments>
</Item><Item><Target_ID> 1415</Target_ID>
<Target_Name>Replication initiator protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q91SC1</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Indian mungbean yellow mosaic virus:88774</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The major player in geminiviral replication is a viralencoded factor, the replication initiator protein (Rep), which creates a site-specific nick in the conserved nonanucleotide sequence TAATATTa</Comments>
</Item><Item><Target_ID> 1416</Target_ID>
<Target_Name>Mast cell protease 4, mMCP-4</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P97592</Target_Sequence>
<Synonyms>EC=3.4.21.-
Mast cell protease IV
rMCP-IV</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1417</Target_ID>
<Target_Name>Thrombopoietin receptor, TPO-R</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P40238</Target_Sequence>
<Synonyms>Myeloproliferative leukemia protein
Proto-oncogene c-Mpl
CD_antigen=CD110</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1418</Target_ID>
<Target_Name>Anti-E-3-G monoclonal antibody 41551</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MAb41551 is a murine IgG1 antibody raised against E-3-G. It was prepared by conventional hybridoma technology.</Comments>
</Item><Item><Target_ID> 1419</Target_ID>
<Target_Name>Anti-MUC1 monoclonal antibody C595</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The murine anti-MUC1 monoclonal antibody  C595 (IgG3 subclass) was originally prepared by conventional hybridoma technology using spleen.</Comments>
</Item><Item><Target_ID> 1420</Target_ID>
<Target_Name>Gamma-gliadin and alpha/beta-gliadin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Gamma-gliadin: P04730, Alpha/beta-gliadin: P02863</Target_Sequence>
<Synonyms>Gliadin B-III
Prolamin</Synonyms>
<Target_Source>Triticum aestivum (Wheat):4565</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1421</Target_ID>
<Target_Name>Anti-rTs-Pmy-N monoclonal antibody 8F12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-rTs-Pmy-N mAb 8F12 was established by using the conventional hybridoma technique. The mAb 8F12 isotype was determined to be IgG1κ.  Western blot analysis revealed that 8F12 not only recognized rTs-Pmy-N  (40 kDa) but also recognized the native Ts-Pmy (110 kDa) in crude somatic extracts of  T. spiralis adult worms, newborn larvae (NBL) and\r\nML.</Comments>
</Item><Item><Target_ID> 1422</Target_ID>
<Target_Name>FGFR-expressing Balb/c 3T3 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Actually the real target is fibroblast growth factor receptor (FGFR).</Comments>
</Item><Item><Target_ID> 1423</Target_ID>
<Target_Name>Anti-SAH monoclonal antibody ab111903</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-SAH rabbit MAb (ab111903) was purchased from Abcam (Cambridge, MA, USA).</Comments>
</Item><Item><Target_ID> 1424</Target_ID>
<Target_Name>MA026</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MA026, a novel lipocyclodepsipeptide isolated from the fermentation broth of Pseudomonas sp. RtIB026, consists of a cyclodepsipeptide, a chain peptide, and an N-terminal (R)-3-hydroxydecanoic acid. The first subunit, side chain 2, was prepared by coupling fatty acid moiety 4 with tripeptide 5.</Comments>
</Item><Item><Target_ID> 1425</Target_ID>
<Target_Name>Mycobacterium Dleu/Dpan strain</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mycobacterium Dleu/Dpan strain was used as a model target because it is easy to manipulate, as it can be grown outside a biosafety level 3 laboratory.</Comments>
</Item><Item><Target_ID> 1426</Target_ID>
<Target_Name>Ephrin type-A receptor 4</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q03137</Target_Sequence>
<Synonyms>EC=2.7.10.1
Tyrosine-protein kinase receptor MPK-3
Tyrosine-protein kinase receptor SEK-1</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>1B0X, 2HEL, 2XYU, 2Y6M, 2Y6O</Target_Structure>
<Comments>The EphA4 receptor is expressed in neurons, where it promotes the repulsive guidance of developing axons. EphA4 receptor binds to both type A ephrins and most type B ephrins, but it also forms a hetero receptor complex with fibroblast growth factor receptor (FGFR). </Comments>
</Item><Item><Target_ID> 1427</Target_ID>
<Target_Name>HIV-1 CDC451 gp120</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Recombinant gp120 CDC451 protein was purchased from Advanced BioScience Labs, MA, USA.</Comments>
</Item><Item><Target_ID> 1428</Target_ID>
<Target_Name>Four- to five-week-old mdx mice heart</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1429</Target_ID>
<Target_Name>Four- to five-week-old mdx mice muscle</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1430</Target_ID>
<Target_Name>Mixtures of 13 anti-dystrophin monoclonal antibodies</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1431</Target_ID>
<Target_Name>IgE of the peanut allergic patient no. 2205</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1432</Target_ID>
<Target_Name>IgE of the peanut allergic patient no. 2208</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1433</Target_ID>
<Target_Name>IgE of the peanut allergic patient no. 2209</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1434</Target_ID>
<Target_Name>IgE of the peanut allergic patient no. 2304</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1435</Target_ID>
<Target_Name>IgE of the peanut allergic patient no. 2305</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1436</Target_ID>
<Target_Name>IgE of animal nr. 19</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1437</Target_ID>
<Target_Name>IgE of animal nr. 49</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1438</Target_ID>
<Target_Name>IgE of animal nr. 52</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1439</Target_ID>
<Target_Name>IgE of animal nr. 53</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1440</Target_ID>
<Target_Name>IgE of animal nr. 54</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1441</Target_ID>
<Target_Name>Interferon-induced, double-stranded RNA-activated protein kinase</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P19525</Target_Sequence>
<Synonyms>EC=2.7.11.1
Eukaryotic translation initiation factor 2-alpha kinase 2
eIF-2A protein kinase 2
Interferon-inducible RNA-dependent protein kinase
P1/eIF-2A protein kinase
Protein kinase RNA-activated
PKR
Tyrosine-protein kinase EIF2AK2
EC=2.7.10.2
p68 kinase</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1QU6, 2A19, 2A1A, 3UIU</Target_Structure>
<Comments>Double-stranded RNA-dependent protein kinase (PKR, EC 2.7.11.1) is one of the best-characterized kinases. Structurally , PKR has two functional domains: an Nterminal double-stranded RNA (dsRNA)-binding regulatory domain and a C-terminal kinase catalytic domain. In the catalytic domain (a.a. 251-551) of PKR (named PKRcat), K296 acts as the binding site for ATP, and mutation of K296 (K296R) has a dominant negative effect on the ability of PKR to phosphorylate eIF2α.</Comments>
</Item><Item><Target_ID> 1442</Target_ID>
<Target_Name>Cyclosporin A, CsA</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CsA is a natural compound showing multiple biological activities, including an immunosuppressive function, anti-chaperone activity, inhibition of transporter activity and antiviral activity against human immunodeficiency virus and HCV.</Comments>
</Item><Item><Target_ID> 1443</Target_ID>
<Target_Name>Serum of dogs with VL</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (Dog) (Canis lupus familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The blood serum samples from animals with CVL were selected on the basis of two serological tests (IFAT [IFATLVC Bio-Manguinhos kit] and ELISA [EIE-LVC Bio-Manguinhos kit], both from Bio-Manguinhos, Fiocruz, Brazil) for Leishmania spp. Animals with an IFAT titer of &gt; 1:40 and an ELISA value over the cutoff were considered to be seropositive.</Comments>
</Item><Item><Target_ID> 1444</Target_ID>
<Target_Name>Anti-BDE47 monoclonal antibody 1H2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1445</Target_ID>
<Target_Name>Mab 1H2-BDE47 immunocomplex</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1446</Target_ID>
<Target_Name>BDE47-polyclonal antibody immunocomplex</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1447</Target_ID>
<Target_Name>Proprotein convertase subtilisin/kexin type 9, PCSK9</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q8NBP7</Target_Sequence>
<Synonyms>EC=3.4.21.-
Neural apoptosis-regulated convertase 1
NARC-1
Proprotein convertase 9
PC9
Subtilisin/kexin-like protease PC9</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2P4E, 2PMW, 2QTW, 2W2M, 2W2N, 2W2O, 2W2P, 2W2Q, 2XTJ, 3BPS, 3GCW, 3GCX, 3H42, 3M0C, 3P5B, 3P5C, 3SQO, 4K8R, 4NMX</Target_Structure>
<Comments>PCSK9 is an ideal antibody target because it circulates in blood and has only modest binding affinity to cell surface LDL receptor and its main interaction site is an exposed 500-Å2 slightly convex region that is readily available for antibody binding.</Comments>
</Item><Item><Target_ID> 1448</Target_ID>
<Target_Name>Bovine insulin-Like growth factor-binding protein 2, bIGFbp-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P13384</Target_Sequence>
<Synonyms>IBP-2
IGF-binding protein 2
IGFBP-2</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1449</Target_ID>
<Target_Name>Death-associated protein kinase 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P53355</Target_Sequence>
<Synonyms>DAP kinase 1
EC=2.7.11.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1IG1, 1JKK, 1JKL, 1JKS, 1JKT, 1P4F, 1WVW, 1WVX, 1WVY, 1YR5, 2W4J, 2W4K, 2X0G, 2XUU, 2XZS, 2Y0A, 2Y4P, 2Y4V, 2YAK, 3DFC, 3DGK, 3EH9, 3EHA, 3F5G, 3F5U, 3GU4, 3GU5, 3GU6, 3GU7, 3GU8, 3GUB, 3ZXT, 4B4L, 4PF4</Target_Structure>
<Comments>At the biochemical level DAPK-1 is composed of several functional domains, including its kinase domain, ankyrin repeat domain, calmodulin binding domain, and death domain.</Comments>
</Item><Item><Target_ID> 1450</Target_ID>
<Target_Name>Globotriaosylceramide, Gb3</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Globotriaosylceramide (Gb3) was purchased from Matreya LLC (Pleasant Gap, PA, USA).</Comments>
</Item><Item><Target_ID> 1451</Target_ID>
<Target_Name>The Domain III of the Japan Encephalitis Virus Envelope Protein, E DIII</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Japanese encephalitis virus:11072</Target_Source>
<Target_Structure>1PJW</Target_Structure>
<Comments>Japanese encephalitis virus (JEV) is a major cause of acute viral encephalitis in both humans and animals. Domain III of the virus envelope glycoprotein (E DIII) plays an important role in the interaction of viral particles with host cell receptors to facilitate viral entry. In addition, DIII has been proposed to act as the binding region for the cellular receptor.</Comments>
</Item><Item><Target_ID> 1452</Target_ID>
<Target_Name>BCR/ABL-expressing NIH3T3 mouse fibroblast cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1453</Target_ID>
<Target_Name>Amorphous Ni3B</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1454</Target_ID>
<Target_Name>Crystalline Ni3B</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1455</Target_ID>
<Target_Name>Fibroblast growth factor 1, FGF-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P05230</Target_Sequence>
<Synonyms>Acidic fibroblast growth factor
aFGF
Endothelial cell growth factor
ECGF
Heparin-binding growth factor 1
HBGF-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AXM, 1DJS ,1DZC ,1DZD ,1E0O ,1EVT ,1HKN ,1JQZ ,1JT3 ,1JT4 ,1JT5 ,1JT7 ,1JTC ,1JY0 ,1K5U ,1K5V ,1M16 ,1NZK ,1P63 ,1PZZ ,1Q03 ,1Q04 ,1RG8 ,1RML ,1RY7 ,1YTO ,1Z2V ,1Z4S ,2AFG ,2AQZ ,2AXM ,2ERM ,2HW9 ,2HWA ,2HWM ,2HZ9 ,2K43 ,2K4A ,2K8R ,2KI4 ,2KI6 ,2LDN ,2NTD ,2Q9X ,2RQ9 ,3B9U ,3BA4 ,3BA5 ,3BA7 ,3BAD ,3BAG ,3BAH ,3BAO ,3BAQ ,3BAU ,3BAV ,3BB2 ,3CQA ,3CRG ,3CRH ,3CRI ,3CU1 ,3FGM ,3FJ8 ,3FJ9 ,3FJA ,3FJB ,3FJC ,3FJD ,3FJE ,3FJF ,3FJH ,3FJI ,3FJJ ,3FJK ,3HOM ,3JUT ,3K1X ,3O3Q ,3OJ2 ,3OJM ,3OJV ,3UD7 ,3UD8 ,3UD9 ,3UDA ,4J23</Target_Structure>
<Comments>Acidic fibroblast growth factor (aFGF) is a member of the fibroblast growth factor family, originally isolated as mitogens for fibroblasts from the brain and pituitary. AFGF executes its pleiotropic biological actions by binding, dimerizing, and activating cell surface FGF receptors (FGFRs). The extra-cellular ligand-binding portion of FGFRs is composed of three immunoglobulin-like (Ig-like) domains (D1-D3). The crystal structure of the ectodomain of the FGFR complex with FGF demonstrated that the ligand-binding domain of FGFR involves Ig-like domains II and III (D2 and D3, respectively), as well as the linker between D2 and D3.</Comments>
</Item><Item><Target_ID> 1456</Target_ID>
<Target_Name>Mixture of murine melanoma cell lines B16.F1 and B16.F10</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1457</Target_ID>
<Target_Name>Calcium silicate hydrate 0.66, C-S-H 0.66</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</Comments>
</Item><Item><Target_ID> 1458</Target_ID>
<Target_Name>Calcium silicate hydrate 1.0, C-S-H 1.0</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</Comments>
</Item><Item><Target_ID> 1459</Target_ID>
<Target_Name>Calcium silicate hydrate 1.5, C-S-H 1.5</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</Comments>
</Item><Item><Target_ID> 1460</Target_ID>
<Target_Name>Calcium silicate hydrate 1.7, C-S-H 1.7</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</Comments>
</Item><Item><Target_ID> 1461</Target_ID>
<Target_Name>Salivary  pellicle</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In the oral cavity, the salivary proteins and peptides are selectively adsorbed to the enamel surface to form a us film called the acquired salivary pellicle. This pellicle is composed of peptides and (glycosylated) proteins, such as statherin, histatins, proline-rich proteins and mucins.</Comments>
</Item><Item><Target_ID> 1462</Target_ID>
<Target_Name>Human umbilical vein endothelial cells, HUVECs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1463</Target_ID>
<Target_Name>IGVH1 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1464</Target_ID>
<Target_Name>IGVH3 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1465</Target_ID>
<Target_Name>IGVH4 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1466</Target_ID>
<Target_Name>IGVH6 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1467</Target_ID>
<Target_Name>IGVK1 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1468</Target_ID>
<Target_Name>IGVK2 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1469</Target_ID>
<Target_Name>IGVK3 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1470</Target_ID>
<Target_Name>IGVK4 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1471</Target_ID>
<Target_Name>IGVK5 template protein</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1472</Target_ID>
<Target_Name>IGVK6 template protein</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</Comments>
</Item><Item><Target_ID> 1473</Target_ID>
<Target_Name>Ephrin type-A receptor 2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q03145</Target_Sequence>
<Synonyms>EC=2.7.10.1
Epithelial cell kinase
Tyrosine-protein kinase receptor ECK
Tyrosine-protein kinase receptor MPK-5
Tyrosine-protein kinase receptor SEK-2</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1474</Target_ID>
<Target_Name>Colonic adenomas</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1475</Target_ID>
<Target_Name>Envelope glycoprotein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P27958 [384-661]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis C virus genotype 1a (isolate H) (HCV):11108</Target_Source>
<Target_Structure>1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2QV1, 2XI2, 2XI3, 2XNI, 4CL1, 4JZN, 4JZO, 4MWF</Target_Structure>
<Comments>Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein and contains regions of extreme variability. E2661 is the C-terminal truncation of E2 at residue 661 (E2661).</Comments>
</Item><Item><Target_ID> 1476</Target_ID>
<Target_Name>The anticodon stem and loop of human tRNA(Lys3), ASL(Lys3)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1477</Target_ID>
<Target_Name>ASL(Lys3) (s2U34;Ψ39)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The modified ASL target is a 17 nucleotide, human ASL tRNA(Lys3) with s2U34 and Ψ39.</Comments>
</Item><Item><Target_ID> 1478</Target_ID>
<Target_Name>ASL(Lys3) (UUU-ms2t6A37;mcm5s2U34;Ψ39)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The htRNA(Lys3) (UUU) with the anticodon UUU is one of some 45 tRNAs. Mature htRNA(Lys3) (UUU) contains the naturally occurring post-transcriptional modifications 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U34) at wobble position 34 and 2-methylthio-N6-threonylcarbamoyladenosine (ms2t6A37) at position 37 within the tRNA\'s anticodon stem and loop domain. Pseudouridine, Ψ39 is locatet at position 39, 3′to the anticodon loop.</Comments>
</Item><Item><Target_ID> 1479</Target_ID>
<Target_Name>Anti-DENV E EDIII HuScFv</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human single-chain variable fragments (HuScFv) with inhibitory effect to DENV infection were generated. HuScFv molecules were screened and selected from the human antibody phage display library by using purified recombinant DENV EDII proteins as target antigens for biopanning.</Comments>
</Item><Item><Target_ID> 1480</Target_ID>
<Target_Name>Human breast carcinoma SKBR-3 (HER positive) cells</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1481</Target_ID>
<Target_Name>Human synovium-derived mesenchymal stem cells, hSMSCs</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human SMSCs (hSMSCs) were isolated from eight patients (three males and five females, aged 60.38 ± 6.28 years with an age range of 50-73 years) who underwent total knee arthroplasty.</Comments>
</Item><Item><Target_ID> 1482</Target_ID>
<Target_Name>Anti-Claudin 18.2 monoclonal antibody IMAB362</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IMAB362 (anti-Claudin 18.2) is a highly tumor-specific monoclonal IgG1 antibody currently in clinical development for the treatment of advanced gastro-esophageal and stomach cancer. The antibody is directed against the cancer-specific cell surface target Claudin 18 isoform 2 (CLDN18.2), a 27.7 kDa gastric differentiation protein that spans the cell membrane with four transmembrane helices. IMAB362 is derived from a murine monoclonal antibody, and has been chimerized to display the human IgG1 constant region. For clinical development, IMAB362 is produced in Chinese Hamster Ovary (CHO) cells by standard recombinant expression technology.</Comments>
</Item><Item><Target_ID> 1483</Target_ID>
<Target_Name>Fc region of human immunoglobulin G (IgG)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1484</Target_ID>
<Target_Name>Human glioblastoma cell line A172</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1485</Target_ID>
<Target_Name>IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606 </Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1486</Target_ID>
<Target_Name>IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1487</Target_ID>
<Target_Name>IgG from a mixture of 20 different CSF of multiple sclerosis (MS) patients</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1488</Target_ID>
<Target_Name>Tyrosyl-tRNA synthetase, TyrRS</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Tyrosyl-tRNA synthetase (TyrRS) from H. influenzae catalyzes the charging of the amino acid tyrosine to tRNA(Tyr).</Comments>
</Item><Item><Target_ID> 1489</Target_ID>
<Target_Name>Proline--tRNA ligase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P16659</Target_Sequence>
<Synonyms>Global RNA synthesis factor
Prolyl-tRNA synthetase
ProRS
EC=6.1.1.15</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Prolyl-tRNA synthetase (ProRS) from E. coli catalyzes the charging of the amino acid proline to tRNA(Pro).</Comments>
</Item><Item><Target_ID> 1490</Target_ID>
<Target_Name>Alcohol dehydrogenase 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00331</Target_Sequence>
<Synonyms>Alcohol dehydrogenase II
EC=1.1.1.1
YADH-2</Synonyms>
<Target_Source>Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Alcohol dehydrogenase (ADH) from Saccharomyces cerevisiae catalyzes the conversion of ethanol to acetaldehyde using NAD+ as a cofactor.</Comments>
</Item><Item><Target_ID> 1491</Target_ID>
<Target_Name>β-glucosidase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>β-Glucosidase from  Agrobacterium faecalis catalyzes the hydrolysis of β-glucosides.</Comments>
</Item><Item><Target_ID> 1492</Target_ID>
<Target_Name>Hexokinase-1 and hexokinase-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Hexokinase-1: P04806, Hexokinase-2: P04807</Target_Sequence>
<Synonyms>Alternative name(s) of Hexokinase-1:
Hexokinase PI
Hexokinase-A
Alternative name(s) of Hexokinase-2:
Hexokinase PII
Hexokinase-B</Synonyms>
<Target_Source>Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</Target_Source>
<Target_Structure>Hexokinase-1: 1HKG, 3B8A
Hexokinase-2: 1IG8, 2YHX</Target_Structure>
<Comments>Hexokinase (HK) from S. cerevisiae catalyzes the phosphorylation of D-glucose by ATP to yield D-glucose 6-phosphate.</Comments>
</Item><Item><Target_ID> 1493</Target_ID>
<Target_Name>Glycogen phosphorylase, muscle form</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00489</Target_Sequence>
<Synonyms>Myophosphorylase
EC=2.4.1.1</Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure>1A8I, 1ABB, 1AXR, 1B4D, 1BX3, 1C50, 1C8K, 1C8L, 1E1Y, 1FS4, 1FTQ, 1FTW, 1FTY, 1FU4, 1FU7, 1FU8, 1GFZ, 1GG8, 1GGN, 1GPA, 1GPB, 1GPY, 1H5U, 1HLF, 1K06, 1K08, 1KTI, 1LWN, 1LWO, 1NOI, 1NOJ, 1NOK, 1P29, 1P2B, 1P2D, 1P2G, 1P4G, 1P4H, 1P4J, 1PYG, 1UZU, 1WUT, 1WUY, 1WV0, 1WV1, 1WW2, 1WW3, 1XC7, 1XKX, 1XL0, 1XL1, 1Z62, 1Z6P, 1Z6Q, 2AMV, 2F3P, 2F3Q, 2F3S, 2F3U, 2FET, 2FF5, 2FFR, 2G9Q, 2G9R, 2G9U, 2G9V, 2GJ4, 2GM9, 2GPA, 2GPB, 2GPN, 2IEG, 2IEI, 2OFF, 2PRI, 2PRJ, 2PYD, 2PYI, 2QLM, 2QLN, 2QN1, 2QN2, 2QN3, 2QN7, 2QN8, 2QN9, 2QNB, 2QRG, 2QRH, 2QRM, 2QRP, 2QRQ, 2SKC, 2SKD, 2SKE, 3AMV, 3BCR, 3BCS, 3BCU, 3BD6, 3BD7, 3BD8, 3BDA, 3CUT, 3CUU, 3CUV, 3CUW, 3E3L, 3E3N, 3E3O, 3EBO, 3EBP, 3G2H, 3G2I, 3G2J, 3G2K, 3G2L, 3G2N, 3GPB, 3L79, 3L7A, 3L7B, 3L7C, 3L7D, 3MQF, 3MRT, 3MRV, 3MRX, 3MS2, 3MS4, 3MS7, 3MSC, 3MT7, 3MT8, 3MT9, 3MTA, 3MTB, 3MTD, 3NC4, 3NP7, 3NP9, 3NPA, 3S0J, 3SYM, 3SYR, 3T3D, 3T3E, 3T3G, 3T3H, 3T3I, 3ZCP, 3ZCQ, 3ZCR, 3ZCS, 3ZCT, 3ZCU, 3ZCV, 4EJ2, 4EKE, 4EKY, 4EL0, 4EL5, 4GPB, 4MRA, 5GPB, 6GPB, 7GPB, 8GPB, 9GPB</Target_Structure>
<Comments>Glycogen phosphorylase a (Pa) from rabbit muscle catalyzes the removal and phosphorylation of the terminal glucose residue of glycogen to generate glucose-1-phosphate.</Comments>
</Item><Item><Target_ID> 1494</Target_ID>
<Target_Name>Carboxypeptidase B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09955</Target_Sequence>
<Synonyms>EC=3.4.17.2</Synonyms>
<Target_Source>Sus scrofa (Pig):9823</Target_Source>
<Target_Structure>1NSA, 1PBA, 1Z5R, 1ZG7, 1ZG8, 1ZG9, 2JEW, 2PIY, 2PIZ, 2PJ0, 2PJ1, 2PJ2, 2PJ3, 2PJ4, 2PJ5, 2PJ6, 2PJ7, 2PJ8, 2PJ9, 2PJA, 2PJB, 2PJC, 3GLJ, 3WAB, 3WC5, 3WC6, 3WC7</Target_Structure>
<Comments>Carboxypeptidase B (CPB) is a metalloprotease that cleaves proteins adjacent to arginine and lysine residues.</Comments>
</Item><Item><Target_ID> 1495</Target_ID>
<Target_Name>MRNA of amyloid precursor protein (APP)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of amyloid precursor protein (APP) has 48 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1496</Target_ID>
<Target_Name>MRNA of hepatitis C virus (HCV)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of hepatitis C virus (HCV) has 51 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1497</Target_ID>
<Target_Name>MRNA of insulin-like growth factor-1 (IGF-1)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of insulin-like growth factor-1 (IGF-1) has 61 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1498</Target_ID>
<Target_Name>MRNA of Rev Response Element (RRE)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of Rev Response Element (RRE) has 47 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1499</Target_ID>
<Target_Name>RIP1-Tag2 tumors</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</Comments>
</Item><Item><Target_ID> 1500</Target_ID>
<Target_Name>RIP1-Tag2 angiogenic islets</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</Comments>
</Item><Item><Target_ID> 1501</Target_ID>
<Target_Name>Fibronectin type Ⅲ10(RGD)-containing fragments</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1502</Target_ID>
<Target_Name>SAS-derived tumors</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>SAS cells were injected subcutaneously into the dorsolateral flank of 4–6-week-old SCID mice to produce oral cancer xenografts.</Comments>
</Item><Item><Target_ID> 1503</Target_ID>
<Target_Name>Phytophthora capsici zoospore</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Phytophthora capsici:4784</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phytophthora capsici is a soilborne pathogenic protist (phylum Oomycota) that infects aerial and subterranean structures of many solanaceous plants. Diseases caused by P. capsici are polycyclic in that multiple cycles of infection and inoculum production occur in a single growing season. The pathogen survives unfavorable conditions in soil by forming thickwalled oospores, while dissemination and infection are achieved through the production of motile biflagellate zoospores from oospores. The zoospores swim through water in the soil and are chemotactically attracted to the exudates released by the roots of potential host plants. After the zoospores have adhered to the root surface, they encyst and produce a precisely oriented germ tube that grows into adjacent host plant tissue.</Comments>
</Item><Item><Target_ID> 1504</Target_ID>
<Target_Name>CD147</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P35613</Target_Sequence>
<Synonyms>Basigin
5F7
Collagenase stimulatory factor
Extracellular matrix metalloproteinase inducer
Leukocyte activation antigen M6
OK blood group antigen
Tumor cell-derived collagenase stimulatory factor</Synonyms>
<Target_Source>Homo sapiens (Human) :9606</Target_Source>
<Target_Structure>3B5H , 3I84 , 3I85 , 3QQN , 3QR2</Target_Structure>
<Comments>CD147 is a transmembrane glycoprotein of the immunoglobulin superfamily. It is highly enriched on the surface of cancer cells. Thus, it has been taken as a biomarker that can be used in cancer detection.</Comments>
</Item><Item><Target_ID> 1505</Target_ID>
<Target_Name>HIV-1 TAR</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The HIV-1 TAR is a 59 nucleotide long element present at the 5' end of the HIV-1 viral RNA and stimulates transcription when bound to protein ligands; the viral Tat protein complexed with the host positive Transcription Elongation Factor b (pTEFb, composed of Cyclin T1 and CDK9), associates to the TAR element with high affinity, and promotes the hyper-phosphorylation of the C-terminal Domain of RNA polymerase Ⅱ large subunit.</Comments>
</Item><Item><Target_ID> 1506</Target_ID>
<Target_Name>Human plasma clots</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Blood was anticoagulated with 0.4% sodium citrate and centrifuged at 2, 500 × g . The plasma was collected, spun again to remove remaining blood cells, and frozen at 80°C. Clotting was initiated by adding CaCl2 to 20 mM, and the clot was repeatedly washed with PBS.</Comments>
</Item><Item><Target_ID> 1507</Target_ID>
<Target_Name>Puumala virus</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Puumala virus belongs to the genus Hantavirus, family Bunyaviridae. Hantaviruses are enveloped and have a trisegmented, single-stranded, negative-sense RNA genome. The large, medium, and small segments are packed into nucleocapsids separately. The large segment encodes the viral RNA polymerase-transcriptase, the medium segment encodes envelope glycoproteins G1 and G2, and the small segment encodes nucleocapsid protein. Each hantavirus is associated with a primary rodent host carrier in which it has evolved and for which it is apathogenic.</Comments>
</Item><Item><Target_ID> 1508</Target_ID>
<Target_Name>SH3 domain of tyrosine-protein kinase Yes</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07947 [91-152]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase Yes alternative name(s):
EC=2.7.10.2
Proto-oncogene c-Yes
p61-Yes</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2HDA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1509</Target_ID>
<Target_Name>SH3 domain of tyrosine-protein kinase ABL1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00519 [61-121]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase ABL1 alternative name(s):
Abelson murine leukemia viral oncogene homolog 1
Abelson tyrosine-protein kinase 1
Proto-oncogene c-Abl
p150
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AB2, 1AWO, 1BBZ, 1JU5, 1OPL, 1ZZP, 2ABL, 2E2B, 2F4J, 2FO0, 2G1T, 2G2F, 2G2H, 2G2I, 2GQG, 2HIW, 2HYY, 2HZ0, 2HZ4, 2HZI, 2O88, 2V7A, 3CS9, 3EG0, 3EG1, 3EG2, 3EG3, 3EGU, 3K2M, 3PYY, 3QRI, 3QRJ, 3QRK, 3T04, 3UE4, 3UYO, 4J9B, 4J9C, 4J9D, 4J9E, 4J9F, 4J9G, 4J9H, 4J9I, 4JJB, 4JJC, 4JJD</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1510</Target_ID>
<Target_Name>SH3 domain of cortactin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1511</Target_ID>
<Target_Name>SH3 domain of apoptosis-stimulating of p53 protein 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q13625 [1057-1119]</Target_Sequence>
<Synonyms>Apoptosis-stimulating of p53 protein 2 alternative name(s):
Bcl2-binding protein
Bbp
Renal carcinoma antigen NY-REN-51
Tumor suppressor p53-binding protein 2
53BP2
p53-binding protein 2
p53BP2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1YCS, 2UWQ, 4A63, 4IRV</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1512</Target_ID>
<Target_Name>SH3 domains of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 and gamma-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>SH3 domain of PLC-gamma-1: P19174 [791-851], SH3 domain of PLC-gamma-2: P16885 [769-829]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>PLC-gamma-1: 1HSQ, 2HSP, 4EY0, 4FBN
PLC-gamma-2: 2K2J, 2W2W, 2W2X</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1513</Target_ID>
<Target_Name>SH3 domain of Crk N</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1514</Target_ID>
<Target_Name>SH3 domain of Grb2 N</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1515</Target_ID>
<Target_Name>Troponin C, skeletal muscle</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02586</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure>1A2X, 1TCF, 1TN4, 2TN4</Target_Structure>
<Comments>Troponin C, the major regulatory protein in striated muscle contraction, is the calcium-binding component of the ternary troponin complex. It regulates the actomyosin activity in a calcium-dependent manner, through its association with tropomyosin and actin.</Comments>
</Item><Item><Target_ID> 1516</Target_ID>
<Target_Name>Purified serum IgG from goat-1 (G1) infection with Map</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1517</Target_ID>
<Target_Name>Purified serum IgG from goat-2 (G2) infection with Map</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1518</Target_ID>
<Target_Name>Anti-EBV monoclonal antibody gp125</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-EBV MAbs were raised by immunizing mice with crude EBV.</Comments>
</Item><Item><Target_ID> 1519</Target_ID>
<Target_Name>Anti-EBV monoclonal antibody F1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-EBV MAbs were raised by immunizing mice with crude EBV.</Comments>
</Item><Item><Target_ID> 1520</Target_ID>
<Target_Name>Anti-EBV monoclonal antibody A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-EBV MAbs were raised by immunizing mice with crude EBV.</Comments>
</Item><Item><Target_ID> 1521</Target_ID>
<Target_Name>Anti-EBV monoclonal antibody A3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-EBV MAbs were raised by immunizing mice with crude EBV.</Comments>
</Item><Item><Target_ID> 1522</Target_ID>
<Target_Name>Purified serum IgG from an EBV-infected patient</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1523</Target_ID>
<Target_Name>Purified serum IgG from an EBV-immunised rabbit</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1524</Target_ID>
<Target_Name>Endoglucanase isozyme AgEGl, IsoA</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Anoplophora glabripennis (Asian longhorn beetle) (Anoplophora nobilis):217634</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1525</Target_ID>
<Target_Name>Anti-Lewis X monoclonal antibody MMA</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1526</Target_ID>
<Target_Name>Anti-Lewis X monoclonal antibody SSEA-1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1527</Target_ID>
<Target_Name>Anti-Lewis X monoclonal antibody Pmn6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1528</Target_ID>
<Target_Name>Anti-Lc4Cer monoclonal antibody AD117m</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1529</Target_ID>
<Target_Name>Anti-nLc4Cer monoclonal antibody H11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1530</Target_ID>
<Target_Name>Anti-GD1α monoclonal antibody KA17</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1531</Target_ID>
<Target_Name>Anti-Lewis A monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1532</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody SA3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1533</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody Strep 9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1534</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody HGAC 39</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1535</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody HGAC 47</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1536</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody HGAC 101</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1537</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody SE155.4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1538</Target_ID>
<Target_Name>Anti-GAS CWPS monoclonal antibody SYAJ/6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1539</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site GCG</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 1 is TGT (5'-CCTGCGTGGTGTCCCTTTTGGGACACCACGCAGG-3'). The selection target site is GCG.</Comments>
</Item><Item><Target_ID> 1540</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site TGT</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 1 is TGT (5'-CCTGCGTGGTGTCCCTTTTGGGACACCACGCAGG-3'). The selection target site is TGT.</Comments>
</Item><Item><Target_ID> 1541</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site TGG</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 2 is TTG (5 '-CCTGCGTTGCGCCCTTTTGGGCGCCAACGCAGG-3'). The selection target site is TGG.</Comments>
</Item><Item><Target_ID> 1542</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site TTG</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 2 is TTG (5 '-CCTGCGTTGCGCCCTTTTGGGCGCCAACGCAGG-3'). The selection target site is TTG.</Comments>
</Item><Item><Target_ID> 1543</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site GCG</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 3 is CTG (5'-CCTCTGTGGGCGCCCTTTTGGGCGCCCACAGAGG-3'). The selection target site is GCG.</Comments>
</Item><Item><Target_ID> 1544</Target_ID>
<Target_Name>Hairpin DNA containing an altered Zif268 binding site CTG</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 3 is CTG (5'-CCTCTGTGGGCGCCCTTTTGGGCGCCCACAGAGG-3'). The selection target site is CTG.</Comments>
</Item><Item><Target_ID> 1545</Target_ID>
<Target_Name>Hairpin DNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Hairpin target oligonucleotides had the sequence 5'-Biotin-GGACGCN'N'N'CGCGGGTTTTCCCGCGNNNGCGTCC-3', where NNN was the 3-nt finger-2 target sequence and N'N'N' its complement. </Comments>
</Item><Item><Target_ID> 1546</Target_ID>
<Target_Name>The SH2 domain of growth factor receptor-bound protein 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P62993 [60-152]</Target_Sequence>
<Synonyms>Growth factor receptor-bound protein 2 alternative name(s):
Adapter protein GRB2
Protein Ash
SH2/SH3 adapter GRB2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AZE, 1BM2, 1BMB, 1CJ1, 1FHS, 1FYR, 1GCQ, 1GFC, 1GFD, 1GHU, 1GRI, 1IO6, 1JYQ, 1JYR, 1JYU, 1QG1, 1TZE, 1X0N, 1ZFP, 2AOA, 2AOB, 2H46, 2H5K, 2HUW, 2VVK, 2VWF, 2W0Z, 3C7I, 3IMD, 3IMJ, 3IN7, 3IN8, 3KFJ, 3MXC, 3MXY, 3N7Y, 3N84, 3N8M, 3OV1, 3OVE, 3S8L, 3S8N, 3S8O, 3WA4</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1547</Target_ID>
<Target_Name>DNA duplex containing an inverted repeat of the Zif12-binding site</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1548</Target_ID>
<Target_Name>SH3 domain of endophilin-A1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99962 [290-349]</Target_Sequence>
<Synonyms>Endophilin-A1 alternative name(s):
EEN-B1
Endophilin-1
SH3 domain protein 2A
SH3 domain-containing GRB2-like protein 2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1549</Target_ID>
<Target_Name>SH3 domain of endophilin-A2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99961 [306-365]</Target_Sequence>
<Synonyms>Endophilin-A2 alternative name(s):
EEN fusion partner of MLL
Endophilin-2
Extra eleven-nineteen leukemia fusion gene protein
EEN
SH3 domain protein 2B
SH3 domain-containing GRB2-like protein 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1550</Target_ID>
<Target_Name>SH3 domain of endophilin-A3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99963 [285-344]</Target_Sequence>
<Synonyms>Endophilin-A2 alternative name(s):
EEN-B2
Endophilin-3
SH3 domain protein 2C
SH3 domain-containing GRB2-like protein 3</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2EW3, 2Z0V</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1551</Target_ID>
<Target_Name>SH3 domain of amphiphysin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P49418 [622-695]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KY7, 1UTC, 3SOG, 4ATM</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1552</Target_ID>
<Target_Name>Elongation factor Tu, EF-Tu</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1553</Target_ID>
<Target_Name>Anti-Puumala virus envelope glycoprotein G1 monoclonal antibody 5A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Myodes glareolus (Bank vole) (Clethrionomys glareolus)：447135</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1554</Target_ID>
<Target_Name>Anti-Puumala virus envelope glycoprotein G2 monoclonal antibody 4G2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Myodes glareolus (Bank vole) (Clethrionomys glareolus)：447135</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1555</Target_ID>
<Target_Name>Anti-Puumala virus envelope glycoprotein G2 monoclonal antibody 1C9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1556</Target_ID>
<Target_Name>Estrogen receptor alpha, ERα</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The estrogen receptor (ER) is a member of the steroid family of nuclear receptors. Like other nuclear receptors, the ER is a ligand-dependent transcriptional activator. In the absence of hormone, the ER resides in the nucleus of target cells where it is associated with an inhibitory heat-shock protein complex. On binding ligand, the receptor is activated. This process permits the formation of stable receptor dimers and subsequent interaction with specific DNA response elements located within the regulatory region of target genes. The DNA-bound receptor can then either positively or negatively regulate target gene transcription.</Comments>
</Item><Item><Target_ID> 1557</Target_ID>
<Target_Name>Estrogen receptor beta, ERβ</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The estrogen receptor (ER) is a member of the steroid family of nuclear receptors. Like other nuclear receptors, the ER is a ligand-dependent transcriptional activator. In the absence of hormone, the ER resides in the nucleus of target cells where it is associated with an inhibitory heat-shock protein complex. On binding ligand, the receptor is activated. This process permits the formation of stable receptor dimers and subsequent interaction with specific DNA response elements located within the regulatory region of target genes. The DNA-bound receptor can then either positively or negatively regulate target gene transcription.</Comments>
</Item><Item><Target_ID> 1558</Target_ID>
<Target_Name>Mouse breast tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1559</Target_ID>
<Target_Name>Angiogenic vessel</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DAS model mice were prepared. In brief, highly metastatic murine B16BL6 melanoma cells (1.0e7 cells/ring) were loaded into a Millipore chamber ring. The chamber rings were dorsally implanted into 5-week-old C57BL/6 male mice. Five days after the implantation, these mice were used for in vivo biopanning.</Comments>
</Item><Item><Target_ID> 1560</Target_ID>
<Target_Name>Angiogenin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03950</Target_Sequence>
<Synonyms>ANG
RNASE5</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A4Y, 1ANG, 1AWZ, 1B1E, 1B1I, 1B1J, 1GV7, 1H0D, 1H52, 1H53, 1HBY, 1K58, 1K59, 1K5A, 1K5B, 1UN3, 1UN4, 1UN5, 2ANG, 4AHD, 4AHE, 4AHF, 4AHG, 4AHH, 4AHI, 4AHJ, 4AHK, 4AHL, 4AHM, 4AHN, 4AOH, 4B36</Target_Structure>
<Comments>Angiogenin is one of the most potent tumor-derived angiogenic factors. Recombinant human angiogenin, rhAng, is the target.</Comments>
</Item><Item><Target_ID> 1561</Target_ID>
<Target_Name>Extracellular domain of receptor tyrosine-protein kinase erbB-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P70424[23-653]</Target_Sequence>
<Synonyms>Receptor tyrosine-protein kinase erbB-2 (EC:2.7.10.1) alternative name(s):
Proto-oncogene Neu
Proto-oncogene c-ErbB-2
p185erbB2
CD_antigen: CD340</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified form of ECD-ErbB2 was fused to AP and purified from a mouse fibroblast cell line, referred to as ECDAP. ECDAP is the real target.</Comments>
</Item><Item><Target_ID> 1562</Target_ID>
<Target_Name>IA/IAA-enriched immunoglobulin G from REM-A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were obtained twice from a 6-year-old Caucasian boy with newly diagnosed Type 1 diabetes. The serum obtained at the onset of diabetes (prior to insulin treatment) was identified as REM-A. IA is short for insulin antibody; IAA insulin autoantibody.</Comments>
</Item><Item><Target_ID> 1563</Target_ID>
<Target_Name>IA/IAA-enriched immunoglobulin G from REM-B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were obtained twice from a 6-year-old Caucasian boy with newly diagnosed Type 1 diabetes. The serum obtained around 3 months after insulin therapy was identified as REM-B. IA is short for insulin antibody; IAA insulin autoantibody.</Comments>
</Item><Item><Target_ID> 1564</Target_ID>
<Target_Name>IA/IAA-enriched immunoglobulin G from NREM-A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were taken from a 9-year-old Caucasian boy who had not entered a honeymoon period. Serum taken at onset of diabetes was designated NREM-A. IA is short for insulin antibody; IAA insulin autoantibody.</Comments>
</Item><Item><Target_ID> 1565</Target_ID>
<Target_Name>IA/IAA-enriched immunoglobulin G from NREM-B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were taken from a 9-year-old Caucasian boy who had not entered a honeymoon period. Serum taken at 3 months after insulin initiation was designated as NREM-B. IA is short for insulin antibody; IAA insulin autoantibody.</Comments>
</Item><Item><Target_ID> 1566</Target_ID>
<Target_Name>RAR-DBD-LBD</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P15207 [538-902]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The abbreviations used are: AR, androgen receptor; rAR, rat androgen receptor; DBD, DNA-binding domain; LBD, ligand-binding domain.</Comments>
</Item><Item><Target_ID> 1567</Target_ID>
<Target_Name>Vitellogenin estrogen response element (ERE)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknonw</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1568</Target_ID>
<Target_Name>Anti-dsDNA monoclonal antibody R4A</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>R4A, a mouse monoclonal IgG2b anti-dsDNA antibody, causes glomerulonephritis in nonautoimmune mice.</Comments>
</Item><Item><Target_ID> 1569</Target_ID>
<Target_Name>Anti-dsDNA monoclonal antibody 52b3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>52b3, one mutant of R4A which is a mouse monoclonal IgG2b anti-dsDNA antibody, has three amino acid substitutions in framework 3 of the H chain (arginine to glutamine at position 66, threonine to alanine at position 82b, and arginine to serine at position 83). 52b3 displays a 10-fold increase in its binding of dsDNA and a shift in tissue pathology from the predominantly glomerular deposition of the parental R4A antibody to tubular deposition.</Comments>
</Item><Item><Target_ID> 1570</Target_ID>
<Target_Name>Anti-the 0-Ag of the S. flexneri serotype 5a LPS monoclonal antibody C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1571</Target_ID>
<Target_Name>Anti-the 0-Ag of the S. flexneri serotype 5a LPS monoclonal antibody I3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1572</Target_ID>
<Target_Name>Yorkie homolog</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P46937 [171-204, 230-263]</Target_Sequence>
<Synonyms>65 kDa Yes-associated protein
YAP65</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1JMQ, 1K5R, 1K9Q, 1K9R, 2LAW, 2LAX, 2LAY, 2LTV, 2LTW, 3KYS, 3MHR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1573</Target_ID>
<Target_Name>Yorkie homolog</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P46938 [156-189, 215-248]</Target_Sequence>
<Synonyms>65 kDa Yes-associated protein
YAP65</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure>3JUA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1574</Target_ID>
<Target_Name>Anti-CTLA4 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1575</Target_ID>
<Target_Name>White fat</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1576</Target_ID>
<Target_Name>Integrin alpha-M-beta-3, integrin αmβ3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Integrin alpha-M: P11215, Integrin beta-3: P05106</Target_Sequence>
<Synonyms>Integrin alpha-M alternative name(s):
CD11 antigen-like family member B
CR-3 alpha chain
Cell surface glycoprotein MAC-1 subunit alpha
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD_antigen: CD11b

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa GPIIIa
CD_antigen=CD61</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3, 4M76
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1577</Target_ID>
<Target_Name>Myeloperoxidase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P05164</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CXP, 1D2V, 1D5L, 1D7W, 1DNU, 1DNW, 1MHL, 1MYP, 3F9P, 3ZS0, 3ZS1, 4C1M, 4DL1, 4EJX, 5FIW, 5MFA</Target_Structure>
<Comments>Human myeloperoxidase (hMPO) is released by activated neutrophils and displays powerful pro-oxidative and proinflammatory properties. Moreover, hMPO has been validated as a biomarker for acute coronary syndrome and as a risk marker for clinical diagnostics.</Comments>
</Item><Item><Target_ID> 1578</Target_ID>
<Target_Name>Alkaline phosphatase, tissue-nonspecific isozyme</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09487</Target_Sequence>
<Synonyms>EC:3.1.3.1
AP-TNAP
TNSALP
Alkaline phosphatase liver/bone/kidney isozyme</Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1579</Target_ID>
<Target_Name>Beta-glucuronidase, GUS</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P05804</Target_Sequence>
<Synonyms>EC:3.2.1.31
Beta-D-glucuronoside glucuronosohydrolase</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>3K46, 3K4A, 3K4D, 3LPF, 3LPG, 4JHZ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1580</Target_ID>
<Target_Name>BCL1 IgM idiotype</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The BALB/c-derived B cell lymphoma (BCL1) soluble IgM idiotype was purified from the serum of a mouse with large BCL1 tumors.</Comments>
</Item><Item><Target_ID> 1581</Target_ID>
<Target_Name>Thrombin receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1582</Target_ID>
<Target_Name>Calmodulin, CaM</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1583</Target_ID>
<Target_Name>Echovirus 22, EV22</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1584</Target_ID>
<Target_Name>Coxsackievirus A9, CAV9</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1585</Target_ID>
<Target_Name>Anti-aflatoxins B1 and G1 monoclonal antibody 24, MAb 24</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1586</Target_ID>
<Target_Name>Anti-aflatoxins B1, G1 and B2 monoclonal antibody, MAb 13</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1587</Target_ID>
<Target_Name>MH01 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1588</Target_ID>
<Target_Name>MH04 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1589</Target_ID>
<Target_Name>MH03 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1590</Target_ID>
<Target_Name>MH06 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1591</Target_ID>
<Target_Name>MH07 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1592</Target_ID>
<Target_Name>MH05 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1593</Target_ID>
<Target_Name>MH02 plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</Comments>
</Item><Item><Target_ID> 1594</Target_ID>
<Target_Name>PDZ domain of rho guanine nucleotide exchange factor 11</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O15085 [47-126]</Target_Sequence>
<Synonyms>Rho guanine nucleotide exchange factor 11 alternative name(s):
PDZ-RhoGEF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1595</Target_ID>
<Target_Name>PDZ domain of rho guanine nucleotide exchange factor 12</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9NZN5 [72-151]</Target_Sequence>
<Synonyms>Rho guanine nucleotide exchange factor 12 alternative name(s):
Leukemia-associated RhoGEF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1TXD, 1X86, 2OMJ, 2OS6</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1596</Target_ID>
<Target_Name>PDZ domain of segment polarity protein dishevelled homolog DVL-2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O14641 [264-353]</Target_Sequence>
<Synonyms>Segment polarity protein dishevelled homolog DVL-2 alternative name(s):
Dishevelled-2 
DSH homolog 2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2REY, 3CBX, 3CBY, 3CBZ, 3CC0</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1597</Target_ID>
<Target_Name>Aspergillus conidium</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1598</Target_ID>
<Target_Name>Aspergillus hypha</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1599</Target_ID>
<Target_Name>Esophageal cancer cell line Eca109</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1600</Target_ID>
<Target_Name>Bisphenol A, BPA</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1601</Target_ID>
<Target_Name>Envelope glycoprotein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q06DW6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Classical swine fever virus:11096</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1602</Target_ID>
<Target_Name>Sera IgG from patients with PMI</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1603</Target_ID>
<Target_Name>Anti-buffalo β-lactoglobulin antibody from rabbit 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1604</Target_ID>
<Target_Name>Anti-buffalo β-lactoglobulin antibody from rabbit 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1605</Target_ID>
<Target_Name>β2-glycoprotein I, β2GPI</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1606</Target_ID>
<Target_Name>Monoclonal chimeric IgG anti-β2GPI antibody, HCAL</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1607</Target_ID>
<Target_Name>Low avidity (LAv) IgG anti-β2GPI polyclonal antibody from patient B</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1608</Target_ID>
<Target_Name>High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient A</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1609</Target_ID>
<Target_Name>High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient B</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1610</Target_ID>
<Target_Name>Phosphatidylcholine liposome</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1611</Target_ID>
<Target_Name>Endosomal lipid mix, ELM</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1612</Target_ID>
<Target_Name>Silver power</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1613</Target_ID>
<Target_Name>Platinum</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1614</Target_ID>
<Target_Name>Polycrystalline platinum powder</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1615</Target_ID>
<Target_Name>Bone-like mineral film and hydroxyapatite sintered disks</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1616</Target_ID>
<Target_Name>82 nm silica nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1617</Target_ID>
<Target_Name>Germanium thin films on silicon, Ge-on-Si</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target Ge-on-Si was unannealed and of high defect density.</Comments>
</Item><Item><Target_ID> 1618</Target_ID>
<Target_Name>Squamous cell cancer cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1619</Target_ID>
<Target_Name>Prostate cancer bone metastasis cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1620</Target_ID>
<Target_Name>Heart muscle of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1621</Target_ID>
<Target_Name>Heart muscle and liver of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1622</Target_ID>
<Target_Name>Quadriceps muscle of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1623</Target_ID>
<Target_Name>Quadriceps muscle and liver of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1624</Target_ID>
<Target_Name>Monocytic myeloid-derived suppressor cells, monocytic MDSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1625</Target_ID>
<Target_Name>Envelope glycoprotein E2(661)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P27958 [384-661]</Target_Sequence>
<Synonyms>Envelope glycoprotein E2 alternative name(s):
NS1
gp68
gp70</Synonyms>
<Target_Source>Hepatitis C virus genotype 1a (isolate H) (HCV):11108</Target_Source>
<Target_Structure>1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1R7Q, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2XI2, 2XI3</Target_Structure>
<Comments>Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein. The C-terminal truncation of E2 at residue 661 is called E2(661). It has been shown that E2 truncated at residue 661 has a high folding efficiency.</Comments>
</Item><Item><Target_ID> 1626</Target_ID>
<Target_Name>Histone demethylase KDM1A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1627</Target_ID>
<Target_Name>Histone demethylase KDM1B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1628</Target_ID>
<Target_Name>Histone demethylase KDM4A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1629</Target_ID>
<Target_Name>Histone demethylase KDM4C</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1630</Target_ID>
<Target_Name>Human brain-seeking breast carcinoma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>231-BR cells</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1631</Target_ID>
<Target_Name>Enantiomeric Lipid I(ent-Lipid I)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phage display screens made use of lipid I inspired targets in both natural and enantiomeric forms. First, by doing so the amount of chemical space explored in the screen is effectively doubled. Secondly, it was considered that L-peptides selected in the screen that possess high affinity for natural lipidI/II might in fact be toxic towards the E.coli used in the amplification step of the phage display experiment, so using enantiomeric forms  was viewed as a way of avoiding any such negative selection bias.</Comments>
</Item><Item><Target_ID> 1632</Target_ID>
<Target_Name>Myoglobin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02144</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3RGK</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1633</Target_ID>
<Target_Name>Anti-TsCa IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The total IgG from 120 serologically positive cattle with high titers was purified according to the procedure based on the reactivity against TsCa.</Comments>
</Item><Item><Target_ID> 1634</Target_ID>
<Target_Name>Anti-soluble CD14-fraction ST monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1635</Target_ID>
<Target_Name>Anti-CD14 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1636</Target_ID>
<Target_Name>Human ovarian adenocarcinoma cell line SKOV-3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1637</Target_ID>
<Target_Name>Anti-1/3NH2TTPI polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1638</Target_ID>
<Target_Name>Enterobactin synthase component E</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P10378</Target_Sequence>
<Synonyms>Enterochelin synthase E</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>3RG2, 4IZ6</Target_Structure>
<Comments>The enterobactin biosynthetic enzyme EntA forms a complex with EntE, the next enzyme in the pathway, to enhance activation of the enterobactin precursor 2,3-dihydroxybenzoate.</Comments>
</Item><Item><Target_ID> 1639</Target_ID>
<Target_Name>Vaccinia virus strain NYCBOH</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>VACV strain NYCBOH (VR-1536TM) was purchased from ATCC®.</Comments>
</Item><Item><Target_ID> 1640</Target_ID>
<Target_Name>Surface glycoprotein Tc85-45</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q2VYD6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Trypanosoma cruzi:5693</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1641</Target_ID>
<Target_Name>Sera IgG from asymptomatic CVL and symptomatic CVL</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris:9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1642</Target_ID>
<Target_Name>Anti-GapC monoclonal antibody 1E11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1643</Target_ID>
<Target_Name>3-hydroxy-3-methylglutaryl-coenzyme A reductase ( (EC:1.1.1.34))</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P04035</Target_Sequence>
<Synonyms>HMG-CoA reductase</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1DQ8, 1DQ9, 1DQA, 1HW8, 1HW9, 1HWI, 1HWJ, 1HWK, 1HWL, 2Q1L, 2Q6B, 2Q6C, 2R4F, 3BGL, 3CCT, 3CCW, 3CCZ, 3CD0, 3CD5, 3CD7, 3CDA, 3CDB</Target_Structure>
<Comments>Human HMG-CoA reductase (hHMGR) is the rate-limiting enzyme of the mevalonate pathway that produces cholesterol and other isoprenoids. The enzyme contains 888 amino acids with the first 339 residues as the membrane anchor domain located in the endoplasmic reticulum. A linker region is located between residues ranging from 340 to 449, while the catalytic domain, from residues ranging from 450 to 888, resides in the cytoplasm.</Comments>
</Item><Item><Target_ID> 1644</Target_ID>
<Target_Name>Bone marrow-derived dendritic cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1645</Target_ID>
<Target_Name>9-fluorenylmethoxycarbonyl-threonine and leucine-methyl ester (Fmoc-T/L-OMe)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fmoc-T was purchased from Sigma-Aldrich and L-OMe.HCl from Fluka.</Comments>
</Item><Item><Target_ID> 1646</Target_ID>
<Target_Name>9-fluorenylmethoxycarbonyl-threonine and leucine-amide (Fmoc-T/L-NH2)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fmoc-T and L-NH2 were purchased from Sigma-Aldrich.</Comments>
</Item><Item><Target_ID> 1647</Target_ID>
<Target_Name>Cerebrospinal fluid</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1648</Target_ID>
<Target_Name>Anti-Lpp20 monoclonal antibody L001</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1649</Target_ID>
<Target_Name>Anti-EGFR monoclonal antibody ICR-62</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1650</Target_ID>
<Target_Name>Tumor necrosis factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01375</Target_Sequence>
<Synonyms>Cachectin
TNF-alpha
Tumor necrosis factor ligand superfamily member 2
TNF-α</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A8M, 1TNF, 2AZ5, 2E7A, 2TUN, 2ZJC, 2ZPX, 3ALQ, 3IT8, 3L9J, 3WD5, 4G3Y, 4TSV, 5TSW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1651</Target_ID>
<Target_Name>IgG from patients with CHB with HBsAg seroclearance following peg-IFN-α therapy</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1652</Target_ID>
<Target_Name>Embryonic progenitor cell line SM30</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1653</Target_ID>
<Target_Name>Ovarian cancer cell lines OC-3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The OC-3 cell line was a primary culture derived from a human surgical sample of clear cell adenocarcinoma of the ovary.</Comments>
</Item><Item><Target_ID> 1654</Target_ID>
<Target_Name>Polyclonal rabbit anti-AK IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1655</Target_ID>
<Target_Name>Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P42771</Target_Sequence>
<Synonyms>CDK4I, MTS-1, p16-INK4, p16INK4A</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A5E, 1BI7, 1DC2, 2A5E</Target_Structure>
<Comments>The target protein (p16) is a cyclin-dependent kinase (CDK) inhibitor, which plays an important role in retinoblastoma (Rb) pathway. Protein p16 has been widely used as a biomarker for HPV-related cancer diagnosis.</Comments>
</Item><Item><Target_ID> 1656</Target_ID>
<Target_Name>Soft tissue of prostate cancer xenograft</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The specimen was obtained by needle biopsy from the sacroiliac zone of an exophytic osteoblastic lesion in the left hemipelvis of a 49-y-old Caucasian male with androgen-independent prostate cancer.</Comments>
</Item><Item><Target_ID> 1657</Target_ID>
<Target_Name>Bonelike matrix tissues of prostate cancer xenograft</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The specimen was obtained by needle biopsy from the sacroiliac zone of an exophytic osteoblastic lesion in the left hemipelvis of a 49-y-old Caucasian male with androgen-independent prostate cancer.</Comments>
</Item><Item><Target_ID> 1658</Target_ID>
<Target_Name>The ligated left carotid artery in male C57/BL6J mice</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>In vivo phage panning was performed in the partial carotid artery ligation model of disturbed flow in male C57/BL6J mice. In this surgical model, three of the four major branches of the left common carotid artery (LCA) are ligated. This results in low and oscillatory flow in the LCA, while flow in the right common carotid artery (RCA) remains normal. The ligated left carotid artery is the target for phage display, while the right artery serves as a normal flow control.</Comments>
</Item><Item><Target_ID> 1659</Target_ID>
<Target_Name>Polyclonal anti-LiAg IgGs</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (dog):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Antibodies used for biopanning were purified from 38 sera from L. infantum naturally infected dogs.</Comments>
</Item><Item><Target_ID> 1660</Target_ID>
<Target_Name>Anti-human cardiac troponin I mAb 11E12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1661</Target_ID>
<Target_Name>Anti-HIV-1 monoclonal antibody VRC01</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1662</Target_ID>
<Target_Name>Plasma kallikrein (EC:3.4.21.34)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P03952</Target_Sequence>
<Synonyms>Fletcher factor, Plasma prekallikrein, Kininogenin</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2ANW, 2ANY, 4OGX, 4OGY, 5F8T, 5F8X, 5F8Z, 5TJX</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1663</Target_ID>
<Target_Name>Human alpha-FXIIa</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>FXII is expressed as a zymogen and activated by proteolytic cleavage in a two-step process. A first cleavage gives rise to the α-FXIIa being composed of a heavy and a catalytic light chain held together by a disulfide bond. Further cleavage yields the smaller β-FXIIa, which comprises only the catalytic domain.</Comments>
</Item><Item><Target_ID> 1664</Target_ID>
<Target_Name>Human beta-FXIIa</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>FXII is expressed as a zymogen and activated by proteolytic cleavage in a two-step process. A first cleavage gives rise to the α-FXIIa being composed of a heavy and a catalytic light chain held together by a disulfide bond. Further cleavage yields the smaller β-FXIIa, which comprises only the catalytic domain.</Comments>
</Item><Item><Target_ID> 1665</Target_ID>
<Target_Name>MgF2 nanoparticles (NPs)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1973</Target_ID>
<Target_Name>EAE-brain capillary endothelial cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Brain endothelial cells derived from four deeply anesthetized rats with acute experimental autoimmune encephalomyelitis (EAE) and four healthy rats were isolated. </Comments>
</Item><Item><Target_ID> 1666</Target_ID>
<Target_Name>Cathepsin G (EC:3.4.21.20)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P08311</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AU8, 1CGH, 1KYN, 1T32</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1667</Target_ID>
<Target_Name>Urokinase-type plasminogen activator (EC:3.4.21.73)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00749</Target_Sequence>
<Synonyms>U-plasminogen activator, uPA</Synonyms>
<Target_Source>U-plasminogen activator, uPA</Target_Source>
<Target_Structure>1C5W, 1C5X, 1C5Y, 1C5Z, 1EJN, 1F5K, 1F5L, 1F92, 1FV9, 1GI7, 1GI8, 1GI9, 1GJ7, 1GJ8, 1GJ9, 1GJA, 1GJB, 1GJC, 1GJD, 1KDU, 1LMW, 1O3P, 1O5A, 1O5B, 1O5C, 1OWD, 1OWE, 1OWH, 1OWI, 1OWJ, 1OWK, 1SC8, 1SQA, 1SQO, 1SQT, 1U6Q, 1URK, 1VJ9, 1VJA, 1W0Z, 1W10, 1W11, 1W12, 1W13, 1W14, 2FD6, 2I9A, 2I9B, 2NWN, 2O8T, 2O8U, 2O8W, 2R2W, 2VIN, 2VIO, 2VIP, 2VIQ, 2VIV, 2VIW, 2VNT, 3BT1, 3BT2, 3IG6, 3KGP, 3KHV, 3KID, 3M61, 3MHW, 3MWI, 3OX7, 3OY5, 3OY6, 3PB1, 3QN7, 3U73, 4DVA, 4DW2, 4FU7, 4FU8, 4FU9, 4FUB, 4FUC, 4FUD, 4FUE, 4FUF, 4FUG, 4FUH, 4FUI, 4FUJ, 4GLY, 4H42, 4JK5, 4JK6, 4JNI, 4JNL, 4K24, 4MNV, 4MNW, 4MNX, 4MNY, 4OS1, 4OS2, 4OS4, 4OS5, 4OS6, 4OS7</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1668</Target_ID>
<Target_Name>Visfatin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Recombinant visfatin with high purity was obtained from a prokaryotic expression system.</Comments>
</Item><Item><Target_ID> 1669</Target_ID>
<Target_Name>Polyclonal anti-LiPA IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (dog):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1670</Target_ID>
<Target_Name>Mycobacterium tuberculosis (H37Rv)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Mycobacterium tuberculosis strain H37Rv</Synonyms>
<Target_Source>Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv):83332</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1671</Target_ID>
<Target_Name>B3β2γ</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>B3β2γ, with the sequence of LSALEKELASLEKE, is based on Acid-pp. The molecule possesses a pentad of alternating βand γ-amino acids, showed as βLγDβLγKβK.</Comments>
</Item><Item><Target_ID> 1672</Target_ID>
<Target_Name>B3β2γ-variant1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>B3β2γ-variant1, with the sequence of LSALEKELASLEKE, is based on Acid-pp. The molecule possesses a pentad of alternating βand γ-amino acids, showned as βAγDβAγKβK.</Comments>
</Item><Item><Target_ID> 1673</Target_ID>
<Target_Name>Anti-NTX monoclonal antibody BNTX21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1674</Target_ID>
<Target_Name>Fibroblast growth factor 23(180-205)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9GZV9 [180-205]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2P39</Target_Structure>
<Comments>Fibroblast growth factor 23 (FGF23) is a bone-derived endocrine regulator of phosphate homeostasis and has been considered as a potential therapeutic target for hypophosphatemic disorders.</Comments>
</Item><Item><Target_ID> 1675</Target_ID>
<Target_Name>Tumor necrosis factor ligand superfamily member 13</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O75888</Target_Sequence>
<Synonyms>A proliferation-inducing ligand, APRIL
TNF- and APOL-related leukocyte expressed ligand 2, TALL-2
TNF-related death ligand 1, TRDL-1
CD_antigen: CD256</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4ZCH</Target_Structure>
<Comments>A Proliferation-Inducing Ligand (APRIL) is a ligand in the tumor necrosis factor (TNF) superfamily that functions as a soluble factor. APRIL is primarily expressed by hematopoietic cells and has biological roles in B cell survival and T cell activation.</Comments>
</Item><Item><Target_ID> 1676</Target_ID>
<Target_Name>Extradomain-B fibronectin (EDB-FN)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Extradomain-B fibronectin (EDB-FN), one of the oncofetal fibronectin (onfFN) isoforms, is a high-molecular-weight glycoprotein that mediates cell adhesion and migration. The expression of EDB-FN is associated with a number of cancer-related biological processes such as tumorigenesis, angiogenesis, and epithelial-to-mesenchymal transition (EMT). The EDB fragment used in the experiment is a type-III homology repeat with a highly conserved sequence of 91 amino acids.</Comments>
</Item><Item><Target_ID> 1677</Target_ID>
<Target_Name>Esophageal squamous carcinoma cell Eca-109 </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1678</Target_ID>
<Target_Name>Anti-aflatoxin monoclonal antibody 1C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1679</Target_ID>
<Target_Name>Anti-thiacloprid monoclonal antibody 3A5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1680</Target_ID>
<Target_Name>Anti-GapC (1-150) mAb 1F2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1681</Target_ID>
<Target_Name>His-tagged porcine reproductive and respiratory syndrome virus (PRRSV) nonstructuralprotein (nsp) 7</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1682</Target_ID>
<Target_Name>Cation-independent mannose-6-phosphate receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P11717</Target_Sequence>
<Synonyms>Insulin-like growth factor II receptor, M6P/IGF2 receptor</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E6F, 1GP0, 1GP3, 1GQB, 1JPL, 1JWG, 1LF8, 2CNJ, 2L29, 2L2A, 2M68, 2M6T, 2V5N, 2V5O, 2V5P</Target_Structure>
<Comments>IGF2R is a 300 kDa glycoprotein containing three domains, the cytoplasmic domain, transmembrane domain, and extracellular domain. The major function of IGF2R is to regulate lysosomal enzymes such as growth factor IGF2 by transporting them into lysosomes, followed by digestion by lysosomal acid hydrolases.</Comments>
</Item><Item><Target_ID> 1683</Target_ID>
<Target_Name>EC1 domain (EC187) of corticotropin-releasing factor receptor 1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P34998 [20-106]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2L27, 3EHS, 3EHT, 3EHU, 4K5Y</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1684</Target_ID>
<Target_Name>Tocilizumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Tocilizumab is a humanized monoclonal antibody that specifically targets both soluble interleukin-6 receptor (sIL-6R) and membrane bound interleukin-6 receptor (mIL-6R) with a high affinity, thereby preventing pro-inflammatory effects of IL-6.</Comments>
</Item><Item><Target_ID> 1685</Target_ID>
<Target_Name>Imidacloprid hapten IMI</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1686</Target_ID>
<Target_Name>Site-specifically biotinylated Complement C3 beta chain (C3b)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1687</Target_ID>
<Target_Name>Type IV secretion system protein virB10</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9RPX5</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Brucella suis biovar 1 (strain 1330):204722</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1688</Target_ID>
<Target_Name>Magnesium fluoride (MgF2) particles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1689</Target_ID>
<Target_Name>Anti-coagulation factor VIII monoclonal antibody (mAb) 2-76</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1690</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1691</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1692</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 5</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1693</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 10</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1694</Target_ID>
<Target_Name>Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 3E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1695</Target_ID>
<Target_Name>Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 1B5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1696</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDVLGVNTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1697</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTLGDRDYTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1698</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTIGTGGHYTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1699</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTLWGIQGNTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1700</Target_ID>
<Target_Name>Biotinylated anti-lysozyme polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1701</Target_ID>
<Target_Name>Biopolymer transport protein ExbD (43–141)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0ABV2 [43-141]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>2PFU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1702</Target_ID>
<Target_Name>Protein TonB (33-239)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02929 [33-239]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>1IHR, 1QXX, 1U07, 1XX3, 2GRX, 2GSK</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1703</Target_ID>
<Target_Name>Membrane protein (FXYD2)γa</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1704</Target_ID>
<Target_Name>Recombinant S-AD (rS-AD) protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Porcine transmissible gastroenteritis coronavirus (strain Purdue) (TGEV):11151</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The spike (S) protein of porcine transmissible gastroenteritis virus (TGEV) is located within the viral envelope and is the only structural protein that possesses epitopes capable of inducing virus-neutralizing antibodies. Among the four N-terminal antigenic sites A, B, C, and D,
site A and to a lesser extent site D (S-AD) induce key neutralizing antibodies. Recently, S-AD (rSAD) in recombinant form was expressed by our group.</Comments>
</Item><Item><Target_ID> 1705</Target_ID>
<Target_Name>Plasmodium berghei female gametes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmodium berghei:5821</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1706</Target_ID>
<Target_Name>Anti-bovine herpesvirus type 1(BoHV-1) polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1707</Target_ID>
<Target_Name>Agrobacterium vitis polygalacturonase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>B9JUR9</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Agrobacterium vitis (strain S4 / ATCC BAA-846) (Rhizobium vitis (strain S4)):311402</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1708</Target_ID>
<Target_Name>TGF-β1 receptors onto peripheral blood mononuclear cells (PBMC) surface</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Peripheral blood mononuclear cells (PBMC) were obtained from twenty healthy volunteers using Ficoll-Paque PLUS (GE Healthcare).</Comments>
</Item><Item><Target_ID> 1709</Target_ID>
<Target_Name>Anti-dengue virus 2 monoclonal antibody DB21-6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1710</Target_ID>
<Target_Name>Anti-dengue virus 2 monoclonal antibody DB39-2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1711</Target_ID>
<Target_Name>Dengue virus serotype 2(DENV-2)</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Dengue virus 2:11060</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1712</Target_ID>
<Target_Name>BG1 ovarian cancer cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The ovarian cancer cell line BG1 (serous type) was obtained from Dr. Keng-Fu Hsu (Department of Obsterics and Gynecology, National Cheng Kung University, Taiwan).</Comments>
</Item><Item><Target_ID> 1713</Target_ID>
<Target_Name>Kupffer cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1714</Target_ID>
<Target_Name>Chromium(III)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1715</Target_ID>
<Target_Name>Extracellular domains(ECD) of epidermal growth factor receptor(EGFR)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P00533 [1-645]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1716</Target_ID>
<Target_Name>IgG from Alzheimer’s disease (AD) patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1717</Target_ID>
<Target_Name>Anti-avian influenza virus nonstructural protein 1 MAb D9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1718</Target_ID>
<Target_Name>Cholera toxin B protein, CTB</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Cholera toxin B subunit, Cholera toxin beta subunit</Synonyms>
<Target_Source>Vibrio cholerae:666</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1719</Target_ID>
<Target_Name>Ovarian cancer A2780 cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1720</Target_ID>
<Target_Name>Histiocytic lymphoma cell line U937</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>U937 cell line was purchased from American Type Culture Collection.</Comments>
</Item><Item><Target_ID> 1721</Target_ID>
<Target_Name>Anti-immunodominant region of the PEDV Spike protein (S1) monoclonal antibody 5E12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1722</Target_ID>
<Target_Name>Small cell lung cancer (SCLC) H446 cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>H446 cell was supplied by Cell Resource Center of Peking Union Medical College and grown in RPMI 1640 with 10% FBS.</Comments>
</Item><Item><Target_ID> 1723</Target_ID>
<Target_Name>Caprine umbilical vein endothelial cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Caprine umbilical vein endothelial cell(CUVEC) were isolated from goat umbilical cords.</Comments>
</Item><Item><Target_ID> 1724</Target_ID>
<Target_Name>Amino acid sequence FDYSEPGNFSDISWPCNSSD from ACKR3/CXCR7</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1725</Target_ID>
<Target_Name>Beta-tri calcium phosphate</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Scaffolds were fabricated at Integra Life Sciences (Plainsboro, NJ, USA) from beta-tri calcium phosphate using the TheriForm 3D rapid prototyping platform.</Comments>
</Item><Item><Target_ID> 1726</Target_ID>
<Target_Name>The composite of beta-tri calcium phosphate and polylactide-co-glycolide (PLGA)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Scaffolds were fabricated at Integra Life Sciences (Plainsboro, NJ, USA) from a composite of beta-tri calcium phosphate and polylactide-co-glycolide (PLGA) using the TheriForm 3D rapid prototyping platform.</Comments>
</Item><Item><Target_ID> 1727</Target_ID>
<Target_Name>Anti-vibrio cholerae O1 Ogawa monoclonal antibody IXiao3G6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1728</Target_ID>
<Target_Name>Anti-S1 subunit of IBV Sczy3 monoclonal antibody 1D5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1729</Target_ID>
<Target_Name>Anti-S1 subunit of IBV Sczy3 monoclonal antibody 6A12</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1730</Target_ID>
<Target_Name>Anti-NS3 monoclonal antibody 3B1C4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1731</Target_ID>
<Target_Name>Serum immunoglobulin (Ig) G antibodies from patients with SARS</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1732</Target_ID>
<Target_Name>Anti-burkholderia pseudomallei protease polyclonal antibody IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus:9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1733</Target_ID>
<Target_Name>Anti-LKM1 autoantibodies from hepatitis C–infected patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</Comments>
</Item><Item><Target_ID> 1734</Target_ID>
<Target_Name>Anti-LKM1 autoantibodies from hepatitis C–infected patient 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</Comments>
</Item><Item><Target_ID> 1735</Target_ID>
<Target_Name>Anti-LKM1 autoantibodies from hepatitis C–infected patient 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</Comments>
</Item><Item><Target_ID> 1736</Target_ID>
<Target_Name>Duck hepatitis B virus polymerase (DHBVP)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Duck hepatitis B virus (isolate brown Shanghai duck S5) (DHBV):10439</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1737</Target_ID>
<Target_Name>Sheep intestinal lymph</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1738</Target_ID>
<Target_Name>Cells from sheep lymph plasma</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1739</Target_ID>
<Target_Name>Epithelial layer overlaying Peyer’s Patches (PP)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1740</Target_ID>
<Target_Name>Anti-pkMSP-142 antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-pkMSP-142 antibodies were obtained via immunization of mice with purified recombinant pkMSP-142.</Comments>
</Item><Item><Target_ID> 1741</Target_ID>
<Target_Name>Human soluble receptor for advanced glycation end products (sRAGE)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human soluble receptor for advanced glycation end products (sRAGE) were obtained from R&amp;D(R&amp;D, USA).</Comments>
</Item><Item><Target_ID> 1742</Target_ID>
<Target_Name>Anti-plant potyviruses capsid proteins (CPs) monoclonal antibody C4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1743</Target_ID>
<Target_Name>Maltase-glucoamylase (MGAM)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1744</Target_ID>
<Target_Name>Colorectal cancer cell(HCT-8)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1745</Target_ID>
<Target_Name>Cancer stem cell(CSCs)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1746</Target_ID>
<Target_Name>Human squalene synthase(hSQS)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P37268</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1EZF, 3ASX, 3LEE, 3Q2Z, 3V66, 3VJ8, 3VJ9, 3VJA, 3VJB, 3VJC, 3WC9, 3WCD, 3WCF, 3WCH, 3WCI, 3WCJ, 3WCL, 3WCM, 3WEF, 3WEG, 3WEH, 3WEI, 3WEJ, 3WEK, 3WSA</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1747</Target_ID>
<Target_Name>Beta-lactamase 2 (EC:3.5.2.6)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P04190</Target_Sequence>
<Synonyms>Beta-lactamase II, Cephalosporinase, Penicillinase</Synonyms>
<Target_Source>Bacillus cereus:1396</Target_Source>
<Target_Structure>1BC2, 1BMC, 1BVT, 1DXK, 1MQO, 2BC2, 2BFK, 2BFL, 2BFZ, 2BG2, 2BG6, 2BG7, 2BG8, 2BGA, 2M5C, 2M5D, 2NXA, 2NYP, 2NZE, 2NZF, 2UYX, 3BC2, 3FCZ, 3I0V, 3I11, 3I13, 3I14, 3I15, 3KNR, 4NQ4, 4NQ6, 4NQ7, 4TYT</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1748</Target_ID>
<Target_Name>Anti-DNA polyclonal antibody IgG1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1749</Target_ID>
<Target_Name>Anti-DNA polyclonal antibody IgG2a</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1750</Target_ID>
<Target_Name>Anti-DNA polyclonal antibody IgG2b</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1751</Target_ID>
<Target_Name>Anti-DNA polyclonal antibody IgG3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1752</Target_ID>
<Target_Name>Human ovarian cancer cell line HO8910</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human ovarian cancer cell line, HO8910, was obtained from the Laboratory Animal Center, Sun-Yatsen University, Guangdong, China.</Comments>
</Item><Item><Target_ID> 1753</Target_ID>
<Target_Name>CD44v3-v10 glycoprotein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CD44s was encoded by the standard exons (S1–S10). Between S5 and S6, variant exons (V3–V10) are spliced to form the variant protein isoforms, CD44v3-v10.</Comments>
</Item><Item><Target_ID> 1754</Target_ID>
<Target_Name>Immunoglobulin G (IgG) of Tuberculosis (TB) patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1755</Target_ID>
<Target_Name>Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of cat 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Felis catus:9685</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of cat 1.</Comments>
</Item><Item><Target_ID> 1756</Target_ID>
<Target_Name>Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of cat 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Felis catus:9685</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of cat 2.</Comments>
</Item><Item><Target_ID> 1757</Target_ID>
<Target_Name>Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of dog</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris (dog):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of dog.</Comments>
</Item><Item><Target_ID> 1758</Target_ID>
<Target_Name>Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of rabbit</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1759</Target_ID>
<Target_Name>FvTox1 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>FvTox1 was expressed in an insect cell line and immobilized on a plate for screening the phage display library.</Comments>
</Item><Item><Target_ID> 1760</Target_ID>
<Target_Name>Anti-HBX monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1761</Target_ID>
<Target_Name>Human KRAS-mutant colorectal cancer cell lines and tissues</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1762</Target_ID>
<Target_Name>Purified IgG from serum of juvenile idiopathic arthritis (JIA) persistent oligoarticular subtype </Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1763</Target_ID>
<Target_Name>Purified IgG from serum of juvenile idiopathic arthritis (JIA) extended oligoarticular subtype</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1764</Target_ID>
<Target_Name>Purified IgG from serum of juvenile idiopathic arthritis (JIA) polyarticular rheumatoid factor negative subtype</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1765</Target_ID>
<Target_Name>Purified IgG from serum of juvenile idiopathic arthritis (JIA) polyarticular rheumatoid factor positive subtype </Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1766</Target_ID>
<Target_Name>Hemagglutinin-esterase (HE)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q8V3U0</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Infectious salmon anemia virus:652965</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1767</Target_ID>
<Target_Name>Fusion glycoprotein F0</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q8V3T9</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Infectious salmon anemia virus:652965</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1768</Target_ID>
<Target_Name>Mucin-5AC</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P98088</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MUC5AC is a large secreted glycoprotein belonging to a family of proteins called mucins with molecular weights ranging from 0.5 to 20 Mda.</Comments>
</Item><Item><Target_ID> 1769</Target_ID>
<Target_Name>Glycoprotein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03522</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Vesicular stomatitis Indiana virus (strain San Juan) (VSIV):11285</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1770</Target_ID>
<Target_Name>Milled wood lignins</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Milled wood lignins (MWLs) derived from a softwood, Japanese cedar (CMWLs) was used as biopanning target.</Comments>
</Item><Item><Target_ID> 1771</Target_ID>
<Target_Name>Fibronectin extradomain B, EDB</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human fibronectin extradomainB (EDB) is a validated tumor-specific biomarker that has been used in tumor imaging and therapy.</Comments>
</Item><Item><Target_ID> 1772</Target_ID>
<Target_Name>Fe3O4 nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1773</Target_ID>
<Target_Name>Anti-birch pollen HMW allergens monoclonal antibody BIP3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1774</Target_ID>
<Target_Name>Nogo-66 receptor (NgR1)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1775</Target_ID>
<Target_Name>Glypican-3 (GPC3) protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>GPC3 is composed of a core protein and two heparansulfate chains and participates in a variety of pathways related to HCC.</Comments>
</Item><Item><Target_ID> 1776</Target_ID>
<Target_Name>Anti-OchratoxinA(OTA) monoclonal antibody 2A11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-OTA mAb 2A11 were prepared in author's laboratory.</Comments>
</Item><Item><Target_ID> 1777</Target_ID>
<Target_Name>α1β glycine receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1778</Target_ID>
<Target_Name>Leishmania major metacyclic parasite</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>L. major (Zymodeme MON25; MHOM/TN/94/GLC94) isolated from skin lesions of patients with CL.</Comments>
</Item><Item><Target_ID> 1779</Target_ID>
<Target_Name>Heterotrimeric tRNA-dependent amidotransferase (GatCAB)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Helicobacter pylori (strain ATCC 700392 / 26695):85962</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1780</Target_ID>
<Target_Name>Lipopolysaccharide, LPS</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Salmonella Typhimurium (Sigma, India)</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Lipopolysaccharide (LPS) of S. Typhimurium is a major surface exposed cell wall component of the outer membrane of bacteria and highly specific for a particular strain. LPS from S. Typhimurium (Sigma, India) was used as a target.</Comments>
</Item><Item><Target_ID> 1781</Target_ID>
<Target_Name>Endothelial cells (ECs) of ligated left carotid artery (LCA)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>We used the partial carotid ligation model of atherosclerosis, which develops disturbed flow rapidly inducing endothelial dysfunction and atherosclerosis (within 2 weeks) in the entire length of left carotid artery (LCA) while the contralateral non-ligated right carotid artery (RCA) in the same mouse exposed to normal laminar flow remains plaque free.</Comments>
</Item><Item><Target_ID> 1782</Target_ID>
<Target_Name>Endothelial cells (ECs) of non-ligated right carotid artery (RCA)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>We used the partial carotid ligation model of atherosclerosis, which develops disturbed flow rapidly inducing endothelial dysfunction and atherosclerosis (within 2 weeks) in the entire length of left carotid artery (LCA) while the contralateral non-ligated right carotid artery (RCA) in the same mouse exposed to normal laminar flow remains plaque free.</Comments>
</Item><Item><Target_ID> 1783</Target_ID>
<Target_Name>Serum from mice with traumatic brain injury (TBI)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Male C57BL/6 mice, 8–10 weeks old, were anesthetized with isoﬂurane (3% induction, 2.5% maintenance). The head was secured in a stereotaxic frame (David Kopf Instruments, CA), and following a midline scalp incision a 5 mm diameter craniotomy was conducted over the left parietal cortex. Cortical contusion was produced using a pneumatically driven impactor (Precision Systems and Instrumentation LLC, Fairfax Station, VA) with a 3 mm diameter rounded impactor tip, 1 mm impact depth, and a velocity of 3.5 m/s. Following injury, the craniotomy was sealed with dental cement and the scalp was sutured. Body temperature was maintained at 37◦C. Six hours following injury, animals were euthanized and blood was collected transcardially in a BD SST
tube, retained 30 min for clotting, and centrifuged at 1300 × g for 15 min. Aliquoted serum was stored at −80◦C. One aliquot of serum
(5 μl) from each of four injured animals was pooled and diluted in 1:100 in TBS. The target protein was glial fibrillary acidic protein (GFAP).</Comments>
</Item><Item><Target_ID> 1784</Target_ID>
<Target_Name>Helix 69 of Escherichia coli 23S rRNA</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Helix 69 (H69) RNA(50-GGCCGWAACm3WAWAACGGUC-30)was custom synthesized at Dharmacon Research, Inc. (Lafayette, CO). The 3-methylpseudouridine (m3W) phosphoramidite was synthesized. H69 was biotinylated at the 50 end using an oligonucleotide biotin-labeling kit from Amersham GE Healthcare Life Sciences (Piscataway, NJ).</Comments>
</Item><Item><Target_ID> 1785</Target_ID>
<Target_Name>Anti-VP3 monoclonal antibody 4A6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mab 4A6 is specific for the VP3 protein of waterfowl parvovirus (WPV). VP3 is a major structural protein that induces neutralizing antibodies in the waterfowl.</Comments>
</Item><Item><Target_ID> 1786</Target_ID>
<Target_Name>Anti-gp90 monoclonal antibody A9E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb A9E8 is specific for the gp90 of avian reticuloendotheliosis-associated virus (REV-A). The gp90 protein is an important envelope glycoprotein, which is responsible for inducing protective antibody immune responses in animals.</Comments>
</Item><Item><Target_ID> 1787</Target_ID>
<Target_Name>Anti-VP1 monoclonal antibody 2D10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1788</Target_ID>
<Target_Name>Low affinity immunoglobulin gamma Fc region receptor III, IgG Fc receptor III</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P08508</Target_Sequence>
<Synonyms>Fc-gamma RIII
FcRIII
CD_antigen: CD16</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1789</Target_ID>
<Target_Name>Hemagglutinin-esterase, HE</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>A0A0D3MN31</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Infectious salmon anemia virus:55987</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Hemagglutinin-esterase (HE) is coded by genomic segment 6 and carries the receptor binding domain (hemagglutinin) and receptor destroying activity (esterase).</Comments>
</Item><Item><Target_ID> 1790</Target_ID>
<Target_Name>Fusion protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>A0A0A0R8Q4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Infectious salmon anemia virus:55987</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Infectious salmon anemia virus (ISAV) fusion activity is related to a second membrane-bound protein, termed fusion protein (F) and coded by segment 5.</Comments>
</Item><Item><Target_ID> 1791</Target_ID>
<Target_Name>C-terminal half of aryl hydrocarbon receptor (AhR)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P35869 [516-848]</Target_Sequence>
<Synonyms>Aryl hydrocarbon receptor alternative name(s):
Ah receptor
AhR
Class E basic helix-loop-helix protein 76
bHLHe76</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The N-terminal half of aryl hydrocarbon receptor (AHR) harbors the bHLH/PAS domain which is responsible for binding of DNA enhancer regions, HSP90, ligand, and ARNT. The transactivation domain where coactivators bind is located at the C-terminal half of AHR.</Comments>
</Item><Item><Target_ID> 1792</Target_ID>
<Target_Name>Neural stem/progenitor cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Primary neural stem and progenitor cells (NSPCs) were isolated from the lateral wall of lateral ventricles (SVZ) and hippocampus (HC) of 4-week-old C57/B6 mice (Charles River Lab., USA).</Comments>
</Item><Item><Target_ID> 1793</Target_ID>
<Target_Name>Granzyme-like I</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q58J84</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ictalurus punctatus (Channel catfish) (Silurus punctatus):7998</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1794</Target_ID>
<Target_Name>Human non-muscle-invasive bladder cancer cell line BIU-87</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1795</Target_ID>
<Target_Name>Human prostate cancer cell line PC3				</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1796</Target_ID>
<Target_Name>Anti-GRA2 monoclonal antibody C3C5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1797</Target_ID>
<Target_Name>Gastric cancer cell line SGC-7901</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1798</Target_ID>
<Target_Name>Protein EaeB</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q05129</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli O127:H6 (strain E2348/69 / EPEC):574521</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The translocator EspB is a key virulence factor in the process of the attaching and effacing effect of enteropathogenic Escherichia coli (EPEC) and plays a critical role in the pathogenesis of the bacteria.</Comments>
</Item><Item><Target_ID> 1799</Target_ID>
<Target_Name>Human ovarian cancer cell line HO-8910</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1800</Target_ID>
<Target_Name>Human blood-brain barrier (BBB) cellular model</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human blood-brain barrier (BBB) cellular model was developed in Prof. Cecchelli’s laboratory and this model consists of a co-culture of human brain capillary endothelial cells derived from pluripotent stem cells and bovine pericytes on semi-permeable membranes of a transwell.</Comments>
</Item><Item><Target_ID> 1801</Target_ID>
<Target_Name>The envelope protein Ampho4070A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1802</Target_ID>
<Target_Name>The cell surface of multidrug resistant Listeria monocytogenes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Listeria monocytogenes:1639</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1803</Target_ID>
<Target_Name>Deinagkistrodon acutus venom</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Deinagkistrodon acutus:36307</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Lyophilized D. acutus venom was obtained from snake farms inYingtan, Jiangxi, China.</Comments>
</Item><Item><Target_ID> 1804</Target_ID>
<Target_Name>Mammary adenocarcinoma murine 4T1 cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mammary adenocarcinoma murine 4T1 cell line was kindly provided by Dr. João Nuno Moreira, from Centre for Neuroscience and Cell Biology(University of Coimbra, Portugal).</Comments>
</Item><Item><Target_ID> 1805</Target_ID>
<Target_Name>Traumatic brain injury (TBI)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1806</Target_ID>
<Target_Name>Anti-Salmonella Typhimurium polyclonal antibody IgY</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1807</Target_ID>
<Target_Name>Staphylococcus aureus biofilm</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus aureus：196620</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1808</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM023</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1809</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM025</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1810</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM031</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1811</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1812</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1813</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM041</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1814</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1815</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1816</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1817</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1818</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1819</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1820</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1821</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1822</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM051</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1823</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM035</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1824</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM077</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1825</Target_ID>
<Target_Name>Kappa fractions mixture of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM023 and MM031 and MM041</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1826</Target_ID>
<Target_Name>Peptide nanotubes (PNTs)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1827</Target_ID>
<Target_Name>Cellulose of paper</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1828</Target_ID>
<Target_Name>The printed toner of standard office laser printers</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1829</Target_ID>
<Target_Name>Recombinant human prostate-specific membrane antigen (PSMA) extracellular domain (ECD)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1830</Target_ID>
<Target_Name>Anti-carbohydrate larval antigen (CarLA) mAb PAB1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries (Sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1831</Target_ID>
<Target_Name>Tuberculosis (TB)-positive sera</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1832</Target_ID>
<Target_Name>Tyrosinase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1833</Target_ID>
<Target_Name>Interleukin-7 receptor subunit alpha, IL-7RA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>&quot;IL-7 receptor subunit alpha
IL-7R subunit alpha
IL-7R-alpha
CDw127
CD_antigen: CD127&quot;</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1834</Target_ID>
<Target_Name>Glioma-initiating cell, GIC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1835</Target_ID>
<Target_Name>Fluorescent phosphor LaPO4:Ce3+,Tb3+ (LAP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1836</Target_ID>
<Target_Name>Anti-EGFR monoclonal antibody panitumumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1837</Target_ID>
<Target_Name>Human β-Ⅻa</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00748</Target_Sequence>
<Synonyms>Alternative names for coagulation factor XII (EC:3.4.21.38): Hageman factor HAF</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4BDW, 4BDX, 4XDE, 4XE4</Target_Structure>
<Comments>Human β-FⅫa is a naturally occurring proteolytic product of coagulation factor Ⅻa (FⅫa) comprising only the catalytic domain.</Comments>
</Item><Item><Target_ID> 1838</Target_ID>
<Target_Name>Anti-E protein monoclonal antibody (mAb) 3B6</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1839</Target_ID>
<Target_Name>Outer membrane protein U, OmpU</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Vibrio mimicus</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1840</Target_ID>
<Target_Name>Anti-E protein monoclonal antibody (mAb) 1F3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1841</Target_ID>
<Target_Name>Anti-E protein monoclonal antibody (mAb) 1A5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1842</Target_ID>
<Target_Name>Phospholipid hydroperoxidase glutathione peroxidase (GPX4) mutant, GPX4mu</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target is biotinylated Avi-tagged phospholipid hydroperoxidase glutathione peroxidase (GPX4) possessing seven mutations (GPX4mu). The seven mutations are Sec73Cys, Cys37Ala, Cys93Arg, Cys134Glu, Cys175Val, Cys64Ser, Cys102Ser. In addition, the GPX4mu had a SUMO-tag in its N-terminus.</Comments>
</Item><Item><Target_ID> 1843</Target_ID>
<Target_Name>Cryptococcus neoformans H99</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1844</Target_ID>
<Target_Name>IgGs of horse immunized by the crude venom of the Hemiscorpius lepturus</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Equus caballus (horse):9796</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target is IgGs purified from the sera of horses immunized by the venom of theHemiscorpius lepturus.</Comments>
</Item><Item><Target_ID> 1845</Target_ID>
<Target_Name>BTB domain of B cell lymphoma 6(5-129)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P41182</Target_Sequence>
<Synonyms>Alternative names for B-cell lymphoma 6 protein:
BCL-6, B-cell lymphoma 5 protein, BCL-5,
Protein LAZ-3, Zinc finger and BTB domain-containing, protein 27, Zinc finger protein 51.</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1R28, 1R29, 1R2B, 2EN2, 2EOS, 2LCE, 2YRM, 3BIM, 3E4U, 3LBZ, 4CP3, 4U2M</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1846</Target_ID>
<Target_Name>Anti-rVMH-HD polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1847</Target_ID>
<Target_Name>Serum 14011 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1848</Target_ID>
<Target_Name>Chalcopyrite</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1849</Target_ID>
<Target_Name>Prominin-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O43490</Target_Sequence>
<Synonyms>Antigen AC133
Prominin-like protein 1
CD_antigen: CD133</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1850</Target_ID>
<Target_Name>TiO2 nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1851</Target_ID>
<Target_Name>The LMP1 C-terminus region</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Epstein-Barr virus (EBV) is a ubiquitous human herpes virus. The Latent Membrane Protein 1 (LMP1) has been reported as the main transforming oncoprotein of this virus. LMP1 is a trans-membranous protein containing three domains: a short cytoplasmic N-terminus, six trans-membrane spanning regions, and a large cytoplasmic C-terminus tail.</Comments>
</Item><Item><Target_ID> 1852</Target_ID>
<Target_Name>Pentaerythritol trinitrate  hemisuccinate(PETNH)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1853</Target_ID>
<Target_Name>The FGFR1c/KLB complex</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fibroblast growth factor receptor-1c (FGFR1c)/βKlotho (KLB) complex is a receptor of fibroblast growth factor 21 (FGF21).</Comments>
</Item><Item><Target_ID> 1854</Target_ID>
<Target_Name>Tumor necrosis factor-α(TNF-α)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1855</Target_ID>
<Target_Name>The heteroternary complex with methyl viologen and cucurbit[8]uril(MV·CB[8])</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1856</Target_ID>
<Target_Name>The acid–alkali treated titanium</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1857</Target_ID>
<Target_Name>The fifth fragment of plasminogen Plasmin light chain B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00747 [581–810]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Plasminogen was cleaved into the following 5 chains: plasmin heavy chain A, activation peptide, angiostatin, plasmin heavy chain A, short form, plasmin light chain B.</Comments>
</Item><Item><Target_ID> 1858</Target_ID>
<Target_Name>Coxsackievirus A9 lacking the RGD motif (CV-A9-RGDdel)</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1859</Target_ID>
<Target_Name>Anti-LPS single-domain antibody fragment VHH</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Camelus dromedarius (Dromedary) (Arabian camel):9838</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1860</Target_ID>
<Target_Name>Ocular tissues </Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1861</Target_ID>
<Target_Name>Tetragonal Barium Titanate (BaTiO3 or BT) Nanocrystals</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1862</Target_ID>
<Target_Name>Anti-OPs monoclonal antibody mAb3C9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1863</Target_ID>
<Target_Name>Anti-TIM polyclonal antibody (pAb)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1864</Target_ID>
<Target_Name>Anti-Dengue virus (DENV) polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence>P00748</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1865</Target_ID>
<Target_Name>NIST RM8670 (NISTmAb)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1866</Target_ID>
<Target_Name>GST-N1-Src SH3 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1867</Target_ID>
<Target_Name>Kelch-like ECH-associated protein 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q14145</Target_Sequence>
<Synonyms>Cytosolic inhibitor of Nrf2, INrf2,
Kelch-like protein 19</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1U6D, 1ZGK, 2FLU, 3VNG, 3VNH, 3ZGC, 3ZGD, 4CXI, 4CXJ, 4CXT, 4IFJ, 4IFL, 4IFN, 4IN4, 4IQK, 4L7B, 4L7C, 4L7D, 4N1B, 4XMB, 5DAD, 5DAF, 5F72</Target_Structure>
<Comments>Keap1 is increasingly recognized as an attractive target for treating diseases involving oxidative stress, including cancer, atherosclerosis, diabetes, arthritis, and neurodegeneration.</Comments>
</Item><Item><Target_ID> 1868</Target_ID>
<Target_Name>Toll-like receptor-4 (TLR4) and myeloid differentiation factor 2 (MD2) complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1869</Target_ID>
<Target_Name>Toll-like receptor-4 (TLR4) and myeloid differentiation factor 2 (MD2) complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1870</Target_ID>
<Target_Name>Anti-E. rhusiopathiae polyclonal antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Erysipelothrix rhusiopathiae(ERYRF):650150</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1871</Target_ID>
<Target_Name>Anti-E. rhusiopathiae polyclonal antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Erysipelothrix rhusiopathiae(ERYRF):650150</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1872</Target_ID>
<Target_Name>Serum antibodies</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1873</Target_ID>
<Target_Name>BDNF/NT-3 growth factors receptor (EC:2.7.10.1)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q16620</Target_Sequence>
<Synonyms>GP145-TrkB, Trk-B
Neurotrophic tyrosine kinase receptor type 2
TrkB tyrosine kinase
Tropomyosin-related kinase B</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HCF, 1WWB, 2MFQ, 4ASZ, 4AT3, 4AT4, 4AT5</Target_Structure>
<Comments>Protein constructs of the extracellular domain of human tropomyosin-related kinase B (Met1-His430) fused to the Fc portion of immunoglobulin G (TrkB-Fc) were produced internally, using a proprietary vector and expression in FreeStyle 293 cells.</Comments>
</Item><Item><Target_ID> 1874</Target_ID>
<Target_Name>Lactotransferrin (EC:3.4.21.-), Lactoferrin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02788</Target_Sequence>
<Synonyms>Growth-inhibiting protein 12 Talalactoferrin</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1B0L, 1BKA, 1CB6, 1DSN, 1EH3, 1FCK, 1H43, 1H44, 1H45, 1HSE, 1L5T, 1LCF, 1LCT, 1LFG, 1LFH, 1LFI, 1LGB, 1N76, 1SQY, 1U62, 1VFD, 1VFE, 1XV4, 1XV7, 1Z6V, 1Z6W, 2BJJ, 2DP4, 2GMC, 2GMD, 2HD4, 2PMS</Target_Structure>
<Comments>Lactoferrin (LF) is an iron-binding secretory protein, which is distributed in the secondary granules of polynuclear lymphocytes as well as in the milk  produced by female mammals.</Comments>
</Item><Item><Target_ID> 1875</Target_ID>
<Target_Name>ATG8</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1876</Target_ID>
<Target_Name>Serum of soy allergic patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1877</Target_ID>
<Target_Name>Dedicator of cytokinesis 2 (DOCK2)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1878</Target_ID>
<Target_Name>Viral protein 1 and 2 (VP1 and VP2)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q83884</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Norwalk virus (strain GI/Human/United States/Norwalk/1968) (Hu/NV/NV/1968/US):524364</Target_Source>
<Target_Structure>1IHM,2ZL5,2ZL6,2ZL7,3BY1,3BY2,3D26,5KW9</Target_Structure>
<Comments>Recombinant GI.1 virus-like particles (VLPs) were generated through the use of a baculovirus expression system. Specifically, VP1 and VP2 capsid proteins were expressed in Sf9 insect cells, and purified through a cesium chloride gradient.</Comments>
</Item><Item><Target_ID> 1879</Target_ID>
<Target_Name>Recombinant V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-Ras) with G12D substitution</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1880</Target_ID>
<Target_Name>Anti-TIM polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit): 9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1881</Target_ID>
<Target_Name>Anti-PRRSV monoclonal antibody A1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</Comments>
</Item><Item><Target_ID> 1882</Target_ID>
<Target_Name>Anti-PRRSV monoclonal antibody A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</Comments>
</Item><Item><Target_ID> 1883</Target_ID>
<Target_Name>Anti-PRRSV monoclonal antibody A7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</Comments>
</Item><Item><Target_ID> 1884</Target_ID>
<Target_Name>Metacaspase, MCA</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>B6DU80</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Leishmania amazonensis</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1885</Target_ID>
<Target_Name>Protein-glutamine gamma-glutamyltransferase K</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P22735</Target_Sequence>
<Synonyms>Epidermal TGase
Transglutaminase K
TG(K)
TGK
TGase K
Transglutaminase-1
TGase-1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2XZZ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1886</Target_ID>
<Target_Name>Sera of peanut allergic patient 1</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1887</Target_ID>
<Target_Name>Sera of peanut allergic patient 2</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1888</Target_ID>
<Target_Name>Sera of peanut allergic patient 3</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1889</Target_ID>
<Target_Name>Sera of peanut allergic patient 4</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1890</Target_ID>
<Target_Name>Plasma of peanut allergic patient 1</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The patient plasma samples were obtained about 9 years after the patient sera samples.</Comments>
</Item><Item><Target_ID> 1891</Target_ID>
<Target_Name>Plasma of peanut allergic patient 4</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The patient plasma samples were obtained about 9 years after the patient sera samples.</Comments>
</Item><Item><Target_ID> 1892</Target_ID>
<Target_Name>Sera of peanut-tolerant subject 1</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1893</Target_ID>
<Target_Name>Sera of peanut-tolerant subject 2</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1894</Target_ID>
<Target_Name>Sera of peanut-tolerant subject 3</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1895</Target_ID>
<Target_Name>Sera of peanut-tolerant subject 4</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1896</Target_ID>
<Target_Name>Plasma of peanut-tolerant subject 2</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1897</Target_ID>
<Target_Name>Plasma of peanut-tolerant subject 3</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1898</Target_ID>
<Target_Name>Progenitor stem cell line KS483 at 4 days of differentiation</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A murine mesenchymal progenitor stem cell line (KS483, Percuros,Enschede, The Netherlands) was cultured into osteoblasts in a-MEM (minimum essential medium, 1 ) with GlutaMAX supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (all from Gibco, Breda, The Netherlands) under 5% CO2. For differentiation, KS483 cells were seeded at a density of 15,000 cells/cm2 in an 8.6-cm Petri dish.</Comments>
</Item><Item><Target_ID> 1899</Target_ID>
<Target_Name>Progenitor stem cell line KS483 at 8 days of differentiation</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A murine mesenchymal progenitor stem cell line (KS483, Percuros,Enschede, The Netherlands) was cultured into osteoblasts in a-MEM (minimum essential medium, 1 ) with GlutaMAX supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (all from Gibco, Breda, The Netherlands) under 5% CO2. For differentiation, KS483 cells were seeded at a density of 15,000 cells/cm2 in an 8.6-cm Petri dish.</Comments>
</Item><Item><Target_ID> 1900</Target_ID>
<Target_Name>IL-4-polarized M2 macrophage</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1901</Target_ID>
<Target_Name>Mycobacterium tuberculosis △leucineD and △panthothenateCD double auxotroph, △leu/△pan</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1902</Target_ID>
<Target_Name>Sortase A from S. aureus (SrtA)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1903</Target_ID>
<Target_Name>Neuraminidase</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>C3W5V0</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Influenza A virus (A/California/05/2009(H1N1)):641807</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1904</Target_ID>
<Target_Name>Eu2O3</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1905</Target_ID>
<Target_Name>Annexin A2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P07355</Target_Sequence>
<Synonyms>Annexin II
Annexin-2
Calpactin I heavy chain
Calpactin-1 heavy chain
Chromobindin-8
Lipocortin II
Placental anticoagulant protein IV
PAP-IV
Protein I
p36</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1W7B,1XJL,2HYU,2HYV,2HYW,4DRW,4FTG,4HRH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1906</Target_ID>
<Target_Name>Human Hair</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1907</Target_ID>
<Target_Name>Human bone marrow stromal cell (hBMSC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Clonally derived human bone marrow stromal cells (hBMSC) were a generous gift from the NIH.</Comments>
</Item><Item><Target_ID> 1908</Target_ID>
<Target_Name>Enargite</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1909</Target_ID>
<Target_Name>Chalcopyrite</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1910</Target_ID>
<Target_Name>LaPO4:Ce3+,Tb3+, LAP</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>The rare earth mineral lanthanum phosphate doped with 27 mole percent cerium and 13 mole percent terbium (LAP) (Leuchtstoffwerk Breitungen GmbH) that is part of the fluorescent phosphors of CFL was used as the bio-panning target.</Comments>
</Item><Item><Target_ID> 1911</Target_ID>
<Target_Name>Particulate matter, PM</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Particulate matter (PM) is defined as fine solid or liquid matter suspended in the Earth’s atmosphere. Both natural and man-made sources contribute to airborne PM. Natural sources include smoke from forest fires and volcanic eruptions while man-made sources include automobile exhaust and smoke from power generation activities. PM is a complex mixture of elemental and organic carbon (EC and OC), inorganic compounds such as sulfates and nitrates, as well as metal compounds. Airborne PM is an important metric of air quality and amajor source of health concern in urban areas. Long-term exposure to fine PM with diameters of less than 2.5 mm is associated with increased risk of lung cancer and cardiovascular diseases, while short-term exposure is associated with cardiopulmonary diseases.</Comments>
</Item><Item><Target_ID> 1912</Target_ID>
<Target_Name>SECp43180</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>The DNA encoding full-length SECp43 was amplified from pUC19-SECp43 (D. Su and D. Söll, Yale University) and subcloned into the PstI/HindIII sites of pETDuet-1 vector (Novagen), containing a Histag coding sequence; a tobacco etch virus (TEV) protease cleavage sequence was added by PCR. The pETDuet-1-SECp43180 construct contains a stop codon inserted by directed mutagenesis after amino acid 180. pETDuet-1-SECp43180 and pRARE (Novagen), required to express human tRNAs for codons not well translated in E. coli, were co-transformed into BL21(DE3) cells and grown under selection in ampicillin (100 μg/mL).</Comments>
</Item><Item><Target_ID> 1913</Target_ID>
<Target_Name>Major structural protein VP28</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q4U3X7</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>White spot syndrome virus:342409</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The recombinant VP28 (rVP28) protein of the white spot syndrome virus (WSSV) was chosen as the target protein. The rVP 28 was expressed in Escherichia coli GJ1158 by cloning the VP28 gene of WSSV into pRSET B expression vector.</Comments>
</Item><Item><Target_ID> 1914</Target_ID>
<Target_Name>Tumor vessels</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1915</Target_ID>
<Target_Name>Anti-Fumonisins B1 monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The anti-fumonisin monoclonal antibody was purchased from BioTez (Berlin, Germany), which has specifity for Fumonisins B1 and B2.</Comments>
</Item><Item><Target_ID> 1916</Target_ID>
<Target_Name> Polystyrene 96-well microtiter plate (polystyrene, PS)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>The polystyrene 96-well microtiter plates were purchased from Corning, Inc. NY, USA. The real target is polystyrene.</Comments>
</Item><Item><Target_ID> 1917</Target_ID>
<Target_Name>T lymphocyte leukemia cell line Jurkat</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>T lymphocyte leukemia cell line Jurkat was purchased from the American Type Culture Collection (ATCC, VA).</Comments>
</Item><Item><Target_ID> 1918</Target_ID>
<Target_Name>Nitrite reductase AniA</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090)</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1919</Target_ID>
<Target_Name>Gap junction alpha-5 protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q01231</Target_Sequence>
<Synonyms>Connexin-40
Cx40</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Recombinant Cx40 (amino acids 231-358) was used as the bait protein.</Comments>
</Item><Item><Target_ID> 1920</Target_ID>
<Target_Name>Anti-triosephosphate isomerase (TIM) polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1921</Target_ID>
<Target_Name>Human gastric cancer cell line MKN-45P</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MKN-45P human gastric cancer cells were isolated from parental MKN-45.3. Nude mice were intraperitoneally injected with 2e6 MKN-45P cells. For dual tumors, nude mice were simultaneously injected  intraperitoneally with 2e6 MKN-45P cells and subcutaneously with 2e5 MKN-45P cells in the right flank. The MKN-45P tumors were grown for 2 weeks.</Comments>
</Item><Item><Target_ID> 1922</Target_ID>
<Target_Name>Mouse colon adenocarcinoma cell line CT26</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CT26 cell lines were purchased from American Type Culture Collection (CT.26 ATCC CLR-2638; ATCC, United Kingdom). Balb/c mice were intraperitoneally injected with 2e6 CT26 cells. The CT26 tumors were grown for 1 week.</Comments>
</Item><Item><Target_ID> 1923</Target_ID>
<Target_Name>Kidney</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1924</Target_ID>
<Target_Name>Crohn disease (CD) inflamed mucosa</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1925</Target_ID>
<Target_Name>Ulcerative colitis (UC) inflamed mucosa</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1926</Target_ID>
<Target_Name>Normal colon mucosa of healthy volunteers</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1927</Target_ID>
<Target_Name>Huamn large cell carcinoma (LCC) cell line H460</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human large cell carcinoma (LCC) cell line H460 was purchased from the American Type Culture Collection (ATCC) and authenticated by ATCC based on their DNA profiles, cytogenetic analyses, and isoenzymology.</Comments>
</Item><Item><Target_ID> 1928</Target_ID>
<Target_Name>Anti-HO-1 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Heme oxygenase-1 (HO-1) is a transmembrane protein, which makes it difficult to obtain prokaryotic, soluble expression of active, full-length rat HO-1. For this reason, the △rHO-1 (recombinant rat HO-1) protein used in the present study was modified. The transmembrane domain of HO-1 was removed. Anti-△rHO-1 polyclonal antibodies were obtained from two rabbits immunized with purified △rHO-1.</Comments>
</Item><Item><Target_ID> 1929</Target_ID>
<Target_Name>Human colorectal cancer cell line HT29</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human colorectal adenocarcinoma cells  (HT29) were obtained from the American Type Culture Collection (ATCC). HT29 cells were cultured in McCoy’s medium (Gibco)  containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen). These cells have the V600E BRAF point mutation found in sessile serrated adenoma (SSA).</Comments>
</Item><Item><Target_ID> 1930</Target_ID>
<Target_Name>Human whole serum</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1931</Target_ID>
<Target_Name>Pancreatic secretory granule membrane major glycoprotein GP2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P55259</Target_Sequence>
<Synonyms>Pancreatic zymogen granule membrane protein GP-2
ZAP75</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1932</Target_ID>
<Target_Name>Human IgG anti-HEV positive serum</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1933</Target_ID>
<Target_Name>T-cell antigen CD7</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P09564</Target_Sequence>
<Synonyms>GP40
T-cell leukemia antigen
T-cell surface antigen Leu-9
TP41
CD_antigen: CD7</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1934</Target_ID>
<Target_Name>His6-tag</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Polyhistidine-tag
Hexa histidine-tag
6xHis-tag</Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A polyhistidine-tag is an amino acid motif in proteins that consists of at least six histidine (His) residues, often at the N- or C-terminus of the protein.</Comments>
</Item><Item><Target_ID> 1935</Target_ID>
<Target_Name>Gold nanocube</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1936</Target_ID>
<Target_Name>Head and neck squamous cell carcinoma (HNSCC) cell line HNO97</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The phages were exposed alternatingly to HNO97 cells and HNO97 protein fractions (100 nmol/L) in 96-well plates for 1 hour.</Comments>
</Item><Item><Target_ID> 1937</Target_ID>
<Target_Name>The μ (mu) homology domain of suppressor of yeast profilin deletion</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Yeast：559292</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1938</Target_ID>
<Target_Name>Cellular tumor antigen p53</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02340</Target_Sequence>
<Synonyms>Antigen NY-CO-13
Phosphoprotein p53
Tumor suppressor p53</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A1U, 1AIE, 1C26, 1DT7, 1GZH, 1H26, 1HS5, 1JSP, 1KZY, 1MA3, 1OLG, 1OLH, 1PES, 1PET, 1SAE, 1SAF, 1SAK, 1SAL, 1TSR, 1TUP, 1UOL, 1XQH, 1YC5, 1YCQ, 1YCR, 1YCS, 2AC0, 2ADY, 2AHI, 2ATA, 2B3G, 2BIM, 2BIN, 2BIO, 2BIP, 2BIQ, 2F1X, 2FEJ, 2FOJ, 2FOO, 2GS0, 2H1L 92-292 [»], 2H2D, 2H2F, 2H4F, 2H4H, 2H4J, 2H59, 2J0Z, 2J10, 2J11, 2J1W, 2J1X, 2J1Y, 2J1Z, 2J20, 2J21, 2K8F, 2L14, 2LY4, 2MEJ, 2MWO, 2MWP, 2MWY, 2MZD, 2OCJ, 2PCX, 2RUK, 2VUK, 2WGX, 2X0U, 2X0V, 2X0W, 2XWR, 2YBG, 2YDR, 2Z5S, 2Z5T, 3D05, 3D06, 3D07, 3D08, 3D09, 3D0A, 3DAB, 3DAC, 3IGK, 3IGL, 3KMD, 3KZ8, 3LW1, 3OQ5, 3PDH, 3Q01, 3Q05, 3Q06, 3SAK, 3TG5, 3TS8, 3ZME, 4AGL, 4AGM, 4AGN, 4AGO, 4AGP, 4AGQ, 4BUZ, 4BV2, 4HFZ, 4HJE, 4IBQ, 4IBS, 4IBT, 4IBU, 4IBV, 4IBW, 4IBY, 4IBZ, 4IJT, 4KVP, 4LO9, 4LOE, 4LOF, 4MZI, 4MZR, 4QO1, 4RP6, 4RP7, 4X34, 4XR8, 4ZZJ, 5A7B, 5AB9, 5ABA, 5AOI, 5AOJ, 5AOK, 5AOL, 5AOM, 5BUA, 5ECG, 5G4M, 5G4N, 5G4O, 5HOU, 5HP0, 5HPD, 5LAP, 5LGY, 5UN8</Target_Structure>
<Comments>pGEX-4T-3 vector (Invitrogen) was used to clone the human-p53 coding DNA (cDNA) into the EcoRI site under the tac promoter, inducible by Isopropyl β-D-1thiogalactopyranoside (IPTG). The p53 coding sequence was thus fused downstream the GST.</Comments>
</Item><Item><Target_ID> 1939</Target_ID>
<Target_Name>Anti-FMDV monoclonal antibody 6C9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1940</Target_ID>
<Target_Name>Tumor necrosis factor receptor superfamily member 12A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9NP84</Target_Sequence>
<Synonyms>Fibroblast growth factor-inducible immediate-early response protein 14, FGF-inducible 14
Tweak-receptor, TweakR
CD_antigen: CD266</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2EQP, 2KMZ, 2RPJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1941</Target_ID>
<Target_Name>The middle ear</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat): 10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1942</Target_ID>
<Target_Name>CTP synthase 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P17812</Target_Sequence>
<Synonyms>CTP synthetase 1
UTP--ammonia ligase 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2VO1,5U03</Target_Structure>
<Comments>CTP synthase 1 (CTPS1) is an enzyme expressed in activated lymphocytes that catalyzes the conversion of uridine triphosphate (UTP) to cytidine triphosphate (CTP) with ATP-dependent amination.</Comments>
</Item><Item><Target_ID> 1943</Target_ID>
<Target_Name>Cholera toxin subunit B, CTX-B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Vibrio cholerae:666</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1944</Target_ID>
<Target_Name>Chicken egg yolk immunoglobulin, IgY</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1945</Target_ID>
<Target_Name>The extracellular portion of tumor necrosis factor receptor superfamily member 10B</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q9QZM4 [53-180]</Target_Sequence>
<Synonyms>Alternative name(s) for tumor necrosis factor receptor superfamily member 10B:
Death receptor 5
MK
CD_antigen: CD262</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A commercially available nucleotide sequence of the DR5 (DR5-Origen) was used to create a vector containing an extracellular portion of the death receptor fused to the mouse antibody Fc domain (pFUSE-DR5-Fcm). HEK293F line cells were transfected with the genetic construct pFUSE-DR5-Fcm by lipofection with 293fectin (Invitrogen). In 5 days, the produced recombinant protein was purified by affinity chromatography on a Protein G chromatographic column (Thermo Fisher Scientific). The homogeneity of the purified samples was evaluated by electrophoresis.</Comments>
</Item><Item><Target_ID> 1946</Target_ID>
<Target_Name>The extracellular domain of receptor tyrosine-protein kinase erbB-3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21860 [20-642]</Target_Sequence>
<Synonyms>Alternative name(s) for receptor tyrosine-protein kinase erbB-3:
Proto-oncogene-like protein c-ErbB-3
Tyrosine kinase-type cell surface receptor HER3</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1947</Target_ID>
<Target_Name>Mouse melanoma carcinoma cell line B16</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1948</Target_ID>
<Target_Name>Anti-VP2 monoclonal antibody 3G11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1949</Target_ID>
<Target_Name>Human pancreatic ductal carcinoma cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1950</Target_ID>
<Target_Name>Refolded apical merozoite antigen 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmodium vivax (strain Salvador I):126793</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DNA from a clinical specimen with PCR-confirmed P.vivax infection was used as the template for recombinant protein expression study. Sequencing of the 18S ssurRNA clone confirmed that this isolate belongs to the P.vivax strain Sal-1 (GenBank accession number: U03079). Protein refolding was performed by dialysis method using 3 ml Slide-A-Lyzer Dialysis Cassettes with 10 kDa MWCO (Pierces Thermo Scientific, Waltham, MA, USA).</Comments>
</Item><Item><Target_ID> 1951</Target_ID>
<Target_Name>Anti-imidaclothiz monoclonal antibody 1E7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1952</Target_ID>
<Target_Name>Macrophage-stimulating protein receptor, MSP receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q04912</Target_Sequence>
<Synonyms>CDw136
Protein-tyrosine kinase 8
p185-Ron
CD_antigen: CD136</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3PLS, 4FWW, 4QT8</Target_Structure>
<Comments>Human recombinant RON (rhRON) protein was purchased from R&amp;D Systems (Minneapolis, MN).</Comments>
</Item><Item><Target_ID> 1953</Target_ID>
<Target_Name>PCSK9ΔP'</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The deleted α-helix version of PCSK9, called PCSK9ΔP'includes an engineered TEV (tobacco etch virus) protease cleavage site (deletion of residues Y166 and R167; insertion of ENLYFQS sequence between R165 and A168). The above procedure was performed and then purified protein was treated with TEV protease (100 µl at 2.5 mg/ml per 10 mg of protein) for 24 h at 4 °C using dialysis (Slidelyzer 10K, Thermo Scientific) versus 0.15 M NaCl, 50 mM Tris, pH 8.0, 10% glycerol and 3 mM reduced glutathione/ 0.3 mM oxidized glutathione. The repurified PCSK9ΔP'protein (Superdex 75 column) was homogenous and had the expected mass, consistent with the loss of the N-terminal sequence 153SIPWNLERITPPR165ENLYFQ (ENLYFQ is TEV cleavage sequence). The new N terminus of the PCSK9 catalytic domain was SA168 (the serine is from the TEV cleavage sequence), which was confirmed by N-terminal sequencing. Therefore, the PCSK9ΔP'construct is missing the first 15 residues of its native N-terminal sequence (153SIPWNLERITPPRYR167).</Comments>
</Item><Item><Target_ID> 1954</Target_ID>
<Target_Name>Immunoglobulins (Igs) of murine 5T33MM cells</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Igs were purified from the culture supernatants by using the Mab Trap™ antibody purification Kit [GE Healthcare, Little Chalfont, UK], according to the manufacturer’s instructions.</Comments>
</Item><Item><Target_ID> 1955</Target_ID>
<Target_Name>Human Colon cancer cell line COLO320HSR</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1956</Target_ID>
<Target_Name>G-protein coupled receptor 55</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1957</Target_ID>
<Target_Name>Anti-CD43 monoclonal antibody UN1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The IgG1 isotype UN1 mAb was produced and puriﬁed by MAbTrap Kit (GEHealthcare).</Comments>
</Item><Item><Target_ID> 1958</Target_ID>
<Target_Name>Human endothelial cells stimulated with vascular endothelial growth factor (VEGF)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1959</Target_ID>
<Target_Name>Peptide KEQWFGNRWHEGYR</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Peptide KEQWFGNRWHEGYR encompassed a 14 amino acid of v6 domain of human CD44 protein, which was synthesized using an Advanced Chem Tech 396 multiple peptide synthesizer (Advanced ChemTech, Louisville, KY) using solid-phase Fmoc chemistry. A linker amino acid sequence of Gly-Ser-Gly (GSG) was inserted between the biotin and the NH2 terminus of the peptide to minimize any steric or chemical effects. Peptides were purified by reverse-phase highpressure liquid chromatography (RP-HPLC) on a C18 column (218TP54, Vydac, Hesparia, CA), lyophilized, and stored at -20 °C. Purity of the peptides was greater than 90% as assessed by HPLC. Identities of the peptides were confirmed by electrospray ionization mass spectrometry (Mass Consortium, San Diego, CA) at the Structure Core of University of Missouri, Columbia.</Comments>
</Item><Item><Target_ID> 1960</Target_ID>
<Target_Name>SH3 domain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>To conduct a large-scale analysis of human SH3 domain binding specificities, we identified 320 SH3 domains within 219 human proteins from an InterPro scan of the Ensembl database. We cloned genes encoding the 320 SH3 domains fused to the C-terminus of glutathione S-transferase(GST). In a high-throughput manner, we expressed the GST-SH3 fusions in Escherichia coli and successfully purified 215 GST-SH3 domains as determined by the presence of bands of the correct size by SDS-PAGE.</Comments>
</Item><Item><Target_ID> 1961</Target_ID>
<Target_Name>Connective tissue growth factor (CTGF)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>CCN family member 2
Hypertrophic chondrocyte-specific protein 24
Protein FISP-12</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1962</Target_ID>
<Target_Name>1-deoxy-D-xylulose-5-phosphate synthase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>1-deoxyxylulose-5-phosphate synthase
DXP synthase
DXPS</Synonyms>
<Target_Source>Deinococcus radiodurans</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1963</Target_ID>
<Target_Name>Peritoneal macrophage of mouse bearing breast cell line 4T1</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Eight-week old Balb/c mice (Charles River, Wilmington, MA, USA) were injected in the mammary fat pad with 1.0e6 4T1 cells in PBS and grown for ten days.</Comments>
</Item><Item><Target_ID> 1964</Target_ID>
<Target_Name>Peritoneal macrophage of healthy mouse</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Eight-week old Balb/c mice (Charles River, Wilmington, MA, USA) were used for in vivo panning.</Comments>
</Item><Item><Target_ID> 1965</Target_ID>
<Target_Name>Mouse macrophage cell line Raw 267.4</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1966</Target_ID>
<Target_Name>bB2-crystallin fibrils</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1967</Target_ID>
<Target_Name>Mouse heart</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1968</Target_ID>
<Target_Name>The second extracellular loop (107-130) of C-C chemokine receptor type 9</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P51686</Target_Sequence>
<Synonyms>Alternative names for C-C chemokine receptor type 9 (CCR-9)
C-C CKR-9
CC-CKR-9
G-protein coupled receptor 28
GPR-9-6
CD_antigen: CDw199</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>5LWE</Target_Structure>
<Comments>The second extracellular loop of CCR9 (AAADQWKFQTFMCKVVNSMYK; SBS Genetech Co., Ltd., Beijing, China) was the target molecule. </Comments>
</Item><Item><Target_ID> 1969</Target_ID>
<Target_Name>Mouse muscle</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1970</Target_ID>
<Target_Name>Extracellular domain of Fibroblast growth factor receptor 2 [1-377]</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P21802</Target_Sequence>
<Synonyms>Alternative names for fibroblast growth factor receptor 2:
FGFR-2
K-sam
KGFR
Keratinocyte growth factor receptor
CD_antigen: CD332</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1DJS, 1E0O, 1EV2, 1GJO, 1II4, 1IIL, 1NUN, 1OEC, 1WVZ, 2FDB, 2PSQ, 2PVF, 2PVY, 2PWL, 2PY3, 2PZ5, 2PZP, 2PZR, 2Q0B, 3B2T, 3CAF, 3CLY, 3CU1, 3DAR, 3EUU, 3OJ2, 3OJM, 3RI1, 4J23, 4J95, 4J96, 4J97, 4J98, 4J99, 4WV1, 5EG3, 5UGL, 5UGX, 5UHN, 5UI0</Target_Structure>
<Comments>The recombinant extracellular domain (ECD) of fibroblast growth factor receptor 2 (FGFR-2c) consisted of 367 amino acids after removal of the signal peptide (#10824-H08H50, Sino Biological). </Comments>
</Item><Item><Target_ID> 1971</Target_ID>
<Target_Name>Domain 3332-3779 of prolow-density lipoprotein receptor-related protein 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q07954</Target_Sequence>
<Synonyms>Alternative name(s) for Prolow-density lipoprotein receptor-related protein 1:
LRP-1
Alpha-2-macroglobulin receptor1 Publication, A2MR
Apolipoprotein E receptor, APOER
CD_antigen: CD91</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CR8, 1D2L, 1J8E, 2FYJ, 2FYL, 2KNX, 2KNY</Target_Structure>
<Comments>Human low-density lipoprotein receptor-related protein 1 (LRP1)-Fc (5395-L4) was purchased from R&amp;D Systems (Minneapolis, MN, USA).</Comments>
</Item><Item><Target_ID> 1972</Target_ID>
<Target_Name>Pesticidal crystal protein Cry1Ab</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0A370</Target_Sequence>
<Synonyms>130 kDa crystal protein
Crystaline entomocidal protoxin
Insecticidal delta-endotoxin CryIA(b)</Synonyms>
<Target_Source>Bacillus thuringiensis:1428</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Cry1Ab protein was obtained from Youlong Co., Ltd. (Shanghai, China).</Comments>
</Item><Item><Target_ID> 1974</Target_ID>
<Target_Name>EAE-CNS brain endothelial cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Experimental autoimmune encephalomyelitis-Inflammatory central nervous system(EAE-CNS) cell. CNS cells were prepared from rat CNS. A rat with acute EAE (score 3) was deeply anesthetized and perfused with 50 mL ice-cold PBS 1×. The whole CNS tissues from both rats were recovered separately (about 2.3 g), cut into small pieces, and incubated for 50 min at 37 ℃.</Comments>
</Item><Item><Target_ID> 1975</Target_ID>
<Target_Name>Anti-S.aureus GapC monoclonal antibody(mAb2A9)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The S.aureus GapC protein in Escherichia coli. (E. coli) Recombinant GapC expressed by molecular cloning techniques was purified and used to immunize BALB/c mice to generate a specific monoclonal antibody (mAb2A9) using a cell hybridization technique.</Comments>
</Item><Item><Target_ID> 1976</Target_ID>
<Target_Name>Vibrio parahaemolyticus</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1977</Target_ID>
<Target_Name>Immunoglobulin G(IgG) of patients with Rheumatoid arthritis-Secondary Sjögren’s syndrome(RA-sSS)</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>A affinity-purified and dialyzed IgGs from ten patients with Rheumatoid arthritis-Secondary Sjögren’s syndrome(RA-sSS) for specific binding to peptides.</Comments>
</Item><Item><Target_ID> 1978</Target_ID>
<Target_Name>Thrombin from prothrombin[328-622]</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00734</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A2C,1A3B,1A3E,1A46,1A4W,1A5G,1A61,1ABI,1ABJ,1AD8,1AE8,1AFE,1AHT,1AI8,1AIX,1AWF,1AWH,1AY6,1B5G,1B7X,1BA8,1BB0,1BCU,1BHX,1BMM,1BMN,1BTH,1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DM4,1DOJ,1DWB,1DWC,1DWD,1DWE,1DX5,1E0F,1EB1,1EOJ,1EOL,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1H8D,1H8I,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MH0,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RD3,1RIW,1SB1,1SFQ,1SG8,1SGI,1SHH,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THP,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1TQ0,1TQ7,1TWX,1UMA,1UVS,1VR1,1VZQ,1W7G,1WAY,1WBG,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1Z8I,1Z8J,1ZGI,1ZGV,1ZRB,2A0Q,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2GP9,2H9T,2HGT,2HNT,2HPP,2HPQ,2HWL,2JH0,2JH5,2JH6,2OD3,2PGB,2PGQ,2PKS,2PW8,2R2M,2THF,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BEI,3BF6,3BIU,3BIV,3BV9,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EE0,3EGK,3EQ0,3F68,3GIC,3GIS,3HAT,3HKJ,3HTC,3JZ1,3JZ2,3K65,3LDX,3LU9,3NXP,3P17,3P6Z,3P70,3PMH,3PO1,3QDZ,3QGN,3QLP,3QTO,3QTV,3QWC,3QX5,3R3G,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3S7H,3S7K,3SHA,3SHC,3SI3,3SI4,3SQE,3SQH,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DT7,4DY7,4E05,4E06,4E7R,4H6S,4H6T,4HFP,4HTC,4HZH,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4MLF,4NZQ,4O03,4RKJ,4RKO,4RN6,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EDK,5EDM,5EW1,5EW2,5GDS,5GIM,5JDU,5JFD,5JZY,5L6N,5MJT,5MLS,5MM6,5NHU,5TO3,6EO6,6EO7,6EO8,6EO9,7KME,8KME</Target_Structure>
<Comments>Thrombin is a well-characterized serine protease, with known substrate recognition determinants. </Comments>
</Item><Item><Target_ID> 1979</Target_ID>
<Target_Name>A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAM-TS 13)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q76LX8</Target_Sequence>
<Synonyms>von Willebrand factor-cleaving protease(vWF-CP)</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3GHM,3GHN,3VN4</Target_Structure>
<Comments>VWF is currently the only known substrate for the metalloprotease ADAMTS13.</Comments>
</Item><Item><Target_ID> 1980</Target_ID>
<Target_Name>Cervical cancer</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1981</Target_ID>
<Target_Name>Insulin-degrading enzyme</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P14735</Target_Sequence>
<Synonyms>Abeta-degrading protease
Insulin protease(Insulinase)
Insulysin</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2G47,2G48,2G49,2G54,2G56,2JBU,2JG4,2WBY,2WC0,2WK3,2YPU,3CWW,3E4A,3E4Z,3E50,3H44,3HGZ,3N56,3N57,3OFI,3QZ2,4DTT,4DWK,4GS8,4GSC,4GSF,4IFH,4IOF,4LTE,4M1C,4NXO,4PES,4PF7,4PF9,4PFC,4Q5Z,4QIA,4RAL,4RE9,5CJO,5UOE,6B3Q,6B70,6B7Y,6B7Z,6BF6,6BF7,6BF9,6BFC</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1982</Target_ID>
<Target_Name>MoS2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>molybdenite</Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1983</Target_ID>
<Target_Name>glucagon receptor(GCGR-) and glucagon-like peptide-1 receptor(GLP1R-)overexpressing cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1984</Target_ID>
<Target_Name>Avi-tagged interleukin-17A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q16552</Target_Sequence>
<Synonyms>IL-17A
IL-17
CTLA-8
Cytotoxic T-lymphocyte-associated antigen 8</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2VXS,4HR9,4HSA,4QHU,5HHV,5HHX,5HI3,5HI4,5HI5,5N92,5NAN,5VB9</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1985</Target_ID>
<Target_Name>Anti-GapC monoclonal antibody (mAb) 1F4</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1986</Target_ID>
<Target_Name>Glycoprotein G</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>A0A1P8VHU0</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bovine ephemeral fever virus (BEFV):11303</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1987</Target_ID>
<Target_Name>Anti-RhD monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1988</Target_ID>
<Target_Name>Recombinant dengue virus type 2 NS1 protein(DENV2 NS1)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Dengue virus 2:11060</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Dengue virus type 2 NS1 (DENV2 NS1) is a specific and sensitive protein biomarker for dengue fever diagnosis.</Comments>
</Item><Item><Target_ID> 1989</Target_ID>
<Target_Name>Astrocyte(AS1)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with AS1.</Comments>
</Item><Item><Target_ID> 1990</Target_ID>
<Target_Name>Proinflammatory microglia(MG1)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with MG1.</Comments>
</Item><Item><Target_ID> 1991</Target_ID>
<Target_Name>Antiinflammatory microglia(MG2)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with MG2.</Comments>
</Item><Item><Target_ID> 1992</Target_ID>
<Target_Name>Acinetobacter baumannii cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Acinetobacter baumannii:710095</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A. baumannii grown in human blood (blood biopanning).</Comments>
</Item><Item><Target_ID> 1993</Target_ID>
<Target_Name>CD63 protein fragment containing the second extracellular loop (CD63 LEL)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1994</Target_ID>
<Target_Name>Folate receptor alpha</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P15328</Target_Sequence>
<Synonyms>Adult folate-binding protein
Short name:
FBP
Folate receptor 1
Folate receptor, adult
KB cells FBP
Ovarian tumor-associated antigen MOv18
FR-alpha</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4KM6, 4KM7, 4KMX, 4LRH, 5TZQ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1995</Target_ID>
<Target_Name>Anti-Haemonchus contortus polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ovis aries(sheep):9940</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sheep polyclonal antibody against H. contortus</Comments>
</Item><Item><Target_ID> 1996</Target_ID>
<Target_Name>Anti-M. pneumoniae serum</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1997</Target_ID>
<Target_Name>Human gastric cancer cell line MKN-45</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MKN-45 human gastric cancer cells were obtained from American Type Culture Collection (ATCC).</Comments>
</Item><Item><Target_ID> 1998</Target_ID>
<Target_Name>human cathepsin G (hCG)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>hCG has previously been reported to have a dual specific ity consisting of chymase and tryptase-type activities. In this study, tryptase activity against substrates with Lys in P1 cleavage position was indeed only 2-fold less efficient as compared to optimal chymase substrates supporting strong dual-type specificity.</Comments>
</Item><Item><Target_ID> 1999</Target_ID>
<Target_Name>Anti-splicing factor 3b subunit 1(SF3B1) monoclonal antibody, XC24</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>XC24, an autoantibody secreted from one of our tumor model mouse B-cell clones, was the bait.</Comments>
</Item><Item><Target_ID> 2000</Target_ID>
<Target_Name>Anti-glomerular basement membrane (GBM) autoantibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2001</Target_ID>
<Target_Name>Platelet-rich plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2002</Target_ID>
<Target_Name>CD177 antigen</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q8N6Q3</Target_Sequence>
<Synonyms>Human neutrophil alloantigen 2a, HNA-2a
NB1 glycoprotein, NB1 GP
Polycythemia rubra vera protein 1, PRV-1
CD_antigen: CD177</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2003</Target_ID>
<Target_Name>Purified serum IgG from a year 1 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2004</Target_ID>
<Target_Name>Purified serum IgG from a year 5 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2005</Target_ID>
<Target_Name>Purified serum IgG from a year 7 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2006</Target_ID>
<Target_Name>Fibroblast growth factor receptor 3, FGFR-3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P22607</Target_Sequence>
<Synonyms>CD_antigen: CD333</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1RY7,2LZL,4K33</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2007</Target_ID>
<Target_Name>Human sural nerve tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2008</Target_ID>
<Target_Name>N-elastase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2009</Target_ID>
<Target_Name>Myeloblastin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P24158</Target_Sequence>
<Synonyms>AGP7
C-ANCA antigen
Leukocyte proteinase 3
PR-3
PR3
Neutrophil proteinase 4, NP-4
P29
Wegener autoantigen</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FUJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2010</Target_ID>
<Target_Name>Lysozyme</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Lysozyme (L 1096), was purchased from Sigma (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2011</Target_ID>
<Target_Name>Isulin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01308</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A7F, 1AI0, 1AIY, 1B9E, 1BEN, 1EFE, 1EV3, 1EV6, 1EVR, 1FU2, 1FUB, 1G7A, 1G7B, 1GUJ, 1HIQ, 1HIS, 1HIT, 1HLS, 1HTV, 1HUI, 1IOG, 1IOH, 1J73, 1JCA, 1JCO, 1JK8, 1K3M, 1KMF, 1LKQ, 1LPH, 1MHI, 1MHJ, 1MSO, 1OS3, 1OS4, 1Q4V, 1QIY, 1QIZ, 1QJ0, 1RWE, 1SF1, 1SJT, 1SJU, 1T0C, 1T1K, 1T1P, 1T1Q, 1TRZ, 1TYL, 1TYM, 1UZ9, 1VKT, 1W8P, 1XDA, 1XGL, 1XW7, 1ZEG, 1ZEH, 1ZNJ, 2AIY, 2C8Q, 2C8R, 2CEU, 2G54, 2G56, 2H67, 2HH4, 2HHO, 2HIU, 2JMN, 2JUM, 2JUU, 2JUV, 2JV1, 2JZQ, 2K91, 2K9R, 2KJJ, 2KJU, 2KQP, 2KQQ, 2KXK, 2L1Y, 2L1Z, 2LGB, 2LWZ, 2M1D, 2M1E, 2M2M, 2M2N, 2M2O, 2M2P, 2MLI, 2MPG, 2MPI, 2MVC, 2MVD, 2N2V, 2N2W, 2N2X, 2OLY, 2OLZ, 2OM0, 2OM1, 2OMG, 2OMH, 2OMI, 2OMQ, 2QIU, 2R34, 2R35, 2R36, 2RN5, 2VJZ, 2VK0, 2W44, 2WBY, 2WC0, 2WRU, 2WRV, 2WRW, 2WRX, 2WS0, 2WS1, 2WS4, 2WS6, 2WS7, 3AIY, 3BXQ, 3E7Y, 3E7Z, 3EXX, 3FQ9, 3HYD, 3I3Z, 3I40, 3ILG, 3INC, 3IR0, 3JSD, 3KQ6, 3P2X, 3P33, 3Q6E, 3ROV, 3TT8, 3U4N, 3UTQ, 3UTS, 3UTT, 3V19, 3V1G, 3W11, 3W12, 3W13, 3W7Y, 3W7Z, 3W80, 3ZI3, 3ZQR, 3ZS2, 3ZU1, 4AIY, 4AJX, 4AJZ, 4AK0, 4AKJ, 4CXL, 4CXN, 4CY7, 4EFX, 4EWW, 4EWX, 4EWZ, 4EX0, 4EX1, 4EXX, 4EY1, 4EY9, 4EYD, 4EYN, 4EYP, 4F0N, 4F0O, 4F1A, 4F1B, 4F1C, 4F1D, 4F1F, 4F1G, 4F4T, 4F4V, 4F51, 4F8F, 4FG3, 4FKA, 4GBC, 4GBI, 4GBK, 4GBL, 4GBN, 4IUZ, 4IYD, 4IYF, 4NIB, 4OGA, 4P65, 4RXW, 4UNE, 4UNG, 4UNH, 4WDI, 4XC4, 4Y19, 4Y1A, 4Z76, 4Z77, 4Z78, 5AIY, 5BOQ, 5BPO, 5BQQ, 5BTS, 5C0D, 5CJO, 5CNY, 5CO2, 5CO6, 5CO9, 5E7W, 5EMS, 5EN9, 5ENA, 5HPR, 5HPU, 5HQI, 5HRQ, 5HYJ, 5MAM, 5MHD, 5MT3, 5MT9, 5MWQ, 5T7R, 5UDP, 5UOZ, 5UQA, 5URT, 5URU, 5USP, 5USS, 5USV, 5UU2, 5UU3, 5UU4, 5VIZ, 5WBT, 5WDM, 5WOB, 6B3Q, 6B70, 6BFC, 6CE7, 6CE9, 6CEB, 6CK2</Target_Structure>
<Comments>Human insulin (99.9%) was a generous gift of Gan &amp; Lee Biotechnology Ltd. (Beijing, China).</Comments>
</Item><Item><Target_ID> 2012</Target_ID>
<Target_Name>Bovine lactoferrin</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2013</Target_ID>
<Target_Name>Barley α-amylase 1</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Crude enzyme from barley malt was precipitated, and the isozymes were separated by ion-exchange chromatography.</Comments>
</Item><Item><Target_ID> 2014</Target_ID>
<Target_Name>Anti-goat immunoglobulin G monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti-goat immunoglobulin G (IgG) antibody was purchased from Sigma (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2015</Target_ID>
<Target_Name>Lipase (EC:3.1.1.3)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P19515</Target_Sequence>
<Synonyms>Triacylglycerol lipase</Synonyms>
<Target_Source>Rhizomucor miehei:4839</Target_Source>
<Target_Structure>1TGL, 3TGL, 4TGL, 5TGL</Target_Structure>
<Comments>Rhizomucor miehei lipase was purified to homogeneity from a crude preparation (Lipozyme 10,000 L; Novo Nordisk, Denmark)</Comments>
</Item><Item><Target_ID> 2016</Target_ID>
<Target_Name>Cystic fibrosis (CF) mucus</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (Pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A cystic fibrosis mucus model (CF mucus) was adapted from McGill and Smyth (McGill and Smyth, 2010). The model comprises of 80 mg/mL mucin from porcine stomach type III (Sigma Aldrich, St. Louis, MO), 60 mg/mL mucin from porcine stomach type II (Sigma Aldrich, St. Louis, MO), 3.2 mg/mL lecithin (Spectrum Chemical, Gardena, CA), 32 mg/mL BSA (Fisher Scientific, Waltham, MA), 4.5 mg/mL NaCl (Fisher Scientific, Waltham, MA) in a 20mM HEPES buffer (Life Technologies, Waltham, MA). The reagents were transferred to a sterile tube and mixed overnight at room temperature in a shaker at 5 rpm (Thermo Fisher Scientific, Waltham, MA).</Comments>
</Item><Item><Target_ID> 2017</Target_ID>
<Target_Name>Trypsin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2018</Target_ID>
<Target_Name>Chymotrypsin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2019</Target_ID>
<Target_Name>Terbium doped cerium-magnesium aluminate (CAT)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Terbium doped cerium-magnesium aluminate (CAT) (Leuchtstoffe Breitungen GmbH, Germany), an indispensable part of fluorescent powder of compact light bulbs, was used for the selection of specific binding peptides out of recombinant phage library.</Comments>
</Item><Item><Target_ID> 2020</Target_ID>
<Target_Name>Serum 13006 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2065</Target_ID>
<Target_Name>Serum 14008 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2066</Target_ID>
<Target_Name>Serum 13009 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2021</Target_ID>
<Target_Name>Nickel ion</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>The biopanning selection process of phage for ion specific binding has been accomplished using planar sol gel materials (GMBU e.V., Germany) with ion exchange properties. Sol gel materials were prepared with cationic binding capacity using tetraethylorthosilicate (TEOS) and different polymers (15% w/w Dispex N40, polyacrylic acid or polystyrene sulfonate). For biopanning the sol gel materials were loaded with divalent nickel-salt containing buffers.</Comments>
</Item><Item><Target_ID> 2022</Target_ID>
<Target_Name>Virus-like particle (VLP) of orange-spotted grouper nervous necrosis virus (OGNNV)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2023</Target_ID>
<Target_Name>C57BL/6 mouse bone marrow mesenchymal stem cell (BMMSC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C57BL/6 mouse BMMSCs (cat. no. MUBMX-01001) were obtained from Cyagen Biosciences, Inc., (Santa Clara,  CA, USA).  Mouse BMMSCs at passage 4-5 were used for biopanning.</Comments>
</Item><Item><Target_ID> 2024</Target_ID>
<Target_Name>Complement decay-accelerating factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08174</Target_Sequence>
<Synonyms>CD_antigen: CD55</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1H03, 1H04, 1H2P, 1H2Q, 1M11, 1NWV, 1OJV, 1OJW, 1OJY, 1OK1, 1OK2, 1OK3, 1OK9, 1UOT, 1UPN, 2C8I, 2QZD, 2QZF, 2QZH, 3IYP, 3J24, 5FOA</Target_Structure>
<Comments>CD55 molecule on the surface of human cervical cancer HeLa cell was the target.</Comments>
</Item><Item><Target_ID> 2025</Target_ID>
<Target_Name>Mast cell protease 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mesocricetus auratus (Golden hamster):10036</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2026</Target_ID>
<Target_Name>Mast cell protease 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>A0A1U7R1S4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mesocricetus auratus (Golden hamster):10036</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2027</Target_ID>
<Target_Name>Anti-GSFLSPEHQRVQ polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti ghrelin polyclonal antibodies (LifeSpan LS-B3661-50 RRID:AB_10633584) raised against synthetic peptide mapping to the N-terminus of the active human ghrelin containing amino acid GS(X)FLSPEHQRVQ (X = Ser modified with n-octanoic acid) were additionally affinity purified using full-length octanoylated human ghrelin (B-031-30, Phoenix Pharmacueticals, Karlsruhe, Germany) immobilized on streptavidin coated magnetic beads (MyOne Streptavidin T1, Life Technologies, Invitrogen, Carlsbad, CA, USA).</Comments>
</Item><Item><Target_ID> 2028</Target_ID>
<Target_Name>Anti N-terminal appetite-regulating hormone[24-51] polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti N-terminal human ghrelin antibodies (Cat# LS-C4896-100, RRID:AB_862046) were provided by LifeSpan, RI, USA.</Comments>
</Item><Item><Target_ID> 2029</Target_ID>
<Target_Name>Anti C-terminal appetite-regulating hormone[24-51] polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Goat anti C-terminal human ghrelin antibodies (Cat# sc-10368, RRID:AB_2232479) were puchased from Santa Cruz Biotechnology, Dallas, TX, USA.</Comments>
</Item><Item><Target_ID> 2030</Target_ID>
<Target_Name>BDNF/NT-3 growth factors receptor (EC:2.7.10.1)[1-430]</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q16620</Target_Sequence>
<Synonyms>Alternative names for BDNF/NT-3 growth factors receptor (EC:2.7.10.1):
GP145-TrkB (Trk-B)
Neurotrophic tyrosine kinase receptor type 2
TrkB tyrosine kinase
Tropomyosin-related kinase B</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HCF, 1WWB, 2MFQ, 4ASZ, 4AT3, 4AT4, 4AT5, 5MO9</Target_Structure>
<Comments>Phage displayed peptides were isolated against recombinant human NTRK2 (Fc‐His NTRK2) (Creative Biomart, New York, NY). Fc‐His NTRK2 is a fusion protein composed of the extracellular domain of the human NTRK2 receptor (Met1‐His430)(NP_001007098.1, transcript variant b) and the poly histidine‐tagged Fc region of human IgG1.</Comments>
</Item><Item><Target_ID> 2031</Target_ID>
<Target_Name>Endoglin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P17813</Target_Sequence>
<Synonyms>CD_antigen: CD105</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>5HZV, 5HZW, 5I04</Target_Structure>
<Comments>The recombinant human CD105 protein was provided by R&amp;D Systems, Inc. (Minneapolis, MN). CD105, also referred to as endoglin, is a type I membrane glycoprotein that forms part of the TGF-β receptor complex on cell membranes. CD105 is a 180 kDa homodimeric transmembrane protein composed of 633 amino acids, which consists of a large extracellular domain, a hydrophobic transmembrane domain and a short intracellular domain. The CD105 external domain binds to the TGF-β1 and TGF-β3 isoforms with a high affinity, forming the TGF-β receptor complex. It serves an important role in regulating cellular proliferation, differentiation, migration, adhesion and angiogenesis, which are vital processes for tumour growth, survival and metastasis. CD105 is predominantly expressed in angiogenic endothelial cells, or blood vessels surrounding tumour tissues and mesenchymal stem cells (MSCs).</Comments>
</Item><Item><Target_ID> 2032</Target_ID>
<Target_Name>Rabbit anti-goat IgG (H + L) superclonal secondary antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2033</Target_ID>
<Target_Name>Ubiquitin carboxyl-terminal hydrolase 11 [1–244 or 24–244]</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P51784</Target_Sequence>
<Synonyms>Deubiquitinating enzyme 11
Ubiquitin thioesterase 11
Ubiquitin-specific-processing protease 11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4MEL</Target_Structure>
<Comments>USP11 harbours a core protease domain as well as non-catalytic regions containing an Nterminal domain present in USPs (DUSP) andinternal ubiquitin-like (UBL) domains.</Comments>
</Item><Item><Target_ID> 2034</Target_ID>
<Target_Name>The variant of photoactive yellow protein (PYP) in the light-state</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The variant of photoactive yellow protein (PYP) is designated cPYP19 in which the thermal relaxation to the dark state was slower than wild type to facilitate complete switching to the light state without requiring very bright light sources. The target light-switchable protein was expressed as a fusion to GST with an AviTag sequence to permit site-specific biotinylation during expression.</Comments>
</Item><Item><Target_ID> 2035</Target_ID>
<Target_Name>The variant of AsLOV2 in the dark-state</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The variant of AsLOV2 is used as the target in which the thermal relaxation to the dark state was slower than wild type to facilitate complete switching to the light state without requiring very bright light sources. The target light-switchable protein was expressed as a fusion to GST with an AviTag sequence to permit site-specific biotinylation during expression.</Comments>
</Item><Item><Target_ID> 2036</Target_ID>
<Target_Name>Serum from patients with wasp sting injuries</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum was collected from ten patients (seven males and three females, with a mean age of 35.73 +/- 18.26 years) with wasp sting injuries at 3 h and 4 days after a wasp sting.</Comments>
</Item><Item><Target_ID> 2037</Target_ID>
<Target_Name>Chitosan</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Chitosan (Mw=30000, deacetylation degree≥95%) was provided by Kuer chemical technology Co., Ltd. (Beijing, China).</Comments>
</Item><Item><Target_ID> 2038</Target_ID>
<Target_Name>Anti-histamine H4 receptor (H4R) monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2039</Target_ID>
<Target_Name>Ovarian cancer tissue slice</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2040</Target_ID>
<Target_Name>Protein A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Protein A-conjugated Sepharose was purchased from Pharmacia (Piscataway, New Jersey).</Comments>
</Item><Item><Target_ID> 2041</Target_ID>
<Target_Name>Goat anti-human IgM polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2042</Target_ID>
<Target_Name>Endothelial Progenitor Cell (EPC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>EPCs (Catalog #: Z7030001) were obtained from BioChain Institute Inc. (Newark, California, United States).</Comments>
</Item><Item><Target_ID> 2043</Target_ID>
<Target_Name>B1 peptide (CMSDWTGG)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Firstly, we synthesized the B1 peptide (CMSDWTGG) based on the sequence of the first extracellular loop of LMP1 which served to screen the peptide library (Ph.D.-C7C).</Comments>
</Item><Item><Target_ID> 2044</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P50339</Target_Sequence>
<Synonyms>Mast cell protease 3, rMCP-3
Mast cell protease 5, rMCP-5
Mast cell protease III, rMCP-III</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2045</Target_ID>
<Target_Name>Mast cell protease 4 (EC:3.4.21.-), mMCP-4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21812</Target_Sequence>
<Synonyms>MSMCP
Myonase
Serosal mast cell protease</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2046</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21844</Target_Sequence>
<Synonyms>Alpha-chymase
Mast cell chymase 1
Mast cell protease 5
mMCP-5
Mast cell protease I</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2047</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P23946</Target_Sequence>
<Synonyms>Alpha-chymase
Mast cell protease I</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KLT, 1NN6, 1PJP, 1T31, 2HVX, 3N7O, 3S0N, 4AFQ, 4AFS, 4AFU, 4AFZ, 4AG1, 4AG2, 4K2Y, 4K5Z, 4K60, 4K69, 4KP0, 5YJM, 5YJP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2048</Target_ID>
<Target_Name>Pseudomonas aeruginosa ATCC 27853</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2049</Target_ID>
<Target_Name>Extracellular domain of vascular endothelial growth factor receptor 3 (EC:2.7.10.1) (VEGFR-3)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P35917[25-770]</Target_Sequence>
<Synonyms>Alternative name(s) for VEGFR-3:
Fms-like tyrosine kinase 4
FLT-4
Tyrosine-protein kinase receptor FLT4</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2050</Target_ID>
<Target_Name>Polycrystalline SnO powder</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Polycrystalline SnO powder (tin(II) oxide 99.9%; 100 Mesh Powder) was purchased from Alfa Aesar, Haverhill, MA, USA.</Comments>
</Item><Item><Target_ID> 2051</Target_ID>
<Target_Name>Olfactory bulk</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2052</Target_ID>
<Target_Name>Hemisphere</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2053</Target_ID>
<Target_Name>Cerebellum</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2054</Target_ID>
<Target_Name>Brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2055</Target_ID>
<Target_Name>Blood</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2056</Target_ID>
<Target_Name>Chondroitin-4-sulfate, C4S</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2057</Target_ID>
<Target_Name>Cysteine protease CP16160</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Giardia assemblage A WB isolate</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2058</Target_ID>
<Target_Name>Natalizumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Natalizumab (marketed as Tysabri) is the top selling biologic drug indicated for multiple sclerosis (MS) and has been used to treat 177,800 patients worldwide as of November 2017. Natalizumab is highly effective in treating MS patients; in the AFFIRM study, natalizumab was shown to reduce sustained physical disability by 42% relative to placebo. Natalizumab is a humanized recombinant IgG4 mAb that targets the α4 chain of α4β1 integrin (also known as very late activation antigen 4; VLA-4) and a4β7 integrin (LPAM-1). It is thought to function by blocking migration of immune cells across the blood-brain barrier into the central nervous system (CNS), thus suppressing inflammation in patients with relapsing-remitting multiple sclerosis.</Comments>
</Item><Item><Target_ID> 2059</Target_ID>
<Target_Name>Human bladder cancer cell line RT112</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human bladder cancer cell line RT112 was obtained from the Cell Culture Center of the Institute of Basic Medical Science (Chinese Academy of Medical Sciences) in 2016.</Comments>
</Item><Item><Target_ID> 2060</Target_ID>
<Target_Name>Hepatitis A virus cellular receptor 1, HAVcr-1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q96D42</Target_Sequence>
<Synonyms>Kidney injury molecule 1
KIM-1
T-cell immunoglobulin and mucin domain-containing protein 1
TIMD-1
T-cell immunoglobulin mucin receptor 1
TIM
TIM-1
T-cell membrane protein 1
CD_antigen: CD365</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>5DZO, 5F70</Target_Structure>
<Comments>Kidney injury molecule-1 (KIM-1), also known as hepatitis A virus cellular receptor-1 and T cell Ig mucin-1, is a transmembrane protein, which is not overexpressed in normal kidneys, but is significantly upregulated in damaged kidney tubular epithelial cells in toxic and ischemic acute kidney injury. KIM-1 is comprised of an extracellular segment containing a mucin domain and six cysteine Ig-like domains and a cytosolic segment containing a tyrosine kinase phosphorylation motif.</Comments>
</Item><Item><Target_ID> 2061</Target_ID>
<Target_Name>Glycoprotein 4, Protein GP4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Porcine reproductive and respiratory syndrome virus (PRRSV)</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2062</Target_ID>
<Target_Name>Human breast cancer cell line MCF7</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>MCF7 (human breast cancer) cell line was obtained from Institute of Basic Medical Science, Chinese Academy of Medical Science (Beijing, China).</Comments>
</Item><Item><Target_ID> 2063</Target_ID>
<Target_Name>IgG from tegumentary leishmaniasis (TL) patients</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purification of IgG antibodies from sera of tegumentary leishmaniasis (TL) patients (n = 12) was performed.</Comments>
</Item><Item><Target_ID> 2064</Target_ID>
<Target_Name>Serum 13003 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2067</Target_ID>
<Target_Name>Serum 13007 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2068</Target_ID>
<Target_Name>Serum 13016 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2069</Target_ID>
<Target_Name>Serum 14012 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2070</Target_ID>
<Target_Name>Serum 13002 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2071</Target_ID>
<Target_Name>Serum 13021 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2072</Target_ID>
<Target_Name>Serum 13001 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2073</Target_ID>
<Target_Name>IgE from patients with allergy to Scylla paramamosain AK</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2074</Target_ID>
<Target_Name>IgE from patients with allergy to Scylla paramamosain SCP</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2075</Target_ID>
<Target_Name>IgE from patients with allergy to Scylla paramamosain TIM</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2076</Target_ID>
<Target_Name>IgE from patients with allergy to Scylla paramamosain FLN c</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2077</Target_ID>
<Target_Name>Spinal Cord</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2078</Target_ID>
<Target_Name>Bone mesenchymal stem cell (BMSC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2079</Target_ID>
<Target_Name>Anti-aflatoxin B1 (AFB1) monoclonal antibody (MAb) 2F5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BALB/c mice were also immunized by AFB1-BSA conjugation and anti-AFB1 monoclonal antibody (MAb) 2F5 was produced by hybridoma techniques.</Comments>
</Item><Item><Target_ID> 2080</Target_ID>
<Target_Name>Apical membrane antigen-1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>F8V414</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Eimeria tenella (Coccidian parasite):5802</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The extracellular domain gene of Eimeria tenella apical membrane antigen-1 (EctoAMA1) was purified and used as the target.</Comments>
</Item><Item><Target_ID> 2081</Target_ID>
<Target_Name>Tubulin alpha chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>A4ZYP4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Phytophthora capsici:4784</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The recombinant alpha-tubulin protein from P. capsici was purified individually to homogeneity using Ni-NTA sepharose affinity chromatography. Analysis of the purified recombinant protein was confirmed on sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) under reducing condition.</Comments>
</Item><Item><Target_ID> 2082</Target_ID>
<Target_Name>Tubulin beta chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>A4ZYP2</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Phytophthora capsici:4784</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The recombinant beta-tubulin protein from P. capsici was purified individually to homogeneity using Ni-NTA sepharose affinity chromatography. Analysis of the purified recombinant protein was confirmed on sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) under reducing condition.</Comments>
</Item><Item><Target_ID> 2083</Target_ID>
<Target_Name>Lipid A</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Gram-negative bacterial lipopolysaccharides are comprised of an outermost highly variable &quot;O-antigenic&quot; oligosaccharide region, relatively less variable middle core oligosaccharide region, and the most invariant innermost hydrophobicpor tion &quot;lipid A&quot;. Lipid A accounts for all the toxic effects of endotoxin.</Comments>
</Item><Item><Target_ID> 2084</Target_ID>
<Target_Name>B-domain deleted form of human factor VIII (BDDrFVIII)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P00451</Target_Sequence>
<Synonyms>Alternative name(s) for factor VIII:
Antihemophilic factor
AHF
Procoagulant component</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CFG, 1D7P, 1FAC, 1IQD, 2R7E, 3CDZ, 3HNB, 3HNY, 3HOB, 3J2Q, 3J2S, 4BDV, 4KI5, 4PT6, 4XZU, 5K8D</Target_Structure>
<Comments>Recombinant B-domain deleted factor VIII was obtained from Wyeth BioPharma (Andover, MA, USA). For use in phage selection and screens, this material was lightly biotinylated, using NHS-LC-biotin (Pierce No.21335), with no loss of activity.</Comments>
</Item><Item><Target_ID> 2085</Target_ID>
<Target_Name>Aflatoxin nanobody Nb28</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The AFB1-specific nanobody Nb28 was selected from a phage-displayed library of nanobody (Nb).</Comments>
</Item><Item><Target_ID> 2086</Target_ID>
<Target_Name>Human prostate cancer cell line LNCaP</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human prostate cancer cell line LNCaP (RCB2144) was provided by the RIKEN BioResource Research Center (BRC).</Comments>
</Item><Item><Target_ID> 2087</Target_ID>
<Target_Name>Gallium ion</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Gallium ions were applied to the system in form of Ga(NO3)3 diluted to a concentration of 10 mM in the equilibration buffer. Gallium was immobilized at a slower flow rate of 0.34 ml/min for 10 ml through the ion exchanger column.</Comments>
</Item><Item><Target_ID> 2088</Target_ID>
<Target_Name>Human colorectal cancer cell line RKO</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human epithelial colorectal cancer (CRC) cell line RKO (ATCC CRL 2577) was cultured in Dulbecco’s Modified Eagle Medium (DMEM, Biochrom).</Comments>
</Item><Item><Target_ID> 2089</Target_ID>
<Target_Name>Aromatic-L-amino-acid decarboxylase (EC:4.1.1.28), AADC</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20711</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3RBF, 3RBL, 3RCH</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2090</Target_ID>
<Target_Name>D2-MT1-MMP (MT-loop deleted MMP-14)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>MMP-14 alternative name(s):
Matrix metalloproteinase-14
Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1
Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP
MMP-X1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2091</Target_ID>
<Target_Name>Proheparin-binding EGF-like growth factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q99075</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1XDT, 2M8S</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2139</Target_ID>
<Target_Name>Invasive U87MG glioblastoma cell line</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>U87MG cells were separated into U87T and U87R subpopulations using in vivo selection. Invasive U87R cells were as the target.</Comments>
</Item><Item><Target_ID> 2140</Target_ID>
<Target_Name>SUS316L stainless steel</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>SUS316L disks [;10 9 1.0 mm, Rare Metallic Co., Ltd. (Tokyo, Japan)] was polished with a 400-grit metal file. To remove surface contaminants, the disks were ultrasonically cleaned in acetone for 15 min three times, then irradiated using an UV/ozone cleaner for 30 min.</Comments>
</Item><Item><Target_ID> 2141</Target_ID>
<Target_Name>Escherichia coli O157:H7 cells</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli O157:H7:83334</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Escherichia coli O157:H7 (E. coli O157:H7) is the predominant virulent serotype in a pathogenic subset of Enterohemorrhagic E. coli (EHEC), and is especially founded responsible for serious foodborne infection outbreaks. The control of E. coli O157:H7 infection outbreaks requires rapid and sensitive detections of microbial contamination.</Comments>
</Item><Item><Target_ID> 2142</Target_ID>
<Target_Name>Non-structural protein 1, NS1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P29990</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure>2R29,3EVG,6FLA</Target_Structure>
<Comments>DENV NS1 is a multifunctional non-structural protein indispensable for virus production, as a new target for inhibition of DENV infection by specific peptides.NS1 is a key viral protein that is required for both DENV replication and dengue disease pathogenesis. The NS1 protein comprises of 352 amino acid residues that share approximately 70% sequence similarity among all four DENV serotypes and 40–50% sequence similarity to other flaviviruses.</Comments>
</Item><Item><Target_ID> 2138</Target_ID>
<Target_Name>Brain tumor initiating cells (BTICs)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Brain tumor initiating cells (BTICs) were supplied by the BTIC Core Facility housed at the University of Calgary.</Comments>
</Item><Item><Target_ID> 2137</Target_ID>
<Target_Name>Anti-fibronectin-binding protein A (FnBPA) N-terminal A domain (FnBPA-A) polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>New Zealand white rabbits were immunized via multiple subcutaneous injections with 0.5 mg of purified rFnBPA-A protein emulsified with an equal volume of Freund's complete adjuvant (Sigma), followed by boosts with the same dose at 2-week intervals. On the 28th day after primary immunization, the cardiac blood from immunized rabbits was collected, and the immune serum was isolated from coagulated blood. Anti-FnBPA-A antibodies in the immune serum were purified using a HiTrap Protein G HP Column (Pharmacia, Sweden) according to the manufacturer's instructions.</Comments>
</Item><Item><Target_ID> 2135</Target_ID>
<Target_Name>Glass dish</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2136</Target_ID>
<Target_Name>Patients' sera pool containing Alternaria specific IgE (s-IgE)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>We established a patients' sera pool of Alternaria specific IgE (s-IgE) to screen mimotopes matching B cell epitopes on the surface of Alternaria allergens by phage display technology. Thirty patients monosensitized to Alternaria and suffering from allergic rhinitis and/or asthma (s-IgEs to Alternaria ≥ 3.5 KUA/L, ImmunoCAP 250; Thermo Fisher Scientific/Phadia) were selected. Those with positive s-IgEs to other allergens (s-IgE ≥ 0.35 KUA/L), such as pollen, house dust mites, pets, and foods, were excluded from our study. Blood samples were obtained, and then serum was isolated and mixed to establish an Alternaria sera pool. The s-IgE level was measured.</Comments>
</Item><Item><Target_ID> 2134</Target_ID>
<Target_Name>Trans-2-nonenal</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Trans-2-nonenal is a fatty aldehyde with a long-chain, containing nine carbons. It was known that trans-2-nonenal is a cause of the odor associated with aging, and mainly found from the ages of 40 years.</Comments>
</Item><Item><Target_ID> 2133</Target_ID>
<Target_Name>Methyl paraben (MP)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The Methyl paraben (MP) (purity: ≥ 99.0%) were purchased from Sigma–Aldrich (Saint Quentin, Fallaviers, France).</Comments>
</Item><Item><Target_ID> 2131</Target_ID>
<Target_Name>Pancreatic cancer cell line MIA PaCa-2</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2132</Target_ID>
<Target_Name>N-propyl paraben (PP)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The en-propyl paraben (PP) (purity: ≥99.0%) were purchased from Sigma–Aldrich (Saint Quentin, Fallaviers, France).</Comments>
</Item><Item><Target_ID> 2130</Target_ID>
<Target_Name>Cystic fibrosis mucus model</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The cystic fibrosis (CF) mucus model was prepared according to literature reports of composition to model sputum of CF patients. The model is an aqueous mixture of 40 mg/mL mucin from porcine stomach type III (Sigma Aldrich, MO; catalog number M1778), 1.4 mg/mL herring sperm DNA (Promega, WI; catalog number D1811), 5 mg/mL egg yolk from chicken (Sigma Aldrich, MO; catalog number E0625), 0.9 mg/mL lactoferrin human (Sigma Aldrich, MO; catalog number L4040), 5 mg/mL sodium chloride (Thermo Fisher Scientific, MA; catalog number S271-500), and 2.2 mg/ mL potassium chloride (Thermo Fisher Scientific, MA; catalog number P217-500) to give the concentration of ions found in CF sputum. The solution was adjusted with 0.5 M hydrogen chloride (Thermo Fisher Scientific, MA; catalog number AC423795000) to pH 6.5, which is the estimated pH of CF airway mucus. The reagents were transferred to a sterile tube, mixed for 2 h in a tube rotator at 5 rpm (Thermo Fisher Scientific, MA), and used within 4 h.</Comments>
</Item><Item><Target_ID> 2128</Target_ID>
<Target_Name>Human colon cancer cell line HT29</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human colon cancer cells (LoVo, HCT116, HT29, SW480, and DLD-1) and colon fibroblast cells (CCD18Co) were used (ATCC, Manassas, VA).</Comments>
</Item><Item><Target_ID> 2129</Target_ID>
<Target_Name>Human colon cancer cell line LoVo</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9607</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human colon cancer cells (LoVo, HCT116, HT29, SW480, and DLD-1) and colon fibroblast cells (CCD18Co) were used (ATCC, Manassas, VA).</Comments>
</Item><Item><Target_ID> 2123</Target_ID>
<Target_Name>Pt–W Coils</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2124</Target_ID>
<Target_Name>Co–Cr Stents</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2125</Target_ID>
<Target_Name>Interleukin-13 receptor subunit alpha-2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q14627</Target_Sequence>
<Synonyms>IL-13 receptor subunit alpha-2
IL-13R subunit alpha-2
IL-13R-alpha-2
IL-13RA2
Interleukin-13-binding protein
CD213a2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3LB6</Target_Structure>
<Comments>Human recombinant IL‐13Rα2/Fc was purchased from R&amp;D Systems.</Comments>
</Item><Item><Target_ID> 2126</Target_ID>
<Target_Name>Human colon cancer cell line SW480</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human colon cancer cells (LoVo, HCT116, HT29, SW480, and DLD-1) and colon fibroblast cells (CCD18Co) were used (ATCC, Manassas, VA).</Comments>
</Item><Item><Target_ID> 2127</Target_ID>
<Target_Name>Human colon cancer cell line HCT116</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human colon cancer cells (LoVo, HCT116, HT29, SW480, and DLD-1) and colon fibroblast cells (CCD18Co) were used (ATCC, Manassas, VA).</Comments>
</Item><Item><Target_ID> 2122</Target_ID>
<Target_Name>Ni–Ti Stents</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2121</Target_ID>
<Target_Name>Amyloid beta 42, Aβ42</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Plasmid DNA of rAβ42 was provided from the Jang Lab, at Gachon University, South Korea. Amyloid beta 42 (Aβ42) is produced by a sequence of enzymes associated with cleavage of amyloid precursor protein (APP). Among Aβ isoforms, Aβ42, which has 42 amino acid residues, is well-known as the main biomarker of AD. Aβ tends to be highly aggregated and forms Aβ oligomers, fibrils, and plaques in the brain under abnormal conditions.</Comments>
</Item><Item><Target_ID> 2120</Target_ID>
<Target_Name>P. aeruginosa H103 (PAO1 wild-type prototroph)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Pseudomonas aeruginosa:287</Target_Source>
<Target_Structure></Target_Structure>
<Comments>P. aeruginosa H103 (PAO1 wild-type prototroph) and H636 (H103 oprF::Ω), the oprF mutant obtained by homologous recombination with an oprF fragment containing a streptomycin cassette , were kindly provided by R. E. W. Hancock (University of British Columbia, Canada).</Comments>
</Item><Item><Target_ID> 2118</Target_ID>
<Target_Name>Multiple Sclerosis recombinant antibodie B1, MS-B1 (G2-160)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Using laser capture microdissection, we isolated single CD38+ plasma cells from lesion areas in MS brain B: G2, and generated recombinant antibody-MS-B1 (G2-160) from clonally expanded plasma cells.</Comments>
</Item><Item><Target_ID> 2119</Target_ID>
<Target_Name>Multiple Sclerosis recombinant antibodie A2, MS-A2 (ST-196)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Using laser capture microdissection, we isolated single CD38+ plasma cells from lesion areas in MS brain A: ST, and generated recombinant antibody-MS-A2 (ST-196) from clonally expanded plasma cells.</Comments>
</Item><Item><Target_ID> 2117</Target_ID>
<Target_Name>Multiple Sclerosis recombinant antibodie A1, MS-A1 (ST-176)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Using laser capture microdissection, we isolated single CD38+ plasma cells from lesion areas in MS brain A: ST, and generated recombinant antibody-MS-A1 (ST-176) from clonally expanded plasma cells.</Comments>
</Item><Item><Target_ID> 2115</Target_ID>
<Target_Name>Copper (II) oxide nanoparticles, CuO-NPs</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CuO-NPs (under 50 nm) were purchased from Sigma-Aldrich (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2116</Target_ID>
<Target_Name>K-ras(LA2) mutant mouse model of lung cancer</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>K-ras(LA2) mutant mice were provided by the NIH (Bethesda, MD). Although mutations in K-ras(LA2) gene are common in human pancreatic and colon cancers, this K-ras(LA2) transgenic mice show a high incidence of lung cancer, whereas they do not develop pancreatic and colon cancers.</Comments>
</Item><Item><Target_ID> 2113</Target_ID>
<Target_Name>Serum IgG of Systemic lupus erythematosus(SLE) patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>All the SLE patients fulfilled the 1997 American College of Rheumatology classification criteria for SLE . The demographic characteristics of the patients and healthy controls are listed in Tables I, ,II,II, and III in the reference.</Comments>
</Item><Item><Target_ID> 2114</Target_ID>
<Target_Name>ArsS N-terminal (ArsS-N) acid-sensing domain</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Helicobacter pylori (strain J99 / ATCC 700824) (Campylobacter pylori J99):85963</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Using proSite, the functional domains (including the N-terminal acid-sensing domain) of H. pylori J99 ArsS were predicted. And the ArsS gene sequence of the standard H. pylori strain NCTC11637 was compared with those of three strains (HP26695, G27, and J99, details of which are provided in GenBank). The homology with J99 was &gt;98% and the gene similarity was 95%. Therefore, the J99 ArsS amino acid sequence in GenBank, which provides the complete ArsS amino acid sequence, was selected.</Comments>
</Item><Item><Target_ID> 2112</Target_ID>
<Target_Name>Major allergen Can f 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O18873</Target_Sequence>
<Synonyms>Allergen Dog 1
Allergen: Can f 1</Synonyms>
<Target_Source>Canis lupus familiaris (Dog) (Canis familiaris):9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments>We used a recombinant dog allergen Can f 1, a salivary protein present in dog hairs and dander (Konieczny et al. 1997), which is homologous to human tear lipocalin. A codon optimized Can f 1 was synthesized (GenScript, Piscataway, USA), cloned into Qiagen´s pQE70 expression plasmid, produced and purified in M15 E.coli according to the manufacturer´s instruction (QIAexpressionist).</Comments>
</Item><Item><Target_ID> 2111</Target_ID>
<Target_Name>Programmed cell death ligand-1 overexpressing HEK 293T cells</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>PD-L1-overexpressing cells were prepared by transiently transfecting HEK 293T cells with GFP-tagged human PD-L1 plasmid. And the expression of PD-L1 in transfected cells is confirmed by the detection of GFP fluorescence and by Western blot analysis.</Comments>
</Item><Item><Target_ID> 2110</Target_ID>
<Target_Name>19-kDa fragment of Merozoite surface protein 1, MSP-I19</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q2I7E9</Target_Sequence>
<Synonyms>Merozoite surface protein 1,PMMSA</Synonyms>
<Target_Source>Plasmodium knowlesi:5850</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DNA from a clinical specimen with PCR‐confirmed P. knowlesi infection was used as the template for recombinant protein expression study (GenBank accession number: MH433610). Plasmodium knowlesi DNA was extracted from EDTA‐blood using QIAamp® DNA Blood Mini Kit (Hilden, Germany) according to the manufacturer’s protocol. Protein expression was performed using the enzyme‐free protein expression kit Expresso® Solubility and Expression Screening System (Lucigen, USA).</Comments>
</Item><Item><Target_ID> 2109</Target_ID>
<Target_Name>Anti-LDL (−) monoclonal antibody 2C7D5F10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The electronegative low density lipoprotein (LDL (-)) was isolated from human blood plasma and used as an antigen for immunization of Balb/c mice. </Comments>
</Item><Item><Target_ID> 2108</Target_ID>
<Target_Name>Anti-LDL (−) monoclonal antibody 1A3H2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The electronegative low density lipoprotein (LDL (-)) was isolated from human blood plasma and used as an antigen for immunization of Balb/c mice. </Comments>
</Item><Item><Target_ID> 2107</Target_ID>
<Target_Name>Anti-imidacloprid monoclonal antibody 3D11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal cells of imidacloprid were injected into the abdominal cavity of mice to produce ascites, and the monoclonal antibody was purified by the ammonium octanoate precipitation method.</Comments>
</Item><Item><Target_ID> 2106</Target_ID>
<Target_Name>Soluble proteins differentially expressed between the control and dimethylhydrazine treated groups</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Protein extraction for the phage display technique was performed from samples of large intestine tissue from Wistar rats with chemically induced colon-rectal tumors. These tumor tissue samples were donated by Silva et al. and treated as follows. Briefly, 50 mg of the tissue was macerated with liquid nitrogen and suspended in 1 mL of 20 mM Tris–HCl pH 7 buffer, 250 mM sucrose, and protease inhibitor cocktail (PIC). The samples were sonicated and centrifuged at 20,000 ×g, 4°C for 30 min.</Comments>
</Item><Item><Target_ID> 2105</Target_ID>
<Target_Name>AdipoR-12C</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Within the AdipoR C-terminal domain, we identified a 12-amino acid sequence (AdipoR-12C) that is homologous in AdipoR1 (Q96A54) and AdipoR2 (Q86V24), both in humans and mice. AdipoR-12C was synthesized by the PolyPeptide company (Strasbourg, France) and presented the following composition: Cys-8-amino-3,6-dioxanoctanoyl-His-Phe-Tyr-Gly-Val-Ser-Asn-Leu-Gln-Glu-Phe-Arg-CONH2.</Comments>
</Item><Item><Target_ID> 2104</Target_ID>
<Target_Name>Neutrophil gelatinase-associated lipocalin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for AKI diagnosis possibly because of its high selectivity and reliability. Diagnosis based on NGAL level can assist in the early identification of high-risk patients with diabetes and AKI and thereby ensure the early detection of AKI and/or prevention of diabetic nephropathy. In this study, recombinant NGAL was purchased from Randox (Crumlin, UK).</Comments>
</Item><Item><Target_ID> 2103</Target_ID>
<Target_Name>Anti-σA monoclonal antibody 1A7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified His-σA proteins were used as antigen to immunize BALB/C mice and MAbs were developed.</Comments>
</Item><Item><Target_ID> 2099</Target_ID>
<Target_Name>Plasma from 10 Alzheimer's disease patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Pooled plasma samples from 10 Alzheimer's disease (AD) patients (5 male and 5 female) were used for screening. For the positive selection of phages in discovery phase, albumin and IgG in the plasma were removed by using ProteoExtract™ Removal Kit according to its manufacturer’s protocol.</Comments>
</Item><Item><Target_ID> 2100</Target_ID>
<Target_Name>Plasma from 10 healthy persons</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Pooled plasma samples from 10 healthy persons (5 male and 5 female) were used for screening. For the positive selection of phages in discovery phase, albumin and IgG in the plasma were removed by using ProteoExtract™ Removal Kit according to its manufacturer’s protocol.</Comments>
</Item><Item><Target_ID> 2101</Target_ID>
<Target_Name>Lectin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sambucus nigra</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Sambucus nigra lectin (Cat# B-1305) was purchased from Vector Laboratories, Burlingame, CA, USA.</Comments>
</Item><Item><Target_ID> 2102</Target_ID>
<Target_Name>Anti-σA monoclonal antibody 4E2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The purified His-σA proteins were used as antigen to immunize BALB/C mice and MAbs were developed.</Comments>
</Item><Item><Target_ID> 2097</Target_ID>
<Target_Name>Se0 nanoparticle (SeNP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2098</Target_ID>
<Target_Name>Anti-HIV-1 monoclonal antibody Y498</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>we isolated and characterized hmAb Y498, which could neutralize 30% of 70 human immunodeficiency virus (HIV-1) pseudoviruses tested. Three antigenic sites on gp120 were characterized by homology modeling and molecular docking.</Comments>
</Item><Item><Target_ID> 2096</Target_ID>
<Target_Name>Anti-D-antigen monoclonal antibody 1G10</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The mAb 1G10 were produced by immunizing mouse with D-antigen of PV-I Sabin following the classical somatic cell fusion procedure.</Comments>
</Item><Item><Target_ID> 2094</Target_ID>
<Target_Name>Signal transducer and activator of transcription 3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P40763</Target_Sequence>
<Synonyms>Acute-phase response factor</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>5AX3,5U5S,6NJS,6NUQ,6QHD,6TLC</Target_Structure>
<Comments>Signal transducer and activator of transcription 3 is a cytosolic transcription factor involved in a multitude of oncogenic and normal signaling pathways.</Comments>
</Item><Item><Target_ID> 2095</Target_ID>
<Target_Name>Extracellular domain of low-density lipoprotein (LDL) receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P01130[22-788 ]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2DM4,3G2S,3G2T,3WSX,3WSY,3WSZ</Target_Structure>
<Comments>The human LDLR is a transmembrane protein composed of 839 amino acids (Ala22–Ala860), whose N-terminal region spans almost the entire molecule (Ala22–Arg788) and is extracellular. The seven Cys-rich type A repeats (R1–R7) of the extracellular domain are responsible for ligand binding, i.e., ApoB100 and ApoE-comprising lipoprotein particles.</Comments>
</Item><Item><Target_ID> 2093</Target_ID>
<Target_Name>Inflamed central nervous system (CNS) of mice with experimental autoimmune encephalomyelitis (EAE)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2092</Target_ID>
<Target_Name>The catalytic domain of rho-associated protein kinase 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q13464[5-348]</Target_Sequence>
<Synonyms>Renal carcinoma antigen NY-REN-35
Rho-associated, coiled-coil-containing protein kinase 1
Rho-associated, coiled-coil-containing protein kinase I (ROCK-I)
p160 ROCK-1 (p160ROCK)</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5F5P,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W</Target_Structure>
<Comments>ROCKs are down-stream effectors of the small GTP-binding protein, RhoA, and have two isoforms, ROCK1 (p160ROCK, ROKb) and ROCK2 (ROKa). ROCK1 and ROCK2 are highly homologous in their kinase catalytic domain (92% and 65% similarities in their kinase domain and overall sequences, respectively). This serine–threonine kinase is composed of three domains including the N-terminal catalytic domain, a coiled-coil and Rho-binding-binding domain (RBD) and the C-terminal Pleckstrin homology domain (PH domain) that contains an internal cysteine-rich region. ROCK activity is negatively regulated by the PH domain. In the study, the catalytic domain of ROCK1 (5–348) was fused to the maltose-binding protein (MBP) and expressed in baculovirus expression system. The resulted MBP-ROCK1 acted as the bait.</Comments>
</Item><Item><Target_ID> 2143</Target_ID>
<Target_Name>Fibroblast growth factor 9, FGF-9</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P31371</Target_Sequence>
<Synonyms>Glia-activating factor, GAF
Heparin-binding growth factor 9, HBGF-9</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1G82,1IHK,5W59</Target_Structure>
<Comments>Fibroblast growth factor 9 (FGF9) is initially identified as a secreted factor displaying a mitogenic effect on glial cells and subscribed to the FGF family (FGFs) for sharing high homology at the protein level with the previously isolated members of the family. FGFs play important roles in a plethora of physiological and pathological processes, and participate in embryonic development, tissue regeneration, oncogenesis, and tumor progress. The recombinant human FGF9 in this study was obtained from PeproTech (Rocky Hill, NJ, USA).</Comments>
</Item><Item><Target_ID> 2144</Target_ID>
<Target_Name>Sera from 30 Systemic lupus erythematosus (SLE) patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum pools were obtained from 30 HCs and 30 SLE patients. Blood samples were collected in venous blood collection tubes with clot activator and gel for serum separation and centrifuged at 4,000rpm for 10 min. All sera were filtered with microcell filters (&lt;0.22 μm) to eliminate red blood cell fragments and bacteria, and frozen at -80°C immediately. Samples were centrifuged and aliquoted within 48 h.</Comments>
</Item><Item><Target_ID> 2145</Target_ID>
<Target_Name>Anti-epstein-barr virus (EBV) multiple sclerosis(MS) brain IgG antibodies (MS 95–2)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Multiple sclerosis (MS) brain IgG antibodies (MS 95–2) used for panning random peptide libraries were purified from a postmortem brain plaque-periplaque white matter of an acute MS patient.</Comments>
</Item><Item><Target_ID> 2146</Target_ID>
<Target_Name>Recombinant envelope (E) protein E-TrX</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Japanese Encephalitis virus(JEV) strain GIII N28</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The gene encoding the residue 1–400 amino acids of JEV strain GIII N28 envelope (E) protein was amplified by PCR and subcloned into the plasmid pET-32a (+) (Novagen).</Comments>
</Item><Item><Target_ID> 2147</Target_ID>
<Target_Name>Recombinant envelope (E) protein TrX</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Japanese Encephalitis virus(JEV) strain GIII N28</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The gene encoding the residue 1–400 amino acids of JEV strain GIII N28 envelope (E) protein was amplified by PCR and subcloned into the plasmid pET-32a (+) (Novagen).</Comments>
</Item><Item><Target_ID> 2148</Target_ID>
<Target_Name>C57bl/6 mice heart</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Spinal cord, brain, and cardiac tissue of C57bl/6 mice was harvested for subsequent screens.</Comments>
</Item><Item><Target_ID> 2149</Target_ID>
<Target_Name>C57bl/6 mice brain</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Spinal cord, brain, and cardiac tissue of C57bl/6 mice was harvested for subsequent screens.</Comments>
</Item><Item><Target_ID> 2150</Target_ID>
<Target_Name>C57bl/6 mice spinal cord</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Spinal cord, brain, and cardiac tissue of C57bl/6 mice was harvested for subsequent screens.</Comments>
</Item><Item><Target_ID> 2151</Target_ID>
<Target_Name>Tobacco Etch Virus protease (TEV protease)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Tobacco etch virus (TEV):12227</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2152</Target_ID>
<Target_Name>Histone deacetylase 8, HD8</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>HD8 is a Zn2+-dependent histone deacetylase that has been implicated as a therapeutic target in various diseases including cancer, X-linked intellectual disability, and parasitic infections.</Comments>
</Item><Item><Target_ID> 2153</Target_ID>
<Target_Name>C-terminal domain of CCN family member 2 </Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P29279</Target_Sequence>
<Synonyms>Cellular communication network factor
Connective tissue growth factor
Hypertrophic chondrocyte-specific protein 24
Insulin-like growth factor-binding protein 8
IBP-8
IGF-binding protein 8
IGFBP-8</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The recombinant fusion protein of CTGF/C and pKW-CTGF was prepared in the authors' laboratory. CTGF/C was purchased from PeproTech.</Comments>
</Item><Item><Target_ID> 2154</Target_ID>
<Target_Name>Anti-F1 capsular antigen monoclonal antibody (YPF19) and human sera pool IgG of Alzheimer’s disease (AD) patients</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090
Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>As a source of antibodies directed against possible conformational epitopes of human polymorphic β-amyloid 1−42 (Aβ1−42), it was decided to use a pool of 5 human sera from patients with AD (IgGAD) (mean age of 77.4 years, mean value of MMSE = 15.2). On the other hand, the monoclonal antibody YPF19 (AbDSerotec A Bio-Rad Company, IgG1-9820-5007) anti-Yersinia pestis F1 (reacting to Y. pestis F1 capsular antigen, Uniprot code P26948) was used to screen for putative conformational mimotopes homologous to Caf1 of Yersinia pestis.</Comments>
</Item><Item><Target_ID> 2155</Target_ID>
<Target_Name>Fab A</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fab A was purchased from NovoNordisk.</Comments>
</Item><Item><Target_ID> 2156</Target_ID>
<Target_Name>Fab A,Fab Z and Fab D</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fab A and Fab D were from NovoNordisk, and cell stock of Fab Z was kindly donated by Prof. P. Tessier.</Comments>
</Item><Item><Target_ID> 2157</Target_ID>
<Target_Name>Copper ion, Cu(2+)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2158</Target_ID>
<Target_Name>Cowpea mosaic virus, CPMV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Cowpea mosaic virus (strain SB) (CPMV):928299</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Cowpea mosaic virus (CPMV) was produced in Vigna unguiculata plants by infecting each primary leave with 4 μg of CPMV via mechanical inoculation (4 μg of CPMV was added per leaf in 40 μL of 0.1 M potassium phosphate buffer (pH 7.0) after leaves were dusted with carborundum). </Comments>
</Item><Item><Target_ID> 2159</Target_ID>
<Target_Name>Purified serum IgG from human T-lymphotropic virus 1 (HTLV-1) infected people</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples were taken from people living with human T-lymphotropic virus 1 (HTLV-1) from the Clinic of Infectious Diseases (Tropical Diseases) of the Center for Tropical Medicine, Institute of Health Sciences, Federal University of Pará (Universidade Federal do Pará).</Comments>
</Item><Item><Target_ID> 2160</Target_ID>
<Target_Name>Ovomucoid</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01005</Target_Sequence>
<Synonyms>Allergen Gal d I</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Ovomucoid purified from chicken egg white was obtained from Sigma-Aldrich (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2161</Target_ID>
<Target_Name>Microcentrifuge tube (polypropylene, PP)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2162</Target_ID>
<Target_Name>Boiled Daphnia magna asexual egg</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Daphnia magna:35525</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2163</Target_ID>
<Target_Name>Daphnia magna asexual egg</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Daphnia magna:35525</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2164</Target_ID>
<Target_Name>Prostate specific antigen (PSA(-/lo)) human prostate cancer cell line LNCaP</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2165</Target_ID>
<Target_Name>Human embryonic kidney cells 293 (HEK293 cells) transfected with free fatty acid receptor 1 (FFAR1)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>HEK293 cells were seeded in a 6-well plate at a density of 4.0e5 cells/well and incubated overnight. Expression vectors (pCAGGS/FFAR1) was kindly provided by Dr. Inoue (Tohoku University) and used for transfection. A mixture of 2.5 μg FFAR1 per well in 6-well plates was transfected using Lipofectamine 3000 reagent (L3000-008, Thermo Fisher Scientific, Waltham, MA, USA).</Comments>
</Item><Item><Target_ID> 2166</Target_ID>
<Target_Name>Interleukin-33 (IL-33) </Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>O95760[117-270]</Target_Sequence>
<Synonyms>Interleukin-1 family member 11 (IL-1F11)
Nuclear factor from high endothelial venules (NF-HEV)
IL-33</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2KLL,4KC3</Target_Structure>
<Comments>Interleukin-33 (IL-33) signaling occurs through a receptor complex of IL-1 receptor-like 1 (ST2) and plays an important role in allergy-causing inflammatory diseases by activating biological reactions via the interaction of IL-33 with the IL-33 receptor. IL-33, a member of the IL-1 cytokine family, is not only an intracellular nuclear factor but also an extracellular cytokine and it is expressed in various cell types, including epithelial cells, endothelial cells, mast cells, macrophages, fibroblasts, osteoclasts, and dendritic cells.</Comments>
</Item><Item><Target_ID> 2167</Target_ID>
<Target_Name>Surfaces of crystalline gypsum</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2168</Target_ID>
<Target_Name>Amyloid β peptide (Aβ) (M1-40) monomer, Aβ40 monomer</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Aβ was short for amyloid β peptide. Aβ(M1-40) with the sequence MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV, here called Aβ40, was recombinantly expressed. Purified aliquots of Aβ40 were separately dissolved in 1 mL 6M GuHCl and monomers were isolated using size exclusion chromatography on a 10/300 Superdex 75 column (GE Healthcare) in 20 mM sodium phosphate, 0.2 mM EDTA, pH 8.0 (Aβ42) or pH 7.4 (Aβ40), in low-binding tubes (Axygen) on ice. The peptide concentration was determined by the integrated absorbance of the collected fraction.</Comments>
</Item><Item><Target_ID> 2169</Target_ID>
<Target_Name>Amyloid β peptide (Aβ) (M1-40) fibril, Aβ40 fibril</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Aβ was short for amyloid β peptide. Aβ(M1-40) with the sequence MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV, here called Aβ40, was recombinantly expressed.. Purified aliquots of Aβ40 were separately dissolved in 1 mL 6M GuHCl and monomers were isolated using size exclusion chromatography on a 10/300 Superdex 75 column (GE Healthcare) in 20 mM sodium phosphate, 0.2 mM EDTA, pH 8.0 (Aβ42) or pH 7.4 (Aβ40), in low-binding tubes (Axygen) on ice. Fibrils were prepared from the monomer solutions at quiescent condition at 37 °C in multiple wells of a PEG-ylated polystyrene 96-well plate (Corning 3881) with ThT in some wells. The ThT fluorescence was monitored through the bottom of the plate using a BMG Optima plate reader with excitation at 440 nM and emission at 480 nM until reaching the ThT plateau. Fibrils were collected from wells without ThT.</Comments>
</Item><Item><Target_ID> 2170</Target_ID>
<Target_Name>Amyloid β peptide (Aβ) (M1-42) monomer, Aβ42 monomer</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Aβ was short for amyloid β peptide. Aβ(M1-42) with the sequence MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA, here called Aβ42, was recombinantly expressed. Purified aliquots of Aβ42 were separately dissolved in 1 mL 6M GuHCl and monomers were isolated using size exclusion chromatography on a 10/300 Superdex 75 column (GE Healthcare) in 20 mM sodium phosphate, 0.2 mM EDTA, pH 8.0 (Aβ42) or pH 7.4 (Aβ40), in low-binding tubes (Axygen) on ice.</Comments>
</Item><Item><Target_ID> 2171</Target_ID>
<Target_Name>Amyloid β peptide (Aβ) (M1-42) fibril, Aβ42 fibril</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Aβ was short for amyloid β peptide. Aβ(M1-42) with the sequence MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA, here called Aβ42, was recombinantly expressed. Purified aliquots of Aβ42 were separately dissolved in 1 mL 6M GuHCl and monomers were isolated using size exclusion chromatography on a 10/300 Superdex 75 column (GE Healthcare) in 20 mM sodium phosphate, 0.2 mM EDTA, pH 8.0 (Aβ42) or pH 7.4 (Aβ40), in low-binding tubes (Axygen) on ice. Fibrils were prepared from the monomer solutions at quiescent condition at 37 °C in multiple wells of a PEG-ylated polystyrene 96-well plate (Corning 3881) with ThT in some wells. The ThT fluorescence was monitored through the bottom of the plate using a BMG Optima plate reader with excitation at 440 nM and emission at 480 nM until reaching the ThT plateau. Fibrils were collected from wells without ThT.</Comments>
</Item><Item><Target_ID> 2172</Target_ID>
<Target_Name>Caspase-3, CASP-3</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P42574</Target_Sequence>
<Synonyms>Apopain
Cysteine protease CPP32 (CPP-32)
Protein Yama
SREBP cleavage activity 1 (SCA-1)</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CP3,1GFW,1I3O,1NME,1NMQ,1NMS,1PAU,1QX3,1RE1,1RHJ,1RHK,1RHM1RHQ,1RHR,1RHU,2C1E,2C2K,2C2M,2C2O,2CDR,2CJX,2CJY,2CNK,2CNL,2CNN,2CNO,2DKO,2H5I,2H5J,2H65,2J30,2J31,2J32,2J33,2XYG,2XYP,2XYH,2XZD,2XZT,2Y0B,3DEH,3DEI,3DEJ,3DEK,3EDQ,3GJQ,3GJR,3GJS,3GJT,3H0E,3ITN,3KJF,3PCX,3PD0,3PD1,4DCJ,4DCO,4DCP,4EHA,4EHD,4EHF,4EHH,4EHK,4EHL,4EHN,4JJE,4JQY,4JQZ,4JR0,4PRY,4PS0,4QTX,4QTY,4QU0,4QU5,4QU8,4QU9,4QUA,4QUB,4QUD,4QUE,4QUG,4QUH,4QUI,4QUJ,4QUL,5I9B,5I9T,5IAB,5IAE,5IAG,5IAJ,5IAK,5IAN,5IAR,5IAS,5IBC,5IBP,5IBR,5IC4,7XN4,7XN5,7XN6</Target_Structure>
<Comments>Caspase-3, a cysteine-dependent protease, is considered a reliable molecular biomarker for the diagnosis and prognosis of apoptosis-related diseases.</Comments>
</Item><Item><Target_ID> 2173</Target_ID>
<Target_Name>M2 macrophages</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Monocytes were isolated from peripheral blood mononuclear cells (PBMCs) using plastic adherence. PBMCs were purified from healthy donor buffy coats by density gradient centrifugation. To generate M1 macrophages, isolated monocytes were cultured in serum free X-vivo 15 medium (Lonza, Basel, Switzerland, Cat#BE02-060Q) supplemented with antibiotics, whereas complete RPMI medium was used for M2 macrophages. M1 and M2 macrophages were firstly primed by 50 ng/mL GM-CSF (Biotechne, R&amp;D systems, Santa Clara, CA, USA, Cat#215-GM-010) and 50 ng/mL M-CSF (Biotechne, R&amp;D systems, Cat#216-MC-035) for 4–6 days, respectively. Thereafter, the cells were cultured for additional two days in the presence of 50 ng/mL LPS and 100 U/mL IFN-gamma (M1) or 50 ng/mL IL-4 (Biotechne, R&amp;D systems, Cat#204-IL/CF) and 1 ng/mL IL-10 (Biotechne, R&amp;D systems, Cat#217-IL) (M2). Under these conditions, the cells displayed the morphological characteristics of M1 or M2 macrophages.</Comments>
</Item><Item><Target_ID> 2174</Target_ID>
<Target_Name>Immunomodulatory protein Ling Zhi-8, LZ-8</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P14945</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Ganoderma lucidum (Ling zhi medicinal fungus) (Bracket fungus):5315</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Studies have shown that LZ-8 can not only promote the proliferation of lymphocytes cells and affect the expression of cytokines, but also directly enter tumor cells and affect their physiological activities by regulating the expression of tumor genes, thereby killing tumor cells without damaging normal cells. </Comments>
</Item><Item><Target_ID> 2175</Target_ID>
<Target_Name>Klebsiella pneumoniae KCTC 2208 cell</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Klebsiella pneumoniae KCTC 2208</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2176</Target_ID>
<Target_Name>Pseudomonas aeruginosa ATCC 27853</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Pseudomonas aeruginosa ATCC 27853</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Pseudomonas aeruginosa ATCC 27853 was provided by Department of Allied Health Sciences, Faculty of Science, Universiti Tunku Abdul Rahman.</Comments>
</Item><Item><Target_ID> 2177</Target_ID>
<Target_Name>Anti-mycophenolic acid (MPA) antibody fragment (Fab), anti-MPA Fab</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The recombinant anti-MPA Fab was obtained from a phage display library.</Comments>
</Item><Item><Target_ID> 2178</Target_ID>
<Target_Name>Human lens capsules from patients with exfoliation syndrome (XFS) </Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2179</Target_ID>
<Target_Name>Aminopeptidase Ey</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O57579</Target_Sequence>
<Synonyms>Aminopeptidase N</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2180</Target_ID>
<Target_Name>Graphene paper, GP</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Graphene paper (GP), a macroscopic self-supporting material, has exceptional flexibility and preserves the excellent physical and chemical properties of graphene nanomaterials.</Comments>
</Item><Item><Target_ID> 2181</Target_ID>
<Target_Name>Nucleoprotein, N</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0DTC9</Target_Sequence>
<Synonyms>Nucleocapsid protein</Synonyms>
<Target_Source>Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2):2697049</Target_Source>
<Target_Structure>6M3M, 6VYO, 6WJI, 6WKP, 6WZO, 6WZQ, 6YI3, 6YUN, 6ZCO, 7ACS, 7ACT, 7C22, 7CDZ, 7CE0, 7CR5, 7DE1, 7F2B, 7F2E, 7KGO, 7KGP, 7KGQ, 7KGR, 7KGS, 7KGT, 7LGD, 7LTU, 7LUX, 7LUZ, 7LV2, 7N0I, 7N0R, 7N3C, 7N3D, 7O05, 7O35, 7O36, 7PKU, 7QIK, 7QIP, 7R98, 7SD4, 7STR, 7STS, 7SUE, 7SUO, 7UW3, 7UXX, 7UXZ, 7VBD, 7VBE, 7VBF, 7VNU, 7WKJ, 7WZO, 7XWX, 7XWZ, 7XX1, 7XXK, 7ZIT, 8FD5, 8FG2</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2182</Target_ID>
<Target_Name>Anti-infectious bronchitis virus (IBV) M41 strain S1 protein monoclonal antibody 3D9</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The monoclonal antibody named 3D9 was prepared by hybridoma cell technology and confirmed by IPMA to recognize the IBV M41 strain.</Comments>
</Item><Item><Target_ID> 2183</Target_ID>
<Target_Name>Spike protein S1 of spike glycoprotein </Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0DTC2[14-685]</Target_Sequence>
<Synonyms>Alternative names for spike glycoprotein:
S glycoprotein
E2
Peplomer protein</Synonyms>
<Target_Source>Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2): 2697049</Target_Source>
<Target_Structure>6LVN, 6LXT, 6LZG, 6M0J, 6M17, 6M1V, 6VSB, 6VW1, 6VXX, 6VYB, 6W41, 6WPS, 6WPT, 6X29, 6X2A, 6X2B, 6X2C, 6X45, 6X6P, 6X79, 6XC2, 6XC3, 6XC4, 6XC7, 6XCM, 6XCN, 6XDG, 6XE1, 6XEY, 6XF5, 6XF6, 6XKL, 6XKP, 6XKQ, 6XLU, 6XM0, 6XM3, 6XM4, 6XM5, 6XR8, 6XRA, 6XS6, 6YLA, 6YM0, 6YOR, 6YZ5, 6YZ7, 6Z2M, 6Z43, 6Z97, 6ZB4, 6ZB5, 6ZBP, 6ZCZ, 6ZDG, 6ZDH, 6ZER, 6ZFO, 6ZGE, 6ZGG, 6ZGI, 6ZH9, 6ZHD, 6ZLR, 6ZOW, 6ZOX, 6ZOY, 6ZOZ, 6ZP0, 6ZP1, 6ZP2, 6ZP5, 6ZP7, 6ZWV, 6ZXN, 7A25, 7A29, 7A4N, 7A5R, 7A5S, 7A91, 7A92, 7A93, 7A94, 7A95, 7A96, 7A97, 7A98, 7AD1, 7AKD, 7B0B, 7B14, 7B17, 7B18, 7B3O, 7B62, 7BEH, 7BEI, 7BEJ, 7BEK, 7BEL, 7BEM, 7BEN, 7BEO, 7BEP, 7BH9, 7BNM, 7BNN, 7BNO, 7BNV, 7BWJ, 7BYR, 7BZ5, 7C01, 7C2L, 7C53, 7C8D, 7C8J, 7C8V, 7C8W, 7CAB, 7CAC, 7CAH, 7CAI, 7CAK, 7CAN, 7CDI, 7CDJ, 7CH4, 7CH5, 7CHB, 7CHC, 7CHE, 7CHF, 7CHH, 7CHO, 7CHP, 7CHS, 7CJF, 7CM4, 7CN4, 7CN9, 7CT5, 7CWL, 7CWM, 7CWN, 7CWO, 7CWS, 7CWT, 7CWU, 7CYH, 7CYP, 7CYV, 7CZP, 7CZQ, 7CZR, 7CZS, 7CZT, 7CZU, 7CZV, 7CZW, 7CZX, 7CZY, 7CZZ, 7D00, 7D03, 7D0B, 7D0C, 7D0D, 7D2Z, 7D30, 7D4G, 7D6I, 7DCC, 7DCX, 7DD2, 7DD8, 7DDD, 7DDN, 7DEO, 7DET, 7DEU, 7DF3, 7DF4, 7DHX, 7DJZ, 7DK0, 7DK2, 7DK3, 7DK4, 7DK5, 7DK6, 7DK7, 7DMU, 7DPM, 7DQA, 7DWX, 7DWY, 7DWZ, 7DX0, 7DX1, 7DX2, 7DX3, 7DX4, 7DX5, 7DX6, 7DX7, 7DX8, 7DX9, 7DZW, 7DZX, 7DZY, 7.00E+23, 7.00E+39, 7E3B, 7E3C, 7E3J, 7E3K, 7E3L, 7E3O, 7E5O, 7E5R, 7E5S, 7E5Y, 7E7B, 7E7D, 7E7X, 7E7Y, 7.00E+86, 7.00E+88, 7E8C, 7E8F, 7E8M, 7E9N, 7E9O, 7E9P, 7E9Q, 7E9T, 7EAM, 7EAN, 7EAZ, 7EB0, 7EB3, 7EB4, 7EB5, 7EDF, 7EDG, 7EDH, 7EDI, 7EDJ, 7EFP, 7EFR, 7EH5, 7EJ4, 7EJ5, 7EJL, 7EJY, 7EJZ, 7EK0, 7EK6, 7EKC, 7EKE, 7EKF, 7EKG, 7EKH, 7ENF, 7ENG, 7EPX, 7EU2, 7EY0, 7EY4, 7EY5, 7EYA, 7EZV, 7F0X, 7F12, 7F15, 7F3Q, 7F46, 7F4W, 7F5G, 7F5H, 7F5R, 7F62, 7F63, 7F6Y, 7F6Z, 7F7E, 7F7H, 7FAE, 7FAF, 7FAT, 7FAU, 7FB0, 7FB1, 7FB3, 7FB4, 7FBJ, 7FBK, 7FC5, 7FCD, 7FCE, 7FCP, 7FCQ, 7FDG, 7FDH, 7FDI, 7FDK, 7FEM, 7FET, 7FG2, 7FG3, 7FG7, 7FH0, 7FJC, 7FJN, 7FJO, 7FJS, 7JJC, 7JJI, 7JJJ, 7JMO, 7JMP, 7JMW, 7JV2, 7JV4, 7JV6, 7JVA, 7JVB, 7JVC, 7JW0, 7JWB, 7JWY, 7JX3, 7JZL, 7JZM, 7JZN, 7JZU, 7K43, 7K45, 7K4N, 7K8M, 7K8S, 7K8T, 7K8U, 7K8V, 7K8W, 7K8X, 7K8Y, 7K8Z, 7K90, 7K9H, 7K9I, 7K9J, 7K9K, 7K9Z, 7KDG, 7KDH, 7KDI, 7KDJ, 7KDK, 7KDL, 7KE4, 7KE6, 7KE7, 7KE8, 7KE9, 7KEA, 7KEB, 7KEC, 7KFV, 7KFW, 7KFX, 7KFY, 7KGJ, 7KGK, 7KJ2, 7KJ3, 7KJ4, 7KJ5, 7KKK, 7KKL, 7KL9, 7KLG, 7KLH, 7KLW, 7KM5, 7KMB, 7KMG, 7KMH, 7KMI, 7KMK, 7KML, 7KMS, 7KMZ, 7KN3, 7KN4, 7KN5, 7KN6, 7KN7, 7KNB, 7KNE, 7KNH, 7KNI, 7KQB, 7KQE, 7KRQ, 7KRR, 7KRS, 7KS9, 7KSG, 7KXJ, 7KXK, 7KZB, 7L02, 7L06, 7L09, 7L0N, 7L2C, 7L2D, 7L2E, 7L2F, 7L3N, 7L4Z, 7L56, 7L57, 7L58, 7L5B, 7L7D, 7L7E, 7L7F, 7L7K, 7LAA, 7LAB, 7LC8, 7LCN, 7LD1, 7LDJ, 7LJR, 7LM8, 7LO4, 7LOP, 7LQ7, 7LQV, 7LQW, 7LRS, 7LRT, 7LS9, 7LSS, 7LWI, 7LWJ, 7LWK, 7LWL, 7LWM, 7LWN, 7LWO, 7LWP, 7LWQ, 7LWS, 7LWT, 7LWU, 7LWV, 7LWW, 7LX5, 7LXW, 7LXX, 7LXY, 7LXZ, 7LY0, 7LY2, 7LY3, 7LYK, 7LYL, 7LYM, 7LYN, 7LYO, 7LYP, 7LYQ, 7M0J, 7M3I, 7M42, 7M53, 7M6D, 7M6E, 7M6F, 7M6G, 7M6H, 7M6I, 7M71, 7M7B, 7M7W, 7M8J, 7M8K, 7M8S, 7M8T, 7M8U, 7MDW, 7ME7, 7MEJ, 7MF1, 7MFU, 7MJG, 7MJH, 7MJI, 7MJJ, 7MJK, 7MJL, 7MJM, 7MJN, 7MKB, 7MKL, 7MKM, 7MLZ, 7MM0, 7MMO, 7MSQ, 7MTC, 7MTD, 7MTE, 7MW2, 7MW3, 7MW4, 7MW5, 7MW6, 7MXP, 7MY2, 7MY3, 7MY8, 7MZF, 7MZG, 7MZH, 7MZI, 7MZJ, 7MZK, 7MZL, 7MZM, 7MZN, 7N0G, 7N0H, 7N1A, 7N1B, 7N1E, 7N1F, 7N1Q, 7N1T, 7N1U, 7N1V, 7N1W, 7N1X, 7N1Y, 7N3I, 7N4I, 7N4J, 7N4L, 7N4M, 7N5H, 7N62, 7N64, 7N6D, 7N6E, 7N8H, 7N8I, 7N9A, 7N9B, 7N9C, 7N9E, 7N9T, 7NAB, 7ND3, 7ND4, 7ND5, 7ND6, 7ND7, 7ND8, 7ND9, 7NDA, 7NDB, 7NDC, 7NDD, 7NEG, 7NEH, 7NKT, 7NLL, 7NP1, 7NS6, 7NT9, 7NTA, 7NTC, 7NX6, 7NX7, 7NX8, 7NX9, 7NXA, 7NXB, 7NXC, 7NY5, 7OAN, 7OAO, 7OAP, 7OAQ, 7OAU, 7OAY, 7OD3, 7ODL, 7OLZ, 7OR9, 7ORA, 7ORB, 7OWX, 7P19, 7P3D, 7P3E, 7P40, 7P5G, 7P5Q, 7P5S, 7P77, 7P78, 7P79, 7P7A, 7P7B, 7PBE, 7PHG, 7PKI, 7PQY, 7PQZ, 7PR0, 7PRY, 7PRZ, 7PS0, 7PS1, 7PS2, 7PS4, 7PS5, 7PS6, 7PS7, 7Q0A, 7Q0G, 7Q0H, 7Q0I, 7Q1Z, 7Q6E, 7Q9F, 7Q9G, 7Q9I, 7Q9J, 7Q9K, 7Q9M, 7Q9P, 7QDG, 7QDH, 7QEZ, 7QF0, 7QF1, 7QNW, 7QNX, 7QNY, 7QO7, 7QO9, 7QTI, 7QUR, 7QUS, 7R0Z, 7R10, 7R11, 7R12, 7R13, 7R14, 7R15, 7R16, 7R17, 7R18, 7R19, 7R1A, 7R1B, 7R40, 7R4I, 7R4Q, 7R4R, 7R6W, 7R6X, 7R7N, 7R8L, 7R8M, 7R8N, 7R8O, 7R95, 7RA8, 7RAL, 7RAQ, 7RBU, 7RBV, 7RBY, 7RKU, 7RKV, 7RNJ, 7RPV, 7RQ6, 7RR0, 7RTD, 7RTR, 7RU1, 7RU2, 7RU3, 7RU4, 7RU5, 7RU8, 7RW2, 7RXD, 7RZQ, 7RZR, 7RZS, 7RZT, 7RZU, 7RZV, 7S0B, 7S0C, 7S0D, 7S0E, 7S3N, 7S4S, 7S5P, 7S5Q, 7S5R, 7S6I, 7S6J, 7S6K, 7S6L, 7S83, 7SA2, 7SBK, 7SBL, 7SBO, 7SBP, 7SBQ, 7SBR, 7SBS, 7SBT, 7SBU, 7SC1, 7SD5, 7SI2, 7SIS, 7SIX, 7SJ0, 7SJS, 7SKZ, 7SL5, 7SN0, 7SN2, 7SN3, 7SO9, 7SOA, 7SOB, 7SOC, 7SOD, 7SOE, 7SOF, 7SPO, 7SPP, 7SWN, 7SWO, 7SWP, 7SWW, 7SWX, 7SXR, 7SXS, 7SXT, 7SXU, 7SXV, 7SXW, 7SXX, 7SXY, 7SXZ, 7SY0, 7SY1, 7SY2, 7SY3, 7SY4, 7SY5, 7SY6, 7SY7, 7SY8, 7T01, 7T3M, 7T67, 7T72, 7T7B, 7T9J, 7T9K, 7T9L, 7TAS, 7TAT, 7TB8, 7TBF, 7TC9, 7TCA, 7TCC, 7TCQ, 7TE1, 7TEW, 7TEX, 7TEY, 7TEZ, 7TF0, 7TF1, 7TF2, 7TF3, 7TF4, 7TF5, 7TGE, 7TGW, 7TGX, 7TGY, 7THE, 7THK, 7THT, 7TIK, 7TLA, 7TLB, 7TLC, 7TLD, 7TLT, 7TN0, 7TOU, 7TOV, 7TOW, 7TOX, 7TOY, 7TOZ, 7TP0, 7TP1, 7TP2, 7TP3, 7TP4, 7TP7, 7TP8, 7TP9, 7TPA, 7TPC, 7TPE, 7TPF, 7TPH, 7TPK, 7TPL, 7TPR, 7TYZ, 7TZ0, 7U0D, 7U0P, 7U0Q, 7U0X, 7U1R, 7U2D, 7U2E, 7U8E, 7U9O, 7U9P, 7UAP, 7UAQ, 7UAR, 7UB0, 7UB5, 7UB6, 7UHB, 7UHC, 7UL0, 7UL1, 7UOW, 7UPW, 7UPX, 7UPY, 7URQ, 7URS, 7UZ4, 7UZ5, 7UZ6, 7UZ7, 7UZ9, 7UZA, 7UZB, 7UZC, 7UZD, 7V20, 7V22, 7V23, 7V24, 7V26, 7V27, 7V2A, 7V76, 7V77, 7V78, 7V79, 7V7A, 7V7D, 7V7E, 7V7F, 7V7G, 7V7H, 7V7I, 7V7J, 7V7N, 7V7O, 7V7P, 7V7Q, 7V7R, 7V7S, 7V7T, 7V7U, 7V7V, 7V7Z, 7V80, 7V81, 7V82, 7V83, 7V84, 7V85, 7V86, 7V87, 7V88, 7V89, 7V8A, 7V8B, 7V8C, 7VHH, 7VHJ, 7VHK, 7VHL, 7VHM, 7VHN, 7VMU, 7VNB, 7VNC, 7VND, 7VNE, 7VOA, 7VQ0, 7VRV, 7VRW, 7VX1, 7VX4, 7VX5, 7VX9, 7VXA, 7VXB, 7VXC, 7VXD, 7VXE, 7VXF, 7VXI, 7VXK, 7VXM, 7VYR, 7W1S, 7W6U, 7W8S, 7W92, 7W94, 7W98, 7W99, 7W9B, 7W9C, 7W9E, 7W9F, 7W9I, 7WA1, 7WBH, 7WBL, 7WBP, 7WBQ, 7WBZ, 7WCD, 7WCR, 7WCZ, 7WD0, 7WD1, 7WD2, 7WD7, 7WD8, 7WD9, 7WDF, 7WED, 7WEF, 7WEV, 7WG7, 7WG8, 7WG9, 7WGB, 7WGC, 7WGV, 7WGX, 7WGY, 7WGZ, 7WH8, 7WHB, 7WHD, 7WHH, 7WHJ, 7WHZ, 7WI0, 7WK0, 7WK2, 7WK3, 7WK8, 7WK9, 7WKA, 7WLC, 7WN2, 7WNB, 7WNM, 7WO4, 7WO5, 7WO7, 7WOA, 7WOB, 7WOC, 7WOG, 7WON, 7WOP, 7WP0, 7WP1, 7WP2, 7WP5, 7WP6, 7WP8, 7WPH, 7WQV, 7WR8, 7WRJ, 7WRL, 7WRO, 7WRY, 7WRZ, 7WS0, 7WS1, 7WS2, 7WS3, 7WS6, 7WS7, 7WSA, 7WSC, 7WSE, 7WSH, 7WSK, 7WTG, 7WTH, 7WTJ, 7WUE, 7WUH, 7WVL, 7WVN, 7WVO, 7WVP, 7WVQ, 7WWK, 7WWL, 7WWM, 7WZ1, 7WZ2, 7X08, 7X1M, 7X2H, 7X2K, 7X2L, 7X2M, 7X63, 7X66, 7X6A, 7X7D, 7X7E, 7X7N, 7X7O, 7X7T, 7X7U, 7X8W, 7X8Y, 7X8Z, 7X90, 7X91, 7X92, 7X93, 7X94, 7X95, 7X96, 7X9E, 7XA7, 7XAZ, 7XB0, 7XB1, 7XBY, 7XCI, 7XCK, 7XCP, 7XCZ, 7XDA, 7XDK, 7XDL, 7XIK, 7XIL, 7XIW, 7XIX, 7XIY, 7XIZ, 7XJ9, 7XMX, 7XMZ, 7XNQ, 7XNR, 7XNS, 7XO7, 7XO8, 7XO9, 7XOA, 7XOB, 7XOC, 7XOD, 7XRP, 7XS8, 7XSA, 7XSB, 7XSC, 7XST, 7XTZ, 7XU0, 7XU1, 7XU2, 7XU3, 7XU4, 7XU5, 7XU6, 7XWA, 7XXL, 7Y0C, 7Y0V, 7Y0W, 7Y42, 7Y75, 7Y76, 7Y7J, 7Y7K, 7YA1, 7YAD, 7YCK, 7YCL, 7YCN, 7YDI, 7YDY, 7YE5, 7YE9, 7YEG, 7YOW, 7YQT, 7YQU, 7YQV, 7YQW, 7YQX, 7YQY, 7YQZ, 7YR0, 7YR1, 7YR2, 7YR3, 7YUE, 7Z0X, 7Z0Y, 7Z1A, 7Z1B, 7Z1C, 7Z1D, 7Z1E, 7Z3Z, 7Z6V, 7Z7X, 7Z85, 7Z86, 7Z9Q, 7Z9R, 7ZBU, 7ZCE, 7ZCF, 7ZDQ, 7ZF3, 7ZF4, 7ZF5, 7ZF7, 7ZF8, 7ZF9, 7ZFA, 7ZFB, 7ZFC, 7ZFD, 7ZFE, 7ZJL, 7ZR2, 7ZR7, 7ZR8, 7ZR9, 7ZRC, 7ZRV, 7ZSD, 7ZSS, 7ZXU, 8A94, 8A96, 8A99, 8AQS, 8AQT, 8AQU, 8AQV, 8AQW, 8ASY, 8BBN, 8BCZ, 8BE1, 8BEV, 8BGG, 8BH5, 8BSE, 8BSF, 8C1V, 8C3V, 8C8P, 8CSA, 8CSJ, 8CWI, 8CWK, 8CWU, 8CWV, 8CXN, 8CXQ, 8CY6, 8CY7, 8CY9, 8CYA, 8CYB, 8CYC, 8CYD, 8CYJ, 8CZI, 8D0Z, 8D36, 8D47, 8D48, 8D6Z, 8D8Q, 8D8R, 8DAD, 8DAO, 8DCC, 8DCE, 8DF5, 8DGU, 8DI5, 8DLI, 8DLJ, 8DLK, 8DLL, 8DLM, 8DLN, 8DLO, 8DLP, 8DLQ, 8DLR, 8DLS, 8DLT, 8DLU, 8DLV, 8DLW, 8DLX, 8DLY, 8DLZ, 8DM0, 8DM1, 8DM2, 8DM3, 8DM4, 8DM5, 8DM6, 8DM7, 8DM8, 8DM9, 8DMA, 8DNN, 8DT3, 8DTR, 8DTT, 8DTX, 8DV1, 8DV2, 8DW2, 8DW3, 8DW9, 8DWA, 8DXS, 8DXT, 8DXU, 8DZH, 8DZI, 8F0G, 8F0H, 8FA1, 8FA2, 8FDW, 8FEZ, 8FU7, 8FU8, 8FU9, 8GB0, 8GB5, 8GB6, 8GB7, 8GB8, 8GJM, 8GJN, 8GOM, 8GON, 8GS6, 8GS9, 8GX9, 8GZ5, 8GZZ, 8H00, 8H01, 8H3D, 8H3E, 8HC4, 8HC5, 8HC8, 8HEB, 8HEC, 8HED, 8HHX, 8HHY, 8HN6, 8HN7, 8I5H, 8I5I, 8IF2, 8IOS, 8IOT, 8IOU, 8IOV, 8ITU</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2184</Target_ID>
<Target_Name>Cathepsin B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P07858</Target_Sequence>
<Synonyms>APP secretase (APPS)
Cathepsin B1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1CSB,1GMY,1HUC,1PBH,2IPP,2PBH,3AI8,3CBJ,3CBK,3K9M,3PBH,5MBL,5MBM,6AY2</Target_Structure>
<Comments>Cathepsin B, a cysteine protease, is considered a potential biomarker for early diagnosis of cancer and inflammatory bowel diseases. Therefore, more feasible and effective diagnostic method may be beneficial for monitoring of cancer or related diseases.</Comments>
</Item><Item><Target_ID> 2185</Target_ID>
<Target_Name>Tyrosine-protein kinase receptor UFO</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P30530</Target_Sequence>
<Synonyms>AXL oncogene</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2C5D,4RA0,5U6B,5VXZ</Target_Structure>
<Comments>AXL is a tyrosine kinase receptor involved in Zika virus entry.</Comments>
</Item><Item><Target_ID> 2186</Target_ID>
<Target_Name>T-cell surface glycoprotein CD3 zeta chain</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P20963</Target_Sequence>
<Synonyms>T-cell receptor T3 zeta chain</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1TCE, 1YGR, 2HAC, 2OQ1, 3IK5, 3IOZ, 4XZ1, 6JXR, 7FJD, 7FJE, 7FJF, 7PHR, 8ES7, 8ES8, 8ES9</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2187</Target_ID>
<Target_Name>Anti-bovine viral diarrhea virus (BVDV) serum</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus(goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Goat anti-BVDV serum produced by immunization of goat with purified BVDV viral particles were ordered from VMDR Inc. (Pullman, WA, USA, cat # PAB-BVD).</Comments>
</Item><Item><Target_ID> 2188</Target_ID>
<Target_Name>Insulinoma cell line MIN6</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2189</Target_ID>
<Target_Name>Recombinant receptor-binding domain (RBD) of glycoprotein protein</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P0DTC2[319-541]</Target_Sequence>
<Synonyms>Alternative names for spike glycoprotein:
S glycoprotein
E2
Peplomer protein</Synonyms>
<Target_Source>Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2):2697049</Target_Source>
<Target_Structure>6LVN, 6LXT, 6LZG, 6M0J, 6M17, 6M1V, 6VSB, 6VW1, 6VXX, 6VYB, 6W41, 6WPS, 6WPT, 6X29, 6X2A, 6X2B, 6X2C, 6X45, 6X6P, 6X79, 6XC2, 6XC3, 6XC4, 6XC7, 6XCM, 6XCN, 6XDG, 6XE1, 6XEY, 6XF5, 6XF6, 6XKL, 6XKP, 6XKQ, 6XLU, 6XM0, 6XM3, 6XM4, 6XM5, 6XR8, 6XRA, 6XS6, 6YLA, 6YM0, 6YOR, 6YZ5, 6YZ7, 6Z2M, 6Z43, 6Z97, 6ZB4, 6ZB5, 6ZBP, 6ZCZ, 6ZDG, 6ZDH, 6ZER, 6ZFO, 6ZGE, 6ZGG, 6ZGI, 6ZH9, 6ZHD, 6ZLR, 6ZOW, 6ZOX, 6ZOY, 6ZOZ, 6ZP0, 6ZP1, 6ZP2, 6ZP5, 6ZP7, 6ZWV, 6ZXN, 7A25, 7A29, 7A4N, 7A5R, 7A5S, 7A91, 7A92, 7A93, 7A94, 7A95, 7A96, 7A97, 7A98, 7AD1, 7AKD, 7B0B, 7B14, 7B17, 7B18, 7B3O, 7B62, 7BEH, 7BEI, 7BEJ, 7BEK, 7BEL, 7BEM, 7BEN, 7BEO, 7BEP, 7BH9, 7BNM, 7BNN, 7BNO, 7BNV, 7BWJ, 7BYR, 7BZ5, 7C01, 7C2L, 7C53, 7C8D, 7C8J, 7C8V, 7C8W, 7CAB, 7CAC, 7CAH, 7CAI, 7CAK, 7CAN, 7CDI, 7CDJ, 7CH4, 7CH5, 7CHB, 7CHC, 7CHE, 7CHF, 7CHH, 7CHO, 7CHP, 7CHS, 7CJF, 7CM4, 7CN4, 7CN9, 7CT5, 7CWL, 7CWM, 7CWN, 7CWO, 7CWS, 7CWT, 7CWU, 7CYH, 7CYP, 7CYV, 7CZP, 7CZQ, 7CZR, 7CZS, 7CZT, 7CZU, 7CZV, 7CZW, 7CZX, 7CZY, 7CZZ, 7D00, 7D03, 7D0B, 7D0C, 7D0D, 7D2Z, 7D30, 7D4G, 7D6I, 7DCC, 7DCX, 7DD2, 7DD8, 7DDD, 7DDN, 7DEO, 7DET, 7DEU, 7DF3, 7DF4, 7DHX, 7DJZ, 7DK0, 7DK2, 7DK3, 7DK4, 7DK5, 7DK6, 7DK7, 7DMU, 7DPM, 7DQA, 7DWX, 7DWY, 7DWZ, 7DX0, 7DX1, 7DX2, 7DX3, 7DX4, 7DX5, 7DX6, 7DX7, 7DX8, 7DX9, 7DZW, 7DZX, 7DZY, 7E23, 7E39, 7E3B, 7E3C, 7E3J, 7E3K, 7E3L, 7E3O, 7E5O, 7E5R, 7E5S, 7E5Y, 7E7B, 7E7D, 7E7X, 7E7Y, 7E86, 7E88, 7E8C, 7E8F, 7E8M, 7E9N, 7E9O, 7E9P, 7E9Q, 7E9T, 7EAM, 7EAN, 7EAZ, 7EB0, 7EB3, 7EB4, 7EB5, 7EDF, 7EDG, 7EDH, 7EDI, 7EDJ, 7EFP, 7EFR, 7EH5, 7EJ4, 7EJ5, 7EJL, 7EJY, 7EJZ, 7EK0, 7EK6, 7EKC, 7EKE, 7EKF, 7EKG, 7EKH, 7ENF, 7ENG, 7EPX, 7EU2, 7EY0, 7EY4, 7EY5, 7EYA, 7EZV, 7F0X, 7F12, 7F15, 7F3Q, 7F46, 7F4W, 7F5G, 7F5H, 7F5R, 7F62, 7F63, 7F6Y, 7F6Z, 7F7E, 7F7H, 7FAE, 7FAF, 7FAT, 7FAU, 7FB0, 7FB1, 7FB3, 7FB4, 7FBJ, 7FBK, 7FC5, 7FCD, 7FCE, 7FCP, 7FCQ, 7FDG, 7FDH, 7FDI, 7FDK, 7FEM, 7FET, 7FG2, 7FG3, 7FG7, 7FH0, 7FJC, 7FJN, 7FJO, 7FJS, 7JJC, 7JJI, 7JJJ, 7JMO, 7JMP, 7JMW, 7JV2, 7JV4, 7JV6, 7JVA, 7JVB, 7JVC, 7JW0, 7JWB, 7JWY, 7JX3, 7JZL, 7JZM, 7JZN, 7JZU, 7K43, 7K45, 7K4N, 7K8M, 7K8S, 7K8T, 7K8U, 7K8V, 7K8W, 7K8X, 7K8Y, 7K8Z, 7K90, 7K9H, 7K9I, 7K9J, 7K9K, 7K9Z, 7KDG, 7KDH, 7KDI, 7KDJ, 7KDK, 7KDL, 7KE4, 7KE6, 7KE7, 7KE8, 7KE9, 7KEA, 7KEB, 7KEC, 7KFV, 7KFW, 7KFX, 7KFY, 7KGJ, 7KGK, 7KJ2, 7KJ3, 7KJ4, 7KJ5, 7KKK, 7KKL, 7KL9, 7KLG, 7KLH, 7KLW, 7KM5, 7KMB, 7KMG, 7KMH, 7KMI, 7KMK, 7KML, 7KMS, 7KMZ, 7KN3, 7KN4, 7KN5, 7KN6, 7KN7, 7KNB, 7KNE, 7KNH, 7KNI, 7KQB, 7KQE, 7KRQ, 7KRR, 7KRS, 7KS9, 7KSG, 7KXJ, 7KXK, 7KZB, 7L02, 7L06, 7L09, 7L0N, 7L2C, 7L2D, 7L2E, 7L2F, 7L3N, 7L4Z, 7L56, 7L57, 7L58, 7L5B, 7L7D, 7L7E, 7L7F, 7L7K, 7LAA, 7LAB, 7LC8, 7LCN, 7LD1, 7LDJ, 7LJR, 7LM8, 7LO4, 7LOP, 7LQ7, 7LQV, 7LQW, 7LRS, 7LRT, 7LS9, 7LSS, 7LWI, 7LWJ, 7LWK, 7LWL, 7LWM, 7LWN, 7LWO, 7LWP, 7LWQ, 7LWS, 7LWT, 7LWU, 7LWV, 7LWW, 7LX5, 7LXW, 7LXX, 7LXY, 7LXZ, 7LY0, 7LY2, 7LY3, 7LYK, 7LYL, 7LYM, 7LYN, 7LYO, 7LYP, 7LYQ, 7M0J, 7M3I, 7M42, 7M53, 7M6D, 7M6E, 7M6F, 7M6G, 7M6H, 7M6I, 7M71, 7M7B, 7M7W, 7M8J, 7M8K, 7M8S, 7M8T, 7M8U, 7MDW, 7ME7, 7MEJ, 7MF1, 7MFU, 7MJG, 7MJH, 7MJI, 7MJJ, 7MJK, 7MJL, 7MJM, 7MJN, 7MKB, 7MKL, 7MKM, 7MLZ, 7MM0, 7MMO, 7MSQ, 7MTC, 7MTD, 7MTE, 7MW2, 7MW3, 7MW4, 7MW5, 7MW6, 7MXP, 7MY2, 7MY3, 7MY8, 7MZF, 7MZG, 7MZH, 7MZI, 7MZJ, 7MZK, 7MZL, 7MZM, 7MZN, 7N0G, 7N0H, 7N1A, 7N1B, 7N1E, 7N1F, 7N1Q, 7N1T, 7N1U, 7N1V, 7N1W, 7N1X, 7N1Y, 7N3I, 7N4I, 7N4J, 7N4L, 7N4M, 7N5H, 7N62, 7N64, 7N6D, 7N6E, 7N8H, 7N8I, 7N9A, 7N9B, 7N9C, 7N9E, 7N9T, 7NAB, 7ND3, 7ND4, 7ND5, 7ND6, 7ND7, 7ND8, 7ND9, 7NDA, 7NDB, 7NDC, 7NDD, 7NEG, 7NEH, 7NKT, 7NLL, 7NP1, 7NS6, 7NT9, 7NTA, 7NTC, 7NX6, 7NX7, 7NX8, 7NX9, 7NXA, 7NXB, 7NXC, 7NY5, 7OAN, 7OAO, 7OAP, 7OAQ, 7OAU, 7OAY, 7OD3, 7ODL, 7OLZ, 7OR9, 7ORA, 7ORB, 7OWX, 7P19, 7P3D, 7P3E, 7P40, 7P5G, 7P5Q, 7P5S, 7P77, 7P78, 7P79, 7P7A, 7P7B, 7PBE, 7PHG, 7PKI, 7PQY, 7PQZ, 7PR0, 7PRY, 7PRZ, 7PS0, 7PS1, 7PS2, 7PS4, 7PS5, 7PS6, 7PS7, 7Q0A, 7Q0G, 7Q0H, 7Q0I, 7Q1Z, 7Q6E, 7Q9F, 7Q9G, 7Q9I, 7Q9J, 7Q9K, 7Q9M, 7Q9P, 7QDG, 7QDH, 7QEZ, 7QF0, 7QF1, 7QNW, 7QNX, 7QNY, 7QO7, 7QO9, 7QTI, 7QUR, 7QUS, 7R0Z, 7R10, 7R11, 7R12, 7R13, 7R14, 7R15, 7R16, 7R17, 7R18, 7R19, 7R1A, 7R1B, 7R40, 7R4I, 7R4Q, 7R4R, 7R6W, 7R6X, 7R7N, 7R8L, 7R8M, 7R8N, 7R8O, 7R95, 7RA8, 7RAL, 7RAQ, 7RBU, 7RBV, 7RBY, 7RKU, 7RKV, 7RNJ, 7RPV, 7RQ6, 7RR0, 7RTD, 7RTR, 7RU1, 7RU2, 7RU3, 7RU4, 7RU5, 7RU8, 7RW2, 7RXD, 7RZQ, 7RZR, 7RZS, 7RZT, 7RZU, 7RZV, 7S0B, 7S0C, 7S0D, 7S0E, 7S3N, 7S4S, 7S5P, 7S5Q, 7S5R, 7S6I, 7S6J, 7S6K, 7S6L, 7S83, 7SA2, 7SBK, 7SBL, 7SBO, 7SBP, 7SBQ, 7SBR, 7SBS, 7SBT, 7SBU, 7SC1, 7SD5, 7SI2, 7SIS, 7SIX, 7SJ0, 7SJS, 7SKZ, 7SL5, 7SN0, 7SN2, 7SN3, 7SO9, 7SOA, 7SOB, 7SOC, 7SOD, 7SOE, 7SOF, 7SPO, 7SPP, 7SWN, 7SWO, 7SWP, 7SWW, 7SWX, 7SXR, 7SXS, 7SXT, 7SXU, 7SXV, 7SXW, 7SXX, 7SXY, 7SXZ, 7SY0, 7SY1, 7SY2, 7SY3, 7SY4, 7SY5, 7SY6, 7SY7, 7SY8, 7T01, 7T3M, 7T67, 7T72, 7T7B, 7T9J, 7T9K, 7T9L, 7TAS, 7TAT, 7TB8, 7TBF, 7TC9, 7TCA, 7TCC, 7TCQ, 7TE1, 7TEW, 7TEX, 7TEY, 7TEZ, 7TF0, 7TF1, 7TF2, 7TF3, 7TF4, 7TF5, 7TGE, 7TGW, 7TGX, 7TGY, 7THE, 7THK, 7THT, 7TIK, 7TLA, 7TLB, 7TLC, 7TLD, 7TLT, 7TN0, 7TOU, 7TOV, 7TOW, 7TOX, 7TOY, 7TOZ, 7TP0, 7TP1, 7TP2, 7TP3, 7TP4, 7TP7, 7TP8, 7TP9, 7TPA, 7TPC, 7TPE, 7TPF, 7TPH, 7TPK, 7TPL, 7TPR, 7TYZ, 7TZ0, 7U0D, 7U0P, 7U0Q, 7U0X, 7U1R, 7U2D, 7U2E, 7U8E, 7U9O, 7U9P, 7UAP, 7UAQ, 7UAR, 7UB0, 7UB5, 7UB6, 7UHB, 7UHC, 7UL0, 7UL1, 7UOW, 7UPW, 7UPX, 7UPY, 7URQ, 7URS, 7UZ4, 7UZ5, 7UZ6, 7UZ7, 7UZ9, 7UZA, 7UZB, 7UZC, 7UZD, 7V20, 7V22, 7V23, 7V24, 7V26, 7V27, 7V2A, 7V76, 7V77, 7V78, 7V79, 7V7A, 7V7D, 7V7E, 7V7F, 7V7G, 7V7H, 7V7I, 7V7J, 7V7N, 7V7O, 7V7P, 7V7Q, 7V7R, 7V7S, 7V7T, 7V7U, 7V7V, 7V7Z, 7V80, 7V81, 7V82, 7V83, 7V84, 7V85, 7V86, 7V87, 7V88, 7V89, 7V8A, 7V8B, 7V8C, 7VHH, 7VHJ, 7VHK, 7VHL, 7VHM, 7VHN, 7VMU, 7VNB, 7VNC, 7VND, 7VNE, 7VOA, 7VQ0, 7VRV, 7VRW, 7VX1, 7VX4, 7VX5, 7VX9, 7VXA, 7VXB, 7VXC, 7VXD, 7VXE, 7VXF, 7VXI, 7VXK, 7VXM, 7VYR, 7W1S, 7W6U, 7W8S, 7W92, 7W94, 7W98, 7W99, 7W9B, 7W9C, 7W9E, 7W9F, 7W9I, 7WA1, 7WBH, 7WBL, 7WBP, 7WBQ, 7WBZ, 7WCD, 7WCR, 7WCZ, 7WD0, 7WD1, 7WD2, 7WD7, 7WD8, 7WD9, 7WDF, 7WED, 7WEF, 7WEV, 7WG7, 7WG8, 7WG9, 7WGB, 7WGC, 7WGV, 7WGX, 7WGY, 7WGZ, 7WH8, 7WHB, 7WHD, 7WHH, 7WHJ, 7WHZ, 7WI0, 7WK0, 7WK2, 7WK3, 7WK8, 7WK9, 7WKA, 7WLC, 7WN2, 7WNB, 7WNM, 7WO4, 7WO5, 7WO7, 7WOA, 7WOB, 7WOC, 7WOG, 7WON, 7WOP, 7WP0, 7WP1, 7WP2, 7WP5, 7WP6, 7WP8, 7WPH, 7WQV, 7WR8, 7WRJ, 7WRL, 7WRO, 7WRY, 7WRZ, 7WS0, 7WS1, 7WS2, 7WS3, 7WS6, 7WS7, 7WSA, 7WSC, 7WSE, 7WSH, 7WSK, 7WTG, 7WTH, 7WTJ, 7WUE, 7WUH, 7WVL, 7WVN, 7WVO, 7WVP, 7WVQ, 7WWK, 7WWL, 7WWM, 7WZ1, 7WZ2, 7X08, 7X1M, 7X2H, 7X2K, 7X2L, 7X2M, 7X63, 7X66, 7X6A, 7X7D, 7X7E, 7X7N, 7X7O, 7X7T, 7X7U, 7X8W, 7X8Y, 7X8Z, 7X90, 7X91, 7X92, 7X93, 7X94, 7X95, 7X96, 7X9E, 7XA7, 7XAZ, 7XB0, 7XB1, 7XBY, 7XCI, 7XCK, 7XCP, 7XCZ, 7XDA, 7XDK, 7XDL, 7XIK, 7XIL, 7XIW, 7XIX, 7XIY, 7XIZ, 7XJ9, 7XMX, 7XMZ, 7XNQ, 7XNR, 7XNS, 7XO7, 7XO8, 7XO9, 7XOA, 7XOB, 7XOC, 7XOD, 7XRP, 7XS8, 7XSA, 7XSB, 7XSC, 7XST, 7XTZ, 7XU0, 7XU1, 7XU2, 7XU3, 7XU4, 7XU5, 7XU6, 7XWA, 7XXL, 7Y0C, 7Y0V, 7Y0W, 7Y42, 7Y75, 7Y76, 7Y7J, 7Y7K, 7YA1, 7YAD, 7YCK, 7YCL, 7YCN, 7YDI, 7YDY, 7YE5, 7YE9, 7YEG, 7YOW, 7YQT, 7YQU, 7YQV, 7YQW, 7YQX, 7YQY, 7YQZ, 7YR0, 7YR1, 7YR2, 7YR3, 7YUE, 7Z0X, 7Z0Y, 7Z1A, 7Z1B, 7Z1C, 7Z1D, 7Z1E, 7Z3Z, 7Z6V, 7Z7X, 7Z85, 7Z86, 7Z9Q, 7Z9R, 7ZBU, 7ZCE, 7ZCF, 7ZDQ, 7ZF3, 7ZF4, 7ZF5, 7ZF7, 7ZF8, 7ZF9, 7ZFA, 7ZFB, 7ZFC, 7ZFD, 7ZFE, 7ZJL, 7ZR2, 7ZR7, 7ZR8, 7ZR9, 7ZRC, 7ZRV, 7ZSD, 7ZSS, 7ZXU, 8A94, 8A96, 8A99, 8AQS, 8AQT, 8AQU, 8AQV, 8AQW, 8ASY, 8BBN, 8BCZ, 8BE1, 8BEV, 8BGG, 8BH5, 8BSE, 8BSF, 8C1V, 8C3V, 8C8P, 8CSA, 8CSJ, 8CWI, 8CWK, 8CWU, 8CWV, 8CXN, 8CXQ, 8CY6, 8CY7, 8CY9, 8CYA, 8CYB, 8CYC, 8CYD, 8CYJ, 8CZI, 8D0Z, 8D36, 8D47, 8D48, 8D6Z, 8D8Q, 8D8R, 8DAD, 8DAO, 8DCC, 8DCE, 8DF5, 8DGU, 8DI5, 8DLI, 8DLJ, 8DLK, 8DLL, 8DLM, 8DLN, 8DLO, 8DLP, 8DLQ, 8DLR, 8DLS, 8DLT, 8DLU, 8DLV, 8DLW, 8DLX, 8DLY, 8DLZ, 8DM0, 8DM1, 8DM2, 8DM3, 8DM4, 8DM5, 8DM6, 8DM7, 8DM8, 8DM9, 8DMA, 8DNN, 8DT3, 8DTR, 8DTT, 8DTX, 8DV1, 8DV2, 8DW2, 8DW3, 8DW9, 8DWA, 8DXS, 8DXT, 8DXU, 8DZH, 8DZI, 8F0G, 8F0H, 8FA1, 8FA2, 8FDW, 8FEZ, 8FU7, 8FU8, 8FU9, 8GB0, 8GB5, 8GB6, 8GB7, 8GB8, 8GJM, 8GJN, 8GOM, 8GON, 8GS6, 8GS9, 8GX9, 8GZ5, 8GZZ, 8H00, 8H01, 8H3D, 8H3E, 8HC4, 8HC5, 8HC8, 8HEB, 8HEC, 8HED, 8HHX, 8HHY, 8HN6, 8HN7, 8I5H, 8I5I, 8IF2, 8IOS, 8IOT, 8IOU, 8IOV, 8ITU</Target_Structure>
<Comments>Recombinant receptor-binding domain (RBD) of spike protein corresponding to aa319-541 of YP_009724390.1, MW 30.7 kDa was a generous gift from Li (Tsinghua University, Beijing, China).</Comments>
</Item><Item><Target_ID> 2190</Target_ID>
<Target_Name>Spike glycoprotein trimer,  S-trimer</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2):2697049</Target_Source>
<Target_Structure>6LVN, 6LXT, 6LZG, 6M0J, 6M17, 6M1V, 6VSB, 6VW1, 6VXX, 6VYB, 6W41, 6WPS, 6WPT, 6X29, 6X2A, 6X2B, 6X2C, 6X45, 6X6P, 6X79, 6XC2, 6XC3, 6XC4, 6XC7, 6XCM, 6XCN, 6XDG, 6XE1, 6XEY, 6XF5, 6XF6, 6XKL, 6XKP, 6XKQ, 6XLU, 6XM0, 6XM3, 6XM4, 6XM5, 6XR8, 6XRA, 6XS6, 6YLA, 6YM0, 6YOR, 6YZ5, 6YZ7, 6Z2M, 6Z43, 6Z97, 6ZB4, 6ZB5, 6ZBP, 6ZCZ, 6ZDG, 6ZDH, 6ZER, 6ZFO, 6ZGE, 6ZGG, 6ZGI, 6ZH9, 6ZHD, 6ZLR, 6ZOW, 6ZOX, 6ZOY, 6ZOZ, 6ZP0, 6ZP1, 6ZP2, 6ZP5, 6ZP7, 6ZWV, 6ZXN, 7A25, 7A29, 7A4N, 7A5R, 7A5S, 7A91, 7A92, 7A93, 7A94, 7A95, 7A96, 7A97, 7A98, 7AD1, 7AKD, 7B0B, 7B14, 7B17, 7B18, 7B3O, 7B62, 7BEH, 7BEI, 7BEJ, 7BEK, 7BEL, 7BEM, 7BEN, 7BEO, 7BEP, 7BH9, 7BNM, 7BNN, 7BNO, 7BNV, 7BWJ, 7BYR, 7BZ5, 7C01, 7C2L, 7C53, 7C8D, 7C8J, 7C8V, 7C8W, 7CAB, 7CAC, 7CAH, 7CAI, 7CAK, 7CAN, 7CDI, 7CDJ, 7CH4, 7CH5, 7CHB, 7CHC, 7CHE, 7CHF, 7CHH, 7CHO, 7CHP, 7CHS, 7CJF, 7CM4, 7CN4, 7CN9, 7CT5, 7CWL, 7CWM, 7CWN, 7CWO, 7CWS, 7CWT, 7CWU, 7CYH, 7CYP, 7CYV, 7CZP, 7CZQ, 7CZR, 7CZS, 7CZT, 7CZU, 7CZV, 7CZW, 7CZX, 7CZY, 7CZZ, 7D00, 7D03, 7D0B, 7D0C, 7D0D, 7D2Z, 7D30, 7D4G, 7D6I, 7DCC, 7DCX, 7DD2, 7DD8, 7DDD, 7DDN, 7DEO, 7DET, 7DEU, 7DF3, 7DF4, 7DHX, 7DJZ, 7DK0, 7DK2, 7DK3, 7DK4, 7DK5, 7DK6, 7DK7, 7DMU, 7DPM, 7DQA, 7DWX, 7DWY, 7DWZ, 7DX0, 7DX1, 7DX2, 7DX3, 7DX4, 7DX5, 7DX6, 7DX7, 7DX8, 7DX9, 7DZW, 7DZX, 7DZY, 7E23, 7E39, 7E3B, 7E3C, 7E3J, 7E3K, 7E3L, 7E3O, 7E5O, 7E5R, 7E5S, 7E5Y, 7E7B, 7E7D, 7E7X, 7E7Y, 7E86, 7E88, 7E8C, 7E8F, 7E8M, 7E9N, 7E9O, 7E9P, 7E9Q, 7E9T, 7EAM, 7EAN, 7EAZ, 7EB0, 7EB3, 7EB4, 7EB5, 7EDF, 7EDG, 7EDH, 7EDI, 7EDJ, 7EFP, 7EFR, 7EH5, 7EJ4, 7EJ5, 7EJL, 7EJY, 7EJZ, 7EK0, 7EK6, 7EKC, 7EKE, 7EKF, 7EKG, 7EKH, 7ENF, 7ENG, 7EPX, 7EU2, 7EY0, 7EY4, 7EY5, 7EYA, 7EZV, 7F0X, 7F12, 7F15, 7F3Q, 7F46, 7F4W, 7F5G, 7F5H, 7F5R, 7F62, 7F63, 7F6Y, 7F6Z, 7F7E, 7F7H, 7FAE, 7FAF, 7FAT, 7FAU, 7FB0, 7FB1, 7FB3, 7FB4, 7FBJ, 7FBK, 7FC5, 7FCD, 7FCE, 7FCP, 7FCQ, 7FDG, 7FDH, 7FDI, 7FDK, 7FEM, 7FET, 7FG2, 7FG3, 7FG7, 7FH0, 7FJC, 7FJN, 7FJO, 7FJS, 7JJC, 7JJI, 7JJJ, 7JMO, 7JMP, 7JMW, 7JV2, 7JV4, 7JV6, 7JVA, 7JVB, 7JVC, 7JW0, 7JWB, 7JWY, 7JX3, 7JZL, 7JZM, 7JZN, 7JZU, 7K43, 7K45, 7K4N, 7K8M, 7K8S, 7K8T, 7K8U, 7K8V, 7K8W, 7K8X, 7K8Y, 7K8Z, 7K90, 7K9H, 7K9I, 7K9J, 7K9K, 7K9Z, 7KDG, 7KDH, 7KDI, 7KDJ, 7KDK, 7KDL, 7KE4, 7KE6, 7KE7, 7KE8, 7KE9, 7KEA, 7KEB, 7KEC, 7KFV, 7KFW, 7KFX, 7KFY, 7KGJ, 7KGK, 7KJ2, 7KJ3, 7KJ4, 7KJ5, 7KKK, 7KKL, 7KL9, 7KLG, 7KLH, 7KLW, 7KM5, 7KMB, 7KMG, 7KMH, 7KMI, 7KMK, 7KML, 7KMS, 7KMZ, 7KN3, 7KN4, 7KN5, 7KN6, 7KN7, 7KNB, 7KNE, 7KNH, 7KNI, 7KQB, 7KQE, 7KRQ, 7KRR, 7KRS, 7KS9, 7KSG, 7KXJ, 7KXK, 7KZB, 7L02, 7L06, 7L09, 7L0N, 7L2C, 7L2D, 7L2E, 7L2F, 7L3N, 7L4Z, 7L56, 7L57, 7L58, 7L5B, 7L7D, 7L7E, 7L7F, 7L7K, 7LAA, 7LAB, 7LC8, 7LCN, 7LD1, 7LDJ, 7LJR, 7LM8, 7LO4, 7LOP, 7LQ7, 7LQV, 7LQW, 7LRS, 7LRT, 7LS9, 7LSS, 7LWI, 7LWJ, 7LWK, 7LWL, 7LWM, 7LWN, 7LWO, 7LWP, 7LWQ, 7LWS, 7LWT, 7LWU, 7LWV, 7LWW, 7LX5, 7LXW, 7LXX, 7LXY, 7LXZ, 7LY0, 7LY2, 7LY3, 7LYK, 7LYL, 7LYM, 7LYN, 7LYO, 7LYP, 7LYQ, 7M0J, 7M3I, 7M42, 7M53, 7M6D, 7M6E, 7M6F, 7M6G, 7M6H, 7M6I, 7M71, 7M7B, 7M7W, 7M8J, 7M8K, 7M8S, 7M8T, 7M8U, 7MDW, 7ME7, 7MEJ, 7MF1, 7MFU, 7MJG, 7MJH, 7MJI, 7MJJ, 7MJK, 7MJL, 7MJM, 7MJN, 7MKB, 7MKL, 7MKM, 7MLZ, 7MM0, 7MMO, 7MSQ, 7MTC, 7MTD, 7MTE, 7MW2, 7MW3, 7MW4, 7MW5, 7MW6, 7MXP, 7MY2, 7MY3, 7MY8, 7MZF, 7MZG, 7MZH, 7MZI, 7MZJ, 7MZK, 7MZL, 7MZM, 7MZN, 7N0G, 7N0H, 7N1A, 7N1B, 7N1E, 7N1F, 7N1Q, 7N1T, 7N1U, 7N1V, 7N1W, 7N1X, 7N1Y, 7N3I, 7N4I, 7N4J, 7N4L, 7N4M, 7N5H, 7N62, 7N64, 7N6D, 7N6E, 7N8H, 7N8I, 7N9A, 7N9B, 7N9C, 7N9E, 7N9T, 7NAB, 7ND3, 7ND4, 7ND5, 7ND6, 7ND7, 7ND8, 7ND9, 7NDA, 7NDB, 7NDC, 7NDD, 7NEG, 7NEH, 7NKT, 7NLL, 7NP1, 7NS6, 7NT9, 7NTA, 7NTC, 7NX6, 7NX7, 7NX8, 7NX9, 7NXA, 7NXB, 7NXC, 7NY5, 7OAN, 7OAO, 7OAP, 7OAQ, 7OAU, 7OAY, 7OD3, 7ODL, 7OLZ, 7OR9, 7ORA, 7ORB, 7OWX, 7P19, 7P3D, 7P3E, 7P40, 7P5G, 7P5Q, 7P5S, 7P77, 7P78, 7P79, 7P7A, 7P7B, 7PBE, 7PHG, 7PKI, 7PQY, 7PQZ, 7PR0, 7PRY, 7PRZ, 7PS0, 7PS1, 7PS2, 7PS4, 7PS5, 7PS6, 7PS7, 7Q0A, 7Q0G, 7Q0H, 7Q0I, 7Q1Z, 7Q6E, 7Q9F, 7Q9G, 7Q9I, 7Q9J, 7Q9K, 7Q9M, 7Q9P, 7QDG, 7QDH, 7QEZ, 7QF0, 7QF1, 7QNW, 7QNX, 7QNY, 7QO7, 7QO9, 7QTI, 7QUR, 7QUS, 7R0Z, 7R10, 7R11, 7R12, 7R13, 7R14, 7R15, 7R16, 7R17, 7R18, 7R19, 7R1A, 7R1B, 7R40, 7R4I, 7R4Q, 7R4R, 7R6W, 7R6X, 7R7N, 7R8L, 7R8M, 7R8N, 7R8O, 7R95, 7RA8, 7RAL, 7RAQ, 7RBU, 7RBV, 7RBY, 7RKU, 7RKV, 7RNJ, 7RPV, 7RQ6, 7RR0, 7RTD, 7RTR, 7RU1, 7RU2, 7RU3, 7RU4, 7RU5, 7RU8, 7RW2, 7RXD, 7RZQ, 7RZR, 7RZS, 7RZT, 7RZU, 7RZV, 7S0B, 7S0C, 7S0D, 7S0E, 7S3N, 7S4S, 7S5P, 7S5Q, 7S5R, 7S6I, 7S6J, 7S6K, 7S6L, 7S83, 7SA2, 7SBK, 7SBL, 7SBO, 7SBP, 7SBQ, 7SBR, 7SBS, 7SBT, 7SBU, 7SC1, 7SD5, 7SI2, 7SIS, 7SIX, 7SJ0, 7SJS, 7SKZ, 7SL5, 7SN0, 7SN2, 7SN3, 7SO9, 7SOA, 7SOB, 7SOC, 7SOD, 7SOE, 7SOF, 7SPO, 7SPP, 7SWN, 7SWO, 7SWP, 7SWW, 7SWX, 7SXR, 7SXS, 7SXT, 7SXU, 7SXV, 7SXW, 7SXX, 7SXY, 7SXZ, 7SY0, 7SY1, 7SY2, 7SY3, 7SY4, 7SY5, 7SY6, 7SY7, 7SY8, 7T01, 7T3M, 7T67, 7T72, 7T7B, 7T9J, 7T9K, 7T9L, 7TAS, 7TAT, 7TB8, 7TBF, 7TC9, 7TCA, 7TCC, 7TCQ, 7TE1, 7TEW, 7TEX, 7TEY, 7TEZ, 7TF0, 7TF1, 7TF2, 7TF3, 7TF4, 7TF5, 7TGE, 7TGW, 7TGX, 7TGY, 7THE, 7THK, 7THT, 7TIK, 7TLA, 7TLB, 7TLC, 7TLD, 7TLT, 7TN0, 7TOU, 7TOV, 7TOW, 7TOX, 7TOY, 7TOZ, 7TP0, 7TP1, 7TP2, 7TP3, 7TP4, 7TP7, 7TP8, 7TP9, 7TPA, 7TPC, 7TPE, 7TPF, 7TPH, 7TPK, 7TPL, 7TPR, 7TYZ, 7TZ0, 7U0D, 7U0P, 7U0Q, 7U0X, 7U1R, 7U2D, 7U2E, 7U8E, 7U9O, 7U9P, 7UAP, 7UAQ, 7UAR, 7UB0, 7UB5, 7UB6, 7UHB, 7UHC, 7UL0, 7UL1, 7UOW, 7UPW, 7UPX, 7UPY, 7URQ, 7URS, 7UZ4, 7UZ5, 7UZ6, 7UZ7, 7UZ9, 7UZA, 7UZB, 7UZC, 7UZD, 7V20, 7V22, 7V23, 7V24, 7V26, 7V27, 7V2A, 7V76, 7V77, 7V78, 7V79, 7V7A, 7V7D, 7V7E, 7V7F, 7V7G, 7V7H, 7V7I, 7V7J, 7V7N, 7V7O, 7V7P, 7V7Q, 7V7R, 7V7S, 7V7T, 7V7U, 7V7V, 7V7Z, 7V80, 7V81, 7V82, 7V83, 7V84, 7V85, 7V86, 7V87, 7V88, 7V89, 7V8A, 7V8B, 7V8C, 7VHH, 7VHJ, 7VHK, 7VHL, 7VHM, 7VHN, 7VMU, 7VNB, 7VNC, 7VND, 7VNE, 7VOA, 7VQ0, 7VRV, 7VRW, 7VX1, 7VX4, 7VX5, 7VX9, 7VXA, 7VXB, 7VXC, 7VXD, 7VXE, 7VXF, 7VXI, 7VXK, 7VXM, 7VYR, 7W1S, 7W6U, 7W8S, 7W92, 7W94, 7W98, 7W99, 7W9B, 7W9C, 7W9E, 7W9F, 7W9I, 7WA1, 7WBH, 7WBL, 7WBP, 7WBQ, 7WBZ, 7WCD, 7WCR, 7WCZ, 7WD0, 7WD1, 7WD2, 7WD7, 7WD8, 7WD9, 7WDF, 7WED, 7WEF, 7WEV, 7WG7, 7WG8, 7WG9, 7WGB, 7WGC, 7WGV, 7WGX, 7WGY, 7WGZ, 7WH8, 7WHB, 7WHD, 7WHH, 7WHJ, 7WHZ, 7WI0, 7WK0, 7WK2, 7WK3, 7WK8, 7WK9, 7WKA, 7WLC, 7WN2, 7WNB, 7WNM, 7WO4, 7WO5, 7WO7, 7WOA, 7WOB, 7WOC, 7WOG, 7WON, 7WOP, 7WP0, 7WP1, 7WP2, 7WP5, 7WP6, 7WP8, 7WPH, 7WQV, 7WR8, 7WRJ, 7WRL, 7WRO, 7WRY, 7WRZ, 7WS0, 7WS1, 7WS2, 7WS3, 7WS6, 7WS7, 7WSA, 7WSC, 7WSE, 7WSH, 7WSK, 7WTG, 7WTH, 7WTJ, 7WUE, 7WUH, 7WVL, 7WVN, 7WVO, 7WVP, 7WVQ, 7WWK, 7WWL, 7WWM, 7WZ1, 7WZ2, 7X08, 7X1M, 7X2H, 7X2K, 7X2L, 7X2M, 7X63, 7X66, 7X6A, 7X7D, 7X7E, 7X7N, 7X7O, 7X7T, 7X7U, 7X8W, 7X8Y, 7X8Z, 7X90, 7X91, 7X92, 7X93, 7X94, 7X95, 7X96, 7X9E, 7XA7, 7XAZ, 7XB0, 7XB1, 7XBY, 7XCI, 7XCK, 7XCP, 7XCZ, 7XDA, 7XDK, 7XDL, 7XIK, 7XIL, 7XIW, 7XIX, 7XIY, 7XIZ, 7XJ9, 7XMX, 7XMZ, 7XNQ, 7XNR, 7XNS, 7XO7, 7XO8, 7XO9, 7XOA, 7XOB, 7XOC, 7XOD, 7XRP, 7XS8, 7XSA, 7XSB, 7XSC, 7XST, 7XTZ, 7XU0, 7XU1, 7XU2, 7XU3, 7XU4, 7XU5, 7XU6, 7XWA, 7XXL, 7Y0C, 7Y0V, 7Y0W, 7Y42, 7Y75, 7Y76, 7Y7J, 7Y7K, 7YA1, 7YAD, 7YCK, 7YCL, 7YCN, 7YDI, 7YDY, 7YE5, 7YE9, 7YEG, 7YOW, 7YQT, 7YQU, 7YQV, 7YQW, 7YQX, 7YQY, 7YQZ, 7YR0, 7YR1, 7YR2, 7YR3, 7YUE, 7Z0X, 7Z0Y, 7Z1A, 7Z1B, 7Z1C, 7Z1D, 7Z1E, 7Z3Z, 7Z6V, 7Z7X, 7Z85, 7Z86, 7Z9Q, 7Z9R, 7ZBU, 7ZCE, 7ZCF, 7ZDQ, 7ZF3, 7ZF4, 7ZF5, 7ZF7, 7ZF8, 7ZF9, 7ZFA, 7ZFB, 7ZFC, 7ZFD, 7ZFE, 7ZJL, 7ZR2, 7ZR7, 7ZR8, 7ZR9, 7ZRC, 7ZRV, 7ZSD, 7ZSS, 7ZXU, 8A94, 8A96, 8A99, 8AQS, 8AQT, 8AQU, 8AQV, 8AQW, 8ASY, 8BBN, 8BCZ, 8BE1, 8BEV, 8BGG, 8BH5, 8BSE, 8BSF, 8C1V, 8C3V, 8C8P, 8CSA, 8CSJ, 8CWI, 8CWK, 8CWU, 8CWV, 8CXN, 8CXQ, 8CY6, 8CY7, 8CY9, 8CYA, 8CYB, 8CYC, 8CYD, 8CYJ, 8CZI, 8D0Z, 8D36, 8D47, 8D48, 8D6Z, 8D8Q, 8D8R, 8DAD, 8DAO, 8DCC, 8DCE, 8DF5, 8DGU, 8DI5, 8DLI, 8DLJ, 8DLK, 8DLL, 8DLM, 8DLN, 8DLO, 8DLP, 8DLQ, 8DLR, 8DLS, 8DLT, 8DLU, 8DLV, 8DLW, 8DLX, 8DLY, 8DLZ, 8DM0, 8DM1, 8DM2, 8DM3, 8DM4, 8DM5, 8DM6, 8DM7, 8DM8, 8DM9, 8DMA, 8DNN, 8DT3, 8DTR, 8DTT, 8DTX, 8DV1, 8DV2, 8DW2, 8DW3, 8DW9, 8DWA, 8DXS, 8DXT, 8DXU, 8DZH, 8DZI, 8F0G, 8F0H, 8FA1, 8FA2, 8FDW, 8FEZ, 8FU7, 8FU8, 8FU9, 8GB0, 8GB5, 8GB6, 8GB7, 8GB8, 8GJM, 8GJN, 8GOM, 8GON, 8GS6, 8GS9, 8GX9, 8GZ5, 8GZZ, 8H00, 8H01, 8H3D, 8H3E, 8HC4, 8HC5, 8HC8, 8HEB, 8HEC, 8HED, 8HHX, 8HHY, 8HN6, 8HN7, 8I5H, 8I5I, 8IF2, 8IOS, 8IOT, 8IOU, 8IOV, 8ITU</Target_Structure>
<Comments>Recombinant SARS-CoV-2 S-trimer proteins were from the commercial resource (Cat# DRA49, MW 136.6 kDa; Novoprotein Company, Suzhou, China).</Comments>
</Item><Item><Target_ID> 2191</Target_ID>
<Target_Name>Synthetic standard tyrosine-nitrated peptide (sTNP, sequence: H2N-GGGGY*GGG-COOH)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2192</Target_ID>
<Target_Name>Mycolic acid</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mycobacterium tuberculosis (strain M4537)</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2193</Target_ID>
<Target_Name>Hyaluronan-binding protein 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Q14520</Target_Sequence>
<Synonyms>Factor VII-activating protease
Factor seven-activating protease (FSAP)
Hepatocyte growth factor activator-like protein
Plasma hyaluronan-binding protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2194</Target_ID>
<Target_Name>Anti-hemagglutinin (HA) monoclonal antibody PR8-23</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2195</Target_ID>
<Target_Name>CD44 variant 6 (CD44v6) overexpressing HEK 293 cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CD44v6, a splice variant of the cell surface glycoprotein CD44, acts as a co-receptor for c-Met and is upregulated in tumors with high metastatic potential.</Comments>
</Item><Item><Target_ID> 2196</Target_ID>
<Target_Name>Chemically synthesized crotamine, SCRO</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Crotamine, a myotoxin from rattlesnake (Crotalus durissus terrificus) venom, causes short-term muscle paralysis through a mechanism that remains debated, as well as long-term myotoxicity due to tissue necrosis. SCRO (chemically synthesized crotamine) has properties similar to NCRO (natural
crotamine), including cell penetration, subcellular localization in myofibers, and effects on muscle contraction.</Comments>
</Item><Item><Target_ID> 2197</Target_ID>
<Target_Name>Extracellular domain of epidermal growth factor tyrosine kinase receptor mutation variant III (EGFRvIII)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>One of the few known cancer-specific cell surface markers, is the epidermal growth factor (EGF) tyrosine kinase receptor mutation variant III (EGFRvIII). The hEGFRvIII proteins used in this study were purchased from Sino Biological (#29662-H08B). A DNA sequence encoding the human EGFRvIII (NP_001333870.1) (Met1-Lys375) was expressed with a polyhistidine tag at the C-terminus.</Comments>
</Item><Item><Target_ID> 2198</Target_ID>
<Target_Name>Integrin alpha-3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q62470</Target_Sequence>
<Synonyms>CD49 antigen-like family member C
Galactoprotein B3 (GAPB3)
VLA-3 subunit alpha</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2199</Target_ID>
<Target_Name>Anti-interferon gamma (IFN-gamma) monoclonal antibody B27</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2200</Target_ID>
<Target_Name>9-fluorenylmethoxycarbonyl-phenylalanine-tyrosinephosphate (Fmoc-Fργ
) micellar aggregates</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2201</Target_ID>
<Target_Name>Anti-CPA monoclonal antibody MAB-1418</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-cyclopiazonic acid (CPA) monoclonal antibody (mAb-1418) was provided by C. M. Maragos (Department of Agriculture, Peoria, IL, USA).</Comments>
</Item><Item><Target_ID> 2202</Target_ID>
<Target_Name>Zc RNase P ribozyme (RPR)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2203</Target_ID>
<Target_Name>Rat heart microvascular endothelial cell, RHMVEC</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Cultured rat heart microvascular EC (RHMVEC) were bought from VEC Technologies.</Comments>
</Item><Item><Target_ID> 2204</Target_ID>
<Target_Name>Membranes of HEK293 cells expressing protease-activated receptor 4 (PAR4), HEK293-PAR4</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2205</Target_ID>
<Target_Name>IgG Fc region </Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2206</Target_ID>
<Target_Name>Maltose-binding protein (MBP) (MBP-VHH2,4-D)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Plasmid pMAL-p5X</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The expression plasmid for MBP-VHH(2,4-D) was pMAL-p5X that already carries the gene of MBP, and the gene of VHH(2,4-D) was inserted between the cloning sites of Not I and EcoR I.</Comments>
</Item><Item><Target_ID> 2207</Target_ID>
<Target_Name>Anti-canine adenovirus 2 (CAdV-2) monoclonal antibody 2C1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The CAdV-2 strain used in this study was stored at the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences. CAdV-2 immunization experiments were conducted on 6-week-old BALB/c mice within the animal biosafety level 2 facilities of the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (approval number SY-2016-MI-013).</Comments>
</Item><Item><Target_ID> 2208</Target_ID>
<Target_Name>Escherichia coli MSI001</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2209</Target_ID>
<Target_Name>Kidney injury molecule 1, KIM-1</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2210</Target_ID>
<Target_Name>GTTYGVCSK-biotin and Domain III of the envelope (E) glycoprotein (DIII)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>West Nile virus (WNV)</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Domain III (DIII) of the envelope (E) glycoprotein is a key receptor-binding domain and an attractive target for antiflavivirus strategies. GTTYGVCSK-biotin is the receptor-binding site (RBS) present on the DIII.</Comments>
</Item><Item><Target_ID> 2211</Target_ID>
<Target_Name>Mouse mammary EF43.fgf4 cell</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2212</Target_ID>
<Target_Name>Ice</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2213</Target_ID>
<Target_Name>Mucin-5B, MUC5B</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9HC84</Target_Sequence>
<Synonyms>Cervical mucin
High molecular weight salivary mucin MG1
Mucin-5 subtype B, tracheobronchial
Sublingual gland mucin</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The salivary glycoprotein MUC5B is expressed by the mucous acini of the (sero)mucous salivary glands including the submandibular (SM), sublingual (SL), palatal and labial glands.</Comments>
</Item><Item><Target_ID> 2214</Target_ID>
<Target_Name>Cathepsin G-like</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The chicken cathepsin G-like sequence was extracted from the NCBI database (Accession number XP_423728).</Comments>
</Item><Item><Target_ID> 2215</Target_ID>
<Target_Name>Good Vibes phage, GV</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Pseudomonas aeruginosa:287</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2216</Target_ID>
<Target_Name>Cytotoxic T-lymphocyte protein 4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P16410 </Target_Sequence>
<Synonyms>Cytotoxic T-lymphocyte-associated antigen 4, CTLA-4
CD_antigen=CD152</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1AH1, 1H6E, 1I85, 1I8L, 2X44, 3BX7, 3OSK, 5GGV, 5TRU, 5XJ3, 6RP8, 6RPJ, 6RQM, 6XY2, 7CIO, 7DV4, 7ELX, 7SU0, 7SU1, 8HIT</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2217</Target_ID>
<Target_Name>APTYSW peptide</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Epitope III</Synonyms>
<Target_Source>Hepatitis C virus </Target_Source>
<Target_Structure></Target_Structure>
<Comments>Epitope III, a highly conserved amino acid motif of 524-APTYSW-529 on the hepatitis C virus (HCV) E2 glycoprotein, resides in the critical loop that binds to the host receptor CD81, thus making it one of the most important antibody targets for blocking HCV infections.</Comments>
</Item><Item><Target_ID> 2218</Target_ID>
<Target_Name>Fe3O4</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2219</Target_ID>
<Target_Name>WD repeat-containing protein 5</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P61964</Target_Sequence>
<Synonyms>BMP2-induced 3-kb gene protein</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2CNX, 2CO0, 2G99, 2G9A, 2GNQ, 2H13, 2H14, 2H68, 2H6K, 2H6N, 2H6Q, 2H9L, 2H9M, 2H9N, 2H9P, 2O9K, 3EG6, 3EMH, 3MXX, 3N0D, 3N0E, 3P4F, 3PSL, 3SMR, 3UR4, 3UVK, 3UVL, 3UVM, 3UVN, 3UVO, 4A7J, 4CY1, 4CY2, 4ERQ, 4ERY, 4ERZ, 4ES0, 4ESG, 4EWR, 4GM3, 4GM8, 4GM9, 4GMB, 4IA9, 4O45, 4QL1, 4Y7R, 5EAL, 5EAM, 5EAP, 5EAR, 5M23, 5M25, 5SXM, 5VFC, 6BYN, 6D9X, 6DAI, 6DAK, 6DAR, 6DAS, 6DY7, 6DYA, 6E1Y, 6E1Z, 6E22, 6E23, 6IAM, 6KIU, 6KIV, 6KIW, 6KIX, 6KIZ, 6OFZ, 6OI0, 6OI1, 6OI2, 6OI3, 6PG3, 6PG4, 6PG5, 6PG6, 6PG7, 6PG8, 6PG9, 6PGA, 6PGB, 6PGC, 6PGD, 6PGE, 6PGF, 6PWV, 6PWW, 6U5M, 6U5Y, 6U6W, 6U80, 6U8B, 6U8L, 6U8O, 6UCS, 6UFX, 6UHY, 6UHZ, 6UIF, 6UIK, 6UJ4, 6UJH, 6UJJ, 6UJL, 6UOZ, 6W5I, 6W5M, 6W5N, 6WJQ, 7AXP, 7AXQ, 7AXS, 7AXU, 7AXX, 7BCY, 7BED, 7CFP, 7CFQ, 7DNO, 7JTO, 7JTP, 7MBM, 7MBN, 7Q2J, 7U9Y, 7UAS, 7UD5, 7WVK, 8BB2, 8BB3, 8BB4, 8BB5, 8DU4, 8E9F, 8F1G</Target_Structure>
<Comments>WDR5 is short for WD repeat-containing protein 5.</Comments>
</Item><Item><Target_ID> 2220</Target_ID>
<Target_Name>T-cell surface glycoprotein CD4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P06332</Target_Sequence>
<Synonyms>T-cell differentiation antigen L3T4
T-cell surface antigen T4/Leu-3</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2221</Target_ID>
<Target_Name>Envelope protein 2, E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Chikungunya virus (CHIKV IND-06-GUJ strain)</Target_Source>
<Target_Structure></Target_Structure>
<Comments>DNA encoding the selected region of CHIKV-E2 protein (57-324 aa), retrieved from CHIKV IND-06-GUJ strain, was cloned in pET SUMO vector (Invitrogen) using the TA cloning strategy.</Comments>
</Item><Item><Target_ID> 2222</Target_ID>
<Target_Name>Anti-Zearalenone (ZEN) monoclonal antibody 4D7</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2223</Target_ID>
<Target_Name>Coagulation Factor XIa (FXIa) </Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2224</Target_ID>
<Target_Name>CD44/FC chimera</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>CD44 is a transmembrane glycoprotein related to cell adhesion, migration and signaling, and exists in normal adult and fetal tissues.</Comments>
</Item><Item><Target_ID> 2225</Target_ID>
<Target_Name>Anti-amyloid protein monoclonal antibody 4G8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-amyloid monoclonal antibody 4G8 was obtained from Life Technologies, Carlsbad, CA, USA.</Comments>
</Item><Item><Target_ID> 2226</Target_ID>
<Target_Name>Anti-Amb a 1 IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Anti-Amb a 1 IgG were affinity-purified from rabbit antiserum (Indoor Biotechnologies, Cat# PA-AM1, RRID:AB_2728628) using natural allergen Amb a 1 (INDOOR Biotechnologies) immobilized on Dynabeads M-280 Tosylactivated (Thermo Fisher Scientific, Waltham, Massachusetts, USA) following the manufacturer’s instructions.</Comments>
</Item><Item><Target_ID> 2227</Target_ID>
<Target_Name>Anti-Api m 1 IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Affinity-purified rabbit anti–Api m 1 IgG (MyBioSource, San Diego, Calif, Cat# MBS573431, RRID: AB_2716318) were used as target.</Comments>
</Item><Item><Target_ID> 2228</Target_ID>
<Target_Name>Anti-Fel d 1 IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2229</Target_ID>
<Target_Name>Anti-Ara h 2 IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti-Ara h 2 antibodies were affinity-purified from rabbit antiserum (INDOOR Biotechnologies, Charlottesville, Virginia, USA) using native Ara h 2 allergens (INDOOR Biotechnologies) immobilized to Dynabeads M-280 Tosylactivated (Thermo Fisher Scientific, Waltham, Massachusetts, USA).</Comments>
</Item><Item><Target_ID> 2230</Target_ID>
<Target_Name>Vitamin D binding protein (VDBP) complex, VDBP-Complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The vitamin D binding protein complex (VDBP-Complex) was provided by Chungbuk National University (Korea).</Comments>
</Item><Item><Target_ID> 2231</Target_ID>
<Target_Name>Vitamin D binding protein, VDBP</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The vitamin D binding protein (VDBP) was provided by MyBioSource (Cat#MBS568853, USA).</Comments>
</Item></Target></result>